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Abstract
Chronic physical illnesses, such as rheumatoid arthritis (RA), that are painful and disabling not only
impact on a person’s ability to complete normal daily activities (e.g. dressing, bathing, walking etc.)
but may also have a negative impact on psychological well-being. Although a large number of prospec-
tive observational studies have examined psychological well-being in RA, none has used appropriate
statistical techniques to examine variability in change over time at the individual level.
The overarching aim of this dissertation is to use advanced quantitative methods to examine how
psychological well-being in RA changes over the course of the disease; and to identify demographic,
clinical and psychosocial factors that influence how the disease affects psychological well-being. This
aim is addressed via a programme of research with three objectives: (i) to describe patterns of change
in psychological well-being during the RA disease course; (ii) to quantify the association between psy-
chological well-being and somatic symptoms; and (iii) to investigate the impact of illness cognitions and
coping on psychological well-being. The programme of research consists mainly of analysis of a subsam-
ple of data collected as part of the Early RA Study (ERAS, N = 784), an ongoing observational study of
RA patients followed prospectively from first presentation to a rheumatologist.
A major problem relating to the assessment of psychological distress in individuals with chronic phys-
ical illness is the overlapping symptomatology with depression. An examination of the factorial validity
of the Hospital Anxiety and Depression Scale (HADS), in the ERAS cohort, indicated the presence of a
bifactor structure. Specifically, a general distress factor along with orthogonal (autonomic) anxiety and
(anhedonic) depression factors was found to provide the optimal empirical explanation of the covariance
in item responses. Further analysis, revealed that responses to one of the depression items were biased
by disease severity. However, the magnitude of this bias was negligible, confirming the suitability of this
tool in RA populations.
For the ERAS cohort, general psychological distress was observed to reduce rapidly early in the
course of the disease, stabilising after around two to three-years. However, further analysis suggested
that subgroups with distinct longitudinal patterns of distress were present within the sample. Confirm-
iii
ing observations in other disease groups, four distinct longitudinal patterns of distress were identified:
resilient, chronic distress, delayed distress and recovered. Interestingly, changes in distress were related
to self-reported somatic symptoms but not serological markers of disease activity. Building on these
findings, analyses that jointly modelled changes in psychological distress with changes in the common
somatic symptoms of pain and functional limitation revealed strong cross-sectional and longitudinal as-
sociations. This extends the findings of previous research by showing the importance of considering the
impact of the disease course on the underlying trajectory of distress.
Due to the lack of psychosocial data available in the ERAS cohort a further prospective study, in-
volving 230 RA patients, was conducted to examine the influence of illness cognitions and coping on
the affect of the disease on psychological well-being over a period of 6-months. Coping was not found
to be related to changes in psychological well-being. Analysis revealed two groupings of patients with
similar patterns of illness cognitions that were labelled adapters and non-adapters. Furthermore, cogni-
tions concerning the attribution of symptoms to RA and the perceived personal consequences of their
condition were related to changes in psychological distress, even after controlling for demographic and
clinical characteristics; and there was some indication that a higher reported level of understanding of
their condition was related to increased future positive outlook.
In conclusion, the findings of this programme of research highlight the need for the early identifica-
tion and treatment of RA, not only to slow the progression of the disease but also to maintain or improve
psychological well-being. Early treatment is currently focused on pharmaceutical interventions. A tai-
lored psychosomatic approach to treatment involving the skills of a wide range of health professionals,
such as nurses, physiotherapists, occupational therapists and psychologists is likely to improve outcomes
in RA.
iv
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Chapter 1
Introduction to the dissertation
1.1 Background
My interest in psychological well-being in chronic physical illness began when I worked in the Rheuma-
tology department at St Albans City Hospital. I was fascinated and inspired by the resilience of some of
the patients that Adam Young saw in his clinic to the adversity posed by the physical consequences of
their condition. At the same time I recognised that others experienced far greater distress and reported
far worse impact on their daily lives despite suffering milder disease.
The position involved working on a large multi-centre prospective observational study of patients
with early rheumatoid arthritis (ERAS). Although a large number of manuscripts utilising this cohort
had been published describing the natural (but treated) course of this condition, no one had made
any serious attempt at analysing the psychological well-being data collected by a number of centres.
Furthermore, it became clear that the large volume of data collected over a number of years posed a
serious analytic problem. The analytic skills I had developed during my first degree in psychology were
not adequate for studying real-life longitudinal data. Furthermore, it was apparent from my reading of
the scientific literature that few others possessed these skills either.
Examining the psychological well-being data collected in the ERAS cohort seemed like an excellent
opportunity to gain greater insight into the factors impacting on psychological well-being in individuals
with rheumatoid arthritis and at the same time develop my skills in longitudinal data analysis. Thank-
fully others felt the same, and with the support of my supervisors I was lucky enough to be awarded
an ESRC-MRC interdisciplinary studentship to undertake an extended period of study to examine these
issues.
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1.2 Aims of the dissertation
The aims of the current dissertation are twofold. The first is to examine changes in psychological well-
being in rheumatoid arthritis over an extended period of time. More specifically, changes from the
early stages of the disease and their relation to the course of the disease as well as to demographic and
psychological factors. In the early stages of the disease, prior to the use of disease modifying treatments,
the individual is presented with a major life event: the onset of a chronic physical condition that at that
time causes them considerable pain and functional limitation, potentially posing a serious threat to their
future health and well-being. Little is known about changes in psychological well-being early in the
course of the disease, or how changes at that time relate to psychological well-being several years later.
The second aim is to examine how latent variable modelling techniques can be applied to provide a
more detailed examination of changes in psychological well-being than currently reported in the liter-
ature, making efficient use of the wealth of data available in the ERAS cohort. Few studies with large
sample sizes have examined psychological well-being in rheumatoid arthritis over an extended period. It
is the combination of these two aims in the programme of research that is presented in this dissertation
that provides the opportunity to drive scientific understanding in this area forward.
1.3 Structure of this dissertation
The first three chapters of this dissertation provide an introduction to the topic and methods used in
the empirical chapters. Chapter 2 provides an introduction to rheumatoid arthritis and the topic of
psychological well-being in chronic physical illnesses in general. Chapter 3 systematically reviews the
existing evidence base considering changes in psychological well-being in rheumatoid arthritis over the
course of the disease and the association between demographic, clinical and psychosocial factors with
changes in psychological well-being. At the end of the chapter the specific objectives of the dissertation
are outlined. Chapter 4 introduces the topic of latent variable modelling with particular emphasis on the
application of latent variable modelling techniques to longitudinal data, and an overview of a common
problem in longitudinal studies, the presence of missing data.
The following four chapters present the main empirical work undertaken during the doctoral studies.
Chapter 5 provides a detailed analysis of the psychometric properties of the measure of psychological
well-being used in the ERAS cohort, the Hospital Anxiety and Depression Scale. The dimensionality
of the measure is assessed and issues concerning possible item bias, for example due to the somatic
symptoms of the condition, are addressed. Chapter 6 examines longitudinal changes in psychological
2
Chapter 1. Introduction to the dissertation
well-being in the ERAS cohort and explores the possibility of multiple groups of patients with distinct
patterns of change in distress over time. Chapter 7 extends these findings to consider the association of
changes in psychological well-being to changes in the somatic symptoms of RA. Chapter 8 examines how
illness cognitions, specifically individuals beliefs about their condition, impact on changes in well-being
using data from a separate prospective study of rheumatoid arthritis patients.
The final chapter, Chapter 9, provides a general discussion of the findings of the empirical chapters
in the context of the objectives outlined in Chapter 3. In addition, a discussion of the utility of latent
variable modelling and observational studies in general is presented, as well as recommendations for fu-
ture research. It is also important to note that Appendix A provides details of the manuscripts published,
or currently under review, in peer review journals that are directly or indirectly related to the research
presented in this dissertation.
3
Chapter 2
General introduction
2.1 Rheumatoid arthritis
2.1.1 Background
RA is a chronic systemic autoimmune disease with a flaring-remitting pattern primarily affecting the
joints. It is the most common form of inflammatory arthritis worldwide (Majithia & Geraci, 2007).
Inflammation of the synovial membrane that lines the joints and tendon sheaths causes the joints to
become swollen and painful and stiffness limits their movement (Figure 2.1). The joints most commonly
involved are the small joints of the hands, feet and cervical spine, however larger joints, such as the
shoulder or knee, may also be affected. Over time, erosions and destruction of the joint surface can
lead to deformity and restrict the range of movement, impacting on the individuals ability to complete
normal daily activities, such as dressing, bathing and walking.
Although RA primarily affects the joints, unlike osteoarthritis, extra-articular manifestations are
common affecting around 15–20% of individuals with RA (Young & Koduri, 2007). The most com-
mon extra-articular manifestation is the rheumatoid nodule, probably the most characteristic feature of
the disease. As well as the skin, extra-articular features may affect organs such as the glands (e.g. Sjo-
grens syndrome), blood vessels (e.g. vasculitis and Raynaud’s disease) and lungs (e.g. pulmonary lesions
and interstitial lung disease). Furthermore, several complications of the disease are common, such as
anaemia, ischemic heart disease and osteoporosis.
RA has a wide clinical spectrum ranging from mild joint symptoms to severe inflammation and joint
damage. The disease burden of RA is considerable. One third of people with the disease will have
stopped working within two years of disease onset (Young et al., 2002). Psychological problems are
common and impact on the relationship between disease variables and outcome (Dickens, McGowan,
4
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Figure 2.1: Rheumatoid arthritis joint
Table 2.1: American College of Rheumatology classification criteria for rheumatoid arthritis
Patients must have four of the following seven criteria:
• Morning stiffness lasting at least 1 hour*
• Arthritis (swelling) in three or more joints*
• Arthritis in hand joints*
• Symmetrical jont inflammation*
• Rheumatoid nodules
• Abnormal serum rheumatoid factor
• Radiographic changes (erosions or decalcification) of hand
* Present for at least six-weeks
Clark-Carter, & Creed, 2002).
Diagnosis of RA is made on clinical, serological and radiological grounds—typically using the Amer-
ican College of Rheumatology classification criteria (Arnett et al., 1988). The criteria are listed in Table
2.1. A Rheumatologist will make a diagnosis of RA if an individual fulfills four of the seven criteria for a
period of at least six weeks. It is now recognised that these criteria do not accurately identify individuals
with recent-onset RA (Harrison, Symmons, Barrett, & Silman, 1998). Resultantly there has been a drive
to treat inflammatory arthritis, which may progress towards RA, with appropriate disease-modifying
treatment as soon as possible after symptom onset (NICE, 2009b)
2.1.2 Epidemiology
RA is the most common type of inflammatory arthritis. Although RA can occur at any age, its incidence
increases with age with a peak age of onset around 50 years. Furthermore, the overall occurrence of RA
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is 2 to 4 times greater in women than men. A 2002 Norfolk based population study estimated the yearly
incidence in the UK to be 1.5 males per 10,000 and 3.6 females per 10,000 (Symmons et al., 2002). This
equates to approximately 12,000 new cases per year in the UK. A more recent estimate using 10 years
of data from the General Practice Research Database (GPRD)—a database of medical records from over
600 UK primary care practices—suggests the figure is substantially higher at 26,000 new case per year
(National Audit Office, 2009). Both estimates indicate that, due to the cumulative number of patients’
surviving into old age, the prevalence of RA in the UK is not insignificant. It is estimated to be around
0.8% to 1% of the adult population, equating to in the region of 400,000 to 580,000 people with the
condition (Symmons, Barrett, Bankhead, Scott, & Silman, 1994; National Audit Office, 2009).
A systemic review of the global incidence and prevalence of RA revealed some variation across coun-
tries (Alamanos, Voulgari, & Drosos, 2006). The review identified 28 studies reporting either prevalence
or incidence figures for adults using the 1987 ACR diagnostic criteria. Southern European studies had a
lower incidence (1.7 per 10,000) than northern European studies (2.9 per 10,000) and north American
studies (3.8 per 10,000). A similar pattern was observed with regard to prevalence studies. Despite
these variations, the prevalence rate is stable across countries, at approximately 0.5–1%. However,
there are populations where particularly high or low prevalence has been observed, indicative of a ge-
netic effect. For example, Native American Indians have the highest reported occurrence of RA (5.3%,
Del Puente, Knowler, Pettitt, & Bennett, 1989; and 6.8%, Harvey, Lotze, Stevens, Lambert, & Jacobson,
1981). Whereas studies of rural African populations have failed to find a single case (Brighton, Harpe,
Staden, Badenhorst, & Myers, 1988; Silman et al., 1993). Furthermore, migrant studies have shown
that individuals of African (MacGregor, Riste, Hazes, & Silman, 1994) and Pakistani (Hameed & Gibson,
1997) origin living in the UK having lower prevalence rates, suggesting possible genetic protection.
2.1.3 Aetiology
RA is a form of autoimmunity, the failure of an organism to recognise its own constituent parts, which
results in an immune response against its own cells or tissue. The causes of this autoimmunity remain
unknown, but it seems that the interaction between genetic and environmental factors play an important
role in the development of disease in susceptible individuals.
2.1.3.1 Genetic factors
Family and twin studies have shown an increased risk of the development of RA if a close relative has
the disease. For example, MacGregor et al. (2000) in a study of UK and Finnish twins found a increased
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concordance in monozygotic compared to dizygotic twins, with 50–60% of the occurrence explained by
shared genetic effects.
Attempts to identify the genes involved in the predisposition to RA have indicated the major histo-
compatibility complex (MHC) a large genetic region on the short arm of chromosome 6. A large part of
the MHC comprises human leukocyte antigen (HLA) genes. HLA class II genes, in particular HLA-DR4
and HLA-DRβ1, have been strongly linked to RA (Silman & Pearson, 2002). The encoded proteins re-
lated to these genes are crucial in determining the individual’s immune response to antigenic stimuli.
Studies have found that susceptibility to RA is associated with several different HLA DRβ1 alleles, with
individuals with the so-called ‘compound heterozygote’ genotype carrying a substantially greater risk
than individuals with a single allele (Thomson et al., 1999). However, there is some indication that the
relationship between HLA and RA may be more related to disease severity, than to the development of
RA (Meyer et al., 1999).
While HLA clearly plays an important role in the predisposition to RA only 50% of the genetic
contribution to RA is thought to be associated with HLA (MacGregor et al., 2000). Other non-MHC genes
must therefore also be involved. Genes encoding cytokines such as tumour necrosis factor α (TNFα) and
several interleukins (ILs) have also been implicated in the aetiology of RA, although attempts to replicate
these findings are often negative (Silman & Pearson, 2002).
It is not entirely surprising that research investigating genetic factors predisposing individuals to the
development of RA is largely inconclusive. RA is a heterogeneous disease, it is likely to be polygenic
and the causative role of different genes may vary between individuals, with different combinations of
polymorphisms in a selection of different genes (the genotype) may predispose different clinical manifes-
tations of the disorder (the phenotype) (Barton & Worthington, 2009; Klareskog, Padyukov, Rönnelid,
& Alfredsson, 2006). In addition, non-inherited environmental factors are also likely to be of great
importance.
2.1.3.2 Environmental factors
Population studies have shown that environmental factors play a major role in the aetiology of RA (Isaacs
& Moreland, 2002). Environmental factors are considered as triggers rather than as being directly
involved in the disease process. A complex interplay between genetic and environmental factors are
probably important for the initiation of the disease process in susceptible individuals.
Certain viruses and bacterial agents contain identical peptide sequences to autoantigen, and infec-
tion with these microbial agents can induce an immune response that cross-reacts with the auto antigen,
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termed ’antigen mimicry’. Epstein-Barr virus (EBV), Parvovirus B19, Mycobacterium Tuberculosis, Es-
cherichia Coli and Proteus Mirabilis have all been implicated, although results are inconsistent (Silman
& Hochberg, 2001).
Hormonal factors may also play a possible role in the aetiology of the disease, as suggested by the
increased prevalence of RA in females (Silman & Hochberg, 2001). RA incidence has been observed
to be higher in women with sub-fertility, and also during the pre-menopausal or post-partum period.
Also use of the oral contraceptive pill has been found to be related to a reduced risk of developing RA
and male sex hormones levels, including testosterone, have been observed to be lower in men with RA
compared to controls.
There have been a number of studies investigating the role of other comorbidities, particularly other
automimmune diseases, as risk factors for RA. Type 1 or insulin dependent diabetes and autoimmune
thyroid disease have been found to be increased frequency in individuals’ with RA and their families
(Silman, Ollier, & Bubel, 1989). Furthermore, diet and stress have also been considered to play a
possible role in the disease expression (Pattison, Harrison, & Symmons, 2004; Pattison, Symmons, &
Young, 2004).
2.1.3.3 Other factors
Research investigating the causal perceptions of individuals’ with RA has revealed various lay theories
regarding the aetiology of the disease. Williams (1986) conducted in depth interviews with a small
number of people diagnosed with RA for at least 5-years. The most frequently mentioned causal factors
were stress and heredity. However, the study revealed a number of misconceptions regarding causal
factors, such as old-age, ’wear-and-tear’ damage to the joints, and the weather. These observations were
confirmed by later quantitative research (Moss-Morris et al., 2002).
Old age is not a cause of RA. This belief is likely to have arisen from the cumulative increase in
individuals’ suffering with the condition with age, but as has already been noted RA can affect individuals
of any age. This perception is likely to be linked to the belief that RA is a result of ‘wear-and-tear’
damage to the joints. Although this is true of osteoarthritis, and may exacerbate the symptoms of RA,
‘wear-and-tear’ damage has not been found to be associated with the development of RA (Hill, Bird,
Hopkins, Lawton, & Wright, 1991). Finally, although cold and damp weather is often reported as being
associated with symptom exacerbation, and the increased incidence of RA in northern compared to
southern European countries, there is little evidence to suggest that weather is a causal factor in the
development of RA (Gorin et al., 1999).
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2.1.4 Physiology
RA is one of a number of autoimmune rheumatic diseases, which also includes systemic lupus ery-
thomatosus, anti-phospholipid syndrome, polymyalgia rheumatica, and Sjögrens syndrome. Although
the autoimmunity in RA involves both the innate and the adaptive arm of the immune system, its clinical
features are directly related to dysregulation of the immune system whereby it attacks the joints causing
inflammation and damage.
2.1.4.1 Autoimmunity
The immune system includes two types of white blood cell—B cells and T cells. B cells are involved in
the humoral response and are an essential component of the adaptive arm of the immune system. Their
principal function is to make antibodies (immunoglobulins; IgA, IgD, IgE, IgG and IgM) against foreign
antigen (e.g. viruses and bacteria). B cells have unique receptors that will bind only to one particular
antigen, which are produced randomly during their development in the thymus. Once a B cell encounters
its associated antigen it will develop into either a plasma B cells or memory B cells. Plasma B cells
secrete large amounts of antibodies that assist with the destruction of the antigen. They are short-lived.
Apoptosis (self-destruction) is induced when the antigen that induced the immune response is removed.
Memory B cells on the other hand live for a long time. They are specific to the antigen encountered
during the primary immune response enabling a quick response following subsequent exposure to the
same antigen.
T cells form part of the innate arm of the immune system and are involved in cell-mediated im-
munity. This involves the removal of virus-infected cells, as well as protecting against fungi, cancers
and intracellular bacteria. This does not directly involve antibodies but instead involves the activation
of macrophages, natural killer cells, cytotoxic T-lymphocytes (induce apoptosis) and various cytokines
(influence function of other cells) in response to an antigen. Although T cells do not produce antibodies
they are seen as directing antibody production.
Once an antigen is ingested by a B cell the pathogens proteins are digested to peptides and attached
to class II MHC proteins that are unique to the type of B cell. This complex triggers the production of T
helper cells (i.e. CD4+ T cells) which activate specific B cell. The T cell secretes cytokines that activate
the B cell causing it to develop into a plasma B cell. In addition, further cytokines released induce the
production of more T cells (Feldmann & Maini, 2008).
Since antibodies are produced randomly antibodies for ’self’ molecules are commonly produced—
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these are known as autoantibodies. Usually, useful antibodies to foreign antigen are positively selected
whereas autoantibodies are negatively selected and therefore do not persist. However, in RA autoanti-
bodies to immunoglobulin-G (IgG), known as rheumatoid factor (RF), are present (Isaacs & Moreland,
2002). Initially the RF antibodies are typically IgM antibodies to IgG (IgM-anti-IgG). IgM-RF forms large
immune complexes with IgG that are rapidly cleared from circulation and are commonly found at low
levels in normal individuals. More dangerous IgG-anti-IgG occur by chance genetic mutation (Isaacs &
Moreland, 2002). These autoantibodies are antibodies against them self—resulting in a vicious cycle.
The immune complexes formed by IgG-RF with IgG are small and not easily cleared from circulation.
They can also cross the endothelium leaving the blood vessels. Once in the tissues they bind with FcRIIIa
receptors on the surface of macropaghes present in only a few specific places including in the synovium,
lung, serosa, bone marrow. Thus triggering the production of interleukins, such as as IL-6, TNF-α and
IL-1β , resulting in the same inflammation as would occur from a real infection (Feldmann & Maini,
2008). The inflammation of the synovium (synovitis) is the dominant feature in RA. The situation is
made worse in the joints since as a result of the inflammation anti-IgG antibodies enter the synovium
and make autoantibodies inside the joint. Synovitis leads to replacement of cartilage by a layer of vas-
cular soft tissue (pannus) and similar erosion of the bone by vascular tissue at the articular margin. It is
this damage that leads to deformity and restricts the range of movement of the joint (Feldmann & Maini,
2008).
2.1.4.2 Inflammation & disease activity
Many serological markers of disease activity and severity have been identified. Disease activity in RA
is routinely assessed by standard biological measures. Erythrocyte sedimentation rate (ESR) relates
to the distance blood cells fall in one hour, which is an indirect measure of the proteins such as C-
reactive protein (CRP), that are released during inflammation (Wolfe, 1997). CRP is a more specific,
although still relatively general, measure of inflammatory activity. Normal levels are considered to
be <10mm/per hour for ESR and <8mg/l for CRP, however it is important to remember that since
both are measures of non-specific inflammatory activity they may be raised, for example, as a result of
infectious illness. Despite this they still provide important markers of inflammation in RA. Both have
been found to be related to mortality in the general population (Strandberg & Tilvis, 2000; Kaptoge et
al., 2010), as well as in the RA population (Young et al., 2007; Wolfe, Michaud, Gefeller, & Choi, 2003;
Wållberg-Jonsson, Johansson, Ohman, & Rantapaa-Dahlqvist, 1999). ESR and CRP are commonly used
in composite measures of disease activity, such as the Disease Activity Score (Prevoo et al., 1995).
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A variety of pro-inflammatory cytokines including IL-6, TNF-α, IL-1, and IL-8—responsible for the
initiation of the acute phase response—are also frequently elevated and fluctuate with disease activity
(McInnes & Schett, 2007). However these cytokines are expensive to measure in routine clinical practice
and the prognostic value of some of these cytokines is still not clear.
Rheumatoid factor, IgM-RF rather than IgG-RF, are commonly measured, indeed abnormal levels
form one of the seven ACR diagnostic criteria listed in Table 2.1. Recently however the importance of
circulating anti-cyclic citrullinated peptide antibodies (anti-CCP) has been discovered. Although these
antibodies are not expressed in the affected tissue, and therefore unlikely to be directly involved in
the pathogenesis of RA, the presence of anti-CCP antibodies provides a useful diagnostic test for RA.
Nishimura et al. (2007) found that sensitivity was only 65%—similar to that of rheumatoid factor—
specificity was high at 95%. This indicates that when anti-CCP antibodies are not observed RA is un-
likely, although presence did not necessarily mean that the individual had RA. Screening for anit-CCP is
increasingly common in clinical practice using widely available assays.
2.1.5 Treatment
There are two specific aims of the drug management in RA. Symptom relief, in particular pain relief,
is the first and usually the main priority for patients. Secondly, modification of the disease process
to slow, or even stop, radiological progression, which is closely associated with progressive functional
impairment. Ultimately the aim of drug management is to achieve disease remission through disease
modification. Remission has been defined in a number of different ways, but is generally taken to mean
scores below a certain threshold on a disease activity index (e.g. the EULAR criteria are DAS <2.6;
Fransen, Creemers, & Van Riel, 2004). Until recently there was a tendency for rheumatologists to treat
patients conservatively, generally due to the worry of adverse side effects of the drugs (Schoels et al.,
2010). However, there is increasing understanding that management during the early stages of the
disease (i.e. the first 2 years) are the most important for long-term outcome (Kiely et al., 2009; Smolen
et al., 2010). As a result treatment is now far more aggressive, in the form of earlier use of disease
modifying drugs and greater use of therapies in combination. Indeed this is reflected in the treatment
guidelines developed by NICE (NICE, 2009b).
2.1.5.1 Symptom relief
Non-steroidal anti-inflammatory drugs (NSAIDs) are the traditional first-line treatment for RA, and
arthritides in general, as they directly reduce joint swelling and thus pain. NSAIDS, including ibupro-
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fen, diclofenac and selective COX-II inhibitors such as celecoxib. Their mode of action is to inhibit the
enzyme cyclooxygenase, which catalyzes prostaglandins that act as messenger molecules in the process
of inflammation (Young, 2008). The main problem with NSAIDs is that adverse reactions are common,
including gastrointestinal and renal effects (Young, 2008). While newer selective COX-II inhibitors were
hoped to reduce gastrointestinal adverse reactions they have been shown to increase the risk of car-
diovascular disease, and in several recent cases have been withdrawn from the market (e.g. rofecoxib,
brand name Vioxx; Couzin, 2004). Despite the risk of adverse reactions most people with RA will take
NSAIDs for a significant amount of time (NICE, 2009b).
Pain is the principle sign of inflammation, although adequate disease control with NSAIDs or disease
modifying drugs will often result in satisfactory pain relief for many people there will be times when
further relief is needed, for example during disease flare. In such circumstances analgesics such as
paracetamol and opiods (e.g. codeine and morphine) are often used to relieve pain (NICE, 2009b).
Glucocorticoids (steriods; e.g. prednisolone) are also used to reduce inflammation via the control of
certain hormones, such as cortisone (Young, 2008). They may be given to reduce systemic inflamma-
tion via oral, intra-muscular, or intra-venously administration, or alternatively localised as intra-articular
injections. However long-term use results in severe side effects, including hypertension, diabetes, osteo-
porosis and weight gain (Donihi, Raval, Saul, Korytkowski, & DeVita, 2006; Verhoeven & Boers, 1997;
Nikiphorou & Young, 2010). The NICE guidelines recommend the use of steroids to alleviate symp-
toms in recent-onset RA whilst waiting for slow-acting disease modifying drugs to take effect and in
established RA for the management of disease flares (NICE, 2009b).
Anti-depressants are also used for people with RA. Apart from the obvious benefit of anti-depressants
when a person with RA is suffering from major depression low-doses of tricyclics such as amitriptyline
have been shown to relieve articular pain and tenderness in patients with RA (Grace, Bellamy, Kassam,
& Watson Buchanan, 1985; Frank et al., 1988) and help with muscle relaxation, especially if they have
disrupted sleep (Moldofsky, 2001). However, the recent NICE guidance on RA found that evidence from
randomized-controlled trials only supported the effectiveness in reducing joint swelling, and helping to
lift a low mood and chronic fatigue at quite high doses, typically used to treat major depressive disorder
(NICE, 2009b).
2.1.5.2 Disease modification
Disease modifying anti-rheumitic drugs (DMARDs) are used to slow down the damaging component
of the disease process (Young, 2008). These include methotrexate, sulphasalazine, hyrdoxchloroquine,
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leflunomide and gold injections. Traditionally, DMARDs were only prescribed after the diagnosis of RA
was made, or when radiological progression was observed, however there is now evidence that there
is a ’window of opportunity’ and the sooner DMARDs are prescribed the better the response and long-
term outcomes are improved. Resultantly, DMARDs are often prescribed for any persistent inflammatory
arthritis, which may later develop into RA (NICE, 2009b). Furthermore, due to the improved benefit
of early introduction there is a tendency to use stronger DMARDS, such as methotrexate that also have
higher risks of more severe side effects, or using two or more DMARDs in combination (NICE, 2009b).
In the last ten years a major improvement has been seen with the development of agents designed
specifically to block key protein messenger molecules, such as TNFα (etanercept) or IL-1 (anakinra),
or cells, such as B-lymphocytes (rituximab), that play an important role in the disease process. This
group of drugs are generally referred to as ‘biologics’. Biologic therapies have been shown to have
dramatic effects with clinical trials showing improvements in symptoms and measures of both function
and radiological damage sustained over several years (Y. F. Chen et al., 2006). However, due to their
cost, around £10,000 per year compared to £300 per year for DMARDs (National Audit Office, 2009),
biologic therapies are only used for individuals with established active disease that have failed to respond
adequately to conventional disease modifying drugs. Owing to their high cost several biologic therapies,
such as abatacept (NICE, 2009b), fall outside the cost-effectiveness cut-off prescribed by NICE and hence
are not available under the NHS.
2.1.5.3 Other treatment
As well as the various classes of drugs used to manage RA other treatments are widely used. Physical
treatment, in the form of physiotherapy and occupational therapy is commonly offered (NICE, 2009b).
Physiotherapy and occupational therapy, particularly aerobic exercise, have been shown to be particu-
larly useful for people with RA without increased ‘wear-and-tear’ related joint degeneration (de Jong
et al., 2004; Hammond, Young, & Kidao, 2004; Neuberger et al., 2007). Exercise is useful because it
builds muscle strength to support the joints. Furthermore, assistive devices, such as tap turners and wrist
splints have also been shown to be useful (Hammond, 2004).
There is some evidence to show that diet is important. Clinical trials have found evidence for symp-
tom improvement associated with vegan gluten-free (Hafström et al., 2001), vegetarian (Müller, Wil-
helmi de Toledo, & Resch, 2001) and the so-called Mediterranean diet (Sköldstam, Hagfors, & Johans-
son, 2003). Furthermore, diets high in omega-3 have also found support for individuals with inflamma-
tory joint pain (Goldberg & Katz, 2007).
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Some people also require professional psychological intervention. Pain management programmes
involving cognitive behavioural therapy have been shown to be effective in the short- (Dixon, Keefe,
Scipio, Perri, & Abernethy, 2007; Sharpe, Sensky, Timberlake, Ryan, & Allard, 2003; Knittle, Maes,
& Gucht, 2010; Pradhan et al., 2007; Zautra et al., 2007) and long-term (Sharpe, Allard, & Sensky,
2008). Although psychological intervention is deemed important by many rheumatologists (e.g. Sheehy,
Murphy, & Barry, 2006), access to psychological services is often absent for many individuals. The
National Audit Office report found that access to psychological services was not available to RA patients
in more than half of acute NHS Trusts in the UK (National Audit Office, 2009). However, the Department
of Health initiative Improving Access to Psychological Therapy will widen the availability of psychological
services to individuals with chronic illnesses including RA.
A substantial number of individuals with RA try complimentary or alternative therapies, including
acupuncture, copper bracelets, aromatherapy, massage, reflexology and homeopathy. Despite their wide
use, evidence for the effectiveness of complimentary or alternative therapies in RA is limited and prob-
ably no more than a placebo effect (Macfarlane et al., 2011; NICE, 2009b). Although, there is limited
evidence that acupuncture may be effective in other rheumatological conditions (Ernst & Lee, 2010).
There is increasing recognition of the importance of education in the management of RA, and in
particular structured education programmes (Hammond, 2004). Furthermore, there has been a drive
for individuals with RA to take a more active role in the management and monitoring of their RA in the
form of ’expert patients’ (Chilton & Collett, 2008; Hewlett et al., 2005; Department of Health, 2001). A
Cochrane meta-analytic review found evidence for short term beifit of patient education programmes,
however no long-term benefit was observed (Riemsma, Kirwan, Taal, & Rasker, 2003). Nevertheless,
education is likely to be an important component in achieving appropriate self management allowing
individuals to make the cognitive, behavioral and emotional responses necessary (Barlow, 2001).
2.1.6 Disease course & prognosis
2.1.6.1 Early RA
At the initial onset of the disease, when antigens are presented to susceptible individuals, the disease
is asymptomatic. Usually the onset of symptoms is gradual and insidious, however, for some symptom
onset may be quite rapid, developing over the course of a few weeks (Young, 2005). Initially, pain
swelling and stiffness are likely to affect the hands and wrists, but individuals may feel fatigue and
general malaise (Carr et al., 2003). These early symptoms are not the result of RA but of inflammatory
14
Chapter 2. General introduction
polyarthritis a more generalised disorder that in some individuals will go on to develop into RA, in others
symptoms may resolve or lead to the development of another form of chronic arthritis (e.g. seronegative
spondarthritis).
There is no clear clinical distinction between inflammatory polyarthritis and RA. The ACR criteria do
not provide help as many of the criteria may be only present in individuals with established disease that
has been present for a number of years (e.g. erosions & nodules; Harrison et al., 1998).
The long-term course of RA is highly varied. Scott and Huskisson (1992) distinguish three different
trajectories. The most common, observed in around two-thirds of individuals, is a progressive disease
with periodic flares and remissions. Around a quarter experience a more intermittent disease course with
longer periods of intermission and possibly remission. A third group consisting of around 5% experience
an extremely severe form, where joint damage and destruction occurs quickly.
Several inception cohorts have provided information about the natural (treated) history of RA (e.g.
Early RA Study, Early RA Network, Norfolk Arthritis Register, Yorkshire Early Arthritis Register; for de-
tails see: Young, 2005, 2004). These inception cohorts typically have a baseline visit when the individual
is first seen by the specialist, typically prior to the initiation of disease-modifying treatment. Accumu-
lated evidence from these studies suggests that the course of RA is established early, and that the most
important phase for therapy is the first 1 to 2-years. (Smolen et al., 2010; Young, 2004).
For a number of individuals remission is achieved. A review indicated that for individuals with
generalised inflammatory arthritis remission was common, achieved by 30% to 40%, but was lower for
individuals whom had been diagnosed with RA at around 10-30% (Katchamart et al., 2010). A recent
study using the ERAS cohort has indicated that the sustained clinical remission over a period of 5-years
was acheived by 11% (Jayakumar et al., 2011, see Appendix A).
Early treatment Early treatment is imperative in RA with several studies showing that earlier treat-
ment has a greatly improved benefit to the patient over the short-and longer term (NICE, 2009b). How-
ever the time between symptom onset and treatment initiation is typically quite long. The recent NAO
report investigated just this (National Audit Office, 2009). The report identified five stages in the typical
diagnosis and treatment pathway: (i) symptom onset; (ii) presentation to G.P.; (iii) referral to specialist;
(iv) treatment (disease-modifying) initiation; and (v) ongoing care.
Optimal timing between symptom onset and initiation of disease-modifying has been suggested to
be less than three months (NICE, 2009b). However the NAO report found that typically the time taken
between the initial onset of symptoms and presentation to the GP was more than 3-months for over
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half of individuals, and was over 1-year of around one-fifth of individuals. The reason for the delay in
presenting to a G.P. were likely to be a lack of awareness of RA meaning that people do not distinguish it
from osteoarthritis, or assuming that the G.P. can do nothing to help them. After visiting a G.P. the time
to treatment initiation is usually fairly rapid (National Audit Office, 2009).
Time taken between stages 3 and 4 is typically fairly short. In 2005, the NHS implemented a target
of a maximum of 18-weeks between referral and treatment initiation. The NAO report found that this
target increased from 46% to 97% in the two years of their investigation (National Audit Office, 2009).
2.1.6.2 Prognosis in patients with persistent disease
Not only is the long-term course of RA varied but so, unsurprisingly, are the long-term outcomes. Overall,
observational studies have revealed pattern of increasing functional disability (Young et al., 2000; Wolfe,
2000; Scott et al., 2000). Generally a ‘j-shaped’ curve is observed, with an initial improvement following
initiation of disease-modifying treatment, followed by a gradual and insidious decline in function after
around two years (Sokka, Kautiainen, Hannonen, & Pincus, 2006; Kobelt, Jönsson, Lindgren, Young, &
Eberhardt, 2002).
Functional disability can fluctuate considerably over time, and when related to disease activity is
amenable to drug therapies. Early in the course of the disease function is mainly impacted by pain and
stiffness. However, over time joint damage makes an increasing contribution, it is this factor that drives
the progressive decline in function (Scott et al., 2000).
The cumulative degree of joint damage in RA is typically assessed using x-rays of the hands, wrists
and feet. Radiological damage is one of the diagnostic criteria for RA and is present at diagnosis in a
considerable number of individuals (Dixey, Solymossy, & Young, 2004). The classic features observed
are erosions and joint space narrowing, but in individuals who have had the disease for many years more
serious features may be observed, including subluxation, misalignment and ankylosis.
This increasing functional limitation can have negative consequences for peoples lives. For example,
one third of people with the disease will have stopped working within two years of onset and around
half will be unable to work through disability within ten years (De Croon et al., 2004; Young, Norton,
& Koduri, 2009, see Appendix A). Furthermore, in patients who do not respond to treatment, surgery
may be required to relieve pain and improve joint function where the joint has been severely deformed.
James et al. (2004) found that within 5-years 11% of individuals not taking biologic therapy had under-
gone orthopaedic surgery to a large or small joint. Furthermore, around 15% of people also required
appliances or aids such as home alterations, splints and wheelchairs.
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2.1.6.3 Morbidity & mortality
An increased risk of mortality has been observed in RA. Several studies have demonstrated an increased
mortality risk, particularly with respect to cardiovascular disease, interstitial lung disease and lymphoma
(e.g. Young et al., 2007, see Appendix A, Koduri et al., 2010, see Appendix A, Sokka, Abelson, & Pincus,
2008). The causes of these are only beginning to be understood. It is true that the risk is at least
partially associated with drug toxicity. As has already been noted the drugs used to manage RA are
related to increased risk of gastrointestinal complications, renal damage and heart disease. However, RA
is known to be a systemic disease with the inflammatory processes also having extra-articular effects,
including impacting on the lungs and vascular system (Young & Koduri, 2007). In particular, the link
with cardiovascular disease has received a great deal of interest over the last decade (Gabriel, 2008).
2.1.6.4 Economic impact
RA can, and often does, result in a wide range of complications for the individual. Not only does RA
have a personal impact to the individual and their family, but also there is a significant economic cost
resulting from the direct cost to the NHS and associated health care support services, but also indirectly
to the economy through lost productivity. The National Audit Office report highlights the importance of
early referral to the economy. It was estimated that increasing the number of individuals treated within
3-months from the current level of 40% to 80% would cost £3.6m but would save around £5m through
reduced G.P. visits and unecesary diagnostic tests (National Audit Office, 2009).
2.1.7 Summary
Clearly, RA represents a huge cost to the UK economy as well as the individual patient. It is a chronic
inflammatory disease of unknown cause, for which there is currently no cure. Resultantly, the aim
of drug management is to reduce symptoms and modify the disease process its impact on individuals
varies, as does its course over time. Greater understanding of the psychosocial factors associated with
RA are important, since they may act as moderators and mediators in the pathway between disease
and psychological and physical well-being in RA. Furthermore, they may ultimately impact on health
outcomes such as the need for orthopaedic surgery, work disability and mortality.
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2.2 Well-being in RA
It is evident from the sections concerning disease progression and outcomes in RA that there are a variety
of ways in which the condition impacts on the well-being of the individual. Most obviously, the pain,
stiffness and joint damage associated with the condition limit functional ability, which gradually and
insidiously increases over the course of the disease (Young et al., 2000). This impacts on individuals
abilities to complete normal daily activities, including dressing, bathing, walking and eating, and may
interfere with psychological well-being and the ability of the individual to complete their social roles
(Kosinski et al., 2002). It is useful to consider the topic of well-being in RA within the broad concept of
health related quality of life.
Health related quality of life is an amorphous concept, largely based on a multi-dimensional per-
spective of health as physical, psychological and social functioning. Health has been traditionally de-
fined as ‘complete physical, mental and social well-being and not merely the absence of disease or
infirmity’ (World Health Organisation, 1946) and assessed by indices that focus on disease and illness,
including mortality, health service use, subjective indicators of morbidity, disability and health behaviour
(e.g. smoking, alcohol use etc.). However, since the 1960’s there has been an increasing interest con-
cerning quality of life (Bowling, 1997). This research has focused on defining what exactly quality of
life is. Drawing from the philosophical literature concerning happiness (eudaimonia) there has been an
increased focus of attention away from negative aspects of health and well-being to positive ones such
as life satisfaction (Seligman & Csikszentmihalyi, 2000).
Quality of life is an extremely broad term that encompasses all aspects of an individual’s circum-
stances, including housing, work, environment, leisure activities, social network, social support. Health
related quality of life however is more narrowly focused and concern aspects of physical and psycho-
logical well-being, such as functional ability, bodily pain, psychological distress, life-satisfaction, vitality
and social role functioning. Contemporary measures of health related quality of life focus on summing
across these domains (e.g. SF36, Euroqol).
It is important to bear in mind that physical and psychological well-being fall under the umbrella of
quality of life, however, in practice it is often more meaningful to consider these domains separately. The
following sections provide an overview of physical and psychological well-being in the wider context of
chronic physical illness as well as more specifically concerning RA.
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2.2.1 Physical well-being
The pain and damage caused to the joints by the inflammation associated with RA and the resultant loss
of function clearly impact on physical well-being and can lead to physical disability. The mechanisms can
be considered within the conceptual framework proposed by Verbrugge and Jette (1994) and adapted
to RA by Escalante and del Rincon (2002). This models posits that the main disease–disability pathway
is a causal chain. This causal chain reflects the natural series of events that occur as consequences of RA
that may ultimately lead to disability.
Commonly referred to as the disablement process, the pathway from disease to disability is described
as being characterised by four distinct stages (Verbrugge & Jette, 1994). The first of which, pathology,
relates to the diagnosed disease (i.e. RA) and the pathophysiological mechanisms by which the dis-
ease manifests itself as physical symptoms (e.g. inflammation and joint damage). The second stage,
impairment, reflects the deranged physiology at the level of the organ or the organ system (e.g. pain,
swelling, stiffness). The third stage is functional limitation, the lack of ability to perform basic normal
daily activities as a direct consequence of the impairment (body level). The fourth and final stage is
physical disability, which reflects the individuals difficulty, limitation, or inability to perform activities of
the person within a social or physical environment (societal level).1
Escalante and del Rincon (2002) expand this model in order to describe the disablement process
in RA. They consider a dual processes model, with separate pathways for pain and joint damage. That
is, inflammation causes joint pain and swelling which leads to limitation in terms of mobility, strength
and dexterity. Whereas, joint damage causes deformity also leading to limited mobility, strength and
dexterity. Outside of the main disease–disability pathway they consider the impact of demographic and
psychosocial factors on each of the four stages, as well as the impact of comorbid physical conditions on
disability.
2.2.2 Psychological well-being
2.2.2.1 Definition
As with the study of quality of life there has been an increase in the focus of positive aspects of psy-
chological well-being (Seligman & Csikszentmihalyi, 2000). Despite this increased interest in positive
1The WHO International Classification of Impairments, Disabilities and Handicaps (ICIDH; World Health Organisation,
1980) further differentiates the disability category into activity restriction, a restriction in the ability to perform instrumental
activities as a result of the functional limitation, and handicap, the inability to complete their normal social role. Due to
confusion surrounding the conceptual framework of the ICIDH (Barbotte, Guillemin, & Chau, 2001), the differentiation of
disability into these categories is not considered further.
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Figure 2.2: The disablement process (source: Escalante & del Rincon, 2002)
well-being, since the implications of RA have negative impacts on physical well-being, research has gen-
erally focused on negative aspects of psychological well-being. This is also generally true of research in
other chronic physical conditions—although there are exceptions (e.g. Strand et al., 2006; Danoff-Burg
& Revenson, 2005).
Negative aspects of psychological well-being, henceforth referred to as psychological distress, are
typically assessed in terms of symptoms of anxiety and depression. Depression refers to a wide range of
conditions characterised by persistently low mood (low negative affect) and a loss of interest or pleasure
(low positive affect). Symptoms of depression typically include feeling sad, empty or tearful, having
diminished interest or pleasure in life, weight loss or gain, sleep disturbance, feelings of restlessness or
being slowed down, fatigue or loss of energy, feelings of worthlessness or guilt, diminished ability to
think or concentrate, and recurrent thoughts of death (American Psychiatric Association, 2000).
While anxiety disorder is also associated with low mood it is not particularly related to positive
affect. There is a large overlap with symptoms of depression—including low mood, restlessness, fatigue
and sleep disturbance—however, anxiety disorder is characterised by excessive anxiety or worry that the
person finds difficult to control (American Psychiatric Association, 2000).
Two broadly similar diagnostic systems are used to diagnose depressive and anxiety disorders. The
ICD-10 Classification of Mental and Behavioural Disorders (World Health Organization, 1992), com-
monly used in the UK, and the Diagnostic and Statistical Manual of Mental Disorders of the American
Psychiatric Association (DSM-IV; American Psychiatric Association, 2000). Both systems recognise that
depression and anxiety differ in severity across individuals, however they assume that depressive and
anxiety disorders exist as real phenomena, and that therefore it is possible to objectively misdiagnose
people as either depressed or non-depressed, and anxious or non-anxious. Borsboom (2008) points out
20
Chapter 2. General introduction
that the presence or absence of symptoms of anxiety or depression relate to the probability of member-
ship of latent classes of individuals (i.e. groups that are unobserved) with depressive or anxiety disorder.
He refers to this as the diagnostic perspective. Although these latent classes are not directly observable,
they are nevertheless assumed real phenomena.
An alternative view is that depression and anxiety are dimensional, that is individuals fall somewhere
along some latent continuum, relating to severity. From a psychometric perspective, these continua are
real but the points along the continua used as diagnostic criteria that define disorders are arbitrary
(Borsboom, 2008). Expanding on this position, researchers have proposed a multi-dimensional view of
psychological distress, whereby anxiety and depressive disorders are lower-order factors in a hierarchical
model with negative affect as the higher-order factor (Clark & Watson, 1991).2 This ‘tripartite’ model
was later extended to include positive affect and anxious arousal as further higher-order factors onto
which depression and anxiety load, respectively (T. A. Brown, Chorpita, & Barlow, 1998; Krueger &
Finger, 2001)
Krueger, Watson, and Barlow (2005), Watson (2005) and several years earlier Mineka, Watson,
and Clark (1998) go further to suggest that all mood and anxiety disorders fall within a complex hi-
erarchical model. Along with psychological distress, two other higher order factors relating to bipolar
disorders and fear disorders (e.g. panic disorders, social phobia) are themselves subsumed within a fur-
ther higher-order emotional disorders factor. It is this dimensional perspective of psychological distress
that is applied in this dissertation. However, the majority of previous research has used the diagnostic
perspective. It is this research that is reviewed now.
2.2.2.2 Psychological well-being in chronic physical illness
The prevalence and incidence of psychiatric disorder, and in particular depression, in RA and other
chronic physical illnesses has received considerable attention. Population studies have revealed an in-
creased prevalence of depression in individuals with a chronic physical illness (e.g. Egede, 2007; Kessler
et al., 2003; Wilhelm, Mitchell, Slade, Brownhill, & Andrews, 2003; Fiest, Currie, Williams, & Wang,
2011; Moussavi et al., 2007). For example, Fiest et al. (2011) examined the prevalence of major de-
pressive episodes, diagnosed using the World Mental Health-Composite Diagnostic Interview based on
DSM-IV criteria, in a sample of 36,894 from the Canadian Community Health Survey. They found that,
in those aged over 50-years, the prevalence of depression was 3.7% in those with at least one chronic
physical illness, compared with 1.0% for those with no chronic physical illness. Other studies have also
2Hierarchical factor models are discussed further in Chapter 5.
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reported marked differences in the rates of depressive disorder (Egede, 2007; Moussavi et al., 2007),
presumably due to differences in methods of classifiying participants as depressed, as well as cultural and
socio-economic differences betweeen the populations under study. Nevertheless, the pattern of findings
is the same, rates of depressive disorder tend to be in the order of two to four times higher in individuals
with chronic physical illness.
Rates of depression appear to increase with the seriousness of the consequences of the chronic phys-
ical condition. Population studies find that arthritis or rheumatism is associated with increased levels
of depressive disorder that is similar to conditions such as diabetes, cardiovascular disease and multiple
sclerosis (Kessler et al., 2003; Wilhelm et al., 2003; Fiest et al., 2011). A review of studies specifi-
cally concerning RA estimated the prevalence of psychological disorder in RA to be between 13 and
20% (Dickens & Creed, 2001). A later report by the same research team systematically reviewed 12
case-control studies comparing RA samples with healthy populations (Dickens et al., 2002). The study
found a moderate increase in symptoms of depression, rather than diagnostic rates, in RA samples
(r = .21, p < .001).
There is one major issue with regard to the diagnosis of depressive and anxiety disorder in chronic
physical illness: there is considerable overlap in the symptomatology of most chronic physical illnesses
with the somatic symptoms of depression and anxiety, including fatigue and sleep disturbance. Since it
may be unclear whether these symptoms can be attributed to mood disorder or are actually sequelae of
the physical illness. Indeed a recent meta-analysis of diagnostic studies indicated that commonly used
tools to assess severity of symptoms of depression or more generally psychological distress3 revealed that
when applied to chronic physical illness populations suffered from reduced diagnostic accuracy (reduced
sensitivity, specificity or both depending on the instrument; NICE, 2009a).
This suggests that at least some of the increased prevalence of depression in chronic physical illnesses
is due to misdiagnosis as a result of individuals mis-attribution of symptoms of the physical condition. To
counter this issue, a diagnostic interview method using only non-somatic criteria has been developed but
is not widely used in research (Zimmerman, Chelminski, McGlinchey, & Young, 2006). Furthermore, the
American Heart Association has recently released guidelines for depression screening in CHD patients
(Lichtman et al., 2008)—though these guidelines have attracted criticism due to the apparent lack of
research on which they are based (Holmes, 2011). Clearly caution needs to be taken when assessing
levels of psychological distress in RA since levels may be artificially inflated as a function of disease
3Beck Depression Inventory, Patient Health Questionnaire (9 and 2-item versions), General Health Questionnaire, Cen-
tre of Epidemiology Studies-Depression, Geriatric Depression Scale, Hospital Anxiety and Depression Scale, Zung Self Rated
Depression Scale
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Figure 2.3: Conceptual model of the relationship between psychological distress and physical
illness (source: Katon, 2003, p.218)
severity. Nevertheless, it is extremely unlikely that this issue accounts for the magnitude of the increased
prevalence observed. The reasons for this increased prevalence are discussed in the following section.
2.2.2.3 The relationship between disease and psychological well-being
The relationship between chronic physical illness and distress is almost certainly reciprocal. That is, not
only can the chronic physical illness increase levels of distress and cause the onset of, for example, a
depressive episode but the reverse is also true. Higher levels of psychological distress and a history of
depressive disorder may precede the onset of the physical condition. Katon (2003) presents a model that
describes the ways in which distress and physical illness are related (Figure 2.3). This model suggests
three main factors of genetic vulnerability, childhood adversity and adverse life events (including the
onset of a chronic physical illness) as impacting on the risk for developing psychological disorder. These
factors are also related to risk factors for developing chronic physical illness, such as obesity, sedentary
lifestyle and smoking. In addition, symptoms of the chronic physical illnesses and related functional im-
pairment as well as indirect pathophysiological effects on the brain, such as increased levels of cytokines
and other inflammatory factors, may cause or exacerbate psychological disorder.
Disease → distress Prospective population based studies have shown that chronic physical illness is
related to an increased risk of the later development of depressive disorder. For example, Patten (2001)
observed that in a Canadian sample of 11,859 adults that were free of depressive disorder (assessed by
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diagnostic interview) at the baseline assessment, the presence of one or more chronic physical illness was
associated with an increased risk of depressive disorder two-years later (OR = 2.5, [95% CI: 1.3-4.6]).
The associated risk increase was relatively stable across the chronic physical conditions considered,
including arthritis and rheumatism.
Studies of clinical samples suggest a similar pattern. The incidence of depression increases after
myocardial infarction, with most of the increased risk experienced in the first month (Strik, Lousberg,
Cheriex, & Honig, 2004). Furthermore, a systematic review observed comorbid depression to be common
in diabetic samples (Anderson, Freedland, Clouse, & Lustman, 2001).
Caution must be taken when interpreting these findings due to the likelihood of reverse causality.
That is, although individuals at the earlier time point did not have clinical levels of depression it cannot
be ruled out that they did not have sub-threshold levels of depression, or a history of depression that was
related to the onset or exacerbation of the physical condition. Nevertheless, it does seem logical that
physical disorder increases the risk later depressive disorder, despite some of the effect observed being
due to reverse causality.
Distress → disease Population based studies highlight that depression is a risk factor for the devel-
opment of future chronic physical illness, particularly cardiovascular disease. Systematic reviews of
population studies report moderate to strong associations between depression and anxiety with incident
coronary heart disease, in the order of a 60 to 100% increased risk (Hemingway & Marmot, 1999; Kuper,
Marmot, & Hemingway, 2002; Rugulies, 2002; Nicholson, Kuper, & Hemingway, 2006). Almost identical
findings are reported by systematic reviews of clinical samples (Barth, Schumacher, & Herrmann-Lingen,
2004; Nicholson et al., 2006; Van Melle et al., 2004). Furthermore, population based cohort studies have
shown depression to be an independent risk factor for stoke (Jonas & Mussolino, 2000; Larson, Owens,
Ford, & Eaton, 2001).
To my knowledge there is no published prospective data concerning earlier depression and the onset
of RA. However, a recent study does provide some retrospective evidence. Looper, Mustafa, Zelkowitz,
Purden, and Baron (2011) examined the association between a history of depressive disorder and illness
severity in a sample of 104 inflammatory arthritis patients with symptoms of less than 1-year. Excluding
patients experiencing a current depressive episode, they found that not only did the 28 patients with a
history of depression have higher self-ratings of disease severity than those with no history of depression,
in terms of functional limitation and disease activity, but physicians assessment of disease activity and
the Disease Activity Score were also increased. Surprisingly, no difference in psychological distress levels
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were observed between those with and without a history of depression.
2.2.2.4 The impact of distress on illness outcomes
Psychological well-being in chronic physical illness is not only essential in terms of health-related quality
of life, but also with regard to disease progression and outcomes. Across a wide range of disorders
increased levels of distress have been shown to be related to poor disease control, health outcomes
and mortality (Prince et al., 2007; Katon, Lin, & Kroenke, 2007). A review of meta-analytic studies
examining the association between psychological distress and mortality across clinical and community
samples revealed that the evidence for an association was strongest for depression, compared to anxiety,
and when considering mortality related to cardiovascular disease (Norton, 2008).
There are several plausible biobehavioural mechanisms by which depression may be linked with
mortality. Considering first behavioural factors perhaps the most obvious mechanism is for an increased
risk of suicide. While suicide rates are undoubtedly raised in individuals with depression, suicide can ex-
plain only a small part of the increased mortality since it is relatively uncommon (Cuijpers & Schoevers,
2004). For example, of the 31 studies of non-psychiatric samples identified by Wulsin, Vaillant, and Wells
(1999) that reported suicide rates, suicides accounted for more than 1% of deaths in only 1 study. Other
potential mediators are lifestyle factors, such as smoking, alcohol use, poor diet and obesity, less physical
activity and hazardous behavior. All have been linked with depression and are associated with increased
mortality (Cuijpers & Schoevers, 2004). Considering specifically individuals with chronic physical illness
a meta-analysis has found depression to be related to non-adherence to prescribed therapies in a range
of medical conditions (DiMatteo, Lepper, & Croghan, 2000).
Another possible explanation for the association between depression and excess mortality is biolog-
ical, through dysregulation of the hypothalamic pituitary adrenal axis (Holsboer, 2000), the immune
system (Kiecolt-Glaser & Glaser, 2002), and also the autonomic nervous system (Ridker, Buring, Shih,
Matias, & Hennekens, 1998). Both of which have been linked to the development of various medical
conditions, most notably cardiovascular disease, but also diabetes, osteoporosis, arthritis, and certain
cancers (Kiecolt-Glaser & Glaser, 2002). Furthermore, considering coronary heart disease specifically,
depression has been shown to be associated with decreased heart rate variability, which has been inde-
pendently shown to be related to worse survival (Carney, Freedland, Miller, & Jaffe, 2002).
The evidence base in RA is not so developed, however, depression has been linked with adverse
clinical and psycho-social outcomes including increased risk of mortality (Ang, Choi, Kroenke, & Wolfe,
2005), work disability (De Croon et al., 2004), and worse quality of life (Kosinski et al., 2002; Lempp et
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al., 2011). Furthermore, the strong evidence for a link between depression and cardiovascular disease
is especially pertinent in RA. As was previously noted, the incidence of cardiovascular disease in RA has
been shown to be increased in comparison to the general population and accounts for a large proportion
of the excess mortality attributed to RA (Gabriel, 2008).
2.2.3 Stress and coping
The relationship between psychological and physical well-being from a medical perspective was sum-
marised by Katon (2003) (Figure 2.3). Expanding on the way in which a chronic physical illness impacts
on psychological well-being it is useful to consider it as a stressful situation. A chronic physical illness
can be defined as a stressful life-event that is characterised by recurrent stressful situations associated
with the symptoms of the condition. Individuals with a chronic physical illness have to cope with the
persistent stress caused by their condition, in an attempt to maintain health related quality of life (De
Ridder, Schreurs, & Bensing, 1998; Moos & Schaeffer, 1984; Zautra, 1996).
2.2.3.1 The transactional model of stress and coping
A large body of research has considered the the role of coping and adjustment in chronic physical illness
using the framework of the stress-coping model proposed by Lazarus and Folkman (1984). According to
this framework, commonly referred to as the transactional model, stress is triggered by an external event
(stressor) that the individual perceives to exceed their personal resources to effectively cope with the
stressor. These coping resources include the psychological, social and physiological resources available.
The central feature of the transactional model is that stress and coping are not single responses to
isolated events but are a dynamic system involving continuous adjustments to the event. It is for this
reason that this model is so applicable to the study of chronic physical illness.
The ‘transactions’ in the name of this model refer to changes in behaviour (coping response) that are
directed by an individuals cognitive appraisal of the situation. This appraisal system consists of three
components: (i) a primary appraisal, the initial assessment of the potential harm of the event; (ii) a
secondary appraisal, an assessment of whether the coping resources available are sufficient to meet the
demands of the event; and (iii) a cognitive reappraisal of the event as it develops over time.
Heijmans et al. (2004) compared the perceptions of potential disease-related stressors across a num-
ber of chronic conditions in a cross-sectional study of over 1300 patients. In comparison to other con-
ditions, patients with RA were observed to experience high levels of pain, fatigue, functional disability,
social disability, visible changes to their appearance and disease fluctuations. A cluster analysis was per-
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Figure 2.4: The self regulation model of illness cognitions
formed on the disease-related stressors. RA patients mainly fell into two clusters who reported moderate
or high levels of disability and low to moderate levels of control over disease-related stressors.
A central feature in the transactional model is the individual’s perception of control. This closely
relates to the concepts in other models relating to health behaviour, including self-efficacy (Bandura,
1977), learned-helplessness (Abramson, Seligman, & Teasdale, 1978) and attribution theory (Weiner,
1986). These models along with other illness related cognitions and coping, can be described in terms
of the Self Regulation Model (SRM) of illness cognitions which focuses on the individuals cognitive rep-
resentation of the illness as informing coping responses (Leventhal, Meyer, & Nerenz, 1980; Leventhal,
Nerenz, & Steele, 1984).
2.2.3.2 The self regulation model of illness cognitions
The SRM focuses on how individuals with a chronic physical illness use the information available to
them to regulate their behaviour over time in order to achieve a goal, such as avoiding pain (Leventhal
et al., 1984). The model posits an adaptive system wherein (i) the cognitive representation of the
illness experience guides (ii) coping responses, which is followed by (iii) appraisal of the coping efforts.
Illness representations are dynamic, and are updated with new information from external (e.g. social
communication) and internal sources (e.g. personal appraisal of coping efforts). A novel feature of the
SRM is that it distinguishes between cognitive and emotional processing. Cognitive, in terms of how
people regulate their responses to illness danger (‘What is this health threat, and what can I do about
it?’) and emotional in terms of their emotional control (‘How do I feel about it, and what can I do to
make myself feel better?’). The model is depicted in Figure 2.4.
The specific content of an illness representation is termed illness perceptions, which have been de-
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scribed as ‘an organized set of beliefs regarding how the illness affects our body, its likely impact on
life activities and experiences, whether it can be cured and so on’ (A. A. Kaptein & Weinman, 2004,
p.85). Naturally, illness perceptions are markedly different across conditions but considerable variation
between individuals with the same condition has also been observed (Moss-Morris et al., 2002). Percep-
tions inevitably vary in accuracy, detail and coherence. For example, one would expect that an individual
with RA who has lived with the condition for many years would have perceptions of the condition that
are rather more accurate, detailed and coherent than another who has only recently received a diagnosis
of RA. Other than the amount of personal experience, personality and cultural factors have also been
shown to be related to an individual’s illness perceptions (Diefenbach & Leventhal, 1996). A consider-
able body of research has identified five key dimensions of illness perceptions—namely, identity, cause,
time-line, consequences and control (Petrie, Weinman, Sharpe, & Buckley, 1996).
Important and related factors are emotional perceptions and illness-coherence. The former can be
seen as a domain specific indicator of the distress associated with the illness whereas the latter relates
to the extent to which the illness makes sense to the individual. Emotional perceptions are processed in
parallel to the main cognitive illness perceptions. For example, illness perceptions may evoke a powerful
emotional response that influences coping, and conversely the distress caused by the condition may
impact on cognitive illness perceptions, such as the perception and interpretation of symptoms. These
concepts will be introduced in the following chapter along with a discussion of the literature on the
longitudinal association between psychological characteristics and psychological well-being in RA.
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Longitudinal studies of psychological
well-being in rheumatoid arthritis
3.1 Introduction
The aim of this chapter is to systematically review the literature concerning depression in RA. Specifically,
to examine (i) how psychological well-being changes over time and (ii) to determine the demographic,
clinical and psychosocial characteristics that are longitudinally associated with changes in psychological
well-being. Expanding on the first aim, the objective of the literature review is to identify how psycho-
logical well-being changes over the course of the disease, that is to examine the psychological response
to the onset of the disease. Changes early in the course of the disease, soon after the onset of symptoms
and diagnosis of the condition, will naturally be a central focus of this part of the review.
With regard to the second aim, the objective is to assess the ways in which demographic, clinical and
psychosocial factors account for changes in psychological well-being. Particular emphasis will be given
to studies assessing changes early in the course of the disease. That is, how factors close to the time of
disease onset impact on adjustment to life with the disease. How changes in physical well-being relate
to changes in psychological well-being will also be considered.
3.2 Methodology
3.2.1 Identification of relevant studies
Relevant studies examining psychological well-being longitudinally were identified from the Institute for
Scientific Information’s Web of Science and the U.S. National Institute of Health’s National Library of
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Medicine’s PubMed databases. The key-words “arthritis” “rheumatoid arthritis” “inflammatory arthritis”
“depress*” “psychol*” “longitudinal” “prospective” “change” were included in various combinations.1
Details of the search terms and the number of papers identified are given in Table 3.1. The optimal
combinations was observed to be “rheumatoid arthritis” AND “depress* OR psychol*” AND “prospective
OR longitudinal OR change”. Limits were also included, such as English language publications and
journal articles, to ensure that further irrelevant papers and conference abstracts were excluded. The
citations identified were merged and duplicate citations excluded, resulting in a total of 798 citations.
A flow chart indicating the numbers of studies excluded based on screening of the title and abstract or
after examination of the full text is given in Figure 3.1.
Titles and abstracts of all of the citations were screened. The majority (n= 721,78%) were excluded
as they were not relevant (e.g. non-RA sample, did not assess psychological well-being; experimental
design, qualitative, retrospective, review) or were cross-sectional in design (22%). The full texts of
the remaining 77 articles were obtained and screened for inclusion. A further 25 were excluded either
because a longitudinal analysis of changes in psychological well-being was not presented, they were
prospective daily or weekly diary studies lasting less than 3-months, or they were based on previously
published data with no additional data regarding longitudinal changes in psychological well-being was
presented. An additional, two papers were identified by screening reference lists of included studies and
review papers.
In total, 50 published papers describing 33 distinct cohorts were identified that assessed changes in
psychological well-being (over a total follow-up period of at least 3-months) for individuals that were
clearly diagnosed with RA (generally using the accepted ARA criteria; Arnett et al., 1988). Seven of
the papers concerned data from the European Research in Incapacitating Diseases and Social Support
network (EURIDISS). This includes patients recruited from rheumatology clinics in France, Holland,
Norway, and Slovakia. Although the data collection procedure was similar in each of three countries
several similar papers were published using the cohort using the samples of individual countries. It is
assumed that this reflects researchers level of access to the data, rather than selective reporting.
Longitudinal studies that did not report changes in psychological well-being over the period of
follow-up were excluded. Changes may have been reported descriptively as means at each time point,
or change scores may have been calculated and used in further analysis, for example as the dependent
variable in a regression model. Regression models where the outcome variable was psychological well-
being at follow-up must have included the baseline psychological well-being score in the model (i.e. a
1In PubMed the key-words were included as exploded MESH headings.
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residualised change score analysis). Where no baseline control was included it is not clear to what extent
the results represent changes in psychological well-being and so were not included. Papers were also
excluded if they only prospectively measured outcomes considered to be psychosocial factors, such as
helplessness, without any psychological well-being outcome.
Table 3.1: Search terms and hits
Search Term PubMed WoS
1 arthritis 191,611 >100,000
2 “rheumatoid arthritis” 85,861 83,739
3 “inflammatory arthritis” 1,811 22,344
4 depress* 302,479 >100,000
5 psychol* 868,650 >100,000
6 depress* OR psychol* 1,076,896 >100,000
7 longitudinal 118,467 >100,000
8 prospective 754,693 >100,000
9 change 558,940 >100,000
10 prospective OR longitudinal OR change 2,545,886 >100,000
11 #1 AND #6 AND #10 1,332 633
12 #2 AND #6 AND #10 642 446
13 #12 + limits 456a 406b
Note. a PubMed limits: Humans, English, Adults. b WoS limits: English, Excluding meeting abstracts
and proceedings paper. * wild-card ending to allow for various forms or pluralisation’s of words
3.2.2 Quality assessment
An assessment of the methodological quality of the studies included in the review was based on four
domains: Sample, Design, Analysis, Reporting (Table 3.2). A maximum score of three was allowed
for each domain, except for design since the robustness of the design is the most important factor in
observational studies where the maximum score was four. It follows that the maximum quality score
that could be achieved is 13. This quality rating system was devised by the author but is based on
recommendations of the STROBE statement checklist for cohort studies (von Elm et al., 2007) and
Egger, Smith, and Schneider (2001).
The quality of the sample was based on its representativeness as assessed by the male:female ratio,
and the average age. The quality of the sample was also based on the average disease duration and the
size of the sample used in the analysis.2 An average disease duration of less than 2-years was given a
higher quality rating since changes would more accurately reflect changes associated with adjustment to
living with RA early in the course of the disease. Studies with such a sample are henceforth referred to
2Usually this was the sample size at the last follow-up since most studies employed a complete case analysis.
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Title/Abstract
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PubMed
n = 456
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Not relevant n = 562
Not longitudinal n = 159
Full text reviewed
n = 77
Included
n = 50
Identified from
reference lists
n = 2
Excluded
n = 29
Figure 3.1: Flowchart of included studies
as ‘early RA samples’.
The quality of the design was based on four factors. Firstly, the validity of the tool used to assess
psychological well-being. Studies were given this score if a well-validated measure of psychological well-
being measuring a distinct psychological dimension was employed (e.g. the Beck Depression Inventory
[BDI] for depression, or the State-Trait Anxiety Inventory [STAI] for anxiety). Measures specifically
designed for rheumatological populations were also included (e.g. the Arthritis impact measurement
scale). Studies using single items (e.g. ‘Have you had a problem with depression in the last 6-months?’;
Wolfe & Michaud, 2009) or using tools that are not well validated (e.g. Quality of life status and change;
Bendtsen & Hörnquist, 1996) were scored zero. Good quality designs were also indicated by follow-up
on three or more occasions, a total period of follow-up greater than three-years, and dropout of less than
20% of the sample over the period of follow-up.
Regarding the statistical analysis, poor quality studies were those that had employed only descriptive
analysis, bivariate correlations or t-tests (i.e. not adjusted for potential confounding variables). Analyses
that employed regression or some related method of analysis that controlled for baseline psychological
well-being and controlled for demographic, clinical and psychological variables were considered high
quality. A further quality score was given if the study had used a statistical method that is appropriate
to using data at multiple times (e.g. path analysis or multi-level growth curve model).
The quality of the reporting of the study was assessed with regard to the inclusion criteria being
clearly defined, the demographic and clinical characteristics at baseline being reported, and differences
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between the whole sample and those included in the analysis (e.g. those not dropping out of the sample
in complete case analyses). It must also be noted that poor reporting may have resulted in lost points in
other domains if the data were not available. An example is, if the number of participants retained at
the end of the study was not reported (e.g. Eberhardt, Larsson, & Nived, 1993).
It must be noted that quality scoring is subjective and potentially unreliable. Since the quality scoring
in this review was not validated elsewhere and was only based on the views of one individual, the quality
scores only provide a rough indication of study quality. As a result of this limitation a conservative ap-
proach to interpreting quality scores is implemented. Rather than referring to studies as high versus low
quality, studies falling above the quality criteria are simply assumed to have adequate methodological
rigor for their findings to be included in this review. Studies that do not meet the basic quality criteria
remain in the quality scoring table (Table 3.3) but are excluded from the textual discussion and the best
evidence synthesis table (Table 3.4). The criterion were, studies scoring three or less overall (≤ 23%),
or scoring more than three but zero for any of the four domains. Based on these criteria two studies
were exlcuded (Eberhardt et al., 1993; Parker et al., 1992). So 50 studies were initially included but 48
are discussed in the remainder of this chapter.
Table 3.2: Quality scoring criteria for the methodological and reporting characteristics of longitu-
dinal studies of psychological well-being in RA
Study feature Score
1. Sample
Less than 70% male or female 0.5
Mean age less than 60-years 0.5
Mean disease duration less than 2-years 1
Final number of participants more than 300 1
2. Design
Psychological well-being precisely measured 1
Number of follow-ups 3 or more 1
Total follow-up time more than 3 years 1
80% of participants retained 1
3. Analysis
Adjustment for clinical and demographic covariates 0.5
Adjustment for psychosocial covariates 0.5
Control for baseline score 1
Appropriate statistical analysis* 1
4. Reporting
Report drop out differences 1
Inclusion criteria clearly defined 1
Clinical and demographic characteristics reported 1
Note: * Use statistical methodology appropriate for longitudinal data
collected at three or more time points
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3.3 Changes in psychological well-being
Fourteen studies involving 10 different cohorts3 examined psychological well-being trajectories in early
RA samples (i.e. within 2-years of disease onset; Crotty et al. (1994); Persson et al. (2005); Schieir
et al. (2009); Thyberg et al. (2009, 2005); West and Wållberg-Jonsson (2009); Sharpe et al. (2001);
Doeglas et al. (2004); Evers et al. (1997); Nagyova et al. (2005); Raspe (1987); Schiaffino et al. (1991);
Schiaffino and Revenson (1995); Strating et al. (2006)). Most of the studies reported on changes in
psychological distress at the group level, rather than within-individual changes. Usually, this was by
reporting mean scores on measures of psychological distress at each follow-up assessment. Only one
study considered changes at the individual level. Crotty et al. (1994) calculated 44-month change
scores as the slopes of separate regression models for each participant in their study of 75 Australian RA
patients. No studies reported directly on changes in positive well-being.
Of the 14 studies of early RA samples, five reported observing significant improvements in psycho-
logical distress (Crotty et al., 1994; Persson et al., 2005; Schieir et al., 2009; Thyberg et al., 2005; West
& Wållberg-Jonsson, 2009), whereas only one study has shown a significant worsening (Sharpe et al.,
2001). However, a further eight studies reported that levels of distress were stable over time (Doeglas
et al., 2004; Evers et al., 1997; Nagyova et al., 2005; Raspe, 1987; Schiaffino et al., 1991; Schiaffino &
Revenson, 1995; Strating et al., 2006; Thyberg et al., 2009). More specifically, the latter eight studies did
not find levels of psychological distress to be stable over time but rather it did not change significantly
based on the particular statistical test employed.
As vote-counting procedures are notoriously unreliable (Egger, Davey Smith, & Altman, 2001) a more
robust meta-analytic procedure was employed. Raw scores reported by each study were standardised
and transformed to represent the average change at the group level from the baseline assessment. The
pooled change from the baseline assessment was then calculated using variance weighted least squares
(VWLS), whereby the conditional variance used in the estimation was the inverse of the standard error
of the mean for each observation. Unlike ordinary least squares estimation this method does not assume
homogeneity of the variance across studies. The conditional variance is specified resulting in more
accurate estimates of the standard errors of the model parameters. A quadratic term for time allowing
for non-linear change was included in the model.
It is worth highlighting that the procedure employed may itself be unreliable4 and I know of no
3Three studies used data from the EURIDISS cohort, two from Schiaffino et al.’s New York cohort and two Thyberg et al.’s
TIRA project
4Data are not adjusted for clustering within samples
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Figure 3.2: Pooled change (standard deviation units) in distress from entry into study of 14 studies
reporting data where inclusion criteria is disease duration less than 2-years
other instance where this specific approach has been employed to pool changes over time from multiple
studies. Therefore, the following observations should be treated with caution. However, it is almost
certainly more reliable than a basic vote-counting procedure and so it may be argued provides some
useful information.
Of the 14 studies, data from 11 were included in the analysis. Crotty et al. (1994) did not report
mean scores for the sample at each assessment occasion. Schiaffino and Revenson (1995) and Thyberg
et al. (2005) were excluded since they reported the same data as other studies involving the same
cohorts. The data from three studies concerning the EURIDISS study were included as the data reported
represented data from different sub-groups of the cohort (Strating et al., 2006; Doeglas et al., 2004;
Nagyova et al., 2005).
The pooled trajectory, shown in Figure 3.2, indicates that overall there is a small decline in psycho-
logical distress that levels off over-time, equivalent to approximately 9% of a standard deviation over
the first year. Confidence intervals are not shown, but encompass 0 (i.e. no change) at all intervals. This
analysis would therefore provide limited support for a trend of (possibly non-linear) improvement in
psychological distress at the group level over time early in the disease course.
3.3.1 Clusters of trajectories
Only one of the 14 studies concerning early RA samples specifically attempted to identify distinct patterns
of psychological distress following the onset of RA. Persson et al. (2005) examined the heterogeneity in
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changes in psychological distress over the 5-years following diagnosis of RA by first splitting their sample
about the median baseline level of distress, and then further splitting them into groups based on whether
distress had reduced over time, stayed the same, or increased. Using this rather arbitrary method, they
found that the two groups below the median were relatively similar over time in terms of average distress
scores (i.e. there was little change over time). In those above the median some did reduce over time,
whereas others showed consistently high levels of distress. This final group, consisting of 12% of the
sample, differed from the others in terms of perceived level of social support.
A further study is worth noting here, though it is not based on an early RA sample. Recently, Morris
et al. (2011) used a more appropriate technique to identify distinct clusters of distress trajectories in a
sample of 1115 participants with established disease in the UCSF RA Panel study (mean disease dura-
tion >10-years). K-means clustering was performed on aggregate data describing the over-time char-
acteristics of the depression (Geriatric Depression Scale [GDS]) data—baseline scores, average scores,
maximum and minimum scores, within-person standard deviations, and the proportion of assessments
for which participants had a score of 7 or higher (indicating caseness). Three clusters were selected
by the authors, and were labelled ‘little/no depression’ (66%), ‘intermittent’ (25%), and ‘chronic’ (9%).
The study was limited in two main ways. Firstly, the timing of entry into the study (the baseline score)
was arbitrary with the average disease duration at this time being greater than 10-years. Resultantly, in-
ferences about changes early in the course of the disease, or even over the course of the disease, are not
possible. Secondly, the aggregate data used in the analysis described average scores and the variability in
scores for each person, but no data concerning actual trends over-time were included. It is perhaps not
suprising then that levels of depression for the clusters identified were stable over-time. Other methods
that based on clustering of observed individual trajectories are available and present an opportunity for
the assessment for distinct groups following similar trends over-time.
3.4 Predictors of change in psychological well-being
This section covers the evidence from longitudinal studies for the association between various factors
and future psychological well-being. It is split into three parts distinguishing between demographic,
clinical and psychosocial factors. Although cross-sectional associations are not the focus of this review a
brief discussion of the cross-sectional associations observed for each is provided for context and to high-
light the differences between cross-sectional and longitudinal relationships. Table C.1 (in the appendix)
provides a brief summary of the findings of each study with respect to predictors of the changes in psy-
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chological well-being. Details concerning the proportion of studies observing significant associations for
specific demographic, clinical and psychosocial factors are provided in the best evidence synthesis table
(Table 3.4). Only studies meeting the specified quality criteria were included. The best evidence table
summarizes the level of support for an association between the factor and psychological well-being as
strong, moderate or weak—relating to >66%, >33% but <66%, and <33% of studies reporting signifi-
cant association, respectively. Furthermore, for factors where few studies are published extra caution in
interpreting the strength of the association must be taken due to the lack of evidence base. These are
indicated by the term “lack” in the table when less than 5 studies consider the construct of interest.
Since the methods used in the studies are heterogeneous and typically only a small number of stud-
ies consider each of the different factors it is not appropriate to pool estimates using meta-analytic
techniques. Instead a simple vote-counting procedure is used to assess the weight of evidence. Since
statistical significance depends on sample size as well as effect size the following findings should be
treated cautiously. To provide a more detailed narrative the findings of studies using this vote-counting
procedure are complemented with discussion of the effect size and the quality of the studies.
Table 3.4: Best evidence synthesis table
Domain Factor Cross-sectional Longitudinal
Demographic Age 3/14 (21%) weak 4/16 (25%) weak
Gender 2/8 (25%) weak 3/10 (30%) weak
Ethnicity 0/1 (0%) weak [lack] 1/3 (33%) weak [lack]
SES 5/14 (36%) moderate 6/11 (55%) moderate
Clinical Disease duration 1/9 (11%) weak 2/12 (17%) weak
Disease activity 7/15 (47%) moderate 8/16 (50%) moderate
Joint damage 1/2 (50%) moderate [lack] 0/2 (0%) weak [lack]
Somatic symptoms 16/19 (84%) strong 14/24 (58%) moderate
Psychosocial Social support 6/6 (100%) strong 3/7 (43%) moderate
Coping
Problem-focused 0/2 (0%) weak [lack] 1/2 (50%) moderate [lack]
Emotion-focused 3/3 (100%) strong [lack] 0/3 (0%) weak [lack]
Active 2/5 (40%) moderate 4/6 (66%) moderate
Passive 1/2 (50%) moderate [lack] 3/3 (100%) strong [lack]
Cognitions
Identity 1/1 (100%) strong [lack] 1/2 (50%) moderate [lack]
Cause (+ internal attribution) 0/2 (0%) weak [lack] 2/3 (66%) moderate [lack]
Chronicity (+ stable attribution) 1/2 (50%) moderate [lack] 2/3 (66%) moderate [lack]
Cyclical 0/1 (0%) weak [lack] 1/1 (100%) strong [lack]
Control (+ self-efficacy, helplessness,
hopelessness)
5/7 (71%) strong 4/8 (50%) moderate
Consequences 0/2 (0%) weak [lack] 3/3 (100%) strong [lack]
Coherence lack lack
Note: Level of evidence considered strong if >66% of studies report significant association, moderate if >33% but <66% of
studies report significant association, and weak if <33% of studies report significant association. Extra caution must be taken
when considering studies with a “lack” of evidence base, considered to be <5 studies.
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3.4.1 Demographic characteristics
Considering first the association between demographic characteristics and changes in psychological well-
being in RA, it is important to note that in most studies demographic characteristics were not the focus
but were included as control variables in studies examining the association between clinical and psy-
chosocial factors and changes in psychological well-being. Nevertheless, it is important to consider how
demographic characteristics relate to psychological well-being since controlling for the effects of demo-
graphic factors in future analysis is essential to ruling out confounding relationships.
3.4.1.1 Age
An important characteristic in relation to RA is age. Logically, the greater number of elderly people with
RA is due to the cumulative incidence of RA with age—since RA cannot be cured. Age is widely known
to be positively related to biological markers of disease activity (Wolfe, 1997) and is also related to an
increased likelihood of co-morbid conditions (Hyrich et al., 2006; Young & Koduri, 2007). Resultantly
one would perhaps expect distress to be positively related with age also. However, the evidence for such
an effect was at best weak.
Three of the 14 studies reporting cross-sectional comparisons found significant correlations between
age and psychological well-being (Hawley & Wolfe, 1988; Treharne et al., 2007; Uhlig et al., 2000).
Furthermore, rather than observing a positive association between age and psychological well-being,
significant negative associations were observed in two studies (Hawley & Wolfe, 1988; Treharne et al.,
2007). That is, the impact of disease on psychological well-being being was greater for those of a
younger age.
Hawley and Wolfe (1988) found that controlling for pain, functional disability, number of active
joints and family income, increasing age was related to a reduction in symptoms of both anxiety (β =
−.22, p < .001) and depression (β = −.19, p < .001). Similarly, Treharne et al. (2007) found age to be
related to a reduction in the symptoms of depression (β =−.23, p < .05) but not anxiety (β =−.13, p <
.001), but also found an increase in reported life satisfaction (β = .30, p < .05), after controlling for a
wide range of demographic, clinical and psychological variables. Although, Uhlig et al. (2000) found
that cross-sectionally mean age was higher in individuals with high versus low levels of psychological
distress they did not control for other variables.
Moving on to consider the relationship between age and change in psychological well-being, the
evidence for an effect is equally weak. Sixteen studies included in the review assessed the effect of age
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on changes in well-being, of which only four reported a significant association (Schiaffino et al., 1998;
Ødegård et al., 2007; Meenan et al., 1988; Hawley & Wolfe, 1988).
Hawley and Wolfe (1988) was the only study reporting a significant longitudinal association be-
tween age and psychological well-being to also report a significant cross-sectional association. They
observed that the 69 (22.5%) individuals whom they classified as having a moderate to large worsening
of depressive symptoms were on average 5-years older than those experiencing no change in symp-
toms. Similarly, Meenan et al. (1988) observed a small but significant effect relating to an increase in
depression equivalent to around 20% of a standard deviation in the depression change score for each
decade increase in age (β = .02, p < .05). However, Ødegård et al. (2007) found conflicting results
for the effect of age on psychological distress. In relation to symptoms of depression the authors also
reported that— controlling for gender and various clinical factors—age was related to increased levels
of depression assessed by the Arthritis Impact Measurement Scale (AIMS; β = .01, p < .001) and also
by the General Health Questionnaire (GHQ; β = .04, p < .001) but decreased levels of anxiety assessed
by the GHQ (β = −.05, p < .001). Furthermore, Schiaffino et al. (1998) observed a moderate nega-
tive association between age and depression in a residualised change score analysis of 63 RA patients
over a period of 4-months, controlling for education, income, disease severity and illness perceptions
(β =−.32, p < .05).
In summary, the evidence for an association between age with psychological well-being is indicative
of only a weak association if indeed one does exist. The majority of studies observed no significant
association either cross-sectionally or longitudinally. It is worth noting that positive studies tended to
consist of larger sample sizes than negative ones, perhaps suggesting an issue with power. Nevertheless,
age is likely to have an important relationship with psychological well-being in RA since it is related to
physical well-being (Young et al., 2000). Gender differences are also important, and it is to this topic
that we now move.
3.4.1.2 Gender
There was only very limited support for an association between gender and psychological well-being in
the longitudinal studies included in this review. Only one of eight studies reported observing a signif-
icant cross-sectional association (Evers et al., 1997) and three of 13 studies a significant longitudinal
association (Hawley & Wolfe, 1988; Ødegård et al., 2007; West & Wållberg-Jonsson, 2009).
In a study of psychological well-being in 91 Dutch RA patients (70% female) recruited within 1-
year of disease onset, Evers et al. (1997) found that women tended to report significantly higher levels
42
Chapter 3. Longitudinal studies of psychological well-being in rheumatoid arthritis
of anxiety at baseline. This was true even after controlling for age, education, clinical status, social
support and coping styles. The trend was also for higher reported levels of depression in females,
but the magnitude of the difference was non-significant. The same study also reported that gender was
associated with higher anxiety (but again not depression) over a period of 12-months using a residualised
change score analysis (β = .11, p < .05). Contrastingly however, Ødegård et al. (2007) reported that,
controlling for gender and clinical status, females were significantly more likely to experience a reduction
in symptoms of anxiety (β = −.29, p = .01)—again no significant effect on depressive symptoms was
observed.
In a study of patients with established RA, Hawley and Wolfe (1988) found that in patients with
worsening levels of anxiety there was a greater proportion of males than in those experiencing no
change. This observation is inconsistent with the previous studies, although differences in the sam-
ples and methodologies used possibly account for the ambiguity in the findings. It is unlikely that this
can be accounted for by regression to the mean due to lower initial levels of anxiety in men, since the
study reported no difference in levels between the sexes at the baseline assessment.
The only study to report a significant association between gender and psychological well-being that
did not directly relate to symptoms of anxiety was West and Wållberg-Jonsson (2009). They observed
a significant improvement in SF36 mental component score (MCS) score in both sexes over a period
of 72-months in 51 Swedish RA patients (34 female) with recent onset RA. However the magnitude
of the change was significantly larger for men the women. Since this assessment relates to general
psychological distress, which includes anxiety, it may be that the effect was accounted for by symptoms
of anxiety.
Although several studies have reported a significant association between gender and psychologi-
cal well-being in RA the vast majority do not. Furthermore, those that do, provide rather ambiguous
findings. Together this suggests that gender is probably not not an important factor in psychological
well-being in RA. This is surprising since population studies generally indicate that women have an
increased lifetime risk of depressive disorder compared to men and also report higher levels of psy-
chological distress (e.g. Hyde, Mezulis, & Abramson, 2008). It is not clear whether this difference in
symptom reporting reflects actual levels or simply that women are more likely to report symptoms than
men (Tousignant, Brosseau, & Tremblay, 1987). Furthermore, it is widely accepted that not only is
RA more prevalent in women but that generally the severity of the disease is worse too (Kvien, Uhlig,
Ødegård, & Heiberg, 2006). It appears that the association of gender with psychological well-being in
RA is complicated, and may be confounded by disease severity.
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3.4.1.3 Ethnicity
Few studies examined the relationship between ethnicity and psychological distress. This is most likely
because of the over representation of people of ‘white’ (American/European) ethnic origin in rheuma-
tological samples. Only one study examined cross-sectional differences in distress across ethnic groups
finding no associations (Hawley & Wolfe, 1988). Furthermore, only one of the three studies that included
an assessment of the longitudinal effects of ethnicity found an association with change in psychological
distress. Margaretten et al. (2009) examined severity of depressive symptoms of 172 patients attending
San Francisco General Hospital, finding that symptoms tended to be lower in Asians compared to other
groups—namely White, Hispanic, and African American. Conversely Morris et al. (2011) found non-
white ethnicity to be associated with increased likelihood of membership in the ’chronic’ cluster in their
longitudinal analysis of the UCSF RA Panel study.
From the literature available there is little available evidence linking ethnicity to depression in RA.
However, this is an area that needs further examination, particularly due to the association of ethnicity
to socio-economic status.
3.4.1.4 Socio-economic status
A far larger number of studies has considered the impact of socio-economic status on psychological
distress in RA. Across these studies, socio-economic status (SES) was operationalised in a number of
different ways. The largest group of studies (n = 9) considered education, with smaller number consid-
ering marital status (n = 3), income (n = 2), and social class (n = 1) as the indicator of SES. Overall,
there was rather stronger evidence for an effect of socio-economic status on psychological well-being
than other demographic characteristics, at least cross-sectionally. Seven out of 11 studies observed a
cross-sectional association, although only 5 out of the 13 studies observing a significant longitudinal
effect.
For education, 4 out of 9 studies observed a significant cross-sectional association with psychological
distress (G. K. Brown, Wallston, & Nicassio, 1989; Doeglas et al., 2004; Schiaffino et al., 1991, 1998)
and 4 out of 10 observed a longitudinal association (Schiaffino et al., 1998; Nicassio & Wallston, 1992;
Hawley & Wolfe, 1988). For example, Schiaffino et al. (1998) observed a moderate negative association
between education, dichotmised as either graduating from high school or not, and depression. The
magnitude of the effect was similar for both concurrent depression (β =−.26, p < .05) and residualised
change over a period of 4-months (β = −.27, p < .05). However, Doeglas et al. (2004) reported a
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similar cross-sectional effect (r = −.19) in 263 patients from the Dutch arm of the EURIDISS study but
found that longitudinally when controlling for initial depression the effect was reduced to non-significant
(b = −.09, p > .05). Similarly, a moderate cross-sectional effect attenuated to a weak non-significant
longitudinal effect was observed by Schiaffino and Revenson (1995). In contrast, Nicassio and Wallston
(1992) reported the opposite, a non-significant cross-sectional association but significant negative one
longitudinally.
Of the two studies examining the effect of income, both found a cross-sectional association between
higher income and lower psychological distress (Hawley & Wolfe, 1988; Schiaffino et al., 1998), though
only one observed an association between income and changes in psychological distress (Hawley &
Wolfe, 1988).
Three studies considered the cross-sectional association between marital status and distress, finding
no significant association (Hawley & Wolfe, 1988; Sharpe et al., 2001; Treharne et al., 2007). Both
(Hawley & Wolfe, 1988; Treharne et al., 2007) also considered longitudinal associations. The former
found that unmarried patients were more likely to experience a worsening of symptoms of depression
but not anxiety. The latter study found no association with residualised changes in depression, anxiety or
life satisfaction at 6-month or 12-month follow-ups. Morris et al. (2008) used a latent curve model5 and
found marital status to be related to future mood in a large sample of patients with established disease.
Specifically, unmarried patients were at an increased risk of persistently increased levels of depressive
symptoms (b =−.81, p < .01)
Only one study considered social class. In this study, Chaney et al. (2004) examined the longitudinal
relationship between causal attributions and depressive symptoms in 42 American RA patients. At the
baseline assessment the correlation between social class and depression was small and non-significant
(r < .19, p > .05). As this association was non-significant it was excluded from the longitudinal analysis.
These studies highlight that the magnitude of the effect with regard to socio-economic status and
psychological well-being is at most weak to moderate. This is perhaps not surprising since it is likely that
there are several intermediate factors that mediate the impact of socio-economic status on psychological
well-being. Nevertheless, they indicate that controlling for socio-economic factors in analyses examining
the relationship between clinical and psychological factors and well-being is essential, since the latter
effect must be greater than those of socio-economic status and other demographic factors to rule out
confounding relationships.
5See section 4.3 for details
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3.4.2 Clinical characteristics
A large number of studies have considered the role of clinical characteristics on the impact of psycho-
logical well-being. For the purposes of this review it is useful to consider clinical characteristics split
across several categorizations. Initially disease duration, which was shown earlier in this chapter to be
related to levels of psychological distress at the group level, is considered. Followed by the considera-
tion of characteristics relating to disease activity, such as serological markers of inflammation and joint
counts. The longitudinal association between psychological distress with somatic symptoms, including
pain, functional limitation and joint stiffness, is then discussed. Finally, the link between the progressive
joint damage associated with RA and distress is considered.
3.4.2.1 Disease duration
Directly relating to the analysis in section 3.3, a large number of studies included disease duration as
a control variable in their analysis (G. K. Brown, Nicassio, & Wallston, 1989; G. K. Brown, Wallston, &
Nicassio, 1989; Chaney et al., 2004; Lowe et al., 2008; McFarlane & Brooks, 1988; Nicassio & Wallston,
1992; Rupp et al., 2006; Treharne et al., 2007; Uhlig et al., 2000; Hawley & Wolfe, 1988; Brekke et al.,
2003; Meenan et al., 1988; Morris et al., 2008; Scharloo et al., 1999; Margaretten et al., 2009). Most
considered samples with established disease and observed no association between disease duration and
psychological well-being, with the exception of two studies (G. K. Brown, Nicassio, & Wallston, 1989;
Treharne et al., 2007). G. K. Brown, Nicassio, and Wallston (1989) found a significant association
between disease duration and distress [effect size not reported], although this was not reported in later
studies using this cohort (G. K. Brown, 1990; G. K. Brown, Wallston, & Nicassio, 1989; Nicassio &
Wallston, 1992). Additionally, Treharne et al. (2007) compared groups with early, intermediate and
long-standing disease and found that individuals in the latter two groups had lower levels of anxiety
(β =−.19, p < .05) but not depression (β =−.09, p > .05) or life satisfaction (β =−.04, p > .05).
It is important to note that none of these studies, with the exclusion of Treharne et al. (2007),
considered whether changes in distress were non-linear over the course of the disease. The finding of
most studies perhaps suggests that for patients with long disease duration levels of distress are relatively
stable. Taken together with the earlier findings this perhaps suggests an average pattern of distress
reducing in the few years following diagnosis and then remaining stable over time.
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3.4.2.2 Inflammation
Several studies examined the association of serological markers of inflammation with psychological dis-
tress. There was no indication that a specific marker of inflammation was particularly predictive of
psychological distress and overall the results were rather ambiguous.
Eryrthocyte sedimentation rate (ESR) was the most commonly assessed marker of inflammation, but
there was only very weak evidence for an association between ESR and distress. Cross-sectionally, only
one of the seven studies observed a significant association with concurrent levels of distress (r = −.22;
West & Wållberg-Jonsson, 2009). The evidence for a longitudinal association was slightly better, three
of the six studies observed a significant relationship (Ødegård et al., 2007; West & Wållberg-Jonsson,
2009; Treharne et al., 2007). Treharne et al. (2007) found that in a multivariable linear regression
analysis, ESR was not associated with anxiety, depression or life satisfaction at baseline (β = −.05 to
.11, p > .05), but was associated with future levels of anxiety (β = −.28, p < .01) and life satisfaction
(β = .18, p < .05) but not depression (β =−.11, p > .05).
Similarly, West and Wållberg-Jonsson (2009) also observed a significant longitudinal association for
ESR with distress, in terms of the SF36 MCS (r = −.33). In their study of 51 Swedish RA patients, they
also found similar effect sizes for CRP with emotional role functioning (r = −.28) but not the MCS.
However, neither of the two other studies considering c-reactive protein (CRP) reported a significant
effect (Sharpe et al., 2001; Uhlig et al., 2000). For Uhlig et al. (2000) the trend was in the expected
direction but the magnitude of the effect smaller and non-significant despite the larger sample size.
Three further studies considered rheumatoid factor. As with CRP, Uhlig et al. (2000) found no cross-
sectional association, although the trend was in the expected direction. Evers et al. (1997); Ødegård et
al. (2007) did, however, provide some support for a longitudinal association. (Evers et al., 1997) found
evidence for an association with anxiety (β =−.14, p < .05) but not depression (β = .08, p > .05), and
Ødegård et al. (2007) found the opposite, an association with depression (β = .75, p = .001 for RF+ vs.
RF-) but not anxiety (β not reported).
Overall, there was only relatively weak support for a longitudinal association between inflammation
and distress. It is not surprising that small effects are observed. Inflammation, as indicated by serological
markers, is likely to be mediated through the joint swelling and tenderness caused by the inflammation.
This is supported by the observation that studies not controlling for these variables tended to be more
likely to observe significant effects (Ødegård et al., 2007; Evers et al., 1997; West & Wållberg-Jonsson,
2009).
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3.4.2.3 Joint counts
Ten studies considered the association between simple counts of the number of tender or swollen joints
and psychological well-being (Nagyova et al., 2005; Schieir et al., 2009; Sharpe et al., 2001; Evers
et al., 1997; McFarlane & Brooks, 1988; Smedstad et al., 1997; Uhlig et al., 2000; Hawley & Wolfe,
1988; Persson et al., 2005; Morris et al., 2008). Of these four out of the eight examining cross-sectional
associations reported a significant association (Hawley & Wolfe, 1988; Nagyova et al., 2005; Schieir et
al., 2009; Sharpe et al., 2001), and two out of six that considered the longitudinal relationship found a
significant effect (Morris et al., 2008; Persson et al., 2005).
An early study of the impact of disease activity on psychological well-being in a small sample of
30 patients followed up over 3-years, McFarlane and Brooks (1988) observed moderate correlations be-
tween psychological distress and a count of the number of swollen joints (r = .28). However, correlation
between the swollen joint score and depression 3-years later was weak, after partialling out initial de-
pression (r = .12). This finding was echoed by later studies with larger sample sizes over the following
decade (Evers et al., 1997; Smedstad et al., 1997; Uhlig et al., 2000). More recent studies, however,
have provided more positive support for an association. In a study of 124 patients from the Slovakian
arm of the EURIDISS study, (Nagyova et al., 2005) found swollen joints to be related to concurrent
levels of distress assessed by the GHQ at all four assessment points, however linear regression indicated
no cross-lagged effect of joint count when controlling for earlier distress. This was echoed by another
study involving 216 patients in the Norwegian arm of the EURIDISS study (Smedstad et al., 1997) and
180 Canadian RA patients (Schieir et al., 2009).
Morris et al. (2008) using a latent growth curve analysis reported an association between swollen
joint count and distress in their sample of 561 patients from the UCSF RA Panel study. Although signifi-
cant, the size of the effect was negligible (b = .09, p < .01). Furthermore, Persson et al. (2005), in their
study of distinct distress trajectories, observed that, despite the overall correlation between swollen joint
count and distress being small (r = .14), swollen joint count was increased in the group with high and
increasing levels of distress. The differences in findings with respect to these studies is likely to be due
to the larger sample sizes in more recent studies. It appears that swollen and tender joint counts are
only moderately to weakly associated with distress, most likely because of the stronger relationship of
both factors with pain. That is, pain mediates the impact of joint count on distress.
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3.4.2.4 Disease activity
Inflammatory markers and joint counts form the basis of the Disease Activity Score. This is a composite
variable formed by a linear combination of the count of the number of tender joints, the number of
swollen joints and either ESR or CRP, and recently a patient report of the disease activity on a visual ana-
logue scale (Prevoo et al., 1995). This widely used measure was included in the analysis of eight studies
included in this review (West & Wållberg-Jonsson, 2009; Scharloo et al., 1999; Bishop & Converse, 1986;
Rupp et al., 2006; Lankveld et al., 2000; Margaretten et al., 2009). As with the inflammatory markers
and joint counts there was limited evidence for an association with distress both cross-sectionally and
longitudinally. Two of four studies considering the cross-sectional relationship reported a significant
effect (Thyberg et al., 2009; Schiaffino et al., 1998), and two of six studies considering a longitudinal
association reported a longitudinal effect (West & Wållberg-Jonsson, 2009; Scharloo et al., 1999).
Inflammation and the swelling and tenderness of joint counts would not be expected to have a direct
effect on psychological well-being. But instead would be expected to be mediated by somatic symptoms
in a causal chain. It is to somatic symptoms that we now turn.
3.4.2.5 Joint damage
Over-time persistent inflammation of the joints ultimately leads to destruction of the joints, leading to
functional disability. Relatively few studies considered the impact of joint damage on future psychologi-
cal well-being, perhaps because of the considerable overlap with functional disability. Rupp et al. (2006)
and Uhlig et al. (2000) examined the relationship between Sharpe score—an assessment of the extent
of erosions and joint space narrowing of joints in the hands, wrists and feet—on both concurrent and
future well-being.
In their study of 227 Dutch RA patients Rupp et al. (2006) observed a significant cross-sectional
relationship between Sharpe score and SF36 mental component score (β = .19, p < .05) even after con-
trolling for demographic and other clinical characteristics—including pain but not functional disability.
Uhlig et al. (2000) however did not observe any association between Sharpe score and psychological
well-being, with the trend small and in the opposite direction. Neither study observed an association
between joint damage and change in psychological well-being.
Although joint damage is an important clinical outcome in RA. It seems that its association with
psychological well-being is not strong. It is more appropriate to consider the relationship between
functional disability, which is in part determined by joint damage, and psychological well-being. The
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lack of an association corroborates the finding of only very limited support for an effect of disease
duration. If the effect was strong an increase in distress with increasing disease duration would be
expected.
3.4.3 Somatic symptoms
A large number of studies considered the association between somatic symptoms and psychological well-
being. Most focused on pain and functional limitation, although a limited number considered stiffness,
fatigue and sleep disturbance.
3.4.3.1 Pain
Pain was found to be strongly associated with psychological well-being both cross-sectionally and also to
some extent longitudinally. A total of 18 studies considered the cross-sectional association with pain. Of
these, 11 reported significant effects (G. K. Brown, Nicassio, & Wallston, 1989; G. K. Brown, Wallston,
& Nicassio, 1989; G. K. Brown, 1990; Evers et al., 1997; Hawley & Wolfe, 1988; Lowe et al., 2008;
Schiaffino et al., 1991; Schiaffino & Revenson, 1995; Sharpe et al., 2001; Smedstad et al., 1997; Thyberg
et al., 2009). The evidence for a longitudinal relationship was weaker, eight out of 18 studies reported
a significant effect (G. K. Brown, Wallston, & Nicassio, 1989; G. K. Brown, 1990; McFarlane & Brooks,
1988; Nicassio & Wallston, 1992; Sharpe et al., 2001; Lankveld et al., 2000; Lowe et al., 2008; Ødegård
et al., 2007). Across these studies pain was most commonly assessed using a visual analogue scale
anchored with phrases such as “no pain at all” and “worst pain ever”.
In a series of studies using the same large sample of patients Brown, Nicassio and Wallston (1989;
1989; 1990; 1992) found evidence for a weak effect of pain on future depression. Moderate effects
were observed in the first study, but were attenuated in later analyses that controlled for the effects of
concurrent pain and depression. Nevertheless, cross-lagged path analysis supported the impact of pain
on depression but not the reverse. In the final study to use this cohort, Nicassio and Wallston (1992)
provided evidence to support their hypothesis that one of the ways in which pain was related to increased
future depression was through sleep disturbance. Controlling for age, education, disease duration and
functional disability the interaction between pain and sleep disturbance explained an additional 2% of
the variance (F = 8.22, p < .001).
Smedstad et al. (1997) reported similar effects. They studied 236 Norwegian RA patients on three
occasions over 2-years. Controlling for joint count, ESR and HAQ disability, pain was not significantly
related to future distress by either the AIMS anxiety or depression scores. It is possible that controlling
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for disability was unwise, since the influence of pain on distress is, at least, partially mediated by the
impact of pain on an individuals ability to complete normal physical tasks. Pain and disability were
indeed highly correlated, and theoretically it is certain that we would expect disability to be strongly
influenced by pain.
Only one study considered the association between pain and life-satisfaction. Across two time-points
6-months apart, Treharne et al. (2007) observed no association between pain and life-satisfaction, cross-
sectionally or longitudinally after controlling for demographic and other clinical characteristics. How-
ever, it should be noted that no association was observed between pain with anxiety or depression either
in this study. Since the analysis controlled for disability the point made in the preceding paragraph
holds true here as well—the influence of pain on depression may be (fully) mediated by its impact on
disability.
3.4.3.2 Functional limitation
Functional limitation is a major outcome in RA, and is typically the secondary outcome that is assessed
after disease activity. By far the most widely used tool for assessing limitation in RA is the Health
Assessment Questionnaire (HAQ) disability index (Fries, Spitz, Kraines, & Holman, 1980). This was true
in this review, although recently the use of the SF36 physical function (PF) scale and physical physical
component score (PCS) are becoming more prominent.
Similar to pain, functional limitation showed a strong cross-sectional association with psychological
well-being. Ten of the 11 studies including such a comparison observed a significant effect (G. K. Brown,
Wallston, & Nicassio, 1989; G. K. Brown, Nicassio, & Wallston, 1989; Chaney et al., 2004; Demange et
al., 2004; Evers et al., 1997; Hawley & Wolfe, 1988; Nicassio & Wallston, 1992; Schiaffino et al., 1991;
Sharpe et al., 2001; Smedstad et al., 1997; Thyberg et al., 2009; Treharne et al., 2007). This was true
whether psychological well-being was assessed by measures of general distress, depression, anxiety or
even life-satisfaction.
Bivariate correlations were in the order of r = .44 to .50. Even after controlling for demographic
and other clinical factors the effect tended not to be dramatically reduced. For example, Treharne et
al. (2007) observed that controlling for age, sex, employment status, marital status, disease duration,
pain, fatigue and comorbidity the standardised regression coefficient for depression, anxiety and life-
satisfaction were large (βD = .48,βA = .30,βLS =−.50).
Longitudinally, however, reported effect sizes where considerably attenuated when controlling for
initial distress. Only six of the 15 studies that examined for a longitudinal association observed a sig-
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nificant effect (DeVellis & Blalock, 1992; Doeglas et al., 2004; Persson et al., 2005; Sharpe et al., 2001;
Margaretten et al., 2009; Treharne et al., 2007). Notably, none of the 4 studies examining anxiety
longitudinally observed a significant association with prior functional limitation (Treharne et al., 2007;
Smedstad et al., 1997; Evers et al., 1997; Hawley & Wolfe, 1988). Therefore, it would appear that the
there is something specific to depression rather than psychological distress in general. Although not
specifically the focus of this review, it is noted that studies using cross-lagged models found no evidence
for depression predicting future functional limitation, indicating that causally prior limitation impacted
on the change in future psychological well-being, such that individuals with worse functional limitation
were at risk of experiencing greater deterioration in depression over time. However, it may be more
important to consider how longitudinal changes in depression are associated with concurrent changes
in disease severity and functional limitation.
Only two studies examined the relationship between changes in functional limitation and psycho-
logical well-being. Both observed strong effects. In their classic study, Hawley and Wolfe (1988) found
that for the 308 patients included in the analysis changes in distress over the 4.5-years of follow-up were
moderately associated with changes in disability. This was true for both depression and anxiety—r = .30
and .26, respectively. Furthermore, Katz (1995) observed an increased odds of having experienced an
worsening of functional disability in the preceding period (OR = 3.96, p < .05) in 319 patients from
the UCSF RA Panel with high rates of depression . Further analysis, revealed that a change in disability
impacted on distress when there was a concomitant loss of valued life activities.
The complex association between changes in functional limitation and changes in psychological dis-
tress will be returned to in further detail later in this chapter.
3.4.3.3 Stiffness
Only two studies considered the impact of stiffness on changes in psychological distress (McFarlane &
Brooks, 1988; Morris et al., 2008). Both assessed stiffness by asking participants to state how long they
experienced early morning stiffness. Early morning stiffness is a characteristic feature of RA. Although
not specific to RA, stiffness for more than one-hour after waking does form part of the diagnostic criteria
(Arnett et al., 1988).
In their study of 30 RA patients with established disease, McFarlane and Brooks (1988) observed no
cross-sectional or longitudinal association between the duration of early morning stiffness and psycho-
logical distress. However, the better quality study of Morris et al. (2008) involving a sample of over 500
patients from the UCSF RA Panel followed for 8-years did observe a longitudinal association, controlling
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for several clinical variables. However, morning stiffness is highly related to functional disability, this
was not controlled for in the study, and it seems likely that the mode of effect is the same—that is by
impacting on valued life activities.
3.4.3.4 Fatigue
Three studies considered the effects of fatigue. All three studies reported a significant positive cross-
sectional association between levels of fatigue and levels of psychological distress (Treharne et al., 2007;
Brekke et al., 2003; Thyberg et al., 2009). Correlations were in the order of r = .4. It is important to
note that, as well as being a common symptom of RA, fatigue is also a symptom of depression so it is per-
haps not surprising that strong and consistent associations were observed. Only Treharne et al. (2007)
examined for a longitudinal relationship, finding no evidence for a role in fatigue predicting residualised
change in distress over 6- or 12-months. Furthermore, the same study observed no association of fa-
tigue with life satisfaction—cross-sectionally or longitudinally. This perhaps points to its overlap with
the symptomatology of depression in RA.
3.4.4 Psychosocial factors
Stronger associations were observed between psychological well-being with clinical rather than demo-
graphic characteristics, particularly those that are assessed using self report measures (e.g. pain, fatigue
and functional disability). However, much of the variance in residualised change is unaccounted for. I
now turn to consider whether psychosocial factors play an important role in the relationship between
disease and psychological well-being in RA.
3.4.4.1 Social support
Social support relates to the different aspects of how supported an individual feels by the members of
their social network. In individuals with a chronic illness that is painful and disabling, such as RA, social
support is likely to provide an important coping resource. This section reviews the findings of studies
examining the influence of various different aspects of social support on changes in psychological well-
being in RA.
Social support was a commonly examined psychosocial factor that was assessed in a total of 8 stud-
ies. However, social support consists of several related concepts and was assessed rather differently
across these studies, including general social support, emotional support, satisfaction with social sup-
port, social network size, marital status, spousal support, and companionship. Cross-sectionally there
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was strong evidence for a relationship between social support and psychological well-being. All of the
studies included in this review observed a significant cross-sectional association for some form of social
support (Emotional: G. K. Brown, Wallston, and Nicassio (1989); Demange et al. (2004); Doeglas et
al. (2004); Treharne et al. (2007); Satisfaction/Perceived: Doeglas et al. (2004); Evers et al. (1997);
Network: G. K. Brown, Wallston, and Nicassio (1989); Evers et al. (1997); Demange et al. (2004);
Companionship/Spousal: Schiaffino and Revenson (1995); Demange et al. (2004)). The picture was
rather different when considering longitudinal associations where only 3 out of 7 studies observed a sig-
nificant longitudinal association with changes in psychological distress (Evers et al., 1997; G. K. Brown,
Wallston, & Nicassio, 1989; Persson et al., 2005).
In a sample of 95 patients followed for 1-year, Evers et al. (1997) identified social network size
(β = −.18, p < .05) but not perceived social support as predictive of residualised change in depression
one year later. G. K. Brown, Wallston, and Nicassio (1989), however, reported that the level of emotional
support but not social network size as being significantly related to change in depression, an effect that
was observed to be consistent over two 6-month periods in 233 individuals (βt1 = −.28,βt2 = −.24).
A more recent study of 158 RA patients identified individuals with low perceived social support as
predictive of increased levels of distress 5-years later (Persson et al., 2005).
Social support is usually only considered as a positive coping resource. However, there is evidence
that social support can have negative effects on well-being. Only one study examined such an effect.
Schiaffino and Revenson (1995) examined whether problematic social support was related to worse
future psychological distress in 64 RA patients, finding no evidence for a link either cross-sectionally or
longitudinally.
The main thesis regarding the link between social support and psychological distress is that it acts
as a buffer between a stressor (e.g. pain) and psychological well-being. Few studies actually examined
such an effect, and interestingly there was relatively little evidence to support it. G. K. Brown, Wallston,
and Nicassio (1989) found no evidence for a moderating effect of social support (either network size or
emotional support) on the relationship between pain and depression measured 1-year later. Similarly,
Schiaffino and Revenson (1995) found no moderating effect for positive or problematic social support on
the association between threat appraisals and future psychological distress, although they did observe
a weak but significant association moderating effect for positive social support with regards the link
between challenge appraisals and psychological distress.
The studies reviewed in this section indicate social support is beneficial for psychological well-being
in RA, at least cross-sectionally. Further research is needed to examine the causal role of social support
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as a potential moderator of pain on social-role functioning and psychological well-being in RA.
3.4.5 Coping with RA
Symptoms of RA, particularly pain and fatigue, can result in functional disability and impact on an
individual’s ability to complete normal activities—activities that healthy individuals typically take for
granted—causing stress to the individual (Heijmans et al., 2004). Studies of coping in RA have tended
to focus on the ways in which individuals cope with their pain, since this is the central symptom of RA.
Although a relatively large number of studies have examined the role of coping on psychological
well-being in RA the findings are mixed. Overall, the evidence that coping plays some role in the
pathway between the symptoms of RA and psychological well-being is relatively strong cross-sectionally
but somewhat weaker longitudinally.
For the sake of simplicity, studies included in this review that examine coping have been broadly cate-
gorised as applying two different approaches to the study of coping strategies. Namely, problem/emotion-
focused coping and engagement/disengagement coping. Both of these can be considered within the
Transactional Model of Stress and Coping (Lazarus & Folkman, 1984). It is important to note that there
is a large amount of overlap between these approaches and both view coping strategies in terms of a dy-
namic process, rather than a disposition (A. A. Kaptein & Weinman, 2004). None of the studies included
in the review applied a dispositional approach to coping.
3.4.5.1 Problem/emotion-focused coping
Problem-focused coping relates to attempts to alter the relationship between demands and resources.
For example, an individual with RA trying to cope with joint pain may take analgesic medications and
may seek social support. Emotion focused coping is used when it is perceived that the problem has no
solution and there is little scope for control so the aim of the coping strategy is to protect psychological
well-being (A. A. Kaptein & Weinman, 2004). An example is, thinking soothing or distracting thoughts.
Four studies examine coping strategies in RA that fit within this framework (Lankveld et al., 2000;
Evers et al., 1997; Lowe et al., 2008; Scharloo et al., 1999). Together these studies provide evidence that
emotion focused coping (strategies such as avoidance and denial) are cross-sectionally associated with
better psychological well-being (Lankveld et al., 2000; Evers et al., 1997; Lowe et al., 2008). However,
none of the studies observed an impact of of emotion focused coping on longitudinal changes in distress
(Lankveld et al., 2000; Evers et al., 1997; Scharloo et al., 1999). The opposite was observed for problem
focused coping. Cross-sectionally, coping strategies such as decreasing activity were not observed to
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be related to psychological well-being (Lankveld et al., 2000; Evers et al., 1997) but there was some
evidence for a longitudinal association. For example, Lankveld et al. (2000) examined the impact of
coping on changes in psychological distress in a Dutch sample of 80 RA patients. They found that over a
three-year period decreasing activity as a means of coping with pain was related to worse psychological
distress although there was no cross-sectional association. The effect persisted after controlling for prior
distress, and prior and current disease activity and symptoms (β = .17). However, emotion focused
coping strategies of self-comforting and diverting attention were related to better psychological well-
being cross-sectionally but not longitudinally.
3.4.5.2 Engagement/disengagement coping
The remaining studies fit broadly within a framework where coping strategies are either seen as engage-
ment or disengagement coping (Lowe et al., 2008; G. K. Brown, Nicassio, & Wallston, 1989; Sharpe et
al., 2001; Schiaffino et al., 1991; Treharne et al., 2007; Evers et al., 1997). Although similar to the above
framework, engagement coping strategies may be emotion or problem-focused (e.g. confrontation, ac-
ceptance, seeking support), whereas disengagement coping strategies are invariably emotion-focused
(e.g. avoidance and denial). Using this taxonomy there was evidence for disengagement coping im-
pacting on future psychological distress. Specifically, Scharloo et al. (1999), Lowe et al. (2008) and
G. K. Brown, Nicassio, and Wallston (1989) all found evidence for passive coping or avoidance relating
to increased levels of distress over periods of between 2-months and 2-years.
3.4.5.3 Moderating effects
Central to the conception of coping is that it moderates the effect of the stressor (e.g. pain) on psycho-
logical well-being (Lazarus & Folkman, 1984). Evidence that coping moderates the impact on pain on
change in psychological well-being is rather weak. Notably, many studies did not report any moderation
effect. It is not clear whether they simply did not test for it, or whether they did but no effect was
reported because it was non-significant (and therefore deemed unimportant). Only one study reported a
significant moderating effect. G. K. Brown, Nicassio, and Wallston (1989) found disengagement coping
rather than engagement coping moderated the effect of pain on depression over a period of 6-months.
3.4.5.4 Appraisals
The Transactional Model posits that coping involves a primary appraisal—that is an appraisal that the
situation is threatening. Most studies in this review assume that the pain and limitation experienced by
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an individual are in themselves stressful, failing to account for the individuals’ appraisal of the situation.
Schiaffino and Revenson (1995) did however investigate this effect. In a study of 64 RA patients, threat
appraisal and challenge appraisal were not observed to have a direct effect on changes in distress and,
furthermore, no moderating effect on the impact of pain was observed.
In summary, there is some evidence for the role of coping strategies, particularly those related to dis-
engagement, being longitudinally related to changes in psychological well-being. However, few studies
have considered the potential stress buffering or elevating effects of particular coping strategies.
A recent systematic review, published after this review was conducted, focused on the longitudinal
association between coping and psychological distress in RA (Vriezekolk, Lankveld, Geenen, & Ende,
2011). The review included all of the studies discussed in the present review but also several others that
did not control for baseline levels of psychological distress. Categorising all studies using a hierarchical
variant of the engagement/disengagement taxonomy, they reported unadjusted bivariate associations be-
tween various coping strategies were moderate (engagement: r = .007 to .46; disengagement: r = .29
to .64), however evidence for a longitudinal association adjusting for baseline distress was weak, con-
firming the findings of this review. In addition, in line with this review they also found that the strongest
evidence was for a moderate association between disengagement coping and changes in distress over
time. The authors suggest that the ‘flexible use of a variety of coping strategies across situations that may
be beneficial for adjustment to a chronic disease, perhaps especially in RA with its fluctuating and often
unpredictable disease course’ (p.6 Vriezekolk et al., 2011). Coping flexibility is likely to be an important
area for future research. Currently there is no research focusing on coping flexibility in RA, and to my
knowledge, no studies have assessed whether coping flexibility is longitudinally related to distress in any
population.
3.4.6 Illness cognitions
This section covers evidence for illness related cognitions that have been implicated in the adjustment
to physical illness. A plethora of social and health psychological models have been developed to explain
cognitive processes in illness. Rather than discussing each in turn a general model of illness cognitions,
the Self-Regulatory Model of illness representations (SRM; Leventhal et al., 1984) is used as a framework
within which evidence from studies applying other (related) theories is discussed. These related theories
include studies of self-efficacy (Bandura, 1977), attribution theory (Weiner, 1986), learned helplessness
(Abramson et al., 1978) and hopelessness depression (DeVellis & Blalock, 1992).
The SRM posits that individuals form a ‘common-sense’ representation of their illness that informs
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coping procedures undertaken to tackle the illness threat (Leventhal et al., 1984). The specific content
of illness representations are termed illness perceptions, which have been described as ‘an organized set
of beliefs regarding how the illness affects our body, it’s likely impact on life activities and experiences,
whether it can be cured and so on’ (p.85 A. A. Kaptein & Weinman, 2004). Five key dimensions of illness
perceptions have been identified—namely, identity, cause, time-line, consequences and control (Petrie et
al., 1996)—which are introduced along with the discussion of the literature in the following sections.
3.4.6.1 Identity
Identity refers to the individual’s mental schema for an illness. Their beliefs concerning the signs and
symptoms—such as joint swelling and pain—that they attribute to an illness (Bishop & Converse, 1986).
Two studies considered the role of illness identity. Unsurprisingly, both found identity to be related to
self-reported somatic symptoms (Scharloo et al., 1999; Sharpe et al., 2001) as well as being related cross-
sectionally with distress (Sharpe et al., 2001). Scharloo et al. (1999) observed a significant longitudinal
association with depression (β = .35, p < .001). However, Sharpe et al. (2001) reported that identity
was not selected in a stepwise regression model for depression assessed by the Hospital Anxiety and
Depression Scale (HADS), although power was limited as a result of the small sample size in their
analysis (n= 22).
3.4.6.2 Cause
Causal beliefs concern the factors believed to have resulted in the development of the illness and are
typically multidimensional. Common causes ascribed to many conditions, including RA, are heredity,
environment, stress, behaviour, fate or chance (Moss-Morris et al., 2002).
Three studies included in this review considered the role of causal perceptions on changes in distress.
Perceptions concerning the causes of their RA held in the early stages of the disease were observed
to impact on subsequent psychological well-being in one study (Scharloo et al., 1999). Specifically,
individuals who perceived themselves to be responsible for their RA experienced significantly increased
levels of distress 4-months later. However, two further studies observed no longitudinal association
(Schiaffino et al., 1998; Sharpe et al., 2001).
The notion of causal perception in the SRM model has considerable overlap with Attribution Theory
(Weiner, 1986), a topic that was the focus of two studies (DeVellis & Blalock, 1992; Chaney et al.,
2004). Causal attribution theory posits that causal beliefs comprise of three dimensions: locus of causality
(internal/external), stability, and controllability (Weiner, 1986). Interpreting the findings of (Schiaffino
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et al., 1998) using this framework suggests that individuals with an internal locus of causality and high
perceptions of the controllability of the condition 6 was related to increasing distress. This was partially
confirmed by the two studies explicitly concerning causal attribution theory. Chaney et al. (2004) found
individuals who tended to make internal attributions were more likely to experience increased depressive
symptoms over a period of one-year (r = .40, p < .05), as well as a general disposition towards negative
attributions (r = .39, p < .05).
Attributions relating to stability and controllability are discussed in the following sections.
3.4.6.3 Timeline
The expected duration of the illness is referred to as its timeline, relating to whether the condition is
considered acute, cyclical or chronic (Leventhal et al., 1984). In practice perceptions of illness timeline
are typically assessed in terms of the conditions perceived chronicity and cyclicality (Moss-Morris et al.,
2002). It is assumed that individuals with beliefs that their condition is acute fall at the low-end of the
chronicity continuum.
Only one study considered the relationship between individuals’ perceptions of the chronicity of their
RA and changes in psychological well-being (Scharloo et al., 1999), finding that increased perceptions
of the chronicity of the condition were related to increased anxiety but not depression 1-year later
(β = .16, p < .001). A separate study considered the role of perceptions of the cyclicality of RA, but did
not consider chronicity (Schiaffino et al., 1998). This study observed no association between perceptions
of the cyclicality of the condition and depression 4-months later.
Returning to the two studies concerning attribution theory, it is expected that individuals with a
stable attribution style are likely to perceive their condition as more chronic. Only one study observed
a significant effect. In their study of 57 RA patients over a period of 4-months, DeVellis and Blalock
(1992) reported that individuals with a stable attribution style experienced greater increases in distress
4-months later (β = .19, p < .05).
3.4.6.4 Control
The role of control in the relationship between stress an illness has been extensively studies and forms
a central component of a variety of psychological theories pertinent to this review. As well as the SRM,
control forms part of Social Learning Theory (Bandura, 1977), Learned Helplessness (Seligman, 1972)
and the Hopelessness Theory of Depression (Abramson, Metalsky, & Alloy, 1989) to name a few.
6assuming that perceptions of curability relate to controllability
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The SRM splits control into two related dimensions—personal control and treatment control. These
dimensions, deliberately, have some overlap with Social Learning Theory (Bandura, 1977). Bandura’s
concept of self-efficacy refers to an individual’s perception of their ability to carry out a certain task,
(personal) control is implicit within this. Furthermore, treatment control relates to Bandura’s concept of
outcome-efficacy, the belief that a certain behaviour (i.e. in this context taking medication) will lead to a
certain outcome.
Three studies specifically, considered the longitudinal association of control with distress in the con-
text of the SRM in RA patients. None of the studies however distinguished between personal and treat-
ment control. Instead using a general measure of control included in the first version of the Illness Per-
ception Questionnaire (Weinman, Petrie, Moss-Morris, & Horne, 1996). Of these studies only Schiaffino
et al. (1998) observed a significant association between control, in terms of the curability of the con-
dition, and distress, such that patients who saw RA as curable experienced increased levels of distress
4-months later. Both Sharpe et al. (2001); Scharloo et al. (1999) observed no longitudinal association
after controlling for baseline levels of distress.
Four studies of three cohorts considered self-efficacy (Brekke et al., 2001, 2003; Lowe et al., 2008;
Schiaffino et al., 1991). All observed significant bivariate correlations between self-efficacy and distress.
In two studies of the same cohort of patients with established disease followed-up after 2- and 5-years
self-efficacy for pain was found to be related to distress, such that individuals with greater perceptions
of their ability to control their pain experienced lower distress (and pain) at both follow-ups (b2-years =
.05, p < .05; b5-years = .13, p = .04). Lowe et al. (2008) also observed a significant association between
self-efficacy and distress, but over a much shorter period of 2-months. They also reported an interaction
between self-efficacy with acceptance, such that individuals with greater increases in acceptance and
self-efficacy over the period of follow-up experienced the greatest improvement in distress. Schiaffino
et al. (1991) however did not report the significance of any longitudinal association and perhaps it is
appropriate to infer that none was observed.
Furthermore, Treharne et al. (2007) did not observe self-efficacy to be associated with future psy-
chological distress or positive well-being. Further tests for moderation with either psychological distress
or psychological well-being were also negative.
T. W. Smith et al. (1994) addressed helplessness, observing a non-significant relationship between
helplessness and later depression, and no interaction between feelings of helplessness and cognitive
distortion, which would have been expected. Although, DeVellis and Blalock (1992) did observe a sig-
nificant longitudinal association between the related construct of hopelessness and changes in distress.
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Although one must caution that the periods of follow up were very different, 4-years in the former and
4-months in the latter. 7
3.4.6.5 Consequences
Consequences refers to beliefs concerning the effects of the illness on physical and psychological well-
being, as well as wider social and economic consequences. Symptoms are commonly related to percep-
tions of consequences, a finding which has been observed for RA as well as a number of other chronic
conditions (Moss-Morris et al., 2002).
Perceptions of the seriousness of the consequences of the condition predicted worse psychological
distress one-year later (Schiaffino et al., 1998). Furthermore, an interaction was observed such that
individuals who saw their disease as more serious experienced greater levels of distress at follow-up if
they also had higher levels of functional disability. In a separate study of the same cohort, Schiaffino and
Revenson (1995) reported that for individuals with greater perceptions of the consequences of the con-
dition, having lower initial depression predicted higher depression at follow-up. In a separate study of
71 Dutch RA patients, Scharloo et al. (1999) observed perceptions concerning consequences as predic-
tive of worse psychological distress one-year later (β = .35, p < .001). Perceptions of consequences also
predicted increased levels of fatigue at follow-up. The finding with regard to the association between
perceptions of consequences and psychological distress was further supported by a small study of just 22
RA patients recruited within 2-years of disease onset assessed 6 times over a 21-month period (Sharpe
et al., 2001). Controlling for initial levels of distress, disability, pain and pain coping, higher perceptions
of consequences were associated with higher levels of distress at later assessments.
Treharne et al. (2007) considered consequences in an analysis of baseline predictors of residualised
change in psychological and physical well-being over a period of 6 and 12-months. Controlling for base-
line well-being and sociodemographic characteristics, perceptions of consequences were not found to be
associated with changes in psychological well-being (assessed by depression, anxiety or life satisfaction).
3.4.6.6 Coherence
Coherence is related to other illness perceptions, representing and individuals’ perceived level of under-
standing of their conditions. Currently, no studies have considered the longitudinal association of illness
coherence and psychological well-being.
7It may not be too much of a theoretical leap to suggest that helplessness relates to personal control, the perception that
one can do something about one’s situation, and hopelessness to treatment control, the perception that something can be done
about the situation.
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3.4.6.7 Summary
Together these findings provide evidence for the importance of illness perceptions in the dynamic rela-
tionship between disease and psychological well-being. Perceptions relating to causality, consequences
and control8 appear to be particularly important. Currently only the doctoral dissertation of Treharne
(2004) considered the longitudinal association between illness perceptions and positive well-being. This
study only considered consequences observing no impact on life satisfaction over 6-months.
3.5 Conclusions and justification for the current study
This chapter has systematically reviewed the evidence for the impact of demographic, clinical and psy-
chosocial factors on changes in distress over time in RA. Although a total of 50 studies were identified,
those focusing on a particular factor or topic, particularly for psychosocial, were usually small in number
and resultantly the weight with which conclusions can be made is limited (see Table 3.4).
Evidence for the influence of demographic factors was in general weak. It seems unlikely that demo-
graphic factors have a direct influence on well-being, their effects mediated by clinical and psychosocial
factors.
Most studies including disease duration as a covariate observed little association with psycholog-
ical well-being. However, a crude meta-analysis of the average levels of distress reported by studies
including only individuals with early RA indicated a potential reduction in distress over time. This first
appears somewhat in contrast with the expectation that distress would be related to somatic symptoms
such as functional limitation, which increase with time due to the progressive nature of the disease.
Furthermore, population based studies report a deterioration in psychological well-being and quality of
life in elderly groups (Netuveli, Wiggins, Hildon, Montgomery, & Blane, 2006; Zaninotto, Falaschetti, &
Sacker, 2009). There are two potential explanations for this finding. Firstly, it may be that the diagnosis
of RA is in itself a stressful experience that causes distress early in the disease course, which gradually
over time normalises. A further explanation lies with disease control. It is notable that in studies of
early RA patients that report reductions in distress, reductions in somatic symptoms, particularly pain,
are also observed (e.g. Schieir et al., 2009; Thyberg et al., 2005). This points to reductions in distress
early in the course of the disease being related to increased control of symptoms through the initiation
of pharmacological treatments.
Longitudinally, although the evidence base was limited, there was little evidence to suggest that
8Personal control measured as self-efficacy
62
Chapter 3. Longitudinal studies of psychological well-being in rheumatoid arthritis
Psychological 
distress
Depression & Anxiety
Disease activity
swelling & 
inflammation
Somatic 
symptoms
pain, stiffness fatigue, 
functional limitation
Psychological 
distress
Disease activity
Somatic 
symptoms
Demographic 
Characteristics
Age, sex, SES
Social support
network, quality
Coping 
strategies
avoidance, denial, 
acceptance, active
Illness 
cognitions
cause, control, 
timeline, identity 
Figure 3.3: Simplified model of reviewed findings
changes in psychological well-being were related to levels of inflammation or joint damage. Although,
since inflammation and joint damage undoubtedly influence symptoms of pain and functional limitation
they are important distal antecedents to psychological well-being.
The overlap in the symptomatology of psychological disorder with somatic symptoms such as fatigue
and pain perception is an issue. Furthermore, since somatic symptoms and distress are both typically
assessed by self-report measures it is likely that the observed relationship is over-estimated due to the
presence of common methods bias. Nevertheless, it is striking that as well as strong cross-sectional
evidence for a link between somatic symptoms with distress, there is also moderate to strong evidence
for somatic symptoms being related to increases in psychological distress even controlling for baseline
levels of distress.
3.5.1 Theoretical model
The findings of the review are summarized graphically in 3.3. Solid lines indicate that evidence for a
link between two factors is moderate or strong. Dashed lines represent association where an association
is indicated by the literature but is supported by very few studies or where evidence is weak but still
theoretically plausible. Lines between psychosocial factors with disease activity, symptoms and distress
at the first time-point are not included for clarity, but are expected if measured concurrently.
Double headed arrows between concurrent symptoms and distress indicate that a bidirectional causal
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association is expected. It is likely that psychosocial factors moderate these effects, again lines are not
shown.
The dashed lines from social support and coping that intersect the path from somatic symptoms to
future distress, indicates an expected moderating effect. Specifically, a buffering effect of social sup-
port on the effect of somatic symptoms on distress is expected. Furthermore, an escalation effect for
disengagement coping on the same path is expected.
This model, which fits within the biopsychosocial framework (Engel, 1980), is adapted from the
models of Katon (2003), Verbrugge and Jette (1994), Escalante and del Rincon (2002) and Leventhal et
al. (1984).
3.5.2 Methodological quality
There were some major limitations concerning the methodologies applied by the studies included in
this review. There were few studies with long follow-up, or with multiple assessment occasions, and,
furthermore, when multiple assessment occasions were available typically statistical methods that could
make use of the richness of such data were not applied. For example, the majority of studies used some
form of residualised change analysis, examining changes between two time points. Only two studies
employed techniques appropriate for the assessment of change over time. Morris et al. (2008) used
latent trajectory models (described in Chapter 4) and Margaretten et al. (2009) employed a related
population averaged technique referred to as generalised estimating equation.
3.5.3 Aims and objectives
To recap, the overarching aim of this dissertation is to examine how psychological well-being in RA
changes over the course of the disease; and to identify demographic, clinical and psychosocial factors
that influence how the disease impacts on psychological well-being. Outlined below are the detailed
objectives of this study and some preliminary hypotheses with regard to the expected findings as each
of the objectives is assessed. The first two objectives will be addressed by secondary analysis of data
collected as part of an ongoing RA inception cohort, the Early RA Study (ERAS), that recruited all newly
diagnosed patients attending nine rheumatology clinics at hospitals in England in the late 1980’s and
early 1990’s. Due to the large size of the cohort and the detailed data with regard to psychological
distress collected over a period of many years advanced quantitative methods will need to be used.
The use of advanced quantitative methods for the analysis of longitudinal data will enable this study to
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resolve some of the ambiguity created by the lack of methodologically appropriate techniques employed
by many of the studies in this review. The three main objectives are now described.
Objective 1: To describe patterns of change in psychological well-being during the RA disease
course Evidence from the systematic review suggests that early in the course of the disease there is
potentially a reduction in psychological distress. Further evidence suggests that in patients with estab-
lished disease levels of distress are relatively stable. Resultantly, it is hypothesised psychological distress
will improve during the first years of the disease gradually stabilising with time. Furthermore, there
is limited evidence from an early RA sample that there are distinct psychological distress trajectories
following the onset of the condition (Persson et al., 2005). Combined with the reported level of hetero-
geneity in distress trajectories from other studies in this review (e.g. Hawley & Wolfe, 1988; Lowe et
al., 2008; Morris et al., 2008) it is expected that heterogeneous distress trajectories will be observed,
and that they will be more parsimoniously described by distinct trajectory characteristics, rather than a
single overall pattern of change.
Objective 2: To quantify the association between psychological well-being and somatic symptoms
The evidence for a cross-sectional association between psychological well-being and somatic symptoms
of RA is strong. However, as evidenced by the systematic review, whether a longitudinal association
exists is somewhat weaker, despite the strong theoretical position outlined in the previous chapter (see
section 2.2.2.3). The second objective of the dissertation is to examine using appropriate statistical
methods the strength of the longitudinal association between distress and somatic symptoms, such as
pain and functional limitation. This will take into account the synchronicity of changes in both domains
to provide greater insight into the causal mechanisms.
Objective 3: To investigate the impact of illness cognitions and coping on psychological well-being
The systematic review provided evidence for a role of illness perceptions—particularly identity, cause and
consequences—and coping strategies on the pathway between disease and psychological well-being.
However, the examination of the role of illness perceptions and coping, and the causal mechanisms
between the two, have not been thoroughly considered in RA samples, particularly in individuals soon
after disease onset. The framework outlined by the Self Regulation Model of illness cognitions (Leventhal
et al., 1984) will be used to guide the study of this objective and will consider whether illness perceptions
and coping impact on psychological well-being. Since illness perceptions and coping were not assessed
in the ERAS study, a separate prospective observational study was undertaken to address this objective.
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Each of these three objectives is addressed in an empirical chapter—Chapters 6, 7, and 8. A further
empirical chapter (Chapter 5) considers the construct validity of the measure of psychological well-being
used in the ERAS study, the Hospital Anxiety and Depression scale (HADS; Zigmond & Snaith, 1983).
This tool, although widely used, has generated much discussion in the literature with respect to the
number of dimensions of distress that it taps into. Given the likelihood of bias due to the overlap in
symptoms of RA and psychological disorder (Pincus, Griffith, Pearce, & Isenberg, 1996), the suitability
of the HADS will need to be considered in detail since the accurate assessment of distress in RA is
necessary for the interpretation of the findings from the longitudinal analyses presented. Due to the
high level of statistical analysis used in the empirical chapters the following chapter provides a detailed
description of the methods used.
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Latent variable modelling
4.1 Introduction
Due to the richness of the longitudinal data collected as part of the ERAS cohort it is necessary to use
appropriately advanced analytical techniques. This chapter provides an overview of the methodological
framework used in this thesis. This framework, which here is referred to as latent variable modelling
(LVM), is essentially a generalisation of the general linear model to incorporate unobserved (i.e. latent)
as well as observed variables. Also referred to as structural equation modelling (SEM), the term latent
variable modelling is preferred as the models considered in this chapter include extensions of traditional
SEM to incorporate multi-level data structures and mixture distributions. Numerous texts discuss these
approaches in detail (e.g. Bollen, 1989; Raudenbush & Bryk, 2002; Skrondal & Rabe-Hesketh, 2004;
Mulaik, 2009).
This chapter focuses on introducing the the concepts of latent variable modelling pertinent to the
analyses conducted in the empirical chapters. It is split into three main sections. The first introduces
latent variable modelling, describing its main principles, the assessment of model fit and estimation is-
sues with categorical data (Section 4.2). The second section provides an overview of the application of
latent variable modelling to longitudinal data (Section 4.3). The relationship to the multi-level model
for change is discussed and the further generalisation of the latent variable model to include mixture
distributions to explain heterogeneity in change is also discussed. The final section provides an overview
of a common problem with longitudinal studies, the presence of missing data. The main issues concern-
ing missing data are discussed, including the assumptions concerning the missing data mechanism made
by conventional analytic methods and the ability of latent variable modelling to relax some of these
assumptions and therefore provide more robust results.
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4.2 Latent variable modelling
4.2.1 Overview
The latent variable modelling framework is rooted in the tradition of path analysis (Wright, 1934). As
noted by Bollen (1989), the core features of latent variable modelling that can be traced back to its path
analytic origins are: (i) the use of path diagrams to graphically represent (causal) relations between
variables; (ii) equations relating covariances or correlation to the parameters represented in the path
diagram; (iii) the decomposition of effects in influences that are considered ‘direct’ or ‘indirect’. A latent
variable model typically, although not necessarily, consists of two components: a structural model and a
measurement model. These are described in the following sections.
4.2.1.1 Structural model
The path analytic component of a latent variable model is referred to as the structural model. This
structural model describes the hypothesized relationships between theoretical constructs. Figure 4.1
presents a path diagram that may represent the hypothesized relationship between pain, joint stiffness
and functional impairment in RA (the disablement process as described by Escalante & del Rincon,
2002). The square boxes indicate that the variables are observed from the data. It is important to note
that this model is simply a pictorial representation of a regression equation. As such the model presented
in Figure 4.1 can be written as
y = γ0+ γ1 x1+ γ2 x2+ ζ (4.1)
where y is the dependent, or endogenous, variable relating to functional limitation and x1 and x2 are the
predictor, or exogenous, variables relating to pain and joint damage, respectively. The γ terms represent
the regression parameters for the model.1 For example, γ1 is the expected change in y for a one unit
change in x1 holding the value of x2 constant. The error term ζ represents the residuals for the model.
The key feature of path analysis is that it extends to the multivariate situation (i.e. where there are
multiple regression equations, a simultaneous system of equations). These models are usually expressed
using matrix notation, which is not discussed here.
1Traditionally, latent variable models were estimated with respect to the covariance matrix of the observed variables only.
The means of the observed variables were not used. Resultantly, although it is now common to include the mean structure in
the latent variable model, typically the constant term γ0 is suppressed from the path diagram, as it is in Figure 4.1. Where
included it would be represented as a regression on a constant, defined by a triangle.
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Figure 4.2: Confirmatory factor analysis
4.2.1.2 Measurement model
Latent variable modelling generalises the path analytic model to include latent variables. A latent vari-
able represents a hypothetical concept that cannot be observed or measured directly but must be inferred
from a set of observed indicator variables. For example, an individuals’ level of functional impairment
cannot be observed directly but may be inferred from their ability to complete various functional tasks.
Within latent variable modelling a measurement model relates the latent variables to the indicator vari-
ables.
A latent variable model consisting of only a measurement model is typically referred to as a confir-
matory factor analytic (CFA) model2. Models that include both structural and measurement models are
commonly referred to as multiple-indicator multiple-cause (MIMC) models. Indicator variables are typi-
cally from self-report measures but may consist of other types of data. For example, indicator variables
for a latent functional impairment variable may be an individuals rating of their ability to complete basic
activities of daily living (walking, dressing etc.) on a continuous scale but could also include objective
measures such as grip strength, a shuttle walk test, or a chair-stand test. Such a model is graphically
2CFA is historically grounded in the tradition of (common) factor analysis (Spearman, 1904, 1927) and is based on
Thurstone (1947) concept of the common factor model. It is a theory-driven alternative to the data-driven method known
as exploratory factor analysis.
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depicted as a path diagram in Figure 4.2, which can be presented as a system of simultaneous equations
y1 = λ1η+ ε1
y2 = λ2η+ ε2
y3 = λ3η+ ε3 (4.2)
The η within a circle in Figure 4.2 indicates a latent variable. Also of note is the direction of the
arrows that go from the latent functional limitation variable η to the indicator variables y1, y2 and
y3, which might represent self-reported ability to complete basic activities of daily living, such as walk-
ing, dressing and bathing. This underlying assumption of factor analysis is that the observed relation
between the indicator variables are a result of the responses being caused by the latent variable. Fur-
thermore, the λ terms representing the regression weights, are also referred to as the factor loadings of
the observed items on the latent variable. Commonly standardised factor loadings are presented, which
can be interpreted as the correlation between the latent variable and the indicator. The residual terms ε
represents the variance in the indicator variables unexplained by the latent variable.
4.2.2 Model fit
The fit of structural equation models is assessed by comparing the covariance matrix predicted by the
model to the observed covariance matrix from the raw data. The χ2 test of exact fit is a test of the
equivalence of these two matrices, calculated as
χ2 = FML(N − 1) (4.3)
where FML is the minimised value of the maximum likelihood (ML) criterion. If the test is significant then
the predicted covariance matrix does not sufficiently reproduce the observed covariance matrix. That is,
the model does not fit the data well. However, several issues regarding the χ2 test of exact fit have been
noted (Mulaik, 2009). Most notably, with the large sample sizes typical of structural equation models
the test is over-powered since the χ2 value is a function of the sample size. That is, with large sample
sizes solutions based on large samples may be rejected when the differences between the predicted and
observed matrices are negligible.
As a result of the problems with the χ2 test of exact fit a number of other indices have been proposed.
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The number of “goodness-of-fit” indices developed is large, but only three popular indices that have been
observed to perform favorably in simulation studies are discussed here. The Root Mean Square Error
of Approximation (RMSEA; Steiger & Lind, 1980), so named because it assesses the extent to which a
model fits reasonably well in the population. The RMSEA is calculated using the non-centrality parameter
corresponding to the non-central χ2 distribution of the test of exact fit. A value of the RMSEA of zero
indicates perfect fit and values close to zero indicate close fit. Models with an RMSEA of less than .08
have been suggested to provide acceptable fit to the observed covariance matrix (Bentler, 2007).
A further index is the Comparative Fit Index (CFI; Bentler, 1990). This index evaluates the fit of
the model to the null model (i.e. a model with the covariances between all variables fixed to 0 but the
variance freely estimated). Values range between zero and one with those approaching one indicating
good fit. A related method is the Tucker-Lewis Index (TLI; Tucker & Lewis, 1973), which additionally
adjusts for the complexity of the model (i.e. less complex models with the same χ2 as more complicated
models are preferred). For both the CFI and TLI values above .95 are suggestive of good fit.
Information criterion are commonly used in the comparison of non-nested models.3 Such indices
allow for the comparison of fit by adjusting for the complexity of the model. Two indices are commonly
reported for latent variable models and are discussed here, although more do exist. The Akaike Infor-
mation Criterion (AIC; Akaike, 1974) is based on the χ2, which is adjusted for model complexity by
a penalty function that is added to the χ2 value based on the number of parameters estimated by the
model. A further index, the Bayesian Information Criterion (BIC; Schwarz, 1978), additionally adjusts
for sample size such that the penalty increases with increasing sample size. Smaller values of both in-
formation criterion indicate better fit, no criteria have been defined with respect to the interpretation of
the magnitude of difference in information criterion across models.
4.2.3 Non-normal and categorical data
The standard ML method for estimating structural equation models (Jöreskog, 1967) assumes that the
data are multivariate normal. However, this assumption is often compromised in the presence of non-
normal or categorical data (Bollen, 1989, p.p.131–134). Continuous variables that contribute to the
violation of this assumption due to non-normal univariate distribution may be normalised by monotonic
transformation—including square-root, logarithmic and inverse transformation. However, ordinal and
nominal level variables are common for which transformation will not typically resolve the issue. The use
of dummy variables for exogenous binary data and sets of dummy variables for ordinal and multinomial
3Nested models can be compared using a standard χ2 difference test
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Figure 4.3: Confirmatory factor analysis with ordinal indicator variables
exogenous data is often satisfactory, resulting in biases to the assumption of multivariate normality that
will not adversely effect model parameters (Bentler & Chou, 1995). However, ordinal or multinomial
endogenous variables are more of a concern.
This issue is particularly salient for confirmatory factor analysis where ordinal variables, for exam-
ple with a Likert type response format, are commonly used as measures of a theoretically continuous
construct. Specifically, when the response format is skewed or there is a restricted number of response
categories the variance may be under estimated, resulting in estimates of correlations and covariances
(by the Pearson method) that are attenuated (Bollen, 1989). This has ramifications for the measurement
model, causing (i) biased parameter estimates, (ii) biased fit statistics, and (iii) underestimation of the
standard errors for model parameters (T. A. Brown, 2006).
Alternative estimation methods have been proposed for latent variable modelling that relax the as-
sumption of multivariate normality. A detailed review and simulation study in the context of confirma-
tory factor analysis is provided by Flora and Curran (2004). A brief summary of these methods and the
recommendations from this simulation are now given.
These alternative estimation methods are all based on the use of polychoric correlations.4 The poly-
choric correlation, originally devised by Pearson (1900), estimates the linear relation between two un-
observed continuous variables given only ordinal level data. The assumption is that the observed values
of the ordinal variables are due to some unobserved underlying continuous latent response distribution
(B. Muthén, 1983). This model is graphically depicted in Figure 4.3, the y∗ variables indicate the unob-
served continuous variables.
4Polychoric correlations are applied to ordinal variables. For binary variables tetrachoric correlations are used, and for
mixtures of ordinal and continuous variables polyserial correlations are used. The same assumption that the categorical
variables manifestly assess unobserved continuous variables holds.
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Differences between the estimators are typically due to the weight matrix applied in conjunction
with the polychoric correlation matrix and are extensions of the weighted least squares method (WLS;
T. A. Brown, 2006)—sometimes referred to as the asymptotic distribution free method (ADF). The WLS
estimator uses a weight matrix that adjusts for violations in multivariate normality by weighting the
asymptotic variances and covariances and kurtosis. However, this method requires large samples for ac-
curate estimation of kurtosis and, furthermore, may result in non-positive definite matrix in the presence
of high levels of skewness in small samples (Flora & Curran, 2004).5
To counter these issues, B. Muthén, du Toit, and Sipsic (1997) developed a robust WLS method
(WLSMV) that uses a diagonal weight matrix that is not inverted, and therefore does not require the
matrix to be positive definite, along with robust standard errors. Furthermore, this method produces a
mean and variance-adjusted χ2 test statistic. The results of the simulation study conducted by Flora and
Curran (2004) indicated that the WLSMV estimator was superior to WLS in samples ranging from 100 to
1000 with varying degrees of non-normality and model complexity. Furthermore, the WLSMV estimator
performed well with sample sizes of 200 with high levels of skewness and kurtosis.
Another alternative is the unweighted least squares (ULS) estimator. This method, analogous to
ordinary least squares, uses an identity matrix rather than a weight matrix avoiding assumption of
multivariate normality. As a result, this estimator does not lead to estimates of standard errors or a χ2
test statistic.
In addition to the WLS and related methods, robust ML is also commonly used in the presence of
non-normal or categorical data (Bentler & Chou, 1995). As with the previously described methods,
robust ML uses a weight matrix that adjusts the parameter estimates and fit statistics for non-normality.
However, since the standard errors of the parameters rather than parameters themselves are adjusted,
in the presence of categorical data, biased parameter estimates remain a potential problem.
It is important to note that the methods above apply not only to confirmatory factor analysis, the
measurement part of latent variable modelling, but also to the structural model as well. That is, latent
variable modelling allows for the multivariate generalisation of the generalised linear model.
4.2.4 Latent variable mixture modelling
Traditionally, latent variable models allowed for only the use of continuous observed and latent vari-
ables. As has been noted the development of more flexible estimation techniques in the 1980’s and
5A non-positive definite matrix refers to a matrix with zero or negative eigenvalues. WLS estimation requires the weight
matrix to be inverted, which is not possible if the matrix is non-positive definite.
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1990’s allowed for the inclusion of ordinal and nominal observed exogenous variables. However, re-
cent extensions of the latent variable modelling framework have allowed for the inclusion of categorical
latent variables, also referred to as mixture modelling (B. Muthén & Muthén, 2000; B. Muthén, 2001;
B. Muthén & Asparouhov, 2009). This increased flexibility has lead to the development of newer and
more complex models that are particularly useful in the analysis of the longitudinal data (Pickles &
Croudace, 2010). However, before these models are discussed in detail a brief overview of latent vari-
able mixture modelling is provided.
The CFA model incorporates continuous latent variables, the corresponding model incorporating a
categorical latent variable is widely known as the latent class model (B. Muthén, 2001). Latent class
analysis6 can be viewed as a model based form of cluster analysis, which in particular relates to the
k-means clustering approach. Although these models are not new (c.f. Lazarsfeld & Henry, 1968;
McDonald, 1967), the ability to fit such models within a latent variable modelling framework allows for
the use of the other features that increase the flexibility of situations where these model may be applied.
For example, building on the earlier work of McDonald (1967, 2003), Lubke and Muthén (2005) applied
a hybrid model incorporating both continuous and categorical latent variables, a factor mixture analysis.
In addition, B. Muthén (1992) presents an interesting approach to the study of alcohol dependency
that provides both a continuous and dimensional account for this disorder (section 2.2.2.1 provided a
discussion of the categorical and dimensional accounts for depression).
These models are interesting and are beginning to be used more widely in the applied literature.
However, the application of latent variable mixture models provides a host of interesting new possibil-
ities. Prior to the discussion of latent variable mixture modelling in the context of longitudinal data
continuous latent variable models are introduced.
4.3 Latent variable models for longitudinal data
Latent curve models (LCM) are an extension of (ordinary least squares) linear regression that accounts
for the hierarchical structure of the data. Different parameterizations of this model have been ascribed
different names (e.g. multi-level modelling, hierarchical linear modelling, mixed-effects models). Models
fitted using the SEM approach are also commonly referred to as latent growth models or latent growth
curve models. These are avoided in this dissertation as the term growth is misleading since models with
6Typically the term latent class analysis is applied when the indicator variables are categorical. For continuous indicator
variables the term latent profile analysis is widely used. The term latent class analysis is used here to refer to both types of
mixture model with continuous and/or categorical data.
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decreasing as well as increasing trajectories are allowed.
The LCM is a special case of CFA (Meredith & Tisak, 1984; McArdle & Epstein, 1987; Meredith
& Tisak, 1990). Although equivalent to hierarchical linear models (Raudenbush & Bryk, 2002) it is
important to recognise that the different parameterizations give the models slightly different features.
For example, the CFA approach allows for greater control over the residual correlation structure, whereas
the multilevel approach can incorporate time values more flexibly (c.f Bollen & Curran, 2006). The LCM
is introduced from a multi-level modelling perspective as it provide a more intuitive explanation of the
model as a direct extension of the general linear model.
Linear regression is not appropriate for longitudinal data since the nested structure of the data
violates several assumptions. Referring to the outcome at each time point yt , the intercept term α,
the time trend variable λt , the slope β and the disturbance for each time point εt we have a model
describing the trajectory of the outcome over t time periods.
yt = α+λtβ + εt (4.4)
Linear regression assumes that the disturbances have a mean of 0, is uncorrelated with the time
trend variable λt , is homescadastic, and is non autocorrelated (Table 4.1). Fitting the model described
in 4.4 violates these assumptions. For example, we would expect the disturbances of each individual to
be associated with other observations for that individual. Also, for longitudinal trajectories, for example
joint damage in RA, we would expect that the variance increases with time, resulting in heteroscadastic-
ity. Furthermore, we would often expect disturbances to be autocorrelated, that is, for disturbances to
be more highly associated at more proximal time points.
To deal with these violations we can extend the above model by indexing several of the parameters
in the equation for each individual i, leading to the trajectory equation
yi t = αi +λtβi + εi t (4.5)
where yi t is the value of the outcome variable y for the ith individual at time t, αi is the random
intercept for individual i, and βi is the random slope for individual i. This allows each individual i to
have a distinct intercept and slope to describe the trajectory of the outcome variable y over time t. The
value of λt is constant over all individuals (and hence is not indexed by i). For example, for three time
points t1 = 0, t2 = 1, and t3 = 2 for all individuals.7
7Typically the time variable λt is coded as λt = t − 1, allowing the interpretation of the intercept factor αi as the starting
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Table 4.1: Assumption of simple linear regression compared to latent curve model
Assumption Linear regression latent curve model
Disturbance has
mean of 0
E(εt) = 0 for t = 1,2, . . . , T E(εi t) = 0 for i = 1,2, . . . , N
and t = 1,2, . . . , T
E(ζαi) = 0 for i = 1,2, . . . , N
E(ζβ i) = 0 for i = 1,2, . . . , N
Disturbance
uncorrelated with
covariates (and other
disturbances)
COV (λt ,εt) = 0 COV (λt ,εt) = 0 for i 6= j
COV (εi t ,ζαi) = 0
COV (εi t ,ζβ i) = 0
COV (ζαi ,ζαi) = 0 for i 6= j
COV (ζβ i ,ζβ i) = 0 for i 6= j
COV (ζαi ,ζβ i) = 0 for i 6= j
Homoscedasticity E(εt 2) = σεε for t = 1,2, . . . , T E(εt 2) = σεε for i 6= j
Nonautocorrelation COV (εt ,εt+1) = 0 COV (εt ,εt+1) = 0 for i 6= j
Adapted from Bollen and Curran (2006).
The mean intercepts and slopes for individuals i are of interest and lead to the intercept and slope
equations
αi = µα+ ζαi (4.6)
βi = µβ + ζβ i (4.7)
where µα and µβ are the mean intercept and mean slope across all individuals i, respectively. Equation
(4.6) represents the individual intercept αi as a function of the mean of the intercept µα for all cases
and a disturbance ζαi . Where ζαi is the difference between the individuals score on outcome y and the
grand mean where λt = 0. Similarly, equation (4.5) represents the individual slope βi as a function of
the mean of the slopes for all cases µβ and a disturbance ζβ i .
Using multi-level terminology the trajectory equation (4.5) is commonly referred to as the level-
1 equation, since it refers to the first level of assessment (observations), and the intercept and slope
equations (4.6) and (4.7) as the level-2 equations, since they refer to the second level of assessment
(individuals).
We can combine the trajectory, intercept and slope equations into a single model that is often referred
to as the reduced form model,
yi t = (µα+λtµβ) + (ζαi +λtζβ i + εi t) (4.8)
point of the trajectory since λ1 = 0.
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The first term in parenthesis is referred to as the fixed component and the second term the random
component. The fixed components reflects the mean structure and the random component the sources
of individual variability. It shows that the trajectory of yi t is a function of the mean intercept, the trend
variable times the mean slope and a composite disturbance term. This formalization leads to familiar
but less restrictive assumptions (Table 4.1).
4.3.1 Latent variable modelling approach
Meredith and Tisak (1984) demonstrated that the latent curve model could be fitted using confirmatory
factor analysis, with the random intercepts and slopes as latent variables (McArdle & Epstein, 1987;
Meredith & Tisak, 1990). Using the linear latent curve model as an example this model can be fitted us-
ing a two-factor multiple indicator confirmatory factor analysis. Figure 4.4 provides a path diagrammatic
representation of the equations of the latent curve model.
The multiple indicators are repeated measures of y for each individual i over time points t. The first
latent factor α represents the random intercept component of the trajectory. The loadings for this factor
are all fixed to one. The loadings of the second factor β define the shape of the trajectory and also at
which time point the intercept is. In the figure the time units are equally spaced, t1 = 0, t2 = 1, t3 = 2,
reflecting equal time passage between assessment such that the shape of the trajectory is linear. Note
that any equally spaced values for λt could be used and the model would be equivalent—although the
slope parameter would differ the model implied trajectory would remain the same.
The two factors are commonly referred to as the trajectory or growth factors, with α referred to as
the intercept factor and β the slope factor. These are unobserved variables that are estimated from the
data. Although it is typical to represent continuous latent factors using the Greek latter η, the Greek
α β
y1 y2 y3 yt
ε1 ε2 ε3 εt
1 1 1 1
0 1 2 λt
Figure 4.4: Linear latent growth curve model
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letters α and β are used here, in line with the multi-level literature, since they make it more explicit that
they measure different characteristics of the trajectory curve.
Unlike many CFAs the LCM explicitly models both the means and the covariance’s among the ob-
served variables, rather than just the covariances. However, a restrictive mean structure is applied, with
the intercepts of the repeated measures set to 0 and the means of the factors estimated. Resultantly the
model-implied mean structure is entirely dependent on the means of the latent factors (Bollen & Curran,
2006).
In addition the CFA approach estimates all the parameters of the latent curve model: residual vari-
ances of the repeated measures (the variance in the repeated measure not explained by the underlying
growth process); the means of the latent growth factors representing the mean starting point the the
mean rate of change; the variances of the growth factors reflecting the variability in the random inter-
cept and slope factors around their mean; and also the covariance between the random intercepts and
slopes.
4.3.2 Nonlinear time trajectories
In the previous section the linear latent curve model was described. For this model the values of the
time variable λt must be equally spaced. In the example given t1 = 0, t2 = 1, t3 = 2, however as noted
equivalent results would be given by any other equally spaced values (e.g. t1 = 0, t2 = 2, t3 = 4, or
t1 = 0, t2 = 10, t3 = 20 etc.). Furthermore, where the repeated measurements are not equally spaced
the time variable loadings can reflect this. For example, in a study with three repeated measurements
where assessments are made at baseline, 1-year and 5-years the loadings for the linear trajectory model
could have the loadings t1 = 0, t2 = 1, t3 = 5.
Nonlinear functions of time are easily estimated via two different methods. Firstly, further latent
variables may be included in a manner akin to including polynomials in a linear regression model, or
non-linear transformations of the λt loadings may be used.
Considering first the polynomial approach. Quadratic trajectories can be modelled by including a
third latent variable in the model, where the loadings of the of the time variable λt are squared. The
level-1 trajectory equation becomes
yi t = αi +λtβ1i +λ
2
tβ2i + εi t (4.9)
where λ2t is the squared value of time at assessment t, and β2i is the individually varying value of the
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α β1 β2
y1 y2 y3 yt
ε1 ε2 ε3 εt
1 1 1 1
0 1 2 λt
0 1 4 λ2t
Figure 4.5: Quadratic latent growth curve model
quadratic component of the curve. That is, β2i represents the curvature of the line. αi still defines
the intercept and β1i the linear slope. Along with the intercept and slope parameters αi and β1i the
curvature parameter β2i is treated as a random variable and the level-2 equations are
αi = µα+ ζαi
β1i = µβ1 + ζβ1i
β2i = µβ2 + ζβ2i (4.10)
Equation (4.10) can be expressed as a path diagram (Figure 4.5). As with the random effects in
the linear model β2i is assumed to be uncorrelated with disturbance, COV (εi t ,ζβ2i ) = 0 for all i and
t = 1, 2, . . . , T .
This method can be extended to cubic trajectories by including a third-order polynomial or, in princi-
ple, any number of polynomial terms. For identification of the quadratic latent curve model a minimum
of four time points is required, and for each additional polynomial term included a an additional mea-
surement i.e. 5 time points for cubic, 6 for quartic and so on. A proof of the identification of the quadratic
model is provided by Bollen and Curran (2006).
In practice, Bollen and Curran (2006) recommend against the use of higher order models above
the quadratic due to the increasing complexity of the interpretation. Since the linear model implies a
constant change over time, the quadratic model a change in the rate of change over time, and the cubic
model a change in the change in the rate of change over time.
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An alternative approach is to incorporate non-linear transformations of the time loadings λt into
the model. These unequally spaced loadings allow for the assessment of different nonlinear trajectories.
This approach is described in detail by Browne and Du Toit (1991) and Toit and Cudeck (2001). Four
common parametric forms are briefly discussed: exponential, logarithmic, square-root and reciprocal
trajectories. For clarity, we can represent the LCM with a non-linear transformation of the time loadings
as
yi t = αi +λ
†
tβi + εi t (4.11)
where λ†t represents the transformed time loadings. For the exponential model λ
†
t corresponds to the
transformation 1 − e1−λt . Exponential functions are common in the assessment of growth or decay
since the exponential trajectory is monotonic tending to an asymptote without changing direction. This
offers an advantage over polynomial models that may increase or decrease without limits. Under the
exponential model βi represents the model implied expected total change in yi t as time tends to infinity.
An alternative specification of the exponential model described by Grimm and Ram (2009) uses the
transformation λ†t = 1− eγλt . Again βi is interpreted as the model implied expected total change in yi t
as time tends to infinity. However, later change is directly proportional to earlier change with e−γ. In
the model γ is a fixed factor representing the rate of acceleration or deceleration over time. This implies
that individual variability is allowed in the individual staring point and the total amount of change over
time, but that the rate of change is fixed for all individuals.
Another useful nonlinear function is the natural logarithm of time. The logarithmic trajectory repre-
sents diminishing increments of change over time—as opposed to equal increments for the linear model.
The logarithmic trajectory may be defined where λ†t = f (λt). For the logarithmic function of time
λ†t = ln(λt), where λt = 1,2, 3, . . . , T corresponds to ln(λt) = 0,0.693, 1.099, . . . which corresponds to
changes of 0.693 between time 1 and 2, 0.496 between time 2 and 3, 0.287 between time 3 and 4, and
so on.
The square root trajectory may be defined where λ†t =
p
λt −1 and the reciprocal λ†t = 1− 1λt . Both
also involve a diminishing rate of change. All transformations are coded such that the intercept relates to
t1—that is, where λ
†
1 = 0. The proportionate change for the four transformations discussed is displayed
in Figure 4.6.
Meredith and Tisak (1990) provide a useful alternative method for modelling curvilinear trajectories
by freeing one or more of the loading on the random slope factor. They propose that the first loading be
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Figure 4.6: Proportional change over 10 repeated measures using non-linear transformations of
time
set to zero (λ1 = 0) and the second to one (λ2 = 1) but freely estimating the λt for t = 3, 4, . . . , T . The
free loadings are a type of nonlinear spline that best fits the data between two time points. Models using
this method with four or more time points are identified8 Interpretation of the estimated factor loadings
is straightforward. Since λ1 = 0 and λ2 = 1 the estimated factor loadings represent change in relation
to the change observed between the first two time points (ratio). For example, if λ3 were estimated to
be 2 the change between time 1 and 3 would be interpreted as double that of the change between time
1 and 2 (i.e. linear change). However, if λ3 were estimated to be 1.5 this would indicate that the change
between time 1 and 3 was only 1.5 times the change between times 1 and 2—indicating a deceleration
in the rate of change. A variation on this method is to fix the first loading to zero (λ1 = 0) and the last
to one (λt = 1) while freely estimating λt for t = 2, 3, . . . , T − 1. In this case the interpretation is the
proportion of the total change.
Other non-linear models, including cyclic patterns and piecewise growth are also possible but are not
considered here. It is worth noting that the implementation of polynomial factors and non-linear trans-
formations of the time λt loading simultaneously possible and may be considered an ad hoc approach to
the fractional polynomial method (Sauerbrei & Royston, 1999; Long & Ryoo, 2010).
8Three or more if µα1 6= µα2 (Bollen & Curran, 2006).
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4.3.3 Latent variable mixture models for longitudinal data
The previous sections have describe the latent variable modelling approach to the analysis of longitudi-
nal data, through the use of continuous latent variables.9 Latent variable mixture modelling approaches
to longitudinal data that use categorical latent variables are also available, commonly referred to as
latent class growth analysis (LCGA) or group-based trajectory modelling (e.g. B. Muthén, 2006a; Nagin &
Odgers, 2010; Pickles & Croudace, 2010). Rather than considering individual trajectories and assuming
that a single trajectory adequately approximates change over time for the entire population, LCGA pro-
vides a typological representation of change. That is, a categorical latent variable represents a mixture
of subpopulations (latent classes) with distinct patterns of change where membership is unknown and
is inferred from the data. Notably, LCGA assumes that there is no within class heterogeneity in either
intercept or slope.
A further latent variable mixture modelling approach that incorporates both continuous and categor-
ical latent variables provides a more flexible approach than the LCGA framework that naturally extends
the LCM. This approach is commonly known as Growth Mixture Modelling (GMM; B. Muthén, 2001;
B. Muthén et al., 2002). To the linear LCM (Equation 4.5) we add a categorical latent variable c repre-
senting the unobserved subpopulation group, with k levels (k = 1,2, . . . , K) and each individual i having
a probability of membership in each of the k levels. Thus, a GMM can be expressed as
yi t =
K∑
k=1
Pr(c = k)[αki +λktβki + εkit]
αki = µαk + ζαki
βki = µβk + ζβki (4.12)
where the subscript k indicates that parameters are allowed to vary across latent classes. Thus, each
latent class can be considered as being defined by its own linear growth model.10 Figure 4.7 provides
a graphical representation of equation (4.12) to show that, as with the LCM, the GMM can be can be
considered a special case of a confirmatory factor analytic model. As such it is possible regress the
categorical latent variable c onto a set of predictor variables to examine their association with class
membership.
Since GMMs are susceptible to converging on local rather than global solutions it is typical to com-
9Other methods are in use, in particular autoregressive models. These are discussed in Chapter 7
10LCGA assumes that the values of ζαki and ζβki are zero for all individuals i.
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α β
c
y1 y2 y3 yt
ε1 ε2 ε3 εt
Figure 4.7: Growth mixture model
pare the convergence of models drawn from multiple random sets of starting values. Observing the same
log-likelihood obtained from multiple sets of random starting values indicates that the solution is not at
a local maximum. A two-stage process is used. Initially a large number of random sets of starting val-
ues are generated and optimized using maximum-likelihood for a fixed maximum number of iterations.
Then a smaller number of sets with the highest log-likelihood values from the initial stage are optimized
until convergence is achieved. For more complex models, such as those with a categorical latent vari-
able with many levels or with more than one categorical latent variable, the number of random sets of
starting values required to achieve convergence may be large (e.g. 1000 or more)—and there is the very
real issue that there may be no global maximum.
For most analyses involving categorical latent variables, models with up to 6 latent classes are usually
considered. The extraction of more than six latent classes may not be advisable for two reasons. Firstly,
having a very large number of latent classes would result in a rather unparsimonious solution. Also, the
likelihood of models converging on a global maximum is increasing unlikely.
Model fit cannot be assessed using standard goodness-of-fit indices used in structural equation mod-
elling (i.e. RMSEA, CFI & TLI). Instead the best fitting model is identified using the Lo-Mendell-Rubin
likelihood ratio test (LMR-LRT), a variation of the χ2 difference test applicable to mixture models, the
Bayesian Information Criterion (BIC), and the consistent Akaike Information Criterion (CAIC) since the
standard AIC is well known to over select the number of classes. All have been shown to perform well
in simulation studies that consider their use in latent variable mixture models (Nylund, Asparouhov, &
Muthén, 2007; Tofighi & Enders, 2006).
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4.3.3.1 Summary
The first part of this chapter has introduced the topic of latent variable modelling, and has discussed
the application of latent variable models to longitudinal data, in particular the LCM and its mixture
modelling generalistion the GMM. The second part of this chapter turns to the issue of missing data
that is a major concern in longitudinal studies. Again this issue is viewed from the perspective of latent
variable modelling.
4.4 Missing data
Missing data is a pervasive problem in longitudinal studies, especially those with long periods of follow
up. Missing data may arise for several reasons. A participant may not complete a particular assessment
during one of the waves of follow up, for example, they may forget or refuse to complete a specific
item of a questionnaire (item missingness). Alternatively the participant may miss an entire wave of data
collection (intermittent missingness), or they may drop out of the study entirely (drop out missingness).
Not only does missing data reduce the statistical power of the the analysis but it may result in biased
parameter estimates if there are systematic differences between those with and without missing data.
Rubin (1976) defined different assumptions concerning missing data mechanisms. The most restric-
tive assumption, and the one made using most traditional analytical methods, is missing completely at
random (MCAR). The assumption of MCAR holds when the probability that missing values on an out-
come variable y are independent of the value of y or any other observed variables x . If my is a binary
variable indicating that the value of y is missing this can be expressed as
Pr(my |y, x) = Pr(my) (4.13)
That is, the conditional probability that y is missing, given y and x , is equal to the unconditional
probability that y is missing. The implication is that the observed values of y are simply a random
subsample of the complete data. The classic example is of a laboratory scientist accidentally dropping a
tray of test tubes.
A less restrictive assumption is that data are missing at random (MAR). Under this assumption the
probability that an observation is missing on variable y may depend on another observed variable x , but
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not on the values of y itself.
Pr(my |y, x) = Pr(my |x) (4.14)
In words, this expression means that the conditional probability that y is missing, given y and x , is
equal to the conditional probability that y is missing, given x alone. That is, missingness is independent
of the unobserved values of y .
The distinction between these two conditions is important because most conventional methods for
handling missing-data (e.g. list-wise and pair-wise deletion) yield unbiased parameter estimates only
under the assumption of MCAR. However, frequently this assumption is not met in practice. (Carpenter
& Kenward, 2007) provides a detailed discussion of the limitations of conventional methods for han-
dling missing data, including various forms of imputation such as mean substitution and regression
imputation.
It is impossible to test whether the MAR condition is satisfied. Since the values of the missing data
are unknown it is not possible to examine whether there are systematic differences on the outcome
variable between those with or without missing data.
The missing data mechanism is referred to as ignorable when the MAR condition holds and the
parameters governing the missing data process are independent of the parameters to be estimated. This
is because there is no need to model the missing data mechanism as part of the estimation model. Allison
(2002) suggests that MAR and ignorability can be treated as equivalent conditions, as even when the
parameters governing the missing data process are not independent of the parameters to be estimated
methods assuming ignorability perform adequately.
When the probability that an observation is missing on an outcome variable y is related to the actual
value of y , even after conditioning on other observed variables x , the data is said to be not missing at
random (NMAR).
Pr(my |y, x) 6= Pr(my |x) (4.15)
Situations where the missing data mechanism is NMAR are typically referred to as non-ignorable
since the missing-data mechanism must be modelled as part of the analysis to provide unbiased results.
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4.4.1 Ignorable missing data
There are currently several methods that handle missing data in a principled way that is generally
efficient and produces unbiased results under the assumption of MAR. The two most applicable in the
context of longitudinal models, particularly LCM, are full-information maximum likelihood (FIML) and
multiple imputation (MI). Alternative approaches, such as inverse probability weighting, are available but
are not discussed as they are not employed in this dissertation.
4.4.1.1 Full information maximum likelihood
FIML, also sometimes referred to as direct ML (Enders, 2001), is similar to pair-wise deletion since the
likelihood function is computed for each individual using all of their observed data. The total likelihood
is the sum of the values of the likelihood for each individual. FIML differs from the usual ML fitting func-
tion for latent variable models since the saturated model is not included, however both methods produce
identical log-likelihoods when there is no missing data (Bollen & Curran, 2006). FIML enables the cal-
culation of the standard chi-square test statistic, and as an ML estimator maintains the desirable features
of ML estimators, such as consistency, asymptotic unbiasedness, asymptotic normality, and asymptotic
efficiency, providing asymptotic estimates of standard errors for significance testing. However, FIML con-
ditions on the missing data of the independent variables, which means that list-wise deletion is applied
to cases with missing values of the covariates.11 It has the advantage over several other methods that
additional covariates can be included in the model indirectly, even where there is no particular rational
for including them in the model of interest—maximizing the likelihood that the underlying assumption
that the data is MAR.
4.4.1.2 Multiple imputation
The use of MI has grown considerably in recent years, and has been incorporated into several statistical
packages (e.g. Stata, SPSS, SAS, S-Plus/R). MI is a likelihood based method that has been shown to
produce results that are consistent, asymptotically efficient and asymptotically normal when the MAR
condition holds. As with FIML, MI allows for additional covariates can be included in the imputation
model.
Deterministic imputation methods (e.g. regression imputation) are flawed since the imputed data are
analyzed as if they were complete data, which produces downwardly biased variances for variables with
11Explicitly estimating the mean and variance of covariates with missing data brings them into the estimation model as
dependent variables ensuring that all cases are included.
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missing data, underestimates of the standard errors, and thus test statistics are overestimated inflating
the chances of Type-I errors. MI solves this problem by adjusting for the fact that there is uncertainty
about the missing values.
MI consists of 4 stages which are succinctly described by van Buuren, Boshuizen, and Knook (1999)
as:
1. Specify the posterior predictive density Pr(my |y, x), where x is a set of predictor variables given
the non-response mechanism and the complete data model
2. Draw random imputations from this density to produce M complete data sets
3. Perform M complete-data analyses on each completed data set
4. Pool the M analyses results into final point and variance estimates
To solve the problem of underestimating the variances of variables with missing data random varia-
tion is introduced into the predicted values of y . This is done by making random draws from the residual
distribution of each imputed variable, which are added to the imputed variables. Moreover, repeating
the imputation process multiple times to produce M imputed data sets provides a distribution of likely
values for each missing data point. Performing the analysis multiple times and pooling the resultant es-
timates (using Rubin’s rule) ensures that standard errors are not underestimated (Carpenter & Kenward,
2007).
The most widely implemented method is the multivariate normal model. This approach assumes
variables are normally distributed and are a linear function of all other variables with a normal, ho-
moscedastic error term, it performs well when normality assumption is violated (Schafer, 1999). An
alternative method using chained equations has also been developed that is applicable to a wider vari-
ety of distributions, since it allows for imputation under generalized linear models (i.e. binary logistic
regression, multinomial logistic regression, and Poisson regression; van Buuren et al., 1999).
The major drawback with MI is that for longitudinal data appropriate MI currently requires a fully
Bayesian framework using Markov Chain Monte Carlo implemented in specialized software programmes,
such as WinBUGS. However, imputing data using repeated cross-sections of the dataset and combining
them for the final analysis has been shown to be relatively robust (Carpenter & Kenward, 2007). Recent
developments in this area are likely to result in more robust methods being implemented in mainstream
statistical programmes (Kenward & Carpenter, 2007).
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4.4.2 Non-ignorable missing data
The basic approach to analyses using methods that assume ignorability of the missing data mechanism
is the same as for standard regression models: adjust for all observable differences for observed and
missing cases and assume that any unobserved differences are unsystematic. However, when the missing
data mechanism is non-ignorable due to NMAR arising from unobserved variables predicting missingness
the missing data mechanism must be modelled as part of the estimation process (Allison, 2002).
Both the FIML and the MI approaches described above can be adapted to deal with non-ignorable
missing data. Adapting these approaches, however, is non-trivial and there is little software available
to implement them (Allison, 2002). The generalised latent variable modelling framework is extremely
flexible and allows for fitting several such models by FIML. Note that implicit in fitting these models is
numerical integration over the missing data, to obtain a likelihood in terms of the observed data which
can then be maximized (see Diggle & Kenward, 1994). In practice, this usually requires Monte-Carlo
integration.
In general, two approaches to NMAR analysis have been developed and are beginning to be applied
in the literature (B. Muthén, Asparouhov, Hunter, & Leuchter, 2011). Selection models, which developed
out of the econometric literature as a means to deal with survey non-response (e.g. the Heckman selec-
tion model), have been applied in longitudinal analysis to jointly model the dropout process (e.g. Diggle
& Kenward, 1994). The alternative approach is the pattern-mixture approach which averages data over
missing data patterns (e.g. Little, 1995). These two approaches are now discussed.
4.4.2.1 Selection models
The first type of NMAR model considered is the selection model. Ignoring covariates, selection models
consider missingness conditional on the observed data using the factorization
f (y, my) = Pr(my |y) f (y) (4.16)
where y represents the observed data and my is a set of missing data indicators. Essentially, y is first
modelled as if there was no missing data then, given a value of y , we model whether the data is missing
or not. The most widely used selection model concerning dropout from longitudinal studies is the model
proposed by (Diggle & Kenward, 1994). For this model the missing data indicators are a set of survival
indicators, which will be referred to as dt , that are coded 0 prior to dropout, 1 at the time of dropout, and
missing thereafter. This includes the survival indicators as dependent variables in a logistic regression
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α β
y1 y2 y3 yt
d2 d3 dt
(a) Diggle-Kenward model
α β
y1 y2 y3 yt
ε1 ε2 ε3 εt
d2 d3 dt
(b) Wu-Carroll model
Figure 4.8: NMAR selection models
model with the observed y value at t and t − 1 included in the model as predictors. According to this
model, the assumption of MAR holds if dropout is not observed to be significantly related to the last
observed value of the data, yt .
An alternative model is the Wu and Carroll (1988) selection model. This model rather than condi-
tioning on the observed data conditions on the growth parameters of a LCM (i.e. the random intercept
and slope factors). Figure 4.8 a depicts both the Diggle and Kenward (1994) and Wu and Carroll (1988)
models diagrammatically.
4.4.2.2 Pattern-mixture models
An alternative approach that reverses the factorization applied in selection models are pattern-mixture
models
f (my , y) = f (y|my)Pr(my) (4.17)
where the observed data y is conditional on the missing data my . That is, pattern mixture models allow
missingness to affect the distribution of the variable of interest. For conventional pattern-mixture models
that assume intermittent missing values are MAR the dt variables are a set of dummy variables indicating
dropout occasion (i.e. coded as 1 at the time of dropout and 0 otherwise). This allows the means of the
random intercept and slope factors to vary as a function of the dropout dummy variables, with a different
growth trajectory for individuals that dropout at each occasion (pattern), plus an additional trajectory
for those that do not dropout. In order for the model to be identified the random slope means for
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α β
y1 y2 y3 yt
ε1 ε2 ε3 εt
d2 d3 dt
(a) Conventional model
α β
c
y1 y2 y3 yt
ε1 ε2 ε3 εt
d2 d3 dt
(b) Roy latent dropout model
Figure 4.9: NMAR pattern-mixture models
individuals who dropout after the first observation is conventionally fixed to be equal that of individuals
who dropout one time point later.
To calculate the overall growth parameters the mean of each of the random growth parameter esti-
mates are mixed over the patterns, which essentially means the weighted average of the growth parame-
ter across each pattern is calculated. This mixture can then be compared to the conventional single-class
model estimated under MAR which assumes that the growth trajectory is equivalent across each dropout
pattern.
Roy (2003) criticized the pattern-mixture approach proposing a latent dropout pattern-mixture
model. The conventional model assumes every subject with the same dropout time shares a common
distribution, which seems unlikely particularly when, as in this instance, dropout may be for a number
of alternate reasons. The Roy (2003) model uses a latent class variable that is influenced by dropout
time, and influences the random effect means for the outcome. Latent class membership is specified as a
multinomial logistic regression with the dropout indicators as covariates. This model, which allows cases
with the same dropout time to come from different distributions, can be considered a shared-parameter
model and implies a growth mixture model (B. Muthén et al., 2011). The conventional pattern-mixture
model and the Roy latent dropout pattern-mixture model are depicted as path diagrams in Figure 4.9.
Recent overviews of NMAR modelling for longitudinal data are given in Fitzmaurice, Davidian, Ver-
beke, and G. (2009) and B. Muthén et al. (2011). Since the assumption of NMAR is untestable. That is,
it is not possible to ever rule out the biasing effects of unobserved variables, analyses are usually under-
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taken as a sensitivity analysis to confirm results under the MAR assumption are robust to the most likely
causes of non-ignorable missingness. In longitudinal studies the non-ignorability concern is typically
focused on missing data due to dropout rather than intermittent missingness. Resultantly, it is only the
likelihood that drop-out is non-ignorable that is considered in this dissertation .
4.5 Summary
This chapter has given a brief overview of the latent variable modelling framework, with particular refer-
ence to the analysis of longitudinal data. Also discussed has been the issues resulting from missing data
that is common in longitudinal studies, the assumptions made by traditional analytic methods, and the
use of latent variable modelling approaches as sensitivty analyses against possible non-ignorable miss-
ing data mechanisms. The techniques introduced within this chapter are used throughout the remainder
of this dissertation. Applications and extensions of the methods introduced here are discussed in the
following chapters.
The following chapter presents an assessment of the construct validity of the Hospital Anxiety and
Depression scale using latent variable modelling methods.
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Psychometric analysis of the Hospital
Anxiety and Depression Scale
5.1 Introduction
Prior to addressing the main aims of the dissertation it is necessary to examine the psychometric proper-
ties of the tool used to assess psychological distress in the following two chapters, the Hospital Anxiety
and Depression Scale (HADS; Zigmond & Snaith, 1983). Section 2.2.2.1 noted that in chronic physi-
cal illnesses the assessment of distress is complicated by the overlap of the symptomatology with the
physical disorder. A detailed assessment of the validity of the HADS as a measure of the severity of psy-
chological distress will ensure the conclusions of the following chapters can be made with confidence,
with a robust understanding of the risk of bias due to conflating elements of psychological and physical
well-being.
The HADS is a commonly used measure of psychological distress designed for use in patient pop-
ulations. Numerous studies examining its construct validity using exploratory (EFA) and confirmatory
(CFA) factor analytic and item response theory (IRT) techniques in various clinical and non-clinical pop-
ulations have been published. Furthermore, several reviews of these psychometric studies have been
undertaken (Bjelland, Dahl, Haug, & Neckelmann, 2002; Herrmann, 1997; Martin, 2005). However,
disagreement concerning the underlying dimensionality of the HADS remains (c.f. Bjelland et al., 2002;
Martin, 2005).
EFA studies generally support an obliquely rotated two-factor anxiety-depression model underlying
the HADS (e.g. Bjelland et al., 2002; Moorey et al., 1991; Pallant & Bailey, 2005). However, CFA studies
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find that such a model fits poorly to the data, generally finding superior fit for a three-factor solution with
the anxiety sub-scale split into two separate, but highly correlated, factors (Caci et al., 2003; Desmond
& MacLachlan, 2005; Dunbar, Ford, Hunt, & Der, 2000; Friedman, Samuelian, Lancrenon, Even, &
Chiarelli, 2001; Johnston, Pollard, & Hennessey, 2000; Martin, 2005; Martin, Lewin, & Thompson,
2003; McCue, Buchanan, & Martin, 2006; Rodgers, Martin, Morse, Kendell, & Verrill, 2005). These have
been labelled anxiety and negative affectivity (NA), as per the tripartite theory of depression (Clark &
Watson, 1991).
The tripartite theory posits that the association observed between anxiety and depression is ac-
counted for by a higher-order NA factor. NA has been described as a ‘general trait of somatopsychic
distress’ (Watson & Pennebaker, 1989, p.248) that subsumes a wide range of negative emotions, which
as well as anxiety and depression, includes anger, disgust, and guilt (Watson & Clark, 1984). Further-
more, the Tripartite theory stipulates that the specific component of anxiety is autonomic arousal marked
by somatic symptoms, and that the prevailing component of depression is anhedonia characterized by
low positive affectivity-a loss of pleasure and interest in life (Clark & Watson, 1991). As was noted by
Dunbar et al. (2000) several of the HADS items would appear to fit these constructs well.
Recently, several IRT studies have indicated that the anxiety and depression scales may be combined
into a single unidimensional psychological distress scale—presumably due to the high inter-factor cor-
relations (Forjaz, Rodriguez-Blazquez, & Martinez-Martin, 2008; Pallant & Tennant, 2007; Tang, Wong,
Chiu, Lum, & Ungvari, 2008; Tang, Wong, Chiu, & Ungvari, 2007). The differences in the dimensionality
suggested by these methods is interesting as the number of factors is stable within methodologies, but
not across.
One possible explanation for the ambiguity between studies applying different methodologies is the
presence of a general factor. Two alternative models—higher-order and bifactor—have been proposed
to represent the factor structure of scales with a general factor (Figure 5.1). Higher-order models are
composed of first-order factors onto which the observed items load, and higher-order factors onto which
the first-order factors load. The higher-order factors are causal determinants of the lower-order factors
accounting for the correlation between the first-order factors, only influencing the observed variables
indirectly. The three-factor models often explain the HADS factor structure in terms of the tripartite
theory of depression, suggesting a possible higher-order NA factor (e.g. Dunbar et al., 2000). The
bifactor model consists of general (e.g. psychological distress) and specific components (e.g. anxiety and
depression). Also known as group-factor models, bifactor models were initially developed in intelligence
research (Schmid & Leiman, 1957) but have recently been applied to the study of psychological distress,
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A
D
G
(a) Bifactor
A
D
G
(b) Higher-order
Figure 5.1: Representations of a bifactor and higher-order model
for example the Beck Depression Inventory (Ward, 2006; Thombs, Ziegelstein, Beck, & Pilote, 2008;
Chilcot et al., 2011)1, the combined pool of items from the Beck Depression Inventory and Beck Anxiety
Inventory (Steer, Clark, Beck, & Ranieri, 1999), the Depression Anxiety and Stress Scale (Crawford &
Henry, 2003) and, pertinently, to extend the tripartite theory (Simms, Gras, Watson, & O’Hara, 2008;
T. A. Brown et al., 1998; Krueger & Finger, 2001). Currently no studies have applied a bifactor model
to the HADS.
As well as issues with dimensionality, there are concerns with measurement equivalence. This relates
to the extent to which comparisons across groups (e.g. defined by age, gender, disease etc.) represent
real differences on the underlying construct, or are an artifact of the measurement process, such as
differing interpretations of an item. That is, individuals with equivalent true scores should have the
same probability of a particular observed score on a test (Meredith, 1993). Several studies have used
CFA to compare the fit of different models across groups (Matsudaira et al., 2009; Johnston et al.,
2000; Martin, Thompson, & Barth, 2008). This is termed configural invariance, and discussed further
in section 5.3.3. Only two studies have directly assessed measurement equivalence of the HADS by
examining for differential functioning of individual items across groups: comparing females with breast
cancer to females in the general population (Osborne, Elsworth, Sprangers, Oort, & Hopper, 2004), and
examining differences across demographic and disease activity groups in end-stage renal disease (Tang
1See appendix A
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et al., 2008). Currently no studies have assessed measurement equivalence of the HADS in patients with
a rheumatological condition, and none have employed multiple group CFA (MG-CFA), which allows for
a more detailed examination of differential item functioning (DIF) (Millsap & Yun-Tein, 2004). This is
particularly important given concerns about bias due to the content of some of the HADS items tapping
into the somatic symptoms of RA (Pincus et al., 1996).
The aim of the current chapter is to examine the psychometric properties of the HADS in patients
with RA, focusing on (i) dimensionality and (ii) measurement equivalence. Exploratory and confirma-
tory factor analysis will be employed to examine the dimensionality of the HADS, and compare the fit
of several models indicated by previous research, as well as assessing the fit of a bifactor model. In
addition, measurement equivalence will be assessed within RA by examining differential item function-
ing across demographic and clinical variables. Furthermore, MG-CFA models will be employed to assess
measurement equivalence across chronic physical illnesses, specifically RA, renal failure and cancer, and
also the stability of measurement over time within RA. The latter is pertinent to Chapter 6 where latent
growth models, which assume measurement equivalence over time, are employed.
5.2 Methods
5.2.1 Sample
The data used in the analysis consists of a sub-sample of the Early RA Study (ERAS). ERAS is a multi-
centre prospective observational study that recruited nearly 1500 individuals with RA on first presenta-
tion to a rheumatologist, prior to the initiation of disease modifying therapy. Greater detail regarding the
design of ERAS is provided in Chapter 6 and Appendix D. Individual HADS item scores, rather than sum-
scores, were available for patients attending the Winchester centre only (N = 279). Of these patients,
HADS data were never collected, or individual HADS scores were not available, for 119 individuals. For
the remaining 160 individuals, one observation per individual was selected at random for the present
analysis.
5.2.2 Hospital Anxiety & Depression Scale
The HADS is a self-administered scale consisting of 14-items split equally across anxiety and depression
sub-scales, each with a four-point ordinal response format. To reduce the risk of a false positive bias, the
scale does not assess somatic symptoms of anxiety and depression related also to physical disorder, such
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as fatigue and insomnia.2 Furthermore, severe psychopathological symptoms uncommon in nonpsychi-
atric patients, such as suicidality, are also not assessed. A copy of the HADS is provided in Appendix
F.
The HADS has been shown to have adequate diagnostic accuracy. In their review, Bjelland et al.
(2002) reported that the optimal cut-off for both the anxiety and depression scales was a score of 8 or
more, across 12 studies of non-cancer medical populations (anxiety: mean sensitivity .90 [range .82,
.94], mean specificity .78 [range .73, .94]; depression: mean sensitivity .83 [range .70, 1.00], mean
specificity .79 [range .68, .91]). Furthermore, the same review found the HADS to have good concurrent
validity, correlating highly with other measures of depression, anxiety and psychological distress. The
range of correlations between the depression scale with the Beck Depression Inventory, General Health
Questionnaire (GHQ-28), Symptom Check List (SCL-90) Depression scale and the Montgomery Asberg
Depression Rating Scale (MADRS) were .50 to .81. For the anxiety scale, correlations with the State-
Trait Anxiety Inventory (STAI), GHQ-28, SCL-90 Anxiety scale, and the Hamilton Anxiety Rating Scale
(HAM-A) ranged between .34 and .81 (Bjelland et al., 2002).
5.2.3 Disease severity measures
Functional disability was operationalised using the UK version of the Health Assessment Questionnaire
(HAQ) disability index (Kirwan & Reeback, 1986). The HAQ consists of 20 items concerning the respon-
dents ability to complete certain activities of daily living (dressing & grooming, arising, eating, walking,
hygiene, reach, grip and activities). Scores range between 0 and 3 with higher values indicating greater
disability. Generally scores greater than 1 indicate that an individual has moderate disability, and above
2 severe disability although specific cut-offs have not been defined. Since the distribution of HAQ dis-
ability was positively skewed scores were square-root transformed for analysis.
Disease activity was assessed using the original Disease Activity Score (DAS; van der Heijde et al.,
1990), a composite measure including a blood marker of inflammation—erythrocyte sedimentation rate
(ESR) or c-reactive protein (CRP)—plus separate counts of the tenderness (TJC) and swelling (SJC) of
44 specific joints (mainly of the hands, feet and wrists). Scores over 5 suggest high disease activity and
scores less than 3 low disease activity.3
2Pincus et al. (1996) note that item D8 “I feel slowed down” should probably have been omitted from the scale based on this
criteria.
3A DAS score of less than 1.6 corresponds to the American Rheumatology Association preliminary criteria for clinical remis-
sion (Fransen et al., 2004).
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5.2.4 Statistical Analysis
There were relatively few missing responses across the HADS items for the RA sample. In total 152
(95%) of the sample had no missing item responses, four individuals had one missing response, two
individuals two missing responses, one individual four missing responses and one with 6 missing re-
sponses. These were imputed using a single run of the ice module in Stata 10.1 (Royston, 2004). ice
imputes responses using chained equations via Gibbs sampling, a Markov Chain Monte Carlo procedure.
As the HADS response format is polytomous ordinal logistic regression models were used. This approach
is acceptable when the correlations between the imputed variables are being generated (Graham, 2009).
EFA and CFA were undertaken in Mplus 5.1 using robust weighted least squares estimation (WLSMV;
B. Muthén, 1984; B. Muthén et al., 1997). This estimator was described in section 4.2.3. Briefly, WLSMV
is an appropriate estimator for indicator variables with an ordinal response format. Its properties have
been observed to be acceptable in a simulation study assessing similar sample size to that of the current
analysis (Flora & Curran, 2004). The best fitting model was selected using conventional indices for
assessing goodness-of-fit of the model to the data: χ2 test of exact fit, root mean square error of ap-
proximation, Tucker-Lewis Index (TLI), and Comparative Fit index (CFI).4 To aid model comparison the
Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) derived using maximum
likelihood (ML) estimation are also presented.5
The models compared consisted of one-, two-, and three-factor models listed below with the loading
patterns provided in Table 5.1.
4See section 4.2.2 for details of the assessment of model fit in latent variable models.
5The value of χ2 is known to be inflated for ML with ordinal indicators, and will be further exaggerated by increasing model
complexity (P. Curran, West, & Finch, 1996). Since the information criterion are related to χ2, some caution must be taken
in their interpretation. However, their use for pragmatic reasons remains important as both AIC and BIC penalise for model
complexity and help avoid problems of over-fitting by using conventional goodness of fit indices only.
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One-factor models:
1. Unidimensional general psychological distress factor with loadings held constant—equivalent
to the one-parameter normal ogive model and comparable to the models estimated by studies
of the HADS employing IRT Rasch analysis (Pallant & Tennant, 2007; Tang et al., 2007; Forjaz
et al., 2008)
2. Unidimensional general psychological distress factor with loadings freely estimated (Razavi,
Delvaux, Farvacques, & Robaye, 1990)—equivalent to the two-parameter normal ogive IRT
model (see Takane & de Leeuw, 1987).
Two-factor models:
3. Original oblique anxiety-depression factorization based on Zigmond and Snaith (1983)
4. Two oblique anxiety depression factors with item A7 revised to load on the depression factor
(Moorey et al., 1991)
Three-factor models:
5. Tri-dimensional model based on the Tripartite theory of anxiety and depression (Clark & Wat-
son, 1991), several items forming a separate, theoretically hierarchical, NA factor (Dunbar
et al., 2000). This is a special case of a hierarchical model referred to as an incomplete
hierarchical model (F. F. Chen, West, & Sousa, 2006).
6. Tri-dimensional model consisting of a depression factor and with the anxiety factor subdivided
into psychic anxiety and psychomotor agitation factors (Friedman et al., 2001)
7. Tri-dimensional model consisting of a depression factor and with the anxiety factor containing
a separate restlessness factor (Caci et al., 2003)
8. A bifactor model, which consists of a general factor as well as (orthogonal) anxiety and de-
pression factors
5.3 Results
5.3.1 Descriptive statistics
Table 5.2 shows the descriptive statistics for the sample at the baseline assessment. The proportion of
females in the subsample was roughly two-thirds, reflecting the distribution in the full ERAS sample and
the RA population in general. Age at onset and functional disability (HAQ) at baseline were similar and
not significantly different from the rest of the ERAS cohort. However, disease activity as indicated by the
DAS score was significantly higher in the sub-sample.
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Table 5.1: Loading patterns for each of the eight dimensional structures proposed to underly the
HADS
Model Params Factor Item loadings
1. Pallant and Tennant (2007) 43 General distress* A1, A3, A5, A7, A9, A11, A13,
D2, D4, D6, D8, D10, D12, D14
2. Razavi et al. (1990) 56 General distress A1, A3, A5, A7, A9, A11, A13,
D2, D4, D6, D8, D10, D12, D14
3. Zigmond and Snaith (1983) 57 Anxiety A1, A3, A5, A7, A9, A11, A13
Depression D2, D4, D6, D8, D10, D12, D14
4. Moorey et al. (1991) 57 Anxiety A1, A3, A5, A9, A11, A13
Depression D2, D4, D6, A7, D8, D10 ,D12, D14
5. Friedman et al. (2001) 59 Anxiety A3, A5, A9, A13
Agitation A1, A7, A11
Depression D2, D4, D6, D8, D10, D12, D14
6. Caci et al. (2003) 59 Anxiety A1, A3, A5, A9, A13
Restlessness A7, A11, D14
Depression D2, D4, D6, D8, D10, D12
7. Dunbar et al. (2000) 59 Anxiety A3, A9, A13
Depression D2, D4, D6, A7, D8, D10, D12, D14
NA A1, A5, A7, A11, A**, D**
8. Bifactor 70 Anxiety A1, A3, A5, A7, A9, A11, A13
Depression D2, D4, D6, D8, D10, D12, D14
General distress A1, A3, A5, A7, A9, A11, A13,
D2, D4, D6, D8, D10, D12, D14
* Equality constraint on factor loadings; ** A and D represent the latent factors loading onto the higher-order NA factor.
Table 5.2: Baseline characteristics of the sample compared to the ERAS cohort
ERAS (n= 1460) Sub-sample (n= 160) significance
Mean SD Mean SD
Female 66% 69% χ2(1) = .727, p = .394
Age at onset (yrs) 55.34 14.61 56.48 14.12 t(1458) = .94, p = .350
HAQ disability (0-3) 1.15 0.77 1.09 0.74 t(1458) = .93, p = .351
DAS (0-10) 4.22 1.63 5.03 1.82 t(1458) = 5.85, p < .001
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Figure 5.2: Box-plot of HADS scores
The mean age at onset was 56-years corresponding to a mean age at the assessment of 62-years,
comparable with the rest of the ERAS cohort. Levels of functional disability at baseline, assessed by the
HAQ, were also similar to the remainder of the ERAS cohort.
As was noted earlier, one record from the ERAS yearly assessments was selected at random for
inclusion in the psychometric analysis. For these randomly selected assessments the average disease
duration was 6.24-years (SD 4.19), HAQ disability was .83 (SD .77), and DAS was 3.70 (SD 2.18). The
mean values of the HADS anxiety and depression scales were 5.8 (SD 3.7) and 4.4 (SD 3.2), respectively.
Using the caseness criteria of a score greater than eight indicating psychopatholgy, 43 (27%) fulfilled the
criteria for anxiety disorder and 23 (14%) fulfilled the criteria for depressive disorder. The distribution
of scores is presented in Figure 5.2.
The individual HADS item responses were generally positively skewed, with scores of 2 or 3 relatively
uncommon for most items (Figure 5.3). Means6 and median values are presented in Table 5.3. On the
whole anxiety items were more likely to be responded to at higher response categories (e.g. 2 or 3).
Although the item most likely to be reported at higher levels was D8 “I feel as if I am slowed down”, with
a mean of 1.58, all other items had values of 1 or lower. This resonates with the earlier suggestion of
possible bias relating to this item in a similar population (Pincus et al., 1996). The item with the lowest
mean value was D4 “I can laugh and see the funny side of things”, which was almost identical to D6 “I feel
cheerful” and D14 “I can enjoy a good book or radio or TV programme”.
Due to the polytomous response format of the HADS items, polychoric correlations were calculated
6In classical test theory means of Likert scored items represents the items difficulty.
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Figure 5.3: Distribution of scores across individual HADS items
Table 5.3: Descriptive statistics for HADS items
Mean Median
A1 0.93 1.00
D2 0.72 1.00
A3 0.75 1.00
D4 0.27 0.00
A5 0.73 1.00
D6 0.29 0.00
A7 0.90 1.00
D8 1.58 1.00
A9 0.51 0.00
D10 0.48 0.00
A11 1.06 1.00
D12 0.57 0.00
A13 0.61 0.50
D14 0.27 0.00
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(Table 5.4). Correlations were generally moderate to high, ranging from .17 to .85. As would be
expected anxiety items were generally more highly correlated with other anxiety items compared to
depression items, and vice versa.
Classical item analysis of the HADS indicated that including all items in a single analysis—therefore
assuming that the items measure a single unidimensional construct—resulted in a relatively high Cron-
bach’s α, .87.7 The item-rest correlations range between .41 and .66, and the item-total correlations .48
to .72. Moreover, Cronbach’s α would have remained stable were any of the items removed.
Considering only the depression items the scale had adequate internal consistency, Cronbach’s α was
.81. The item-total correlations were .51 to .82, and the item-rest correlations .37 to .73. D14 “I can
enjoy a good book or radio or TV programme” did not appear to add to the reliability of the scale, but was
not detrimental either.
For the anxiety items the internal consistency was again good, Cronbach’s α, .83. The item-total
correlations were relatively high, .59 to .81; and the item rest-correlations were also high. Again, the
reliability of the scale was fairly stable were any of the items to be removed, although A7 and A11
appeared to add little.
To summarise, the reliability of the HADS, according to classical test theory was good. The reliability
of the anxiety and depression sub-scales were both greater than .8, which is broadly comparable to
previous research (Bjelland et al., 2002). Furthermore, the use of the total sumscore is indicated as
being appropriate, all items show relatively high correlations with the total score.8 This supports the
findings of previous research employing Rasch analysis (Forjaz et al., 2008; Pallant & Tennant, 2007;
Tang et al., 2008, 2007), however dimensionality needs to be further assessed using factor analytic
techniques. This is addressed in the following section.
5.3.2 Dimensionality
5.3.2.1 Exploratory factor analysis
Inspection of the Kaiser-Meier-Olkin (KMO) measure of sampling adequacy indicated that the correlation
matrix was suitable for factorization. The lowest value was .70 for A9, well within the acceptable
range (Kaiser, 1974). The overall statistic, .83, corresponded to a classification of the suitability of the
correlation matrix for factorization as ’meritorious’.
7Cronbach’s α is a measure of internal consistency that may be interpreted as the lower bound of the reliability of the test.
Values greater than .7 are suggested as indicating acceptable reliability (Nunally & Bernstein, 1994).
8The higher value Chronbach’s α for the total, compared to anxiety and depression sub-scales, is likely an artifact due to its
relationship with test length—the Spearman-Browne prophecy
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Figure 5.4: Parallel analysis for principle components averaged over 1000 replications
Principle components analysis of the polychoric correlation matrix was undertaken to identify the
number of factors that should be extracted. The Kaiser criterion—extracting as many factors as there are
Eigenvalues above 1—indicated the extraction of the first three principle components. However, parallel
analysis using 1000 randomly drawn samples indicated that the Eigenvalue for the third component was
lower than would be expected by chance (Figure 5.4), suggesting only two factors should be extracted.9
EFA initially suggested a general psychological distress factor upon which all items loaded >.4, and a
depression group-factor onto which all of the depression items and A7 “I can sit at ease and feel relaxed”
loaded >.4. Factor loadings are displayed in Table 5.5. The fit of the model was borderline acceptable
(RMSEA = .090; CFI = .984; TLI = .977).
In order to try to extract a simple structure from the pattern of loadings an oblique geomin rotation
was applied. Using an oblique rotation allows the two factors to correlate, as we would reasonably
expect for the latent constructs of anxiety and depression. After rotation, the items fitted the structure as
would be expected. All of the depression items loaded onto a single factor, along with two of the items
from the anxiety scale, A1 and A7—the former being a double loading. Only five of the seven anxiety
items loaded onto the anxiety scale. A7 loaded only onto the depression factor and A11 loaded weakly
and equally on both the anxiety and depression scales.
For the rotated solution, the correlation between the two factors was .51, which is comparable to
what has been previously reported (Bjelland et al., 2002; Herrmann, 1997). After oblique rotation
9This third factor was consistent with the third factor described by (Martin, 2005), as A7 and D14 only loaded on this factor.
Previous EFA studies that have found a three-factor solution may have extracted too many factors due to reliance on the Kaiser
criterion (Preacher & MacCallum, 2003)
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Table 5.5: Exploratory factor analysis
Unrotated Rotated Uniqueness Structure matrix
Factor 1 Factor 2 Factor 1 Factor 2 Factor 1 Factor 2
A1 0.76 0.14 0.41 0.50 0.36 0.67 0.76
A3 0.78 -0.14 0.06 0.78 0.34 0.48 0.82
A5 0.77 -0.06 0.25 0.64 0.37 0.55 0.75
A7 0.59 0.42 0.64 0.16 0.46 0.72 0.44
A9 0.83 -0.32 -0.14 0.95 0.15 0.32 0.94
A11 0.48 0.12 0.36 0.27 0.70 0.48 0.46
A13 0.92 -0.33 0.00 0.92 0.16 0.42 0.96
D2 0.56 0.57 0.94 -0.14 0.23 0.81 0.36
D4 0.70 0.51 0.80 0.11 0.25 0.88 0.51
D6 0.63 0.35 0.48 0.30 0.53 0.64 0.55
D8 0.49 0.49 0.81 -0.03 0.37 0.75 0.36
D10 0.44 0.53 0.71 -0.06 0.54 0.65 0.31
D12 0.66 0.61 0.85 0.06 0.22 0.81 0.43
D14 0.44 0.40 0.56 0.03 0.67 0.54 0.34
the factors loadings no longer represent the correlations between the items and the underlying factors
therefore the structure matrix, the correlations between the items and the factors is also presented in
table 5.5. For the depression factor each of the depression items correlations with the factor ranged
between .54 and .88. Furthermore, A1 and A7 correlated highly with the depression factor, .67 and .72
respectively. The anxiety item correlations with the anxiety factor ranged between .44 and .96. As would
be expected with strong inter-factor correlations each item correlates fairly highly on the opposing factor
(range .29 to .73).
In summary, the initial solution indicated a general psychological distress factor with a depres-
sion group-factor. However, following oblique rotation the anxiety-depression factor structure emerged
(Bjelland et al., 2002). As with previous research item A7 was observed to load more strongly on the
depression scale than the anxiety scale (Moorey et al., 1991).
5.3.2.2 Confirmatory factor analysis
While the results of the EFA presented here replicate the findings of studies employing similar methods,
recent CFA research indicates a three-factor solution. CFA analysis allows for the direct comparison of
the fit of these models. Eight plausible models were tested (Table 5.6).
One-factor models The initial model fitted to the data was the one-parameter normal ogive model,
this is a unidimensional model with all parameter loadings held equal (Model 1). It is analogous to
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Table 5.6: Goodness of fit statistics for CFA models
Model χ2 df p CFI TLI RMSEA WRMR AIC BIC
1-factor
1 164.4 28 0.000 0.85 0.91 0.17 1.93 3403.0 3400.4
2 155.9 25 0.000 0.85 0.91 0.18 1.56 3396.7 3392.9
2-factor
3 107.7 26 0.000 0.91 0.94 0.14 1.25 3303.1 3299.2
4 84.6 26 0.000 0.94 0.96 0.12 1.11 3280.2 3276.3
3-factor
5 64.2 27 0.000 0.96 0.98 0.09 0.91 3256.0 3253.9
6 74.5 27 0.000 0.95 0.97 0.11 0.98 3263.6 3259.5
7 77.8 26 0.000 0.94 0.96 0.11 1.03 3270.0 3266.0
8 40.7 26 0.033 0.98 0.99 0.06 0.62 3241.5 3236.4
Final 37.5 26 0.068 0.99 0.99 0.05 0.63 * *
* Information criterion not computable for final model due to conditional independence assumption
the Rasch model fitted by the IRT papers (Forjaz et al., 2008; Pallant & Tennant, 2007; Tang et al.,
2008, 2007). Although in these papers fit was adequate, here it was poor. The test of (non) exact fit
is highly significant and the χ2:df ratio large, indicating the test was not significant simply because it
was overpowered. Furthermore, the fit statistics indicate that the degree of ill fit is quite large, with all
outside acceptable fit levels.
Model 2 frees the factor loadings resulting in a significantly improved fit , χ2DIFFTEST(10) = 52.8, p <
.001, although the test of exact fit remained highly significant and the fit statistics outside acceptable
limits. The BIC and the AIC also favoured the more complex Model 2.
Two-factor models The two two-factor models exhibited better fit to the data than the one-factor
models however there was still significant ill fit. Models 3, the original Zigmond and Snaith (1983)
formulation, showed worse fit compared to Model 4, which loaded A7 on the depression rather than
anxiety sub-scale.
Three-factor models Four three-factor models were compared. Three of which, Models 5, 6 and 7,
split the anxiety sub-scale into two factors. Model 8, a bifactor model, includes a general psychological
distress factor as well as specific depression and anxiety factors. Notably, Model 5, based on the tripartite
theory of depression includes a higher-order negative affectivity factor—in an incomplete hierarchical
model (F. F. Chen et al., 2006). All of the three-factor models show better fit than the two and one-factor
models. The goodness of fit statistics were optimal for Model 8, the bifactor model. This was supported
by values of the AIC and BIC.
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Final model Modifications were made to the bifactor model, Model 8, by excluding items that either
did not load significantly onto the general or specific factors, furthermore modification indices were
inspected and additional paths and residual correlations included where necessary. Parameter estimates
are given in Table 5.7. All factor loadings on the general factor were retained. However, for the anxiety
factor the loadings of A7 and A11 were non-significant and therefore removed. For the depression
factor, the loadings for D6 and D14 were non-significant and also removed. Furthermore, modification
indices suggested adding a residual correlation between D2 and D8. Including this path in the model
significantly increased the fit of the model. Although, modification indices suggested additional residual
correlations their inclusion did not improve the fit of the model values of these were less than 10 and
were ignored to avoid over-fitting. The final model fitted the data well. The test of exact fit was non-
significant and all measures of goodness of fit were within acceptable levels.
The general psychological distress factor explained the largest amount of the common variance
(69%). The anxiety and depression group-factors were associated with relatively modest contributions
to the total common variance, accounting for 17% and 13%, respectively. Furthermore, the proportion
of test variance due to the general factor, ωh, is 44%, indicating that the saturation of the HADS by the
general factor is high. Item communalities ranged from 35% for A11 “I feel restless as if I have to be on
the move” to 87% for D12 “I look forward with enjoyment to things”.
In conclusion, the comparison of several plausible factorizations of the underlying constructs relating
to the HADS items reveals superior fit for the bifactor model. While the fit of models 5, 6 and 7 was
within acceptable limits, and similar to that reported by previous CFA studies (Martin, 2005), the bifactor
model produced a lower χ2 statistic and was supported by both the AIC and BIC despite the increased
model complexity.
5.3.2.3 Comparison of predicted and sumscores
In order to gauge what the general factor underlying the HADS items relates to, and to assess the mag-
nitude of the distortion when using the HADS as a unidimensional rather than multidimensional scale,
the predicted factor scores from the bifactor model were compared to the observed sumscores. The
correlations between the factor scores and sumscores and are displayed in Table 5.8. The correlation
between the anxiety factor and sumscore was high (r = .50), as was the correlation between the depres-
sion factor and sumscore (r = .64). However, both the anxiety and depression sumscores were more
highly correlated with the general distress factor (r = .87 and .82, respectively), although not as highly
as the total sumscore (r = .95). As expected the correlations between the factors are low (i.e. they are
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Table 5.7: Estimated factor loadings and thresholds for bifactor model
Factor Threshold
G A D 0-1 1-2/3
A1 I feel tense or wound up 0.77 0.27 -0.60 0.98
A3 I get a sort of frightened feeling as if some-
thing awful is about to happen
0.56 0.60 -0.03 0.80
A5 Worrying thoughts go through my mind 0.67 0.43 -0.13 1.18
A7 I can sit at ease and feel relaxed 0.79 -0.52 0.96
A9 I get a sort of frightened feeling like butter-
flies in the stomach
0.47 0.82 0.08 1.65
A11 I feel restless as if I have to be on the move 0.59 -0.52 0.51
A13 I get sudden feelings of panic 0.59 0.70 0.00 1.21
D2 I still enjoy the things I used to enjoy 0.63 0.55 -0.17 1.25
D4 I can laugh and see the funny side of things 0.80 0.36 0.71 1.96
D6 I feel cheerful 0.74 0.67 1.96
D8 I feel as if I am slowed down 0.65 0.28 -1.18 0.08
D10 I have lost interest in my appearance 0.54 0.43 0.39 1.25
D12 I look forward with enjoyment to things 0.78 0.51 0.09 1.32
D14 I can enjoy a good book or radio or TV pro-
gramme
0.59 0.74 1.86
Note: G = General distress; A = Anxiety; D = Depression
orthogonal).
These observations suggest that factor scores should be utilised in future research. Where this is
not possible, the use of the total score is more advisable than the anxiety and depression sumscores
by themselves. To be sure, the correlations do indicate that the anxiety and depression sumscores do
relate the the underlying constructs. However, using the sumscores of the separate subscales will not
differentiate between the specific elements of anxiety and depression from general distress, due to the
saturation of the sumscores by the general factor. Further consideration of the nature of the general
factor and the HADS total sumscore is provided at the end of this chapter.
5.3.3 Measurement equivalence
Moving forward, the following section tests for measurement equivalence under the assumption that the
bifactor model is the correct model. Measurement equivalence relates to the condition where individ-
uals with equivalent true scores would have the same probability of a particular observed score on an
associated test (Meredith, 1993). Differences across groups, or time points, thus reflect real differences
rather than differential item interpretation.
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Table 5.8: Pearson correlations between HADS factor and summed scores
1 2 3 4 5 6
1 Anxiety factor 1.000
2 Depression factor -0.148 1.000
3 General factor 0.098 0.246 1.000
4 Anxiety sumscore 0.496 0.022 0.872 1.000
5 Depression sumscore -0.103 0.640 0.815 0.582 1.000
6 Total sumscore 0.240 0.353 0.950 0.902 0.876 1.000
Measurement equivalence has been described extensively elsewhere (e.g. Meredith, 1993; Millsap &
Yun-Tein, 2004), therefore detailed discussion is not presented here. Briefly, the literature surrounding
the HADS generally suggests that it conforms to the assumptions of dimensional and configural invari-
ance.10 That is, equal numbers of factors are observed across populations and the same items are ob-
served to load on the same factors. However, this observation does not indicate whether items function
the same way across different groups. Where individual items are found to function differently across
groups this item bias is often termed differential item functioning (DIF).
5.3.3.1 Differential item functioning across demographic and clinical variables
Within the RA sample DIF for demographic and clinical variables was assessed using multiple-indicator
multiple-cause (MIMC) models. This was partly due to the limited sample size. Splitting the sample into
groups, for example based on gender, would have meant any MG-CFA would have lacked robustness
due to the size of the sub-groups. However, the MIMC approach has the advantage that it allows for
the inclusion of continuous independent variables, which meant that continuous variables could be
examined without the necessity to split them into groups at some arbitrary point.
MIMC models allow for the estimation of both the direct and indirect (i.e. via the latent construct)
effects of a covariate on the item responses. The assumption is that the effect of group on response is
fully mediated by the underlying construct—that is, there is no direct effect. If there is a direct effect on
an item, the item is said to display DIF. Biased items were identified by the examination of modification
indices in models where the latent factors and observed variables were regressed on the demographic
and clinical variables, but the parameters for the direct effects of these variables on the observed items
was constrained to zero. Items showing DIF were added on a systematic basis using the procedure
described by (Saris, Satorra, & Veld, 2009). This involves the examination of the expected parameter
change for freely estimating the direct path in combination with the MI and the power of the MI test.
10Although differences have been observed across methodologies (c.f. Bjelland et al., 2002; Martin, 2005).
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Age Age in years at the time of assessment was included in the model. Age was significantly associated
with Depression, b = 0.032, p = 0.001, but not the general factor, b = −0.010, p = 0.143, or Anxiety,
b = −0.003, p = 0.715. Examination of the modification indices indicated no problem with DIF in
relation to Age.
Gender A dummy coded variable for female gender was included in the model. Females scored sig-
nificantly higher on the depression, b = 0.764, p = 0.028, and anxiety factors b = 0.831, p < 0.001,
compared to males, but scored lower than males on the G factor, b =−0.440, p = 0.033.
Inspection of the modification indices suggested freeing the path from female to D14 “I can enjoy
a good book or radio or TV programme”. Re-estimating the model with this path freed showed that the
path was significantly different from zero, b = 0.621, p = 0.003, and significantly improved the fit of the
model, χ2(1) = 7.56, p = .006. This indicates that DIF is present between gender groups for this item.
Specifically, females, compared with males at the same level on the general factor, had lower likelihood
of responding in the higher categories. Holding the three factors constant at the sample mean, the
probability of a male scoring 1 “Sometimes” compared to 0 “Often” on item D14 was 0.37, as opposed to
0.20 for females. This is displayed graphically in Figure 5.5. This accounts for the differences between
the sexes observed on the general and depression factors in the previous model. In the re-estimated
model males and females differ significantly only in terms of anxiety, b = 0.706, p = 0.001, and not
depression, b = 0.350, p = 0.207, or general distress, b =−0.251, p = 0.208.
Functional limitation HAQ disability was significantly associated with the general factor, b = 0.505, p =
0.001, and Depression, b = 0.737, p < 0.001, but not Anxiety, b = −0.019, p = 0.925. Examination of
the modification indices indicated no problem with DIF. The inclusion of direct paths would not result in
significant improvement in fit using a likelihood ratio test.
Disease Activity Disease activity, as indexed by the DAS (Prevoo et al., 1995) was entered into the
model. Individuals with higher levels of disease activity scored significantly higher on average on the
depression factor, b = 0.270, p < 0.001, and marginally so on the general factor, b = 0.095, p = 0.073,
but not on the anxiety factor, b = 0.057, p = 0.332.
Inspection of modification indices suggested freeing the path from DAS to item D8, “I feel slowed
down”. Doing so the parameter estimate was significant, b = 0.224, p = 0.003, as was the change in
model fit, χ2(1) = 7.35, p = .007. For item D8, holding the level of underlying psychological distress
factors at the mean, the probability of scoring 1 “Sometimes” instead of 0 “Not at all” was .50 for those
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Figure 5.5: Item characteristic curve for D14, by gender
Figure 5.6: Item characteristic curve for D8, by low (mean – .5 SD) and high (mean + .5 SD) DAS
groups
half a SD below the mean on DAS, compared to 0.68 for those half a SD above the mean (Figure 5.6).
Despite the presence of DIF, there was little impact on the interpretation of differences on the anxiety,
b = 0.053, p = 0.364, depression, b = 0.200, p = 0.002, and general distress factors, b = 0.096, p =
0.060.
In summary, these analyses, using MIMC models, suggest that concerns regarding item bias due to
underlying level of disease severity are unwarranted. Although DIF was observed for disease activity the
effect was small, and appears to contribute little to overall scores on the factors. It is unlikely that the
bias will have a major impact except for those with extreme levels of disease activity.
A concern relates to linearity. MIMC models assume DIF is equal (uniform) across the distribution
of the variable, however it would be plausible for a an increasing effect of the bias at higher levels of
disease activity. Greater concern must be given to the finding of DIF for gender, which for D14 loading
onto the depression and general factor appeared to account for the difference between the sexes on
these two factors
111
Chapter 5. Psychometric analysis of the Hospital Anxiety and Depression Scale
5.3.3.2 Measurement equivalence across chronic physical conditions
The factor structure of the HADS in the RA sample was compared to patients with renal failure (RF) and
cancer. The RF sample consisted of the baseline HADS assessment completed by 170 patients enrolled
in an observational study being undertaken within the Renal Department at the Lister Hospital, East
& North Hertfordshire NHS trust. These patients were, at the time, not receiving dialysis but were
expected to require this treatment within the next 12-months. The mean age of the sample was 61.0
(SD 16.2), similar to that of the RA sample. The cancer sample consisted of 96 patients attending for
PET-CT scans at the Paul Strickland Scanner Centre, Mount Vernon Hospital. The data was collected as
part of a student project to investigate predictors of panic attack during a scan. Mean age of the group
was slightly younger than the rheumatological sample used in the preceding analysis, at 50.6 years (SD
16.1).
CFA assessment of dimensional and configural invariance Separate CFA models were fitted based
on the eight models previously assessed (Tables 5.6, 5.9 and 5.10). For dimensional invariance to hold
the best fitting model for each group should include the same number of factors. Furthermore, for
configural invariance the same model should fit the data best.
For all three groups, the three-factor models show better fit than the two and one factor models.
For both the RA and the renal failure groups the goodness of fit statistics was optimal for Model 8, the
bifactor model. Furthermore, for the renal failure group the test of exact fit was non-significant. This
was supported by values of the AIC and BIC. For the cancer group however, model 5, the Tripartite model
(Dunbar et al., 2000), showed the best fit, although little difference in the goodness-of-fit statistics was
observed between Models 5 and 8.
For all groups modifications were made to the bifactor model, Model 8, by excluding items that
either did not load significantly onto the general or specific factors, furthermore modification indices
were inspected and additional paths and residual correlations included where necessary.
For the RA group, as was previously reported, all factor loadings on the general factor were retained,
the loadings of items A7 and A11 on the anxiety factor fixed to zero, and the loadings for D6 and D14
on the depression factor were fixed to zero. Furthermore, a residual correlation between D2 and D8 was
included. The test of exact fit for this model was non-significant and all measures of goodness-of-fit were
within acceptable levels.
Similarly, for both the renal and cancer groups all items loaded significantly on the general factor
and were retained, and the loadings for A11 on the anxiety factor were non-significant and thus fixed to
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Table 5.9: CFA model fit statistics, renal failure group
Model χ2 df p CFI TLI RMSEA AIC BIC
1-factor
1 142.0 34 0.000 0.82 0.89 0.14 4063 4062
2 112.8 36 0.000 0.87 0.93 0.11 4035 4033
2-factor
3 74.6 36 0.000 0.94 0.96 0.08 3984 3982
4 78.0 35 0.000 0.93 0.96 0.09 3990 3989
3-factor
5 61.8 35 0.003 0.96 0.97 0.07 3971 3969
6 59.7 35 0.006 0.96 0.98 0.06 3965 3964
7 69.0 35 0.001 0.94 0.97 0.08 3978 3976
8 48.3 34 0.053 0.98 0.99 0.05 3955 3953
Final 43.3 32 0.087 0.98 0.99 0.05 3959 3957
zero. Item A7 loaded non-significantly on the anxiety factor in only the renal failure group. Again for the
depression factor, D14 did not load significantly and its loading on the factor were fixed to zero in both
the renal and cancer groups. D2 was also excluded in the renal failure group, but not the cancer group.
In addition, D4 and D12 were also non-significant in the renal failure group and thus their loadings on
the depression factor fixed to zero. D6 was non significant and excluded from loading on the depression
factor in the caner group. No residual correlations were included for the renal failure group, but a
residual correlation was included between items D4 and A11 in the cancer group. The test of exact fit
was non-significant for both groups and all measures of goodness of fit were within acceptable levels.
The final models for each group were similar, although the minor differences observed do pose a
threat to the assumption of configural invariance. However, it is conceivable that differences may be a
result of over fitting to the data, and particularly for the cancer group may result from random variation
due to the relatively small sample sizes.
Multiple group CFA MG-CFA was applied to test the assumption of strong measurement invariance.
Following the recommended strategy of B. Muthén and Asparouhov (2002)11. Initially a baseline non-
invariant model was fitted that freely estimated the factor loadings and thresholds followed by an invari-
ant model that constrain the factor loadings and thresholds to be equal across groups. Scale factors12
11Meredith (1993) suggests testing the equivalence of the factor loadings and intercepts in separate stages (metric and strong
invariance). Millsap and Yun-Tein (2004) proposes a commensurate approach for categorical indicators but convergence
problems were encountered for this approach. These issues were likely due to the small sample sizes for each group and
limited number of thresholds per item (Bontempo, 2006). The alternative approach proposed by B. Muthén and Asparouhov
(2002) combines the tests of metric and strong invariance, which is defensible since they have a combined impact on the item
characteristic function (B. Muthén & Asparouhov, 2002).
12Scale factors are used in multiple group analysis when the dependent variables are categorical and a WLSMV estimator
is applied. The scale factors account for “across group differences in the variances of the latent response variables for the
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Table 5.10: CFA model fit statistics, cancer group
Model χ2 df p CFI TLI RMSEA AIC BIC
1-factor
1 113.6 28 0.000 0.63 0.70 0.18 2358 2340
2 94.4 26 0.000 0.71 0.74 0.17 2335 2310
2-factor
3 59.5 28 0.001 0.86 0.89 0.11 2272 2247
4 50.7 26 0.005 0.90 0.92 0.09 2264 2239
3-factor
5 37.0 27 0.094 0.96 0.96 0.06 2258 2231
6 54.6 28 0.002 0.89 0.91 0.10 * *
7 47.2 28 0.013 0.92 0.93 0.08 2261 2234
8 39.4 26 0.045 0.94 0.95 0.07 * *
Final 35.3 26 0.105 0.96 0.96 0.06 ** **
* Information criterion not computable due to non convergence of ML estimation
** Information criterion not computable for final model due to conditional independence assumption of ML
and factor means were fixed at one and zero, respectively, in one group and freely estimated in the
others, as is the convention to achieve model identification. Since the invariant model is nested within
the baseline model the two can be compared using a χ2 difference test.
The baseline non-invariant model specified all items to freely load onto a general factor, all depres-
sion items except D6 and D14 to load onto a depression factor, and all anxiety items except A7 and A11
to load onto an anxiety factor. In addition, a residual correlation between items D2 and D8 was included,
as this was indicated by the CFA of the RA data in section 5.3.2.2 and notably it was significant for RF
group although not indicated by modification indices. For the RA and RF groups the test of exact fit was
non-significant, χ2RA(26) = 39.29, p = .057, χ
2
renal(33) = 44.92, p = .094. However, for the cancer group
the test of exact fit was significant, χ2cancer(25) = 54.65, p < .001. A requirement for invariance testing
is that the baseline model is non-significant (Millsap & Yun-Tein, 2004).
The baseline MG-CFA model showed poor fit to the data, largely due to the contribution of the cancer
group to the overall value of the χ2 statistic (Table 5.11), although fit indices indicate that the degree of
misfit is small. The invariance model showed significant worsening of fit, χ2(36) = 84.43, p < 0.001, and
the change in the fit indices of around .02. Inspection of the parameter estimates for the non-invariance
model presented in Table 5.13 indicates that this finding is likely to be due to the magnitude of the
differences with the cancer group, which showed generally lower factor loadings on the general factor,
concurrently higher loadings on the anxiety and depression factors, and differing thresholds (items A1,
D2, A3, D8, A9, A11, D12). By contrast, the estimates were largely similar for the RA and RF groups.
observed categorical dependent variables” (p. 395 L. Muthén & Muthén, 2007). This allows for the recovery of across group
differences in factor means and variances.
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Table 5.11: Multi-group CFA models, RA, RF and cancer groups
Model χ2 df p CFI TLI RMSEA
Non-invariat 128.19 81 0.000 0.98 0.98 0.06
Invariant* 174.92 92 0.000 0.96 0.97 0.08
*∆χ2(36) = 84.43, p < 0.001
Table 5.12: Multi-group CFA models, RA and RF groups only
Model χ2 df p CFI TLI RMSEA
Non-invariant 84.17 58 0.014 0.98 0.99 0.05
Invariant* 97.48 62 0.003 0.98 0.99 0.06
*∆χ2(16) = 23.7, p = 0.096
A biasing factor for the cancer sample may be that the assessment was taken immediately preceding
a PET-CT scan. At this time levels of anxiety—particularly symptoms of autonomic arousal that several
anxiety items assess—are likely to be raised, and it may be that the test is being influenced to a greater
extent by state levels of anxiety than in the RA and renal failure groups. Resultantly, it was deemed
appropriate to exclude the cancer group from the analysis and examine measurement invariance across
the RA and renal failure groups separately (Table 5.12). The test of exact fit for the non-invariant model
remained significant considering only the RA and renal failure groups. However, the fit indices indicated
the fit to the data was acceptable. On constraining the factor loadings and thresholds to be equal,
the worsening in fit was non-significant, χ2(16) = 23.7, p = 0.096, and only marginal reduction was
observed in the goodness of fit indices.
It would appear that while the assumption of invariant factor loadings and thresholds does not hold
when considering the cancer group, this assumption is tenable when considering the RA and RF groups.
5.3.3.3 Measurement equivalence over time
It is important that the HADS actually measure the same underlying latent constructs with time. If
not, it may result in comparisons between time points being misleading, as changes, or lack of, may be
due to changes in the measurement of the underlying constructs rather than changes in the constructs
themselves. Resultantly any longitudinal modelling may be biased.
The HADS sumscores have been found to have good test-retest reliability (Herrmann, 1997), and
Osborne et al. (2004) found no evidence for DIF when considering time from diagnosis using a MIMC
model approach, however I have found no study reporting an assessment of measurement invariance
over time. For the findings of the following chapters to be robust this must be assessed. This section
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Table 5.13: Parameter estimates for the non-invariance model for the RA, renal failure (RF) and
cancer (CA) groups
Group Factor Threshold
Item G A D 0–1 1–2/3
A1 I feel tense or wound up RA 0.77 0.27 -0.60 0.98
RF 0.68 0.27 -0.67 0.70
CA 0.34 0.68 -1.26 0.67
A3 I get a sort of frightened feeling as if
something awful is about to happen
RA 0.56 0.60 -0.03 0.80
RF 0.52 0.64 -0.25 0.63
CA 0.24 0.73 -0.85 -0.08
A5 Worrying thoughts go through my mind RA 0.67 0.43 -0.13 1.18
RF 0.62 0.48 -0.33 0.63
CA 0.59 0.61 -1.10 0.21
A7 I can sit at ease and feel relaxed RA 0.79 -0.52 0.96
RF 0.83 -0.27 1.02
CA 0.86 -0.81 0.85
A9 I have lost interest in my appearance RA 0.47 0.82 0.08 1.65
RF 0.59 0.64 0.09 1.47
CA 0.23 0.60 -0.64 1.05
A11 I feel restless as if I have to be on the move RA 0.59 -0.52 0.51
RF 0.36 -0.43 0.63
CA 0.25 -0.97 0.46
A13 I get sudden feelings of panic RA 0.59 0.70 0.00 1.21
RF 0.59 0.49 0.06 1.16
CA 0.45 0.63 -0.55 1.10
D2 I still enjoy the things I used to enjoy RA 0.63 0.55 -0.17 1.25
RF 0.54 0.13 -0.59 0.51
CA 0.31 0.57 -0.16 1.38
D4 I can laugh and see the funny side of things RA 0.80 0.36 0.71 1.96
RF 0.75 0.33 0.61 1.67
CA 0.63 0.26 0.37 1.26
D6 I feel cheerful RA 0.74 0.67 1.96
RF 0.79 0.10 1.81
CA 0.93 0.43 1.45
D8 I feel as if I am slowed down RA 0.65 0.28 -1.18 0.08
RF 0.45 0.28 -1.57 -0.24
CA 0.22 0.32 -1.15 0.16
D10 I have lost interest in my appearance RA 0.54 0.43 0.39 1.25
RF 0.52 0.92 0.19 0.91
CA 0.50 0.40 0.37 1.05
D12 I look forward with enjoyment to things RA 0.78 0.51 0.09 1.32
RF 0.71 0.01 0.10 1.08
CA 0.51 0.65 0.03 1.01
D14 I can enjoy a good book or radio or TV
programme
RA 0.59 0.74 1.86
RF 0.50 0.68 1.57
CA 0.63 0.78 1.86
Note: G = General distress; A = Anxiety; D = Depression
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Table 5.14: Multi-group CFA models using delta parametrisation
Model χ2 df p CFI TLI RMSEA
Non-invariance 89.36 55 0.002 0.97 0.98 0.08
Invariance 111.12 54 0.000 0.95 0.96 0.10
*χ2(18) = 14.62, p = 0.688
addressed this issue by considering measurement invariance between the baseline and 1-year follow-up
assessments for the members of the ERAS cohort for whom individual item responses were available. As
with the previous MG-CFA analysis the procedure described by B. Muthén and Asparouhov (2002) was
applied. From the 160 individuals all individuals completing a HADS at either the baseline or 1-year
follow-up assessment were used, N = 100 and 99 observations respectively (96 at both).13
The baseline non-invariant model with the same bifactor structure as described in the previous sec-
tion was used, again factor loadings and thresholds were freely estimated across the two repeated as-
sessments. Despite the small sample size, the test of exact fit was highly significant, although the CFI and
TLI were within acceptable levels (Table 5.14). An invariant model with factor loadings and thresholds
constrained to be equal across the two repeated assessments was then estimated. A χ2 difference test
revealed no significant worsening of fit for the invariant model, χ2(18) = 14.62, p = 0.688, and negligi-
ble changes in the fit indices indicating the assumption of measurement invariance holds. However, it is
important to be mindful that with such small sample sizes the power to detect meaningful measurement
invariance is likely to be low.
Table 5.15 displays the parameter estimates for the non-invariant model. Inspection of these esti-
mates reveals that for the general factor the factor loadings were relatively similar. The trend was for
higher values at the second assessment. The differences were larger for the specific factors, indicating
a possible issue with measurement invariance when considering the depression or anxiety factors in
isolation.
Generally, the threshold parameters were similar, with differences ranging -.39 to +.49 (NB. 1 =
1 SD). There appeared to be a systematic shift further up the distribution for the second threshold
parameter only at the second time point. Fifteen of the 28 threshold parameters changed by less than a
fifth of a standard deviation, while six changed by more than a third of a SD up the latent construct.
13As the HADS was only included in the set of data collected around 1990, HADS scores were not available for those
recruited between 1986 and that time. The rationale for using these time-point rather than later time where more data are
available is that it is changes early in the course of the disease that are of most importance and it is at that time that the threat
to measurement invariance is strongest, for example disease-modifying treatment was typically initiated between these two
assessments.
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Table 5.15: Parameter estimates for the time non-invariant model
Time Factor Threshold
Item G A D 0–1 1–2/3
A1 I feel tense or wound up Baseline 0.60 0.51 -0.74 1.04
1-year 0.64 0.42 -0.87 1.22
A3 I get a sort of frightened feeling as if
something awful is about to happen
Baseline 0.66 0.40 0.08 0.92
1-year 0.78 0.50 0.01 0.94
A5 Worrying thoughts go through my mind Baseline 0.57 0.52 -0.13 0.84
1-year 0.67 0.39 -0.01 1.33
A7 I can sit at ease and feel relaxed Baseline 0.80 -0.92 0.84
1-year 0.86 -0.43 1.22
A9 I get a sort of frightened feeling like butterflies
in the stomach
Baseline 0.44 0.64 0.20 1.48
1-year 0.47 0.84 0.03 1.87
A11 I feel restless as if I have to be on the move Baseline 0.43 -0.44 0.58
1-year 0.59 -0.45 0.60
A13 I get sudden feelings of panic Baseline 0.53 0.70 0.13 1.34
1-year 0.65 0.48 0.08 1.55
D2 I still enjoy the things I used to enjoy Baseline 0.46 0.36 -0.50 1.13
1-year 0.49 0.55 -0.16 1.22
D4 I can laugh and see the funny side of things Baseline 0.85 -0.01 0.61 1.75
1-year 0.87 0.28 0.76 2.05
D6 I feel cheerful Baseline 0.76 0.67 1.88
1-year 0.79 0.90 2.05
D8 I feel as if I am slowed down Baseline 0.68 -0.06 -1.48 -0.13
1-year 0.64 0.07 -1.22 0.19
D10 I have lost interest in my appearance Baseline 0.51 0.26 0.52 1.56
1-year 0.66 0.30 0.60 1.16
D12 I look forward with enjoyment to things Baseline 0.76 0.84 0.08 1.34
1-year 0.67 0.53 0.19 1.55
D14 I can enjoy a good book or radio or TV
programme
Baseline 0.58 0.77 1.65
1-year 0.77 0.90 2.05
Note: G = General distress; A = Anxiety; D = Depression
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5.4 Discussion
This chapter has examined the psychometric properties of the HADS. Previous research has indicated
that there may be issue concerning dimensionality using this instrument, and also that some of the
items of the instrument may be biased, differentially assessing the underlying constructs of anxiety and
depression for different individuals.
For the patients with RA (and renal failure) the bifactor model provides superior fit to the HADS
item covariance structure compared to alternative formulations, such as the original anxiety-depression
formulation (Zigmond & Snaith, 1983) and three-factor solutions centering around the tripartite theory
of anxiety and depression (Dunbar et al., 2000; Friedman et al., 2001; Caci et al., 2003). The finding of a
bifactor structure reconciles the conflicting results of previous studies applying different methodologies.
Despite the competing models identified, several studies using alternate methodologies have indicated a
general factor: the first unrotated factor in EFA studies indicates a general factor but the aim of finding
a simple structure leads to rotation and the anxiety-depression factorization (Herrmann, 1997); CFA
studies have supported a general NA factor (Martin, 2005; Dunbar et al., 2000; Desmond & MacLachlan,
2005; Martin et al., 2003; McCue et al., 2006; Rodgers et al., 2005; Barth & Martin, 2005; Martin,
Thompson, & Chan, 2004; Martin, Tweed, & Metcalfe, 2004; Martin et al., 2008; Pallant & Bailey,
2005; Wang, Lopez, Thompson, & Martin, 2006); and IRT studies applying Rasch models find that a
unidimensional solution is appropriate (Forjaz et al., 2008; Pallant & Tennant, 2007; Tang et al., 2007,
2008).
Previous CFA studies have indicated at a possible higher-order factor, but have failed to consider a
bifactor solution. Although, the general conclusion has been that a tripartite like structure exists, these
conclusions are dubious since model fit is often only marginally better for this compared to competing
models. This would seem to suggest model mis-specification.
IRT studies find that a unidimensional solution is appropriate, however these apply fairly restrictive
Rasch models (Pallant & Tennant, 2007; Tang et al., 2008, 2007). Although multivariate IRT models ex-
ist, they are rarely used in practice and have thus far not been considered for the HADS. IRT approaches
have been criticized for the reliance on unidimensionality (Reise, Morizot, & Hays, 2007) and it would
seem that those conducted on the HADS have not been sensitive enough to identify the anxiety and
depression group factors.
The remaining issue concerns the interpretation of the general factor. The general factor may mea-
sure general psychological distress or may reflect NA, a a “common, underlying disposition of somatopsy-
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chic distress” that subsumes a wide range of negative emotions (Watson & Clark, 1984). Although sev-
eral items that are closely related to the NA construct had high loadings on the general factor and low
loadings on the anxiety factor (restlessness and tension: A1, A7 and A11; worry: A5), all items had high
loadings on the general factor. This would seem to suggest that although the general factor does capture
elements of NA it is a measure of general psychological distress.
This interpretation of the general factor and support for a bifactor structure is provided by recent
research extending the Tripartite theory. Simms et al. (2008) used IRT based full-information factor
analysis on the Inventory of Depression and Anxiety Symptoms (IDAS). The authors found that a bifactor
solution fitted the data better than a unidimensional Rasch model, identifying 13 factors relating to
symptom groups such as suicidality, dysphoria, panic and generalized anxiety. Comparing the general
factor to other instruments they concluded that the general factor measured general distress, although
was strongly associated with anxiety, depression and NA. It would seem likely that this is also true of the
HADS.
The group-factors do however appear to be good markers for the Tripartite constructs of autonomic
anxiety and anhedonic depression. The highest loading items on the anxiety factor were for items A3 “I
get a sort of frightened feeling as if something awful is about to happen”, A9 “I get a sort of frightened feeling
like butterflies in the stomach” and A13 “I get sudden feelings of panic”, which assess somatic responses to
anxiety and panic. Moreover, items A1 “I feel tense and wound up”, A7 “I can sit at ease and feel relaxed”
and A11 “I feel restless as if I have to be on the move” exhibit low loadings on the anxiety factor and are
removed due to non-significant paths in the final RA model.
According to the Tripartite theory, the prevailing component of depression is anhedonia characterized
by low positive affectivity—a loss of pleasure and interest in life (Watson et al., 1995). For the depression
factor items D2 “I still enjoy the things I used to enjoy” and D12 “I look forward with enjoyment to things”
typify anhedonia and have the highest loadings on the depression factor. Furthermore, item D8 “I feel
slowed down” which concerns psychomotor retardation exhibited only a low loading on the depression
factor.
The correlations observed between the general and specific factors and the sumscores indicate that
the HADS sumscores, although capturing some of the specific variance in item responses associated with
anxiety and depression, predominantly tap into the the general psychological distress factor. As such,
the HADS total sumscore rather than the individual anxiety and depression sumscores will be utilized in
the analyses in following chapters.
In terms of measurement equivalence, the results presented no major cause for concern. While prob-
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lems were uncovered with the cancer group, it is likely that the higher psychological distress experienced
within cancer patients was due to increased levels of state anxiety.
The HADS was intended to be administered in hospital clinics, as such it was designed to avoid
being biased by the elevated levels of anxiety often concomitant in this setting. This was the setting in
which the RA and renal failure patients completed the questionnaire. However the cancer patients were
administered the HADS shortly before a PET-CT, a procedure which requires them to be injected with a
radioactive isotope and be confined to a small space for an extended period of time—not to mention the
reason for the scan being to inform them whether their treatment had caused their tumor to shrink. It
may be that the high state anxiety as a result of the immediate situation impacted on the interpretation
of the HADS items, such that the “last two weeks” reference frame was not adhered to. Supporting
this proposition, mean sum-score anxiety levels were 8.1 (SD 3.7) for the cancer group compared to
5.8 (SD 3.7) and 5.9 (SD 4.0) for the RA and renal failure groups, respectively. Whereas, mean levels
of the depression sum-score were similar across the three groups (cancer: 4.5 [SD 3.2]; RA: 4.4 [SD
3.2]; renal: 5.5 [SD 3.2]). This does however raise some concern regarding the ability of the HADS to
differentiate between trait and state components of psychological well-being.
A limitation of the analysis is that the group sizes were small. While Flora and Curran (2004) did
report WLSMV estimation to work acceptably well in simulations with similar sized groups, the study did
not assess models with a structure as complicated as a bifactor structure. Furthermore, the examination
of measurement equivalence typically requires larger sample sizes than is required for CFA with ordinal
indicators alone. This limits the statistical power of the test for an invariant structure across groups.
However, in line with previous research the violations of measurement equivalence uncovered were
relatively small (Osborne et al., 2004; Tang et al., 2008). Whats more, the cumulative bias observed
for individual items is likely to have only a minor impact on scores on the general factor, or indeed the
HADS total sumscore.
A further limitation is that there was no other measure of psychological distress or indicator for NA,
such as an assessment of neuroticism, with which to examine the convergent validity of the HADS.
In summary, the data presented in this chapter support the utility of the HADS among a chronically ill
populations assessed in outpatient clinics during routine appointments. The bifactor structure provides
an acceptable empirical explanation of the HADS item covariance structure and allows a conceptual
interpretation that reconciles the ambiguous findings of previous studies.
As it is not be possible to use individual item responses in the remainder of this dissertation, the
HADS total score will be used as a marker for the individuals level of general psychological distress. The
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use of the sumscores for the separate anxiety and depression scales is limited by the level of saturation
of the general factor and so are not considered separately. That is, the anxiety and depression scales
provide an assessment of autonomic anxiety and anhedonic depression that incorporates large elements
of general psychological distress. Using the total score provides a broader assessment of psychological
distress that incorporates symptoms of autonomic arousal and anhedonia. Further reasons to favour the
use of the total sumscore, include a decreased likelihood of bias as a result of DIF, increased precision of
measurement and a less skewed distribution.
The following chapter examines changes in psychological well-being using the HADS total score over
an extended period of time in the ERAS cohort.
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The course of psychological distress
6.1 Introduction
This chapter examines changes in psychological well-being during the RA disease course, addressing the
first objective of this dissertation (see section 3.5.3). Data from the ERAS cohort is used to examine the
rate of change over-time, including whether any change is constant or varies as a function of disease
duration, and factors that affect the rate of change over time. In addition, heterogeneity in changes is
assessed to see if the data was is appropriately described using a single trajectory or whether multiple
groups of patients with distinct trajectories provides a better explanation. Following from the findings of
Chapter 5, the HADS total score will be used as a measure of general psychological distress incorporating
symptoms of anhedonia depression and autonomic arousal.
Psychological distress in RA is typically high compared to the general population, with rates of de-
pressive disorder roughly 2-4 times higher (Katon & Schulberg, 1992; Dickens et al., 2002). Despite
a large number of studies assessing the prevalence of psychological disorder in RA, few studies have
appropriately considered how, or why, levels of psychological distress change over time. Longitudinal
studies examining changes in psychological distress in RA studies were reviewed in Chapter 3. To recap,
these studies typically fall into two types.
Firstly, several studies examined changes in the average level of distress over time, using repeated
measures ANOVA, t-tests or descriptive data (e.g. means and standard deviations). The vast majority
of these studies found levels of distress to be stable over time, that is, no change in distress over time
was observed at the group level (e.g. Brekke et al., 2003). The other type of study typically used
regression analysis—such as using the change in distress between two time points as the dependent
variable, residualised change score analysis, or path analysis—finding that certain covariates predict
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changes in distress over time, that is at the individual level covariates explain the heterogeneity in
change (e.g. Treharne et al., 2007; Schiaffino et al., 1998).
Although these two approaches at first appear to present conflicting findings, it is important to note
that no difference in the average level of distress over time does not rule out important within individual
changes. The first type of analysis simply is not intended to identify such individual level heterogeneity.
For example, there may be equal numbers of individuals experiencing worsening or improvement in
distress over the time period, which sums to zero creating the impression of no change when the analysis
uses only the marginal means.
Considering further studies that examine changes in the average level of distress over time there
is another serious flaw in the design of the vast majority of studies. As was discussed in Chapter 3,
the major limitation is the failure to adequately control for disease duration in either the design or the
analysis. Most studies include patients irrespective of their disease duration, the failure to control for
disease duration in further analysis means that the finding of no change over time is meaningless. More
specifically, the inclusion of individuals’ with wildly varying disease durations means that assessments of
change in psychological distress from t = 1 to t = 2 for the group are not sensible, since individuals are
at different stages of the disease course and we might expect psychological distress to change differently
at different times.
In section 3.3 the distress data from 14 studies that restricted the inclusion criteria to only those with
recent onset disease were pooled. This suggested a potentially non-linear trend of reducing distress over
time. This was supported by a further study that found lower levels of distress in 134 RA patients with
early versus long-standing disease Treharne et al. (2007).
In addition, one study of patients early in the disease course identified distinct trajectories of psy-
chological distress following the onset of RA. Persson et al. (2005) first split their sample of 158 patients
with recent onset RA at the median baseline level of distress and then by whether levels of psychological
distress decreased over time. Those below the median at baseline showed little change is distress over
time. However, for individuals scoring above the median baseline level of distress there was a clear
differentiation into a group with a decline in distress over time (38%) and those with consistently high
levels of psychological distress (12%). This finding suggests heterogeneity in the psychological response
to the onset of RA. However, the groups derived are likely to be a result of the process used to define
them and these findings need to be confirmed.
In a recent study, Morris et al. (2011) employed cluster analysis to identify three distinct long-term
patterns of depressive symptoms (low/none 66%, intermittent 25%, chronic 9%). However, this study
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Figure 6.1: Prototypical trajectories of disruption in normal functioning following a loss or poten-
tial trauma: source Bonanno (2005, p.136)
was limited by the large range in disease duration for the sample at study entry, on average greater than
10-years. Resultantly, their analyses would not be able to identify changes that may occur early in the
disease course.
Several studies of psychological distress in individuals following breast cancer surgery, heart surgery
or a myocardial infarction have attempted to define distinct trajectories using sophisticated analytical
methods. Prior to discussing these studies it is useful to introduce a psychological model that postulates
different trajectories that should be identified.
Bonanno (2005) describes four response trajectories following a traumatic life experience (Figure
6.1): (i) many individuals are ‘resilient’ to the effects of the stressor, experiencing little or no disruption
in functioning; (ii) a further group consists of individuals initially experiences high levels of distress but
who recover in a relatively short period;1 (iii) some individuals however experience a ’chronic’ disruption
in functioning and experience persistently high levels of distress caused by the traumatic experience; (iv)
while a final group initially have a delayed disruption in functioning. Although initially developed for
major traumatic events, such as an act of terrorism, these response trajectories may generalise to other
situations. As has already been noted the onset of a chronic physical illness may be considered a stressful
life-event, characterised by recurrent stressful situations associated with the symptoms of the condition
(De Ridder et al., 1998; Moos & Schaeffer, 1984; Zautra, 1996).
Lam et al. (2009) assessed depression on four occasions in the 8-months following surgery for breast
cancer in 285 women from Hong Kong. Using growth mixture modelling they identified 4 distinct
1According to resilience theory this group is also resilient (Ryff, Singer, Love, & Essex, 1998).
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trajectories relating to Bonanno’s model: chronic distress (15%), resilient (67%), recovered (12%),
and delayed-recovered (7%). The delayed-recovered group showed initial levels of depression that
were comparable to the resilient group, but were raised at the 1-month and 4-month time points before
reducing at the 8-month-timepoint. Compared to the resilient group the chronic distress group had lower
baseline levels of optimism (OR=.62 [.51-.77]), worse physical symptoms (OR=1.28; 95% CI: 1.18,
1.34), and issues with treatment decision-making (expectancy-outcome incongruence: OR=1.45; 95%
CI: 1.28, 1.65). Similarly, the recovered group also had worse baseline physical symptoms (OR=1.22;
95% CI: 1.13, 1.33) and more treatment decision-making difficulties (OR=1.44; 95% CI: 1.27, 1.64)
but did not have worse optimism (OR=.90; 95% CI: .72, 1.11). The “delayed-recovered” group reported
worse physical symptoms (OR=1.23; 95% CI: 1.13, 1.34]), and lower satisfaction with the medical
consultation (OR=.77; 95% CI: .66, .89).
Another study also using a sample of women with breast cancer again provided support for this
model. Helgeson, Snyder, and Seltman (2004) examined psychological and physical adjustment fol-
lowing surgery and initiation of chemotherapy for breast cancer (N=363). Using latent class growth
analysis the authors identified four latent trajectory classes in SF-36 mental component scores. The
largest class representing a “resilient” group consisted of 43% of individuals who had the lowest levels
of distress throughout the study. A second group of around 18% showed showed minor ups and downs.
Both groups appeared to show a small increase in psychological well-being over time. Around 27% of
individuals showed poor psychological well-being over the first that substantially improved over time.
The final group showed an immediate and substantial decline over time (13%).
These two studies of cancer patients conform approximately to the predictions of the Bonanno model.
However, studies in individuals with cardiovascular disease have not provided the same level of support.
Martens, Smith, Winter, Denollet, and Pedersen (2008) used latent class growth analysis to examine
trajectories of depressive symptoms in myocardial infarction patients over 1-year (N = 287). They
identified a 4-class solution that was differentiated only by initial level of distress (i.e. stable over time:
non-depressed, mildly depressed, moderately depressed and severely depressed).
In a similar study, B. M. Murphy, Elliott, Worcester, et al. (2008) used growth mixture modelling
to identify two common trajectories in both anxiety and depression symptoms in 226 women over 12-
months following myocardial infarction or coronary bypass surgery. The majority of patients showed
relatively low levels of anxiety and depression with an improvement in psychological functioning over
time (Anxiety 84%, Depression 89%). The other classes representing only a small number of individuals
showed a worsening of symptoms of anxiety and depression. The same research group examined trajec-
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tories of depression and anxiety in 184 individuals following coronary artery bypass surgery (B. M. Mur-
phy, Elliott, Higgins, et al., 2008). Using growth mixture modelling they identified non-linear patterns of
change (cube-root). Two trajectory classes were identified regarding anxiety: remitted-minor (92%) and
remitted-major (8%)). However, three depression trajectories were identified: remitted-minor (72%),
partially remmited-major (14%), and worsening-minor (14%). Anxiety class membership was related
only to presurgery depression. Remitted-minor depression was associated with older age. Partially re-
mitted major was associated with being unpartnered, smoking, high presurgery anxiety, cholesterol,
angina, and earlier surgery. Low ejection fraction and worse physical function was associated with the
minor-worsening class.
Although, the studies involving patients with cardiovascular disease have not shown the same robust
level of support for the Bonanno model as the two cancer studies the resilient group was consistently
observed across all studies. It may be that the three cardiovascular disease studies did not have large
enough sample sizes to be able to detect all four classes.
6.1.1 Aims & Objectives of the chapter
This second empirical chapter will examine the longitudinal trajectories of psychological distress as-
sessed using the HADS in the ERAS cohort. Initially the shape of the trajectory will be assessed by
examining different non-linear trajectories with latent curve models (LCMs). After finding the best
fitting trajectory covariates will be added to the models to assess their impact on the initial levels of
psychological distress and changes over time. The unconditional model will then be extended to ex-
amine whether latent classes of trajectories exist using growth mixture modelling (GMM). This will be
theoretically driven by past research. Additionally, a sensitivity analysis will be undertaken to assess the
impact of missing data on the models (particularly the dropout mechanism).
6.2 Methods
6.2.1 Sample
The sample used in the current analysis consisted of a sub-sample of individuals from the ERAS cohort.
This is a prospective inception cohort initiated in 1986, with participants recruited from rheumatology
clinics at 9 UK hospitals. Inclusion criteria for the study were all adults (≥18-years) meeting the Amer-
ican College of Rheumatology criteria for the diagnosis of Rheumatoid Arthritis, with symptoms of less
than 2-years and prior to the initiation of disease-modifying medication. Between 1986 and 1994, 1460
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individuals were recruited and continue to be followed up yearly. Further details on the ERAS cohort
are provided in Appendix D.
Three of the ERAS centres Grimsby, Winchester and Basingstoke collected information on psycho-
logical distress using the Hospital Anxiety and Depression Scale (N = 421). In addition, a further 363
individuals were recruited from the Winchester centre after 1994 although they were not included in the
ERAS database. For these individuals only the core clinical data and HADS scores were collected. The
total sample size was 784.
The maximum number of years of follow up was 19 (Median = 7). Due to very few individuals
completing more than 15 years follow-up only information collected at visits up to this point was used,
resulting in a total of 6167 follow-up visits completed. The pattern of dropout and questionnaire non-
completion (intermittent missingness) is displayed graphically in Figure 6.2
Since the ERAS study is a longitudinal cohort with a large number of individuals recruited over a
long period of time right censoring is common. Of the initial 784 individuals only 63 (8%) completed
the full 15-years of follow-up. Of the remaining 721 individuals, 236 were lost to follow-up (151 died,
45 moved, 35 can’t/won’t, 5 discharged/remission) and 485 remained within follow-up but had not
completed 15-years follow-up at the time of the last follow-up assessment.
Intermittent missingness was also common, partly due to the decision to include the HADS in the
data collection procedure in 1989, several years after the initiation of the study. Excluding missing data
as a result of right censoring (i.e. dropout or death), 400 (42%) had no missing HADS data during the
course of follow up, with 571 (60%) with less than one-third of missing data. The dropout rate was
relatively low, with the majority of losses to follow-up due to death. However, as a result of the length of
the period of recruitment, there are large differences in the total number of years that individuals have
been followed up. Figure 6.2 shows the number of individuals completing each year of follow-up and
for each year then number that completed the HADS. Overall, no HADS data was collected for 25% of
completed visits. The amount of missing HADS data ranged between a maximum of 32% at year 1 and
minimum of 18% at year 6.
6.2.2 Measures
Data concerning the main study variable of psychological distress, the HADS (Zigmond & Snaith, 1983)2,
assessed at yearly intervals was used in the analysis. The previous chapter identified a bifactor structure
underlying the HADS and that the total score appears to give a consistent estimate of general psycholog-
2The HADS was described in section 5.2.2
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Figure 6.2: Frequency of completed follow-up visits and completed HADS for each follow-up visit
ical distress incorporating specific features of anxiety (autonomic arousal) and depression (anhedonia).
Since only sum-scores for the anxiety and depression subscales were available the total sum-score was
used rather than estimates of the three separate constructs.
With regard to covariates listed below, unless otherwise stated the values of the covariates at the
baseline assessment were used in the analysis.
Functional limitation Functional disability was operationalised using the UK version of the Health
Assessment Questionnaire (HAQ) disability index (Fries et al., 1980; Kirwan & Reeback, 1986). The
HAQ consists of 20 items concerning eight activities of daily living (dressing & grooming, arising, eating,
walking, hygiene, reach, grip and activities). Items are scored on a four-point ordinal scale ranging
from 0 ‘without any difficulty’ to 3 ‘unable to do’. In addition, for each activity respondents also report
whether they receive assistance from other people or use assistive devices. The aggregated score is the
average of the maximum rating within each of the eight activities of daily living adjusted for the use of
devices and assistance. Scores range between 0 and 3 with higher values indicating greater disability.
Generally scores greater than 1 indicate that an individual has moderate disability, and above 2 severe
disability although specific cut-offs have not been universally agreed. Since the distribution of HAQ
disability was positively skewed scores were square-root transformed for analysis.
Disease activity The original Disease Activity Score (DAS; van der Heijde et al., 1990) is a composite
measure including a blood marker of inflammation—erythrocyte sedimentation rate (ESR) or c-reactive
protein (CRP)—plus separate counts of the tenderness (TJC) and swelling (SJC) of 28 specific joints
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(mainly of the hands, feet and wrists). Scores for the DAS range between 0 and around 10 (although
there is technically no upper limit since ESR and CRP are unbounded), with scores of over 5 indicating
high disease activity and scores less than 3 low disease activity.3 DAS scores were approximately nor-
mally distributed. However, CRP, ESR, SJC and TJC were all positively skewed and were square-root
transformed where used in the analysis.
Pain A 100mm visual analogue scale (VAS) anchored at 0 "No pain at all" and 100 "Worst pain ever"
was used to assess the patients level of bodily pain in the clinic. VAS pain scores followed a uniform
distribution.
Morning stiffness The amount, in hours, of early morning stiffness (EMS), an indicator of disease ac-
tivity, was also recorded. Responses were positively skewed and therefore were square-root transformed.
Comorbidity Comorbidity was assessed using the Charlson comorbidity index (Charlson, Pompei, Ales,
& MacKenzie, 1987). This is essentially a weighted count of comorbidities that have been found to be
related to mortality (e.g. cancer, heart disease, diabetes, renal failure etc). For the current analysis,
Charlson scores were dichotomised as the presence or absence of at least one Charlson comorbidity.
Socio-economic status Social class was assessed using the Registrar Generals social class categories.
This information was only available for those in the ERAS database, and is therefore missing for the
additional individuals. This index is based on the persons current occupation. For those not currently
in employment social class was based on their spouses occupation or their occupation during their last
period of employment. Those in the former typically consisted of females who declared themselves to
be housewives and the latter males or females who were unemployed or retired. Information on work
status was also available.
The level of social deprivation was measured using the Carstair Index based on the level of social
deprivation by post-code area. Again, this was only available for those in the main ERAS cohort. The
variable was dichotomised with the lowest 2 quintiles defined as socially deprived.
6.2.3 Statistical analysis
The change in psychological distress over time will be assessed using LCMs. This method was introduced
in section 4.3 and so is only briefly described here. LCMs extend the simple linear regression model to
3A DAS score of less than 1.6 corresponds to the American Rheumatology Association preliminary criteria for clinical remis-
sion (Fransen et al., 2004).
130
Chapter 6. The course of psychological distress
α β
y1 y2 y3 yt
ε1 ε2 ε3 εt
1 1 1 1
0 1 2 λt
Figure 6.3: Linear latent growth curve model with autocorrelated errors
allow for the multi-level nature of longitudinal data, corresponding to the equation system
yi t = αi +λtβi + εi t
αi = µα+ ζαi
βi = µβ + ζβ i (6.1)
This model may be estimated as a special case of confirmatory factor analysis (Bollen & Curran,
2006; McArdle & Epstein, 1987), expressed as a path diagram in Figure 6.3. The intercept factor αi
represents the level of the outcome variable yi t—distress as indicated by the HADS total score—at the
baseline assessment since t1 = 0, and the (linear) slope factor αi the rate of change in yi t for each one
unit increase in time t. Scores on these factors are allowed to vary across individuals, and are a function
of the mean intercept µα and slope µβ and an individual specific disturbances ζαi and ζβ i , respectively.
Potential non-linear trajectories in distress were assessed by comparing a linear model with a model
including a quadratic slope factor, various non-linear transformations of λt , and using the free-loading
method proposed by Meredith and Tisak (1990). All models allowed for an auto-correlated error struc-
ture since this was observed to increase model fit in preliminary analysis.
Although the LCMs allow variation in the intercept and slope between individuals, it is assumed
that all individuals come from a common population that can be approximated by a single growth
trajectory, defined by µα and µβ . GMM relaxes this assumption using latent trajectory classes, which
allow for different groups of individual growth trajectories to vary around different means. GMM was
described in detail in section 4.3.3. To briefly recap, equation 6.1 can be extended through the inclusion
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α β
c
y1 y2 y3 yt
ε1 ε2 ε3 εt
Figure 6.4: Growth mixture model
of categorical latent variable c, with k levels (k = 1, 2, . . . , K)
yi t =
K∑
k=1
Pr(c = k)[αki +λktβki + εkit]
αki = µαk + ζαki
βki = µβk + ζβki (6.2)
where the subscript k indicates the that parameters are allowed to vary across latent classes. The result
is separate trajectories for each latent class, each with its unique estimates of variances and covariate
influences (B. Muthén, 2006b). This model is expressed as a path diagram in Figure 6.4.
6.3 Results
6.3.1 Demographic and clinical characteristics
Table 6.1 shows the demographic and clinical characteristics for the sample. The distribution of demo-
graphic characteristics was similar to the full ERAS cohort. The clinical and demographic profile was
similar to the full ERAS cohort (for figures of the full ERAS cohort see Table 5.2). As a multi-centre
inception cohort ERAS provides an accurate representation of the UK RA population. There is a 2:1
female-male ratio, and the average age at diagnosis is in the mid 50’s. The sample was predominantly
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white and around 40% left school at or before the age of 16. The only variable that showed any dif-
ference from the full ERAS cohort was HAQ disability. The current sample showed lower HAQ (.74 vs.
1.15; Cohen’s d = .35). It is not clear why this difference is observed particularly since all other clinical
variables were comparable. It is useful to note that HAQ disability exhibited considerable heterogeneity
across centres. Those from the Winchester centre, from which the majority of these patients were drawn,
on average reported lower levels of functional limitation than from other centres.
At the baseline assessment the number of individuals above the caseness criteria for the individual
HADS sub-scales (>8) was 27.3% for anxiety and 16.1% for depression. Furthermore, 11.0% scored
above both cut-offs. These figures are similar to those reported using the smaller sample of patients for
whom item responses were available in the previous chapter.
6.3.2 Descriptive analysis
Pair-wise correlations between HADS total scores at different visits indicated an autoregressive structure,
with first-order correlations above .7, except for baseline (Table 6.2). The correlations between the
baseline HADS total score and subsequent assessments were smaller compared to other assessments
(r ≈ .5), and remained stable over time. The N contributing to each correlation are also shown. Over
time the numbers reduce dramatically, with no one from the baseline visit also being assessed at the
15-year visit (NB. the missing data pattern is non-monotone).
Examination of the mean levels of distress at each follow-up shows that on average scores were
highest at the baseline assessment and there was possibly a reduction over time. However, the magnitude
of the change is relatively small with the difference between the highest (t0 = 11.4) and lowest (t14 =
8.0) scores being only 3.4 units—around half a standard deviation. This observation was confirmed by
the examination of Figure 6.5. Since different individuals are contributing to assessments at different
time points this trend may be artefactual, as a result of individuals who were followed up for longer
periods being on average less depressed.
Figure 6.6 shows individual trajectories for HADS total scores over the 15-years of follow-up. The
overlaid LOWESS smoothed line shows a decreasing trend over time. However, there is a large amount
of variability within individual trajectories. Although not particularly clear, large increases and decreases
in scores over time can be observed.
Further clarity is provided by Figure 6.7, which shows the individual trajectories for 20 randomly
selected individuals. The plot shows several different trajectory types. Several individuals show fairly
consistent levels of psychological distress over time (e.g. 7210, 7233, 7248, 7256). One individual,
133
Chapter 6. The course of psychological distress
Ta
bl
e
6.
1:
D
em
og
ra
ph
ic
an
d
ba
se
lin
e
cl
in
ic
al
ch
ar
ac
te
ri
st
ic
s
(N
=
78
4)
N
M
ea
n
SD
M
in
25
th
%
ile
M
ed
ia
n
75
th
%
ile
M
ax
Sk
ew
ne
ss
Ku
rt
os
is
D
em
og
ra
ph
ic
A
ge
77
9
56
.9
9
15
.0
5
15
46
57
69
93
-0
.2
5
0.
5
Fe
m
al
e
78
4
67
%
H
ei
gh
t
(m
)
66
8
1.
65
0.
09
1.
45
1.
58
1.
64
1.
71
1.
93
0.
43
0.
32
W
ei
gh
t
(k
g)
67
1
72
.1
1
14
.7
8
42
.3
60
.8
70
.6
80
.5
15
7
0.
74
-1
.2
4
B
M
I
77
0
26
.5
1
4.
84
15
.9
2
23
25
.9
3
29
.1
7
47
.4
0.
87
-1
W
hi
te
76
0
98
%
M
ar
ri
ed
64
1
71
%
Lo
w
ed
uc
at
io
n
(N
on
e/
<
C
SE
)
36
9
41
%
So
ci
al
cl
as
s
(I
V
/V
)
36
9
60
%
So
ci
al
ly
de
pr
iv
ed
(C
ar
st
ai
r)
38
0
32
%
W
or
ki
ng
37
7
43
%
Sm
ok
er
78
4
23
%
Cl
in
ic
al
H
A
D
S
an
xi
et
y
54
2
6.
33
4.
12
0
3
6
9
17
0.
6
0.
26
H
A
D
S
de
pr
es
si
on
54
2
5.
11
3.
55
0
2
5
7
19
0.
75
-0
.3
H
A
D
S
to
ta
l
54
2
11
.4
4
6.
81
0
6
10
15
34
0.
67
-0
.0
6
M
or
ni
ng
st
if
fn
es
s
(h
ou
rs
)
78
4
1.
76
1.
8
0
1
1
2
9
2.
15
-4
.7
3
H
A
Q
di
sa
bi
lit
y
78
4
0.
74
0.
68
0
0.
21
0.
54
1
3
1.
19
-0
.8
1
VA
S
pa
in
78
4
49
.8
8
27
.7
9
0
27
50
72
10
0
0.
04
1
D
A
S
77
8
4.
33
1.
76
0.
13
3.
81
5.
07
6.
47
9.
4
-0
.1
1
0.
57
Te
nd
er
jo
in
t
co
un
t
78
3
18
.7
5
15
.2
6
0
6
15
27
67
0.
94
-0
.2
Sw
ol
le
n
jo
in
t
co
un
t
78
4
16
.6
9
14
.4
3
0
5
13
26
59
0.
86
0.
03
ES
R
77
9
38
.4
4
28
.1
1
16
32
57
13
3
0.
81
0.
03
C
R
P
62
7
34
.3
3
40
.2
2
0
6
18
47
27
8
2.
07
-5
.6
C
ha
rl
so
n
co
m
or
bi
di
ty
38
6
20
%
134
Chapter 6. The course of psychological distress
Ta
bl
e
6.
2:
Pa
ir
w
is
e
co
rr
el
at
io
ns
(b
el
ow
di
ag
on
al
),
co
nt
ri
bu
ti
ng
N
(a
bo
ve
di
ag
on
al
),
m
ea
ns
an
d
st
an
da
rd
de
vi
at
io
n’
s
fo
r
H
A
D
S
to
ta
ls
co
re
ov
er
15
-y
ea
rs
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
H
A
D
S-
T
0y
r
54
2
42
5
39
4
35
1
27
4
25
2
20
5
16
6
14
7
12
1
90
64
37
20
5
0
H
A
D
S-
T
1y
r
0.
55
46
9
37
2
33
1
26
3
24
1
20
4
16
1
14
5
12
1
92
68
40
25
8
3
H
A
D
S-
T
2y
r
0.
52
0.
76
47
4
37
9
31
1
29
0
24
1
19
4
17
5
14
6
11
5
86
59
42
24
15
H
A
D
S-
T
3y
r
0.
57
0.
75
0.
75
46
0
34
0
32
3
27
9
22
6
19
9
17
2
13
7
10
7
77
58
39
29
H
A
D
S-
T
4y
r
0.
46
0.
71
0.
76
0.
78
40
7
32
7
28
9
24
2
20
9
18
1
13
4
10
7
76
59
40
30
H
A
D
S-
T
5y
r
0.
49
0.
71
0.
70
0.
74
0.
79
40
9
31
4
26
3
23
9
20
6
14
9
11
7
87
67
50
38
H
A
D
S-
T
6y
r
0.
47
0.
64
0.
73
0.
71
0.
76
0.
81
35
8
26
8
23
9
21
3
15
3
12
3
91
73
55
40
H
A
D
S-
T
7y
r
0.
50
0.
65
0.
71
0.
75
0.
75
0.
75
0.
80
29
9
24
6
21
1
15
2
12
2
91
73
53
41
H
A
D
S-
T
8y
r
0.
50
0.
58
0.
70
0.
72
0.
77
0.
73
0.
75
0.
78
27
8
22
3
16
4
13
2
10
2
83
59
45
H
A
D
S-
T
9y
r
0.
42
0.
47
0.
67
0.
67
0.
71
0.
65
0.
72
0.
74
0.
83
24
7
16
7
13
3
10
3
83
60
47
H
A
D
S-
T
10
yr
0.
55
0.
54
0.
61
0.
72
0.
65
0.
68
0.
62
0.
68
0.
78
0.
75
17
2
13
4
10
4
85
62
48
H
A
D
S-
T
11
yr
0.
50
0.
49
0.
62
0.
63
0.
72
0.
67
0.
67
0.
74
0.
73
0.
74
0.
73
13
7
10
0
83
60
46
H
A
D
S-
T
12
yr
0.
48
0.
41
0.
64
0.
60
0.
72
0.
74
0.
67
0.
65
0.
68
0.
76
0.
73
0.
80
10
7
79
59
47
H
A
D
S-
T
13
yr
0.
46
0.
53
0.
68
0.
63
0.
69
0.
70
0.
59
0.
75
0.
68
0.
77
0.
68
0.
67
0.
85
86
62
48
H
A
D
S-
T
14
yr
-0
.0
7
0.
04
0.
62
0.
51
0.
62
0.
62
0.
50
0.
71
0.
69
0.
83
0.
72
0.
62
0.
76
0.
88
64
48
H
A
D
S-
T
15
yr
.
-0
.0
3
0.
66
0.
52
0.
73
0.
62
0.
52
0.
59
0.
64
0.
71
0.
68
0.
63
0.
65
0.
80
0.
84
49
M
ea
n
11
.4
4
9.
78
9.
21
9.
96
10
.1
7
10
.0
5
9.
50
9.
93
9.
29
9.
34
8.
80
8.
67
9.
07
8.
37
8.
04
9.
86
SD
6.
81
6.
85
6.
72
7.
11
7.
11
6.
94
6.
62
6.
83
6.
88
7.
04
6.
86
6.
92
7.
00
6.
68
6.
08
6.
51
135
Chapter 6. The course of psychological distress
Figure 6.5: Box-plots of observed HADS total scores for each year of follow up
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Figure 6.6: Observed HADS total score trajectories with overlaid LOWESS smoothed line
7218, shows a rather chaotic pattern. There also seems to be a consistent pattern in some individuals for
a decrease in psychological distress over time notably over the first few years of the disease (e.g. 7152,
7170, 7172, 7175, 7177, 7207, 7247, 7278).
6.3.3 Latent curve model
LCMs were fitted to the HADS total scores. Initially unconditional (i.e. without covariates) LCMs were
fitted to examine the shape of the mean psychological distress trajectory over the course of follow-up.
After the best fitting function of time was identified covariates were added to the model, a conditional
LCM.
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Figure 6.7: Observed HADS total score trajectories with overlaid LOWESS smoothed line for 20
randomly selected individuals (of those with less than 5 missing data points): bandwidth .50
6.3.3.1 Unconditional latent curve model
Several different models allowing for different trajectory shapes were fitted to the data. Based on the
descriptive analysis several non-linear models allowing for non-linear monotonic changes with a decel-
eration in the rate of change over time were fitted to the data: square-root, logarithmic, reciprocal and
exponential. All models were fitted allowing for autocorrelation between residuals. All of the models
had similar goodness-of-fit statistics but the reciprocal function was selected by RMSEA, TLI and both
information criterion (Table 6.3).
All models had a negative estimate of the slope factor indicating a reduction in levels of psychological
distress over time (Table 6.4). Inspection of the model-implied trajectories from the fixed portion of the
model in Figure 6.8 indicates that this reduction typically occurs during the first few years after disease
onset, as was indicated in the descriptive analysis.
For the model with the reciprocal functional form of time, the mean value of the random intercept
factor was 11.29, which is close to the value of 11.44 reported in Table 6.2. The variance of the intercept
was significant indicating that there was significant heterogeneity in the baseline level of depression. The
mean of the random slope factor was significant negative, -1.74, indicating the average total change as
t →∞. Half of this change is expected to occur during the first year, two-thirds by the second year and
so on. This relates to an overall reduction in the HADS for the sample of - 1.58 units over the period of
follow-up (Cohens’ d =−.23). The majority of this change occurred during the first few years following
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Table 6.3: Unconditional latent curve model fit
Free-loading Linear Quadratic Square-root Logarithmic Reciprocal Exponential
χ2 276 333 291.7 318.8 306.8 298.7 305.9
DF 102 116 112 116 116 116 116
CFI 0.955 0.944 0.954 0.948 0.951 0.953 0.951
TLI 0.947 0.942 0.951 0.946 0.949 0.951 0.949
RMSEA 0.047 0.049 0.045 0.047 0.046 0.045 0.046
-2LL 26751 26808 26767 26794 26782 26774 26781
AIC 26851 26880 26847 26866 26854 26846 26853
BIC 27084 27048 27033 27034 27022 27014 27021
Note. Emboldened figures represent the best fitting model.
diagnosis: -0.87 units between diagnosis and 1-year follow-up and -1.31 units by 3 years. Furthermore,
the variance of the slope was significant indicating heterogeneity in the rate of change over time.
The correlation between the random intercept and slope for the best fitting model with reciprocal
functional form was -.31 (p = .02), indicating that individuals with increased psychological distress at
baseline were more likely to experience a reduction over time.
Figure 6.9 shows the estimated (i.e. model-implied) individual trajectories for the same 20 randomly
selected individuals used in Figure 6.7 plotted alongside their observed scores. The estimated trajectories
tend to fit the observed scores relatively well for most people, although there is often much within person
variability. It is important to remember that LCMs try to fit a smooth trajectory to the scores, however
HADS scores, by design, are influenced cross-sectionally by other factors, such as disease activity at that
time. Inclusion of these cross-sectional associations is likely to improve the fit of the model.
Checking the assumptions of the LCM (stated above) indicated no cause for concern. Specifically, (i)
residuals were approximately normally distributed within each year; (ii) residuals showed homoscedas-
ticity within each year; and (ii) standardizing residuals, only 46 (1%) had an absolute value greater than
3, as would be expected.
6.3.3.2 Conditional latent curve models
To examine the effect on initial level and change in distress, the intercept and slope factors were re-
gressed onto a selection of covariates. Initially covariates were entered into separate models to examine
the effect unadjusted for other variables (Table 6.5). Continuous covariates were centered at their means
to maintain the interpretability of the intercept and slope factors.
Gender and social class showed significant effects on intercept, indicating worse psychological dis-
tress for those who were female and for individuals in more disadvantaged social classes. Furthermore,
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Figure 6.8: Predicted HADS total scores for each model
Figure 6.9: Model implied trajectories for a 20 randomly selected individuals, dashed lines repre-
sent model-implied trajectories
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individuals with more severe disease also showed worse levels of psychological distress with duration of
early morning stiffness, HAQ disability, tender and swollen joint counts, Disease Activity Score and pain
all related to the random intercept.
There was a significant effect of age on the slope factor with older individuals more likely to show less
improvement in distress over time. All of the measures of disease severity at baseline were estimated
to have negative relationships with the random slope (i.e. more improvement), although only early
morning stiffness, CRP, and pain were significant. This suggests that those with more active disease at
baseline, and worse psychological distress, were more likely to experience an improvement in distress
with time.
Table 6.6 shows the estimates from a multivariate model with all covariates added together. Due to
missing data for some covariates (see Table 6.5) the model would have included only 215 cases.4. As a
result multiple imputation was employed using the ice package in Stata, that implements imputation by
chained equations (Royston, 2004). Ten imputed datasets were generated with missing values imputed.
Continuous variables were modelled using linear regression and binary variables using logistic regres-
sion. The LCMs were then estimated using Mplus 5.1 and combined within Mplus 5.1 using Rubin’s rules
(i.e. the coefficients were averaged and the standard errors adjusted). The HADS total scores over follow
up were not imputed since they are handled appropriately via the full information maximum likelihood
estimator.
A restricted number of covariates were entered into the model. Several of the disease severity vari-
ables were excluded due to high correlations, and furthermore DAS being a composite of three of the
variables. CRP was removed from the final model as it contained a lot of missing values and the effect
was strongly, although not significantly, in the opposite direction as was previously observed (i.e. high
CRP related to better psychological distress).
In the conditional model the mean of the random intercept (µα) was 9.52 and the mean of the
random slope (µβ) was -.71. The slope was non-significantly different from 0 indicating that in the
reference group trajectories were stable over time. This represents patients that were female, not social
disadvantaged, non-smokers, that were not working, and had levels of the other variables at the sample
mean.
Concerning the random intercept, there was little change in the estimates of the effect of social class
and early morning stiffness on the random intercept compared to the figures presented in Table 6.5.
4Although FIML uses all available data for the dependent vriables, the estimation is conditional on the covariates resulting
in listwise deletion for observations with missing covariates
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However, the effect of sex was reduced to non-significant (p = .460). This may be due to males being
less likely to suffer from early morning stiffness and on average having less severe disease in general. It
would seem then that the effect of gender on psychological distress may be mediated via disease severity.
Furthermore, when early morning stiffness was included in the model, the effects of other measures of
disease severity were non-significant.
Only gender and DAS were observed to be significantly related to the random slope factor. Males
showed a significantly worse trajectory of psychology distress although the difference compared to fe-
males was small. Disease activity score also showed a small but significant effect, whereby individuals
with higher disease activity had worse psychological distress with a faster rate of improvement in those
with higher DAS at baseline.
Figure 6.10 graphically depicts the model-implied trajectories. The reference line represents the
model-implied trajectory at the mean of all continuous variables and where all binary variables are held
at 0 (i.e. female, social Class I-III, non-smoker, not working). The dashed lines represent varying the
factor whilst holding others constant. For continuous variables, the lines represent a 1SD increase in
continuous covariates or a change from yes to no for binary covariates. It is clear that the two most
important factors are the duration of early morning stiffness and the individual’s social class. The effects
are mainly on baseline levels, with little variation over time. However the slope at 1SD above the mean
for EMS was almost 0. Also for those in social class IV or V there was a slightly increased reduction,
possibly related to the fact that they were higher in the first place and therefore more likely to reduce
(regression to the mean).
6.3.3.3 Time varying covariates
To examine whether the effect of HAQ disability, disease activity and pain on psychological distress was
stable over time the effects were entered into the LCM as time varying covariates. This enables for the
examination of any differential effect of these variables over time.
The square-root of HAQ disability score was included as time varying with distress being regressed
on it at each time point. The parameter estimates were all very similar and hence were constrained
to be equal. Although the change in the model fit was significantly worse, χ2(15) = 32.4, p = .007,
the BIC indicated the constrained model was more parsimonious (35013 vs.34945). The constrained
parameter estimate was significant, b = 5.42,SE = 0.23, and similar to the effect observed for the
intercept regressed onto baseline HAQ disability score.
In a separate model, DAS was included as a time-varying-covariate with distress at each time point
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Table 6.5: Parameter estimates (and standard errors) for separate conditional LCMs, with corre-
lated residuals, including covariates with complete cases
N α β
Age 779 -0.02 (0.02) 0.08 (0.02)
Male 784 -1.98 (0.58) 0.48 (0.72)
BMI 770 0.09 (0.06) 0.13 (0.07)
Socially deprived (Carstair) 380 0.24 (0.89) 1.04 (1.02)
Education (None/<CSE) 369 0.09 (0.96) 1.75 (1.08)
Social class (IV/V) 369 2.49 (0.96) -0.52 (1.15)
Smoker 723 1.09 (0.65) 0.66 (0.80)
Working 377 -1.07 (0.96) -1.59 (1.42)
Early morning stiffness (hours) 784 1.99 (0.38) -1.74 (0.48)
HAQ disability 784 4.97 (0.63) -1.02 (0.79)
ESR 779 0.09 (0.12) -0.22 (0.15)
CRP 627 0.14 (0.10) -0.29 (0.12)
Tender joint count 784 1.05 (0.14) -0.12 (0.18)
Swollen joint count 784 0.31 (0.14) -0.02 (0.17)
DAS 779 0.75 (0.14) -0.74 (0.17)
VAS pain 784 0.09 (0.01) -0.04 (0.01)
*Note. Figures in bold are significant at the 5% level.
Table 6.6: Parameter estimates (and standard errors) for conditional LCMs, with correlated resid-
uals, including multiply imputed covariates
α β
Age 0.03 (-0.04) 0.08 (-0.04)
Male 0.03 (-0.05) 0.16 (0.08)
BMI 0.59 (-0.41) -0.82 (-0.58)
Social class (IV/V) 2.28 (0.90) -1.37 (-1.00)
Smoker 0.75 (-0.59) 1.28 (-0.85)
Working -0.35 (-1.52) -0.41 (-1.73)
Early morning stiffness (hours) 2.76 (0.95) 1.014 (-0.89)
HAQ disability 0.05 (-0.23) -0.04 (-0.27)
DAS 0.07 (0.01) -0.04 (0.02)
VAS pain -0.13 (-0.11) -0.24 (-0.17)
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Figure 6.10: Model implied trajectories of psychological distress, at specified levels of selected
covariates (Reference relates to trajectory for all continuous variables at mean and dichotomous
variables held at 0)
regressed onto the DAS at the same time point. Again, the parameter estimates were all similar. Con-
straining them to be equal resulted in a non-significant reduction in model fit, χ2(15) = 19.7, p = .184,
with the BIC indicating increased model parsimony (54349 vs.54268). The constrained parameter esti-
mate was significant b = 0.87,SE = 0.05, and again was similar to the effect observed for the random
intercept regressed on baseline DAS.
VAS pain score was also entered into the growth model including age and sex as a time varying
covariate. The parameter estimates were all similar and the model with them constrained to be equal
was not of significantly worse fit, χ2(15) = 24.0, p = .065, and the parsimony was improved (BIC: 85553
vs.85476). The parameter estimate for the constrained model was significant, b = 0.07, SE= 0.003, and
similar to the effect observed for the random intercept regressed onto baseline VAS pain score.
The estimated parameters for HAQ, DAS and VAS pain entered as time varying covariates were all
similar over time. Constraining them to be equal did not appear to reduce model fit in a substantive
way. The regression of the time varying covariate at baseline on baseline total HADS score is equivalent
to the regression on the intercept of the LCM, and the parameter estimates were comparable. Hence, it
would seem that the effect of each of these process variables is stable over time and therefore does not
need to be included in the model as time-varying.
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6.3.4 Growth mixture model
GMMs were fitted to the data to assess whether changes in distress in the sample were adequately
described by a single overall trajectory or whether multiple distinct subgroups exhibiting distinct patterns
of change were present. Initially, this was done without covariates as this approach has been shown to
enable more precise selection of the appropriate number of classes (Tofighi & Enders, 2006). Due to the
large amount of missing data after 10-years of follow-up and the apparent stability of the trajectories the
following analysis was restricted to the follow-ups recorded over the first 10-years since disease onset.
Sensitivity analysis, using all data up to 15-years gave comparable results. However, there were issues
with model convergence, namely the time to achieve convergence was substantially longer and there
were issues with local maximum for models with larger numbers of latent classes.
The fit of models with 1 through 6 latent classes was assessed using standard model comparison
techniques, such as information criterion and the Lo-Mendell-Rubin likelihood ratio (LMR) test. For
each model the reciprocal functional form of time was estimated, with first-order correlated residuals.
Although the log-likelihood and the AIC favoured the 6-class model both have been shown to over-
select the number of classes (Nylund et al., 2007; Tofighi & Enders, 2006). The consistent AIC (CAIC)
which takes the sample size into account and the BIC, which have been found to perform relatively
well (Nylund et al., 2007; Tofighi & Enders, 2006), both favoured a 4-class solution. Furthermore, the
LMR test also indicated a 4-class solution. The parameter estimates for the growth factors of the 4-class
solution are given in Table 6.8 and the estimated trajectories plotted in Figure 6.11.5
The 4-class model specifies the majority of individuals as being in a class with consistently low levels
of psychological distress that would appear to conform to Bonanno (2005) resilient trajectory (68%).
This class experienced a small but significant reduction in psychological distress over the period (Co-
hen’s d = −.23, p < .001). The other three classes were of roughly equal size. One class consisted of
individuals with consistently high levels of psychological distress (chronic; 12%). Although, the mag-
nitude of the expected change, µβ , in this class was similar to the resilient class it was non-significant
(Cohen’s d = −.31, p = .081). A further class consisted of individuals with high levels of psychological
distress at the time of diagnosis that decreased to normal levels (recovered; 9%). Unsuprisingly the slope
parameter for this class was highly significant (Cohen’s d = −2.28, p < .001). Each of these groups
was also observed in the 3-class model. The fourth class, which was not identified in the 3-class model,
consisted of individuals with psychological dsitress levels that were, on average, similar to the resilient
5For the 4-class model a global maxima was achieved using 100 randomly selected starting values and 10 final stage
optimizations. Seven of the ten optimizations converged on the same log-likelihood solution. Sensitivity analysis comparing
models where the time trajectories were estimated using the free-loading method gave comparable results.
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Table 6.7: GMM fit
# Classes 1 2 3 4 5 6
Parameters 26 29 32 35 38 41
Entropy . 0.678 0.726 0.666 0.635 0.640
AIC 24386 24324 24299 24274 24266 24260
CAIC 24533 24488 24481 24472 24482 24492
BIC 24507 24459 24449 24437 24444 24451
LMR . 0.0171 0.025 0.0451 0.6657 0.3505
Table 6.8: GMM estimates of growth factors
Class Chronic Resilient Recovered Delayed
µα 21.45 (1.08) 8.70 (0.33) 20.05 (1.30) 8.55 (1.04)
µβ1 -1.85 (1.32) -1.68 (0.49) -15.59 (1.96) 10.22 (2.03)
COV (α,β1) 10.30 (2.78) 10.30 (2.78) 10.30 (2.78) 10.30 (2.78)
VAR(α) 4.34 (2.14) 4.34 (2.14) 4.34 (2.14) 4.34 (2.14)
VAR(β1) 4.97 (3.60) 4.97 (3.60) 4.97 (3.60) 4.97 (3.60)
group but dramatically increased over the period of follow-up (delayed; 11%). Again the value of the
random slope parameter was higly significant (Cohen’s d = 1.40, p < .001).
The trajectories of the 5-class model were also inspected. In addition to the four trajectory groups
observed in the 4-class model, an additional class with stable and moderate levels of psychological
distress was observed. This appeared to mainly consist of individuals previously in the resilient class. Fit
indices and the LMR likelihood ratio test indicated that this further separation was not necessary and
merely constitutes and over extraction of classes.
6.3.4.1 Predictors of latent class membership
To identify variables that were associated with latent class membership the means across latent classes,
estimated using posterior-probability based imputation, were compared (Table 6.9). As well as the
overall test for a significant difference between the classes three pair-wise comparisons are of interest.
Firstly, in what characteristics do the two classes with initially low levels of distress differ compared to
the two classes with initially high levels of distress? Secondly on what characteristics do the resilient and
delayed classes differ? And finally on what characteristics do the chronic and recovered classes differ?
Overall, differences between classes tended to be characterised by clinical rather than demographic
features. Moreover, for clinical features, differences were observed for self-reported features (early
morning stiffness, HAQ disability, tender joint count and VAS pain all p < .05) rather than objective
measures, such as ESR, CRP and the clinicians’ report of the number of swollen joints.
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Figure 6.11: Predicted trajectories of 4-class GMM. Markers are sample means weighted by class
probabilities and solid lines are model-implied trajectories.
Grouping the classes by the initial level of psychological distress the resilient and delayed classes,
compared to the chronic and recovered classes, tended to be younger, male and from a more advantaged
social class. Furthermore they were less likely to report severe disease as indexed by self-reported
measures. For example, the chronic class had higher initial levels of HAQ disability compared to the
resilient (χ2(1) = 11.94, p = 0.001) and delayed classes (χ2(1) = 4.18, p = 0.041); the resilient class
significantly lower baseline VAS pain compared to the chronic (χ2(1) = 20.290 =, p < 0.001) and
recovered classes (χ2(1) = 7.30, p = 0.007); and the resilient class had significantly fewer tender joints
at baseline compared to the chronic (χ2(1) = 23.21, p < 0.001) class with the difference compared
to the recovered class on the margins of significance (χ2(1) = 3.01, p = 0.083). Since the number of
tender joints is used in the calculation of the DAS, the difference observed may account for the significant
difference in DAS observed between the chronic and resilient classes (χ2(1) = 5.36, p = 0.02).
Considering the resilient and delayed classes, both of which had low levels of psychological distress
initially, only the comparison for the number of tender joints was significant (χ2(1) = 3.88, p = 0.049).
There was a (non-significant) trend for individuals in the delayed class to be female, have less education,
disadvataged social class, smoke, not be in work and have worse disease severity as indexed by the
number of tender joints and VAS pain. Although noteworthy due to the difference being in the expected
direction, no conclusion may be drawn from this observation.
147
Chapter 6. The course of psychological distress
Compared to the recovered class the chronic class were more likely to be from a deprived area,
smoke, have less education (χ2(1) = 3.52, p = 0.061) and report worse disease, as indexed by HAQ
disability (χ2(1) = 4.18, p = 0.041), the number of tender joints (χ2(1) = 5.12, p = 0.024), and VAS
pain.
In summary, the largest group of individuals had on average consistently low levels of psychological
distress, accounting for around two-thirds of the sample. This does not mean that individuals in this
class did not experience psychological distress it is simply that on average distress was low to moderate,
although may have been high at times, for example as a result of a disease flare. The chronic group on
average experienced consistently high levels of psychological distress. This does not necessarily mean
that these individual were clinically depressed or anxious at all time points, but that in general they
tended to experience higher levels of anxiety or depression, or both.
6.3.5 NMAR sensitivity analysis
Due to the proportion of missing data a sensitivity analysis was conducted examining for possible bias
introduced into the growth parameter estimates by the missingness mechanism being not missing at
random (NMAR). For example, it is plausible that individuals with higher levels of psychological distress
are more likely to have worse levels of disease and other coexistent medical comorbidities and therefore
more likely to dropout of the study through death or being unable to attend clinic. As is the convention,
intermittent missingness is assumed to be MAR with sources of NMAR coming from dropout (B. Muthén
et al., 2011).
Issues concerning missing data and appropriate analytical methods were introduced in section 4.4.2.
The approaches used for modelling NMAR mechanisms are complicated involving, in this instance, the
joint modelling of the growth model and the dropout model. The generalised latent variable modelling
framework is extremely flexible and allows for fitting several such models. A full investigation of such
models requires a dissertation length investigation in itself. The following analyses are therefore rela-
tively simple sensitivity analyses to ensure that the dropout mechanism does not overly influence the
estimates of the growth parameters.
6.3.5.1 Selection models
Initially the Diggle and Kenward (1994) and Wu and Carroll (1988) selection models were considered.
As was previously discussed selection models consider dropout conditioned on the observed data. The
Diggle and Kenward (1994) selection model was the first to be considered. Applying this model to the
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Figure 6.12: Estimated HADS total score mean trajectories for MAR, Diggle-Kenward and Wu-
Carroll selection models
data, the estimated association between the level of psychological distress and dropout was small and
non-significant (OR yt = 0.96, p = 0.319), suggesting that the MAR assumption holds. Furthermore, the
estimate of the lagged effect of psychological distress on dropout was also non-significant (OR yt−1 =
1.04, p = .179) indicating that psychological distress was not predictive of future dropout.
The Wu and Carroll (1988) model also supported the assumption that the data was MAR. No signif-
icant effect of either the random intercept (OR = 1.11, p = .094) or the random slope (OR = 0.92, p =
.324) on dropout was observed.
The number of parameters and the information criterion for the MAR, Diggle-Kenward and Wu-
Carroll models are shown in Table 6.10. The Diggle-Kenward model was indicated as being the best
fitting model by the AIC, BIC and sample size adjusted BIC, whereas the MAR model is indicated as being
the best fitting model by the consistent AIC. The estimated mean psychological distress trajectory for the
Diggle-Kenward model and the Wu-Carrol model are shown in Figure 6.12. The estimated trajectories
of the Wu-Carroll and the MAR model are almost identical. The Diggle-Kenward model indicates a
slightly greater reduction in psychological distress over time (µα = 2.02), although the magnitude of the
difference is small.
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Table 6.10: Selection models fit statistics
MAR Diggle-Kenward Wu-Carroll
Params 27 28 28
AIC 27794 27789 27822
CAIC 27947 27948 27980
BIC 27921 27920 27952
sBIC 27834 27831 27864
Table 6.11: Pattern-mixture model fit statistics
MAR PMM Roy 2c Roy 3c Roy 4c Roy 5c
Params 16 35 29 42 55 68
AIC 24384 24392 24324 24307 24293 24289
CAIC 24474 24591 24488 24545 24621 24674
BIC 24458 24556 24459 24503 24550 24606
sBIC 24407 24444 24367 24369 24375 24390
6.3.5.2 Pattern-mixture models
Next the pattern-mixture models were considered, which model the observed data conditional on the
missing data. Both the conventional pattern-mixture model6 and the Roy (2003) latent dropout pattern-
mixture model were fitted to the data.
Table 6.11 shows the the fit of the conventional pattern-mixture model, and the Roy latent dropout
pattern-mixture model with C = 2,3, 4,5. In addition, the fit statistics for a MAR model are presented
where the model is specified with the same log-likelihood metric by constraining the random effect mean
estimates to be equal. The information criterion support different models. The AIC indicates that best
fitting model is the Roy model with 5 latent classes, however the AIC has been shown to over select
the number of classes in growth mixture models and should therefore be treated with caution (Tofighi
& Enders, 2006). The consistent AIC and the BIC, which have both shown more acceptable properties,
indicate the MAR model, whereas the sample size adjusted BIC selects the 2-class Roy model. Inspection
of the individual trajectories for each dropout pattern shows similar trends for 9 of the 11 patterns with
no obvious time trend (Figure 6.13). Mixing over the trajectories gives an estimate of the overall growth
trajectory that is almost identical to the MAR estimate (Figure 6.14).
Although not indicated by the fit indices it is of interest to consider the Roy 4-class dropout pattern-
mixture model in relation to the 4-class GMM that was identified in the previous section since the Roy
model provides a sensitivity analysis for the MAR assumption of the GMM. Similar latent classes of
6The model was specified with respect to dropout rather than general item missingness. As such one pattern was considered
for individuals dropping out of the study at each year of follow-up.
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Figure 6.13: Estimated HADS total score trajectories for each dropout pattern-mixture model
Figure 6.14: Estimated HADS total score
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growth trajectories are identified by the model with little change in the proportion of people in each
class. Respectively, for the MAR model and the 4-class latent class dropout model the number in each of
the classes was resilient 68% & 66%, chronic 12% & 11%, recovered 9% & 9%, delayed 11% & 14%. The
overall trajectory mixing across these latent classes is shown in Figure 6.14. The mean of the random
intercept is similar to that of the MAR model but the mean of the random slope indicates a slightly
greater average reduction in distress (µβ = 1.98) similar to that of the Diggle-Kenward selection model.
Sensitivity analysis exploring a number of NMAR dropout mechanisms supports the validity of the
estimates under the assumption that the missingness mechanism is MAR. Caution is still needed con-
cerning the interpretation of the results in light of the proportion of missing data since the sensitivity
analysis assumed that the intermittent missingness mechanism was MAR. Furthermore, since the miss-
ing data mechanism can never be known there are an infinite number of possible NMAR mechanisms.
(B. Muthén et al., 2011) describes several extensions of the selection and pattern-mixture models as-
sessed that add extra complexity to the models estimated, for example by allowing for separate latent
classes for the growth and dropout parts of the model, that may provide more appropriate sensitivity
analyses. However, a fuller investigation of NMAR mechanisms is beyond the scope of this dissertation
and further models are not considered.
6.4 Discussion
This chapter explored the shape of the trajectories of psychological distress over the fifteen years from
diagnosis of RA. Analyses employing LCM’s confirmed the initial findings of the descriptive analysis,
the mean trajectory showed a slight decrease initially that stayed stable over time. There was however
much inter-individual heterogeneity. Male sex, social class IV or V and factors relating to severity of
disease symptoms were related to higher initial levels of psychological distress. Moreover, worse disease
severity at baseline was associated with a greater decline in psychological distress over time. Growth
mixture modeling was employed to assess whether the data were appropriately described using a sin-
gle trajectory. Four trajectories, relating to the Bonanno (2005) response to trauma model, were found
to provide the most parsimonious grouping of the individual trajectories. Self-reported somatic symp-
toms explained differences between the classes. Finally, sensitivity analysis exploring the assumptions
concerning the missing data mechanism indicated that the assumption that data were MAR was sound.
While there have been a large number of studies examining psychological distress and adjustment
in RA none have examined changes in distress over such long periods of time or employed appropriate
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longitudinal models to examine change. The finding of a reduction in distress in the years following
diagnosis is in line with previous research using appropriate methodologies (e.g. Ødegård et al., 2007;
Schieir et al., 2009, see section 3.3), and fits more broadly with the literature concerning adjustment
to life with a chronic illness (Stanton, Revenson, & Tennen, 2007). Furthermore, in line with other
studies psychological distress cross-sectionally levels of psychological distress were associated with de-
mographic characteristics such as sex and socio-economic status, and with clinical features relating the
severity of disease symptoms. For example, Treharne et al. (2007) found that cross-sectionally older age
and worse HAQ disability were associated with increased levels of psychological distress, and Schiaffino
et al. (1998) found lower education and more active disease were related to worse psychological dis-
tress. Examination using time-varying covariates indicated that the cross-sectional association between
variables was stable across time, confirming previous reports (Covic, Pallant, Conaghan, & Tennant,
2007; Smedstad et al., 1997).
Growth mixture modelling revealed that four trajectories, comparable to those predicted by the Bo-
nanno response to trauma model (Bonanno, 2005), best summarized the distributions over time. The
largest group, consisting of around two-thirds of the sample, was resilient to the traumatic effects of the
disease with consistently low levels of psychological distress over time. Another group however expe-
rienced chronic disruption in psychological well-being. Two further groups showed opposite reactions.
One showed a short-lived episode of high distress with recovery to normal levels after a couple of years,
whereas the other group experienced an insidious increase in distress over time.
The resilient group was the largest consisting of around two-thirds of the sample. This is larger than
expected under Bonanno’s model but seems reasonable since the severity of the traumatic experience,
development of a chronic physical illness, is less than the model was typically intended for (e.g. a
terrorist attack). The figures is towards the upper limit of the proportion observed in studies applying
similar methods to other clinical populations (Helgeson et al., 2004; Lam et al., 2009; A. A. Kaptein &
Weinman, 2004; Martens et al., 2008; B. M. Murphy, Elliott, Higgins, et al., 2008). This is not entirely
surprising since, despite its impact on health-related quality of life, it seems unlikely that diagnosis
of RA is potentially as traumatic an experience as a myocardial infarction or breast cancer surgery.
Furthermore, consistent with several of these studies the majority of the change occurred early in the
course of the disease (Helgeson et al., 2004; Lam et al., 2009; K. I. Kaptein, Jonge, Brink, & Korf, 2006).
This would explain the apparent stability observed in the majority of longitudinal studies of individuals
with established RA (see section 3.3).
The current study identified differences between the groups at the time of presentation to the
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rheumatologist in terms of subjective self-reported disease symptoms—pain, stiffness and functional
impairment—rather than objective measures of disease activity. One explanation is that differences re-
sult from some negative dispositional reporting style. There has been considerable discussion of such
an effect in the literature, and is generally referred to as negative affectivity (NA). The previous chapter
indicated that it is likely that the HADS, which assesses general psychological distress, in part captures
some of this negative affectivity. While NA may account for some of the association between the level
of psychological distress at baseline and self-reported symptoms, it does not account for differences be-
tween the resilient and delayed classes or between the chronic and recovered classes, whom showed
similar levels of distress at baseline but experienced different changes.
It seems likely that psychological factors play an important role role in driving the changes in dis-
tress. For example, negative illness perceptions such as the over interpretation of symptoms may help
to maintain levels of psychological distress or act as a vulnerability factor that increases the level of
psychological distress over time (Leventhal, Diefenbach, & Leventhal, 1992). Alternately, there may be a
difference in the coping strategies employed with, for example, avoidant and denial working in the short
term but causing problems later in the disease (Scharloo et al., 1999; Lowe et al., 2008; G. K. Brown,
Nicassio, & Wallston, 1989).
An alternative and equally plausible explanation is physiological. It may be that the classes expe-
rience different disease trajectories. For example, the delayed group may experience a disease that is
initially relatively benign but is fast progressing and has severe impact on quality of life in general. Vice-
versa it may be that those in the recovered group initially experience a very severe disease but one that is
well managed by treatment and disease progression is relatively slow. This explanation is limited by the
null finding for baseline differences in objective measures of disease severity between these two classes.
In reality it seems likely that there is an interplay between the psychosocial and physiological factors
that drives the levels of psychological well-being.
There are a number of strengths and limitations of the current study. The major strength relates
to the design of the study and the methods of analysis used. The combination of a large sample of
individuals followed, since diagnosis, for a long period with advance longitudinal modeling techniques
allows for a greater insight into the response to the development of RA than previous studies.
The main limitation of the study relates to the amount of missing data. As with all longitudinal stud-
ies there was a large number of individuals that had dropped out of the study. Furthermore, specifically
for the HADS questionnaire there was relatively large amounts of intermittent missingness. Despite this
limitation the findings of the models are likely to be fairly robust. The models used assume that data
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were MAR, which is less restrictive than the MCAR assumption of more traditional analytic methods.
Furthermore, sensitivity analysis examining whether the dropout mechanism was likely to be NMAR
indicated that any violation of the models assumptions was limited and would have little impact on the
substantive results. However, one needs to be mindful that the NMAR condition is untestable and the
missing data mechanism may still be non-ignorable leading to biased results. Full investigation of such
mechanisms is beyond the scope of this dissertation.
A further limitation is that the analytical methods employed presupposes a longitudinal course. The
HADS is intended as a prolonged state measure of psychological distress with a reference frame of two-
weeks. As such, it is likely to be influenced by trait and state factors. Since RA generally follows a
flaring-remitting pattern, it seems likely that psychological distress will be affected by current levels
of somatic symptoms. This would add to the measurement error when trying to define trajectories.
However, analysis investigating the cross-sectional association between functional impairment, pain and
disease activity using time-varying-covariates showed similar associations and no improvement in model
fit compared to regression on the random intercept. Further, analysis jointly modeling distress with the
disease course is likely to provide greater insight.
Knowledge of the factors associated with distinct psychological response trajectories may help guide
targeted interventions to groups of individuals that would benefit most, with potential benefits to qual-
ity of life and clinical outcomes. Specifically the results suggest targeting those with worse self-reported
somatic symptoms that experience less of an improvement in well-being than one might expect follow-
ing the initiation of disease-modifying treatment. Indeed randomised controlled trials of psychological
therapies in RA samples have observed greater improvements in somatic symptoms as well as depression
in treatment versus control groups (Sharpe et al., 2003, 2008; Knittle et al., 2010; Pradhan et al., 2007;
Zautra et al., 2007; Dixon et al., 2007). Psychological or behavioural interventions soon after diagno-
sis, such as tailored CBT targeting somatic symptoms, may help to reduce psychological distress in this
condition. It is important however to note that a substantial number of individuals with high levels of
distress early in the course of the disease will resolve without intervention. Nevertheless, for an equally
large number of individuals distress will remain chronically high. These individuals are most likely to
be vulnerable to poor disease outcomes and be a greater burden on health services (Katon et al., 2007;
Sharpe et al., 2008).
The remaining two empirical chapters will extend the findings of the current chapter. The next chap-
ter will examine the synchronous relationship between psychological distress and disease symptoms
using the same cohort. Joint models of disease progression according to somatic symptoms and trajec-
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tories of psychological distress will provide greater insight into the impact of the physiological aspects
of the disease on distress. The proceeding chapter will examine the role of psychosocial factors, par-
ticularly illness perceptions and coping strategies, on changes in psychological distress using a smaller
sample with shorter follow-up duration.
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The longitudinal association between
distress and somatic symptoms
7.1 Introduction
In the previous chapter it was shown that psychological distress in RA follows a non-linear pattern with
rapid improvements observed early in the course of the disease that stabilise two to three-years following
diagnosis. This is perhaps due to psychological adaptation to the disease and the individual’s ability to
cope with the stress associated with the somatic symptoms of the disease improving in efficiency and
efficacy (Stanton et al., 2007). Alternatively, these changes may be due to better control of the disease
through effective therapeutic management of the disease activity that causes these somatic symptoms.
The current chapter will extend these findings and explore the evidence in relation to these explanations
by examining in greater detail the association between changes in psychological distress and the common
somatic symptoms of pain and functional limitation. The aim is to provide greater insight into the
strength of the association between psychological distress with pain and functional limitation, as well as
into the direction of causality.
Numerous studies have examined the longitudinal association between function and psychological
distress in RA. The findings of these studies were reviewed in detail in Chapter 3 and are now briefly
discussed to provide the background and motivation of the current chapter.
Strong cross-sectional associations have beeen observed for psychological distress with pain (G. K. Brown,
Nicassio, & Wallston, 1989; Evers et al., 1997; Hawley & Wolfe, 1988; Schiaffino et al., 1991; Sharpe et
al., 2001; Smedstad et al., 1997; Thyberg et al., 2009) and functional limitation (G. K. Brown, Nicassio,
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& Wallston, 1989; Chaney et al., 2004; Demange et al., 2004; Evers et al., 1997; Hawley & Wolfe, 1988;
Nicassio & Wallston, 1992; Schiaffino et al., 1991; Sharpe et al., 2001; Smedstad et al., 1997), even
after controlling for demographic and clinical characteristics. However, findings regarding longitudinal
associations are rather less conclusive. After controlling for earlier distress, of the 18 studies examining
a longitudinal effect of pain on distress only 8 (44%) reported a significant effect (section 3.4.3.1). The
proportion was similar for functional limitation, with 6 out of 15 studies (40%) reporting a significant
longitudinal effect (section 3.4.3.2). Obviously, judgments based on the number of studies reporting
a significant result are not robust. Although no formal meta-analysis was conducted, inspection of the
reported effect sizes indicated that any longitudinal effect was likely to be weak. This is perhaps not un-
surprising since for these studies the duration between measurement occasions ranged from 6-months
to 18-months.
Three of the studies included in the above number used auto-regressive cross-lagged path models
(G. K. Brown, 1990; Schieir et al., 2009; Smedstad et al., 1997).1 Two of these studies examined the
cross-lagged effects between pain and psychological distress (G. K. Brown, 1990; Schieir et al., 2009).
G. K. Brown (1990) reported a weak positive cross-lagged effect of pain on psychological distress (CESD)
in 233 RA patients assessed at three-waves each six-months apart (ρt2 = .23 & ρt3 = .26). No cross-
lagged effects were observed for depression on pain. Conversely, however Schieir et al. (2009) found
a weak positive cross-lagged effect of psychological distress (CESD) on pain (ρt2 = .28) in 180 RA pa-
tients, assessed on two occasions 6-months apart, but no effect of pain on psychological distress. Only
one study employing cross-lagged path analysis examined the longitudinal association between psycho-
logical distress and functional limitation. In a study of 216 RA patients assessed on three equally spaced
occasions over 2-years, Smedstad et al. (1997) found that psychological distress (AIMS depression) was
predicted by prior functional limitation (HAQ), albeit very weakly and only between the first two time-
points (ρt2 = .13). Anxiety (AIMS anxiety), however, was not predicted by prior functional limitation.
Furthermore, no effect of psychological distress in terms of anxiety or depression was predictive of future
functional limitation. Only tentative conclusions can be drawn from the findings of these studies, but
it would seem that any longitudinal association between psychological distress with pain or functional
limitation is weak and likely to be bidirectional.
Although excluded from the review chapter it is appropriate to discuss the findings from experimen-
tal research in relation to the causal relations between psychological distress and somatic symptoms.
1(G. K. Brown, Nicassio, & Wallston, 1989) also reported on a cross-lagged path model but the same data was used in path
analysis reported by (G. K. Brown, 1990) so was excluded.
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Considering first experimental studies based on clinical trials of disease modifying drugs, it is clear that
treatments that are effective in reducing somatic symptoms such as pain and functional limitation con-
currently reduce levels of psychological distress (e.g. Westhovens et al., 2006). The reverse is also true,
studies of antidepressant usage suggest that, as well as reducing levels of distress, somatic symptoms
are improved (e.g. Frank et al., 1988; Lynch, 2001). These findings provide further support for a
bidirectional causal relationship between distress and functional limitation.2
Returning to the weak cross-lagged effects observed, that such small effect sizes are observed is not
surprising since studies consider whether the level of psychological distress at one time point is predicted
by levels of pain and functional limitation 6-months or even a year earlier. It is more appropriate to
consider whether changes in psychological distress occur synchronously with changes in pain and func-
tional limitation. Only one study examined the relationship between changes in psychological distress
and changes in symptoms. In a study of 319 RA patients followed for three-years, Katz (1995) observed
that individuals experiencing an increase in symptoms of depression (GDS) there was a fourfold increase
in the odds of experiencing a worsening of functional limitation over the same period (OR= 3.96; 95%
CI: 1.01,15.67). Clearly, this is an area that needs further examination.
An appropriate analytic strategy not currently employed in the rheumatological literature is to use
bivariate latent curve models (LCM) to examine intra-individual changes in function and psychological
distress. These models extend the standard LCM model (see section 4.3) to jointly model two longitu-
dinal processes. Examining the covariance’s between the resulting random effects, which indicate the
baseline level and rate of change in function and distress for the individual, will provide greater insight
into the relationship between distress and function as well as the direction of causality. A recent develop-
ment extending LCM through the inclusion of a nested autoregressive path model—autoregressive latent
trajectory (ALT) modelling—may provide further useful information (Bollen & Curran, 2004; P. J. Cur-
ran & Bollen, 2001). Specifically, it may also provide information regarding the direction of the causal
effect between psychological distress, pain and functional limitation.
7.1.1 Aims & Objectives of the chapter
The overarching aim of this chapter is to examine the synchronous association between psychological
distress with pain and functional limitation over a period of 5-years following the diagnosis of RA,
2This assumes that the effect of DMARDs on distress is mediated through disease activity and the associated reduction in
functional limitation, and that the effect of antidepressants is mediated by changes in the levels of neurotransmitters in the
brain that reduce symptoms of depression. It is possible that either DMARDs or antidepressants may have a more direct effect
on distress or disease activity, respectively (Lynch, 2001; Straub & Cutolo, 2001), but this is beyond the scope of this chapter.
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using data from the ERAS cohort. With respect to this aim, there are three specific objectives: (i)
to quantify the strength of the cross-sectional relationship between psychological distress, pain, and
functional limitation; (ii) examine whether changes in psychological distress occur in synchrony with
changes in pain and functional limitation; and (iii) assess the ability of pain and functional limitation
at a previous time point to predict changes in psychological distress at a later time point, and vice-versa.
These objectives map to the second objective of the dissertation, outlined in section 3.5.3.
7.2 Methods
7.2.1 Sample
As in the previous chapter, the sample used in the current analysis consisted of a sub-sample of indi-
viduals from the ERAS cohort (N = 784). For the present analysis data over the five-years following
diagnosis was used—the reason for this discussed later, in section 7.2.3. The recruitment procedure,
demographic profile and pattern of dropout for the sample were described in detail in Chapter 6 so are
not discussed in detail here. At the five-year assessment 534 (68%) remained in the sample. Missing
data concerning psychological distress was common, ranging between 32% at 1-year to 17% at 5-years
for those completing follow up. For pain and functional limitation however data was far more complete.
At the baseline assessment there were no missing values and at the later assessments there were less
than 5% for those remaining at follow-up.
7.2.2 Measures
Psychological distress The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983)
total score was used as a measure of psychological distress. As in the previous chapter, since only sum
scores for the anxiety and depression subscales were available the total score was used as a measure of
general psychological distress incorporating specific features of anxiety (autonomic arousal) and depres-
sion (anhedonia).
Functional limitation Functional disability was operationalised using the UK version of the Health
Assessment Questionnaire (HAQ) disability index (Fries et al., 1980; Kirwan & Reeback, 1986). The
HAQ consists of 20-items concerning eight activities of daily living: dressing & grooming, arising, eating,
walking, hygiene, reach, grip and activities. Items are scored on a four-point ordinal scale ranging from
zero “without any difficulty” to three “unable to do”. In addition, for each activity respondents also
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report whether they receive assistance from other people or use assistive devices. The aggregated score
is the average of the maximum rating within each of the eight activities of daily living adjusted for the
use of devices and assistance. Scores range between zero and three with higher values indicating greater
limitation. Generally, scores greater than 1 indicate that an individual has moderate disability, and above
two severe disability.
Pain A 100mm visual analogue scale (VAS) anchored at zero ‘No pain at all’ and 100 ‘Worst pain ever’
was used to assess the patients level of bodily pain in the clinic. VAS pain scores followed a uniform
distribution.
Disease activity The original version of the Disease Activity Score was used to measure disease activity
(van der Heijde et al., 1990). This is a composite measure including either erythrocyte sedimentation
rate (ESR) (or C-reactive protein [CRP]) plus a count of the number of tender (TJC) and/or swollen
joints (SJC) of 44 specific joints (mainly the hands, feet and wrists). Scores for the DAS range between
zero and around ten (although there is technically no upper limit since ESR and CRP are unbounded),
with scores of over five indicating severe disease and scores less than three low disease activity.3 DAS
scores were approximately normally distributed. However, CRP, ESR, SJC and TJC were all positively
skewed and were square-root transformed when used separately in the analysis.
Early morning stiffness The amount, in hours, of early morning stiffness (EMS), an indicator of dis-
ease activity, was also recorded. Responses were positively skewed and therefore were square-root
transformed.
Comorbidity Comorbidity was assessed using the Charlson comorbidity index (Charlson et al., 1987).
This is essentially a weighted count of comorbidities that have been found to be related to mortality (e.g.
cancer, heart disease, diabetes, chronic obstructive pulmonary disease etc.). For the current analysis,
Charlson scores were dichotomised as the presence or absence of at least one Charlson comorbidity.
Socio-economic status SES was assessed at baseline according to the Registrar General’s classification
for social class, the Carstair Index of social deprivation based on the patients post-code area and their
highest level of educational qualification. All were dichotomized, social class IV or V categorized as “low
social class”, patients living in areas falling in the lowest 2 quintiles of the Carstair Index were defined as
3A DAS score of less than 1.6 corresponds to the American Rheumatology Association preliminary criteria for clinical remis-
sion (Fransen et al., 2004).
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Figure 7.1: Autoregressive model
“socially deprived”, and ’left school with no educational qualifications’ categorized as “low education”.
In addition, work status (employed/unemployed) was also used. This information was only available
for those in the ERAS database, and is therefore missing for the additional individuals (see section 6.2.1
and Appendix D).
7.2.3 Autoregressive latent trajectory models
There are two main approaches to the analysis of longitudinal repeated data (Raykov, 1998). As well as
the LCM, discussed extensively in Chapter 4, a further approach, generally referred to as autoregressive
(AR) modelling, is also widely used. AR models are commonly employed in the analysis of long time-
series, for example the autoregressive moving average (ARMA) model which combines an autoregressive
component with a moving average part is widely used in the field of economics. The AR model is
also applicable for shorter time-series; indeed the residualised change model widely used in the social
sciences to examine change over two measurement occasions is the most basic form of the AR model.
The standard (simplex) AR model can be expressed as
yi t = αt +ρt(t−1) yi t−1+ εi t (7.1)
where yi t are the observed values on variable y for person i at time t, αt is the intercept, ρt(t−1)
is the autoregressive parameter representing the strength of the association between the value of y at
a previous time-point yi t−1 on its current value yi t . All of the parameters are allowed to vary across
time-points.
For t = 1 the autoregressive term ρt(t−1) yi t−1 is not included in the model since no predictor is avail-
able. That is, to avoid problems of infinite regress, the first observation yi1 it is treated as predetermined.
The simplex AR model is depicted graphically in Figure 7.1. Furthermore, the univariate AR model can
easily be extended to include a second autoregressive process with cross-lagged effects (Figure 7.2).
The AR model has been widely criticised (e.g. Marsh & Grayson, 1994). The main issue is that
the AR model is based on covariance stability and therefore cannot take in to account the underlying
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Figure 7.2: Autoregressive cross-lagged model
trajectory of the variable of interest. Furthermore, the time specific intercepts αt and autoregressive
parameters ρt(t−1) are fixed effects and thus do not account for intra-individual differences in change. In
contrast, the LCM model incorporates random effects for the growth parameters allowing them to vary
across individuals. For this reason the use of LCMs have become increasingly popular in recent years.
A limitation of the LCM model is that, usually, only overall intra-individual trajectories are estimated,
thus autocorrelations between time-points are not accounted for. Deviations from the intra-individual
trajectories are treated as random errors. However, in many situations it is likely that these deviations
are substantively meaningful. For example, RA follows a flaring-remitting course, during a disease flare
physical ability is likely to be impaired irrespective of the underlying trajectory of physical ability that is
associated with the progression of the condition. Furthermore, it is likely that individuals experiencing
a flare at one time point will have an increased propensity for a flare at other time points. Morin,
Maïano, Marsh, Janosz, and Nagengast (2010, p.8) explain that “such time-specific, state-like, relations
may indeed be quite strong and/or vary across time and thus potentially bias the estimation of the full
trajectories by causing them to be ‘absorbed’ by the remaining parameters of the model”. Although, it is
possible to incorporate autocorrelations between adjacent time-points within the LCM model,4 a more
flexible alternative is to incorporate an AR model within the LCM model (P. J. Curran & Bollen, 2001;
Bollen & Curran, 2004).5
Although the AR and LCM models are often seen as competing approaches, Bollen and Curran (2004,
p.336) have shown how they can be seen as “special cases of a more encompassing model that [they]
call the autoregressive latent trajectory (ALT) model”. Combining the notation used in equations 4.5
and 7.1 the ALT model for t > 1 can be expressed as
4The LCM models estimated in Chapter 6 incorporated an autocorrelated error structure
5Hamaker (2005) notes the equivalence of the ALT and the LCM with an autocorrelated error structure
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Figure 7.3: Autoregressive latent trajectory model
yi t = αi +λtβi +ρt(t−1) yt−1+ εi t (7.2)
αi = µα+ ζαi (7.3)
βi = µβ + ζβ i (7.4)
As in the AR model, the first time-point is treated as predetermined and is therefore not included
in the LGM part of the model. The ALT model is depicted graphically in Figure 7.3. In this model the
specifications are similar to the standard LCM, except the correlation between the first time-point, the
intercept factor and the slope factor are always estimated. For identification, linear ALT models require at
least five time-points, although additional constraints can be added to allow the identification of models
with three or four time-points. Additional details of these models and the assumptions underlying them
are described in detail by P. J. Curran and Bollen (2001) and Bollen and Curran (2004).
As with the standard AR model and the LCM model, extending the model from one process to two
is possible. However, due to the increased complexity of the ALT model (i.e. the number of parameters
being estimated) problems with convergence are common. Bollen and Curran (2004) recommend a
systematic approach whereby the unconditional univariate LGM and AR models are first examined and
then combined as a univariate ALT model, with the best fitting model selected for inclusion in the
bivariate model. Then unconditional bivariate LCM and AR models incorporating cross-lagged effects
are estimated, which are combined as an an unconditional bivariate ALT model. Prior to the inclusion
of covariates, constraints on parameters usually need to be applied to improve the parsimony of the
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model—such as, incorporating equality constraints for the time specific uniqueness correlations, the
autoregressive parameters and the cross-lagged parameters. In addition to these constraints, Voelkle
(2008) recommends restricting the number of assessment occasions included in the model to ensure
that the LCM part of the model is correctly specified,6 hence the decision to restrict the current analysis
to 5-years.
The ALT model provides a useful framework to examine longitudinal processes, in particular when
we are concerned with two processes that we expect to be related. Specifically, the ALT model allows
for the researcher to distinguish between LCM and AR models. Morin et al. (2010) argue that the ALT
model allows for the disaggregation of state and trait processes due to the differential interpretation of
the AR parameters for the ALT compared to the AR model. Whereas for the AR model in which the AR
parameters reflect inter-individual rank order stability, for the ALT model the AR parameters reflect ‘the
impact of individual state-like deviations from the overall trajectories’ (Morin et al., 2010, p.9).
In relation to the objectives of this chapter, fitting bivariate ALT models for psychological distress
separately with pain and functional limitation will allow for the assessment of the strength of the asso-
ciation for the underlying trajectories. Controlling for the underlying trajectories, it will be possible to
assess whether there are time-specific correlations, as well as autoregressive and cross-lagged effects for
the variables.
7.3 Results
7.3.1 Demographic and clinical characteristics
The baseline demographic profile of the sample was described in Chapter 6. Briefly, the average age
at onset was 57.0-years (SD = 15.1), 67% were female, 41% and 60% were classed as educationally
or socioeconomically disadvantaged, respectively, 43% were in paid employment, and 24% were smok-
ers. On average, invididuals experienced symptoms for 7-months prior to their first presentation to the
rheumatologist, at which time they were recruited to the ERAS cohot. The average scores for psycholog-
ical distress, pain, and functional limitation at baseline and over the five-years following diagnosis are
given in Table 7.1. For all, levels were raised at the baseline assessment, with a dramatic reduction over
the first year and then stable and possibly increasing levels thereafter.
6In a simulation study Voelkle (2008) shows that misspecification of the LCM part of the ALT model will bias parameter
estimates in the AR part. This is because the AR part of the model is concerned with the residualised values of yi t after
accounting for the underlying trajectory, misspecification of the LCM model directly influences the residuals thus biasing the
AR parameter estimates. Voelkle (2008) recommends restricting the number of occasions used in ALT models since obtaining
a well specified LCM is more difficult with increasing numbers of occasions included.
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7.3.2 Preliminary analyses
7.3.2.1 Correlations
The pattern of correlations shown in Table 7.1 would appear to suggest that at the time of diagnosis when
levels of pain, functional limitation and psychological distress are typically high there is only modest
association between between the three domains (r = .28 to .40). After 1-year of follow-up, when most
patients have started disease-modifying therapy, the association is stronger and remains stable over time
(r = .43 to .57). For pain, functional limitation and psychological distress an individual’s position in
the distribution of scores on the same variable is highly related across time points. Furthermore, an
individual’s position in the distribution of scores on an alternate variable at the same time is strongly
positively related, and moderately so for different time points.
The correlations for 1-year change scores showed moderate associations between changes in psycho-
logical distress accompanying changes in pain (r = .20 to .35) and functional limitation (r = .24 to .36).
Changes in disability and pain were also positively correlated (r = .34 to .53). This highlights the issue
that changes in the somatic symptoms of the condition tend to be associated with concurrent changes in
psychological distress.
7.3.2.2 Growth mixture modelling
A report based on a growth mixture modelling (GMM) analysis of the functional limitation data over
10-years is presented in Appendix A. As with the GMM of the HADS distress data, four latent trajectory
classes were identified as providing the best fit to the data. The trajectories for each class are shown in
Figure 7.4. Confirming previous research, a ‘j-shaped’ trajectory described the average trajectory for the
cohort as a whole and for the largest of the four distinct trajectories (46%). For this class, there was
an initial improvement in functional limitation, presumably due to the initiation of disease-modifying
therapy, followed by a gradual and insiduous decline. Three further trajectories accounting for over
half of the cohort, however, did not follow this prototypical trajectory. Two classes also showed an
initial improvement in functioning but with stable levels of either low or no limitation. For around one-
fifth of individuals however there was no improvement in function with levels of functional limitation
staying stable and high throughout the period of follow-up. Compared to the prototypical trajectory,
individuals with consistently high levels of functional limitation were more likely to be female, have
lower educational attainment, less likely to work and have worse disease severity. Those in the no
or low limitation classes were more likely to be younger, male, from a higher social class, be in paid
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employment and have milder disease severity.
Table 7.2 shows the marginal distribution for the most likely classes from the separate GMMs for
functional limitation and psychological distress. There is a clear association between the most likely
class memberships. There was a larger proportion of individuals in the delayed and chronic psycho-
logical distress classes who were also in the moderate-increasing and high-stable functional limitation
classes. This indicates that changes in functional limitation and psychological distress do appear to occur
concurrently. The findings of the GMM models are not discussed further, since the bivariate ALT models
provide greater insight into the temporal association and synchronicity of change between psychological
distress and the somatic symptoms of the disease.
0
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Figure 7.4: Predicted trajectories for the 4-class growth mixture model for HAQ disability
Table 7.2: Marginal distribution of the most-likely class for functional limitation GMM within
most-likely class for psychological distress GMM
HAQ disability class
HADS distress class Low-stable Moderate-stable Moderate-increasing High-stable
Resilient 12% 36% 37% 16%
Recovered 8% 54% 38% 0%
Delayed 0% 17% 34% 48%
Chronic 0% 11% 30% 59%
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7.3.3 Autoregressive latent trajectory models
The ALT models for psychological distress were estimated following the framework described by Bollen
and Curran (2004) that was introduced in section 7.2.3. This involves first examining the fit of univariate
AR models, then univariate LCMs and finally univariate ALT models. Following this framework should
ensure that neither the AR nor the LCM part of the ALT model is misspecified for psychological distress,
pain or functional limitation. Reducing the likelihood of misspecification and convergence issues when
combined into a bivariate ALT model for psychological distress with pain or functional limitation.
7.3.3.1 Univariate autoregressive models
Separately fitting AR models to the pain, disability and distress data over the five years following dis-
ease onset indicated poor fit for each model (Table 7.3). For each model, the χ2 test of exact fit was
significant with the ratio of the χ2 statistic to the degrees of freedom being large. Furthermore, values
of the Comparative Fit Index (CFI), Tucker-Lewis Index (TLI) and the root mean square error of approx-
imation (RMSEA) were outside acceptable limits of fit.7 This would indicate that fixed effects for the
autoregressive association do not adequately account for underlying inter-individual changes, and that
other factors may be important in the prediction of pain, distress and disability at future time points. It
is important to note that for each of the models strong autoregressive effects for each of the variables
was indicated, with standardized paths ρ ≈ .60 for pain, ρ ≈ .85 for disability, and ρ ≈ .75 for distress.
This suggests that for pain, functional limitation and distress prior status is a strong predictor of status
1-year later.
7.3.3.2 Univariate latent curve models
LCMs using linear, polynomial and the free-loading method were considered. Voelkle (2008) has shown
that misspecification of the LCM part of the model can lead to major problems in the LCM and autore-
gressive parts of the ALT model, hence considerable attention was given to ensuring that they were
correctly specified.
Pain The univariate LCM for pain assessed at the one through five-year measurement occasions with
random intercept and linear slope factors exhibited poor fit to the data by the χ2 test of exact fit.
However, the RMSEA, CFI and TLI goodness-of-fit statistics all suggested acceptable fit, indicating that
the degree of misfit was not large. Including a random quadratic slope factor did not significantly
7See section 4.2.2 for details of the assessment of model fit in latent variable models.
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improve the fit of the model over the linear LCM (Table 7.3). Neither did freeing the loadings on the
random slope. Thus the linear LCM (Model 2) for pain was accepted as the best fitting model and
implemented as the LCM part of the ALT model.
Functional limitation The univariate LCM of HAQ disability with a linear rate of change between one
and five-years showed significant misfit to the data. Both the model including a random quadratic slope
parameter and a model allowing the loadings on the slope parameter to be freely estimated provided
significant improvement in model fit, assessed by χ2 difference tests (Table 7.3). A model allowing for a
linear trend between 1 and 5-years except for year 2 where the loading on the random slope variable was
freely estimated was observed to fit the data better than the linear model, but provided no significant
reduction in fit when compared to the full free-loading model. Despite showing significant misfit to the
data, model five for HAQ disability was selected as the LCM for the HAQ in the ALT model since the
goodness of fit indices were optimal. The estimated trajectory for the linear latent curve model for pain
against the observed data is shown in Figure 7.5.
Psychological distress The univariate linear LCM for psychological distress assessed at the one through
and 5-years follow-up assessments showed no significant misfit to the data (Table 7.3). Furthermore, al-
lowing for a quadratic growth factor or for the loadings on the slope growth factor to be freely-estimated
resulted in no significant improvement in fit. Therefore, the linear LCM (Model 2) for psychological dis-
tress was selected for inclusion in the ALT model.
7.3.3.3 Univariate autoregressive latent trajectory models
Unconditional ALT models were estimated separately for pain, functional limitation and psychological
distress. Since the ALT model cannot be directly compared to either the AR or LCMs they were compared
against the ALT model with the AR paths fixed to zero, this is referred to by Bollen and Curran (2004)
as the ‘nested LCM’. It follows that if the χ2 difference test is non-significant then the inclusion of the
AR paths is unnecessary and the LCM model adequately describes changes from one point to the next.
Pain The univariate ALT model for pain showed good fit to the data. Although the χ2 test of fit was
significant, the value of the χ2 statistic was relatively low as was its ratio to the degrees of freedom.
Examining the fit against the nested LCM alternative indicated superior fit for the full ALT model (Table
7.3). The estimated trajectory for pain for the full ALT model is shown in Figure 7.5. The blue triangles
represent the means for the observed data and the spikes 95% confidence intervals of these means. The
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Figure 7.5: Predicted trajectories for the univariate autoregressive latent trajectory models. Tri-
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implied trajectories between the one and five-year assessments.
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connected red squares represent the predicted trajectories. At baseline the mean level of pain was 49.89
(95% CI: 47.95, 51.84), reducing to 30.61 (95% CI: 28.85, 32.36) after 1-year following the initiation
of disease-modifying therapy. Between 1 and 5-years after diagnosis pain increased on average by 0.64
(95% CI: 0.09, 1.19). The variances of both the random intercept and slope factors were significant,
indicating heterogeneity in both the level of pain at 1-year and the rate of change in pain between 1 and
5-years in the sample.
Functional limitation The χ2 test of fit for the univariate ALT model of functional limitation was non-
significant, which considering the size of the sample suggests excellent fit to the data. Furthermore,
the goodness-of-fit indices also indicated excellent fit to the data. The test of the nested LCM against
the full ALT model was highly significant, indicating that the inclusion of the autoregressive effects was
appropriate.
The estimated overall trajectory of functional limitation for the full unconditional univariate ALT
model is shown in Figure 7.5. The mean HAQ functional limitation score at baseline was 0.73 (95%
CI: 0.69, 0.77). This reduced to 0.44 (95% CI: 0.39, 0.49) after 1-year of follow-up, presumably due
to the initiation of disease-modifying treatment. Between 1 and 5-years following diagnosis the average
annual rate of progression of functional limitation was .034 units per year (95% CI: 0.029, 0.039), except
for the change from 1 to 2-years which was notably reduced in comparison to the change observed at
other years, .019 (95% CI: 0.014, 0.024). The variances of both the random intercept and slope factors
were again significant. This suggests that there is considerable individual variability around the level of
limitation at 1-year and in the rate of change between 1 and 5-years, consistent with the earlier findings
of the GMM (section 7.3.2.2)
Psychological distress For psychological distress the full unconditional univariate ALT model exhibited
excellent fit to the data according to the χ2 test of fit and the goodness-of-fit indices. The test of the full
model against the nested LCM model indicated no significant worsening of fit when the autoregressive
paths were excluded. This suggests that after accounting for the latent trajectory part of the model the
size of the residuals are small and it does not seem necessary to incorporate systematic autoregressive
effects as was observed for both pain and functional limitation.
The estimated trajectory for the ALT model against the observed values of psychological distress
are shown in Figure 7.5. The mean HADS psychological distress score at baseline was 11.66 (95% CI:
11.12, 12.20). This reduced to 9.60 (95% CI: 8.71, 10.50) after 1-year of follow-up. Between 1 and
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5-years following diagnosis the average annual rate of change in psychological distress was significant
and positive 0.124 (95% CI: 0.001, 0.247). This is in contrast to the estimates from Chapter 6 where
reductions over this period were indicated. It is important to note that the magnitude of the change is
small, equivalent to a standardized mean difference for the 1 to 5-year assessments of just 0.073. Thus
it seems appropriate to conclude that levels of psychological distress are relatively stable over the period
of 1 to 5-years following diagnosis. However, since the variance of the random linear slope factor was
significantly greater than zero it seems that there is heterogeneity in the rate of change over 5-years,
consistent with the findings of the GMM reported in the previous chapter.
7.3.3.4 Bivariate autoregressive latent trajectory models
As recommended by Bollen and Curran (2004) prior to estimating the bivariate ALT models bivariate AR
models incorporating cross-lagged effects and bivariate LCMs were considered. As well as comparing
the ALT model with the nested LCM, as before, separate models were estimated fixing first the AR paths
for psychological distress and then the AR paths for either pain or functional limitation to zero. Further-
more, models fixing the random linear slope factor variance to zero and excluding this factor altogether
were also considered. From the best fitting of these models further constraints were considered to im-
prove model parsimony. This involved testing the equality of the time specific correlations, testing the
equality of the AR paths, and testing the equality of the cross-lagged paths. The bivariate ALT models for
psychological distress with pain and psychological distress with functional limitations are now discussed.
Pain and psychological distress The model fit statistics for all bivariate models involving pain and
psychological distress are listed in Table 7.4. The AR model with cross-lagged effects (Model 1) exhibited
poor fit to the data as indexed by the χ2 test of exact fit and the goodness-of-fit indices. The bivariate
LCM model (Model 2) however provided an acceptable fit to the data by the goodness-of-fit indices,
although the χ2 statistic was significant.
The bivariate ALT model (Model 3) showed excellent fit to the data as indicated by the goodness-
of-fit indices, furthermore, the χ2 difference test against the nested LCM (Model 4) was significant
indicating that the inclusion of the AR paths was required. Comparing models that separately fixed the
AR paths for psychological distress (Model 5) and pain (Model 6) to zero indicated that, consistant with
the univariate analysis, the AR paths could be excluded for psychological distress without significant loss
of model fit.
Next, fixing the variance of the distress slope factor to zero (Model 7) and excluding the distress
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slope factor entirely (Model 8) did not result in a significant reduction in model fit. This suggests no
significant change in distress or individual variation in the rate of change in distress between 1 and 5-
years. Since this finding was in contrast to the univariate ALT model, the findings of the previous chapter
and, furthermore, would result in not being able to compare the rate of change in distress with the rate
of change in pain neither constraint was retained.
Fixing the variance of the pain slope factor to zero (Model 9) and excluding the pain slope factor
entirely (Model 10) did result in a significant reduction in model fit. As was indicated by the univariate
model, this suggests heterogeneity within the rate of change in pain across individuals between 1 and
5-years. Neither constraint was retained in later models.
The progressive inclusion of equality constraints for the time specific correlations (Model 11), the
AR paths (Model 12) and the cross-lagged paths (Models 13 & 14) resulted in no significant loss of
model fit. Moreover, the constrained cross-lagged paths for pain→ distress and for distress→ pain were
non-significant indicating no cross-lagged effects. Following the inclusion of the equality constraints loss
of fit through fixing the distress slope variance to zero (Model 15) or excluding the distress slope factor
entirely (Model 16) was retested. This time excluding the distress slope resulted in a significantly poorer
fit. Fixing the slope factor variance to 0 resulted in a marginally significant loss of fit. Therefore, it was
decided it is appropriate to keep these in the model. Model 14 was selected as the final ALT model to
which predictor variables would be added. This model (Model 17) had excellent fit to the data according
to the goodness-of-fit indices and although the χ2 test of exact fit, which was non-significant.
The standardized parameter estimates for Model 14 are displayed in Figure 7.6—note that non-
significant paths are not displayed. The time specific correlations between distress and pain were mod-
erate (r = .30) but were lower than those shown in Table 7.1. This is to be expected since these
correlations represent the associations between the residuals after accounting for the latent trajectory
part of the model. The correlation between the two random intercept factors was higher (r = .46)
and equivalent to the associations observed in Table 7.1. The correlation between distress at the first
time-point and the random intercept for distress was high (r = .59), whereas correlation between pain
at the same time-point and the random intercept for pain was weak (r = .19). Both were equivalent
to the correlation between the observed scores at the same time-points. The consistency between the
estimated model parameters and the observed correlations support the good fit of the model.
Relating to the second objective of this chapter, there was a strong positive correlation observed
between the random slope factors for distress and pain (r = .42). This indicates that changes in pain
occur synchronously with changes in psychological distress. Furthermore, the cross-lagged effects were
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αHADS βHADS
αPain βPain
HADS0
HADS1 HADS2 HADS3 HADS4 HADS5
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Pain1 Pain2 Pain3 Pain4 Pain5
.59
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Figure 7.6: Unconditional autoregressive latent trajectory model for psychological distress and
pain. Statistics are standardized parameters, non-significant paths are not shown
all small and non-significant.
In summary, the bivariate ALT model for distress and pain over 5-years in the ERAS cohort indicates
that concurrent levels of pain and distress are highly related, as are longitudinal changes. The distress
intercept factor was not related to the pain slope factor, and vice versa the pain intercept factor was not
related to the distress slope factor, indicating that initial levels of one are not causally related to later
changes in the other over one-year periods. The lack of causal association between the two is further
supported by the lack of cross-lagged effects between the residualised values of pain and distress after
accounting for the trajectory part of the model. This finding contrasts with those of previous research
using autoregressive cross-lagged models (G. K. Brown, 1990; Schieir et al., 2009). It is likely the
weak positive causal effects previously reported were due to the failure to account for the underlying
trajectory.
Functional limitation and psychological distress The model building process for the bivariate ALT
model for functional limitation and distress followed much the same process (Table 7.5). The best
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fitting model prior to incorporating equality constraints was Model 5, which included AR paths only
for HAQ. As with pain, fixing the slope factor variance to 0 (Model 7) or excluding the distress slope
factor (Model 8) resulted in no significant loss of fit. This was true even after the inclusion of equality
constraints. However, since the exclusion of the factor or its variance would result in the hypothesis
under question being untestable they were retained within the model. The final model selected for the
conditional model was Model 14. This included equality constraints for the time specific correlations,
the AR paths for functional limitation, and the cross-lagged effects.
Figure 7.7 shows the standardized parameter estimates for model 14—again, non-significant paths
are not displayed. As with the model for pain and distress the cross-lagged association were non-
significant and moderate time specific correlations were observed (r = .29). There was a moderate
autoregressive effect for functional limitation (r = .28), but not distress, after accounting for the under-
lying longitudinal trajectory. The correlations between the intercept factors for distress and functional
limitation were again strong (r = .44), as were the correlations between the slope factors (r = .37).
For functional limitation only, there was a weak, but significant, correlation between the intercept and
slope factor (r = .17), suggesting that patients with higher levels of limitation at one-year tended to
experience a faster decline in function.
To summarise the bivariate ALT model for distress and functional limitation, concurrent levels of
distress and functional limitation and changes in distress and functional limitation are highly related.
Similar to the model concerning pain, a lack of causal association between distress and disability is
observed. It does not appear that either the initial level of distress or functional limitation is related
to future changes in the other, or between the residuals. The autoregressive effect for HAQ disability
indicates that, after controlling for the underlying rate of functional decline, worse functional limitation
is predicted by having worse functional limitation one-year earlier. Since the underlying trajectory is
likely to be related to progression of joint damage, this may be indicative that those with worse limitation
due to other causes at one time-point are more likely to have worse functional limitation at later-time
points, independent of their level of limitation at 1-year. Since no effect was observed for pain it seems
unlikely that these other causes include disease flare.
7.3.3.5 Conditional bivariate autoregressive latent trajectory models
Predictors were added to the best fitting bivariate ALT models for psychological distress with pain and
psychological distress with functional limitation—Model 14 for both. Distress, pain and functional lim-
itation at the baseline assessment, the random intercepts (representing the level at one-year) and the
180
Chapter 7. The longitudinal association between distress and somatic symptoms
αHADS βHADS
αHAQ βHAQ
HADS0
HADS1 HADS2 HADS3 HADS4 HADS5
HAQ0
HAQ1 HAQ2 HAQ3 HAQ4 HAQ5
.34
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Figure 7.7: Unconditional autoregressive latent trajectory model for psychological distress and
functional limitation. Statistics are standardized parameters, non-significant paths are not shown
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random slopes (representing the rate of change) were each regressed on the predictor variables. Rather
than incorporating the associations between distress, pain and functional limitation at the baseline as-
sessment with the respective intercept and slope factors as correlations they were included as paths in
the model. Including the associations as correlations or paths results in models that are equivalent (in
terms of fit), although the model including paths leads to a more intuitive interpretation of intercept
factors regressed on the predictors as relating to residualised change.
Convergence problems were experienced, mainly due to the small variance of the distress slope
factor. Reinstating the autoregressive paths for distress for both models and constraining them to equality
resolved the issue for both models—the estimated paths remained non-significant.
Table 7.6: Predictors of psychological distress
Baseline Intercept Slope
β SE β SE β SE
Age at onset -0.07 0.04 0.10 0.04 0.04 0.09
Female 0.08 0.04 0.07 0.04 0.03 0.09
Low social class 0.15 0.08 0.02 0.08 -0.07 0.15
Low educational attainment -0.07 0.07 -0.05 0.07 0.25 0.14
Smoker 0.07 0.04 0.03 0.04 0.14 0.09
Disease activity (baseline) 0.20 0.09 -0.06 0.10 0.17 0.21
Pain (baseline) 0.35 0.04 -0.03 0.05 0.19 0.11
HAQ disability (baseline) 0.11 0.04 0.21 0.10
HADT distress (baseline) 0.60 0.05 0.00 0.12
R2 0.17 0.39 0.15
Note. Parameters are standardised estimates, emboldened figures are significant (p < .05)
Table 7.7: Predictors of pain
Baseline Intercept Slope
β SE β SE β SE
Age at onset 0.06 0.04 0.05 0.05 0.14 0.11
Female 0.04 0.03 0.08 0.05 0.01 0.10
Low social class 0.04 0.06 0.09 0.08 0.01 0.14
Low educational attainment -0.10 0.06 0.06 0.08 0.03 0.14
Smoker 0.07 0.04 0.05 0.05 -0.06 0.11
Disease activity (baseline) 0.18 0.03 0.00 0.05 0.10 0.10
HAQ disability (baseline) 0.32 0.03 0.04 0.05 0.00 0.09
Pain (baseline) 0.19 0.06 -0.03 0.13
HADT distress (baseline) 0.20 0.06 -0.02 0.16
R2 0.18 0.17 0.04
Note. Parameters are standardised estimates, emboldened figures are significant (p < .05)
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Table 7.8: Predictors of functional limitation
Baseline Intercept Slope
β SE β SE β SE
Age at onset 0.08 0.03 0.11 0.03 0.08 0.08
Female 0.12 0.03 0.11 0.03 0.03 0.07
Low social class -0.03 0.05 0.08 0.04 -0.09 0.09
Low educational attainment 0.13 0.05 0.05 0.04 0.15 0.09
Smoker 0.03 0.04 0.04 0.03 0.11 0.08
Disease activity (baseline) 0.12 0.03 0.00 0.04 0.01 0.07
Pain (baseline) 0.32 0.03 -0.18 0.04 -0.04 0.09
HAQ disability (baseline) 0.62 0.03 0.24 0.08
HADT distress (baseline) 0.12 0.05 0.16 0.12
R2 0.13 0.46 0.15
Note. Parameters are standardised estimates, emboldened figures are significant (p < .05)
Predictors of psychological distress Table 7.6 shows the standardised parameter estimates for the
regression of psychological distress at the first time-point, the distress intercept factor, and the distress
slope factor on the predictor variables.8 At the baseline assessment occasion female sex, higher pain and
greater disease activity were related to more symptoms of psychological distress. Only a modest amount
of the variance in the initial level of distress was explained by the covariates.
Baseline psychological distress was the strongest predictor of the distress random intercept factor
(i.e. 1-year psychological distress). Baseline functional limitation and age at onset were also predictive
of the intercept factor. Just under 40% of the variance in the intercept was explained by the covariates.
The only baseline predictor of the change in distress between 1- and 5-years was functional limita-
tion, which indicated the faster increase in psychological distress between 1 and 5-years for those with
higher functional disability at baseline.
Predictors of pain Standardised parameter estimate for the regression of pain at the baseline assess-
ment, the pain intercept factor, and the pain slope factor on the predictor variables are shown in Table
7.7. At the baseline assessment occasion, only functional limitation and disease activity at the same
time were associated with pain. Little of the variance in pain scores at this time was explained by the
covariates.
Pain and distress at the first time-point were significant but weak predictors of the random intercept
for pain. Again, the model explained little of the variance in pain scores. None of the variables explained
the rate of change in pain.
8The parameter estimates shown are from the conditional bivariate ALT model involving HAQ. Estimates from the model
involving pain were similar and are not shown since they suggested no substantive difference in interpretation.
183
Chapter 7. The longitudinal association between distress and somatic symptoms
Predictors of functional limitation Cross-sectionally older age at onset, female sex, low educational
attainment, higher pain and worse DAS score were significantly associated with functional limitation at
the time of presentation to the rheumatologist (Table 7.8).
Functional limitation at the baseline assessment was the strongest predictor of one-year functional
limitation. Older age at onset, female sex, and higher psychological distress at baseline were also signif-
icantly related to functional limitation at 1-year. The covariates explained around half the variance in
the intercept factor. Unexpectedly baseline pain showed a significant negative effect. Further analysis
revealed that it was not that those with a higher pain at baseline experienced lower 1-year functional
limitation per se, but that those with higher baseline pain levels tended to experience a greater reduction
in functional limitation between baseline and one-year than individuals with lower levels of pain but the
same level of functional limitation at baseline (i.e. the negative relationship was conditional on baseline
functioning).
Only baseline functional limitation was significantly related to the rate of progression in functional
limitation. Those with worse functional disability at baseline tended to have a faster rate of progression.
7.4 Discussion
This chapter examined the synchronous relationship of psychological distress with pain and functional
limitation in rheumatoid arthritis using ALT models. Regarding the objectives of the chapter, the analy-
ses showed strong cross-sectional associations between psychological distress with pain and functional
limitation, moderate associations between the rate of change in psychological distress with the rate of
change in pain and functional limitation over the period 1 to 5-years following diagnosis. No cross-
lagged effects between the variables were observed after accounting for the inter-individual differences
in the rate of change. Moreover, no autoregressive effect for psychological distress or pain and only a
relatively modest autoregressive effect was observed for functional limitation after accounting for the
inter-individual trajectories.
The observation of strong cross-sectional correlations between psychological distress, pain and func-
tional limitation was in line with the findings of previous research (G. K. Brown, Nicassio, & Wallston,
1989; Evers et al., 1997; Hawley & Wolfe, 1988; Schiaffino et al., 1991; Sharpe et al., 2001; Smedstad et
al., 1997; Thyberg et al., 2009; Chaney et al., 2004; Demange et al., 2004; Nicassio & Wallston, 1992).
Extending the findings of previous research (G. K. Brown, 1990; Schieir et al., 2009; Smedstad et al.,
1997), the application of ALT models showed that rather than an autoregressive relationship it is more
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appropriate to consider changes in psychological distress by considering the individual’s underlying tra-
jectory over a number of years. Whereas, the previous chapter showed that the majority of the change
in psychological distress occurs early in the course of the disease, with stable levels observed from two
to three-years after the initial diagnosis of the condition. This chapter extended these findings to show
apparent stability in psychological distress from around one-year post diagnosis over a period of five
years.
An important issue is whether the synchronous changes observed are driven by affect or the control
of the disease. According to the Bonanno (2005) model, the change in distress observed in the first
year of the disease is mainly the psychological response to a potentially traumatic event—namely, the
diagnosis of RA. This is itself a manifestation of the individuals’ coping response. However, it is perhaps
more likely that the changes observed are due to changes in somatic symptoms due to the initiation of
disease modifying therapy. The bivariate ALT model for distress and functional limitation showed that in-
dividuals with higher levels of limitation at the time of presentation to the rheumatologist were likely to
experience greater decline in function, independent of demographic characteristics. Furthermore, indi-
viduals with higher levels of limitation at the time of presentation to the rheumatologist were also more
likely to experience greater increases in psychological distress. This may suggest that it is the change
in functional limitation—associated with worse initial disease status—that drives the change in distress.
However, it may be that cognitive appraisals play an important role. Individuals with poorer function
at baseline are likely to have heightened perceptions of the consequences of their RA (Moss-Morris et
al., 2002) and when functioning begins to deteriorate again there understanding of the consequences
may lead to greater distress. Chapter 3 identified Schiaffino and Revenson (1995), Schiaffino et al.
(1998) and (Scharloo et al., 1999) as observing worse perceptions of consequences as predictive of later
changes in distress in RA samples. Nevertheless the analysis in this chapter does suggest that the effect
of functional limitation on distress is stronger than the reverse.
Similar to the findings of Chapter 6 low social class and disease activity were predictive of baseline
distress. Age at onset was predictive of distress at one-year but not the baseline assessment. That older
individuals have greater distress at one-year, controlling for initial distress, suggests that they are less
likely to experience an improvement during the first years of the disease. In Chapter 6, it was observed
that age at onset was related to the slope factor of the LCM modelling change over time using a reciprocal
function. It would appear that this observation resulted from changes early in the course of the disease,
that this functional form of time is particularly sensitive to. The greater distress at one year for older
individuals may be due to the initiation of disease modifying treatment being less effective in older
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individuals, or that they experience heightened perceptions of the consequences of the condition. That
age at onset was predictive of functional limitation at one-year perhaps supports the former proposition.
A limitation of this analysis is that although no cross-lagged effects were observed between psycho-
logical distress with pain and functional limitation this does not mean that none existed. The duration
between follow-up assessments was one-year. It is perhaps not surprising that after controlling for the
underlying general trajectory no effects were observed between measurements taken at such intervals.
Studies involving daily or weekly assessments perhaps provide a more natural way of examining cross-
lagged effects. Several studies involving individuals with chronic pain conditions, including RA, suggest
that at this interval cross-lagged effects may occur (Strand et al., 2006; Zautra et al., 2007; B. W. Smith
& Zautra, 2008), although these studies do not account for the underlying trend.
In addition, in this situation the utility of the ALT model in general can be called into question. Only
weak AR effects and no cross-lagged effects were observed. Thus, the findings of the ALT model offer
little over estimating a bivariate LCM. However, the framework of building an ALT model provided a
useful way of teasing out whether these effects do or do not exist. In situations where stronger AR
processes and cross-lagged effects are likely, the ALT model provides an approach for distinguishing
between the two processes (e.g. Simons-Morton & Chen, 2006).
An extension of the analyses in the chapter would be to consider autoregressive latent trajectory
mixture models. That is, combining an ALT model with a GMM. It would be a relatively straightforward
programming modification to consider multiple latent trajectory classes within the ALT model. However,
this would be computationally highly demanding and add extra-complexity to models that may already
be considered over parameterized. A simpler alternative would be to model a bivariate growth mixture
model incorporating an autocorrelated error structure.
In summary, this chapter has shown that changes in psychological distress in rheumatoid arthritis
occur synchronously with, and are perhaps mainly driven by, changes in somatic features of the condi-
tion. Other factors, particularly psychosocial ones, are likely to play a part in the relationship between
disease and distress in RA. This will be assessed in the following chapter.
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The role of illness perceptions
8.1 Introduction
The previous two chapters have shown that levels of the psychological distress in RA are highly variable
following distinct non-linear patterns after diagnosis and that change in distress co-varies with change
in physical well-being. Specifically the rate of change in self-reported psychological distress correlated in
the order of .4 with changes in pain and functional limitation. No clear causal association was observed.
That is, it did not appear that depression caused increased disability, or alternatively that disability
caused increased distress, or that there was some pattern of causality akin to a ’vicious cycle’—at least
over assessment periods one-year apart. Rather it would appear that increased distress was related
with increased disability at the concurrent time. Although this rather simplifies the likely mechanism,
in reality, it is likely that the inflammation caused by the disease leads to pain and stiffness which
impacts on functional ability and leads to increased levels of distress (Katon, 2003). Distress may also be
associated with increased symptom perception and through behavioural and physiological mechanisms
lead to disease exacerbation and worse physical outcomes, either directly through disease or via the
development of further comorbidity such as cardiovascular disease (Katon, 2003).
Psychological and social factors are likely to act as mediating or moderating factors in the relation-
ship between disease and psychological well-being in RA. Hale, Treharne, and Kitas (2007, p.904) state
that, in RA, there is “often a difference between objective clinical and radiographic evidence of muscu-
loskeletal disease activity or severity and the experience of pain, other symptoms and functional ability
reported by the patient”. Chapter 3 systematically reviewed the published literature investigating the
role of psychosocial variables in longitudinal studies of psychological well-being. Although some sup-
port has been found for a wide range of different factors, there is particular evidence for the role of
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illness perceptions and coping. The contribution of illness perceptions and coping is the focus of the
Self Regulation Model (SRM) of illness cognitions and behaviour developed by Leventhal and colleagues
(Leventhal, Weinman, Leventhal, & Phillips, 2007; Leventhal et al., 1992, 1980, 1984). This chapter
will build on the findings of the existing literature reviewed in Chapter 3 to assess whether illness per-
ceptions and coping impact on changes in psychological distress. Specifically, this chapter will examine
whether distinct patterns of illness perceptions are associated with changes in psychological and physi-
cal well-being and whether they these individual illness perceptions act as mediators or moderators of
disease severity on psychological well-being. Prior to outlining the specific aims and objectives of this
chapter the SRM and the literature concerning the study of the SRM in RA is introduced.
8.1.1 Illness perceptions
8.1.1.1 The Self Regulation Model of illness representations
The SRM was introduced in section 2.2.3.2 (in particular see Figure 2.4) and the evidence for an asso-
ciation between illness perceptions and changes in psychological well-being was reviewed in Chapter 3.
The SRM and the role of illness perceptions in RA are now reintroduced.
Briefly, the SRM is a self-regulatory framework, which posits that an individuals’ illness representa-
tion informs there coping response to illness related threats (Leventhal et al., 1984). The specific content
of illness representations are termed illness perceptions (identity, timeline, consequences, control/cure
and causes), which have been described as “an organized set of beliefs regarding how the illness af-
fects our body, its likely impact on life activities and experiences, whether it can be cured and so on”
(A. A. Kaptein & Weinman, 2004, p.85).
There is a considerable body of evidence examining the role of illness perceptions in RA. As well as
the four studies included in the systematic review presented in Chapter 3 (Schiaffino & Revenson, 1995;
Schiaffino et al., 1998; Scharloo et al., 1999; Sharpe et al., 2001), there are numerous other studies
examining the cross-sectional relationship between illness perceptions and psychological and physical
well-being (H. Murphy, Dickens, Creed, & Bernstein, 1999; Groarke, Curtis, Coughlan, & Gsel, 2005;
Graves, Scott, Lempp, & Weinman, 2009; Carlisle, John, Fife-Schaw, & Lloyd, 2005; Treharne, 2004).
The cross-sectional studies indicate a moderate association between the illness perceptions of identity,
consequences and controllability with both psychological and physical well-being (H. Murphy et al.,
1999; Groarke et al., 2005; Graves et al., 2009; Carlisle et al., 2005). The longitudinal studies reported
mixed findings but provided evidence for the role of perceptions relating to identity, consequences,
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timeline, and cause and change in psychological distress.
In two studies of the same cohort of 63 RA patients, Schiaffino and colleagues (Schiaffino & Reven-
son, 1995; Schiaffino et al., 1998) found that, controlling for baseline depression, higher perceptions of
the curability and stronger causal perceptions of personal responsibility (internal attributions) for their
RA were related to increased depression 4- and 18-months later. Furthermore, interaction effects were
observed such that individuals with negative perceptions of the consequences of their illness and high
functional disability had increased levels of depression four-months later (Schiaffino et al., 1998).
In a separate study of 71 Dutch RA patients, Scharloo et al. (1999) observed that perceptions of
serious consequences, identity, and chronic timeline predicted worse psychological distress one-year
later, controlling for baseline levels. Furthermore, perceptions of consequences and identity predicted
increased levels of fatigue at follow-up, while identity also predicted higher pain at follow-up. None of
the perceptions was related to changes in functional disability. Similarly, a small study of just 22 RA
patients recruited within 2-years of disease onset and assessed 6 times over a 21-month period revealed
that—controlling for the initial levels of distress, disability, pain and pain coping—higher perceptions of
consequences were associated with higher levels of distress at later assessments (Sharpe et al., 2001).
Further to these studies, in his doctoral dissertation Treharne (2004) assessed the longitudinal as-
sociation between selected psychosocial variables and both psychological and physical well-being in
134 RA patients.1 Amongst the psychosocial variables, only the illness perception of consequences was
considered. Controlling for baseline well-being and sociodemographic characteristics, perceptions of
consequences were not found to be associated with psychological well-being (assessed by depression,
anxiety or life satisfaction) or physical well-being (assessed by functional disability or pain) assessed six
or 12-months later. Furthermore, self-efficacy, which was previously noted as being conceptually close
to the perception of personal control was not found to be associated with any of these outcomes either.
Further tests for moderation with either psychological distress and psychological well-being were also
negative.
These studies are all limited by small sample size, meaning that statistical power was only sufficient
to detect large effects. For example, for even the most basic assessment of the bivariate correlation
between an illness perception and psychological well-being none of the four published studies would
have had sufficient power to detect correlations smaller than ρPearson = .33 not adjusting for multiple
testing (1 − β = .80; α = .05). Furthermore, the studies generally considered illness perceptions in
separate analyses even though a considerable overlap in the constructs is indicated by the strength
1Selected findings reported in the dissertation are reported in Treharne et al. (2007) but do not consider illness perceptions.
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of the inter-correlations. This is perhaps understandable considering the low statistical power of the
studies.
Recently, two studies of illness perceptions in other conditions have sought to identify common
patterns of illness perceptions using cluster analytic methods (Hobro, Weinman, & Hankins, 2004;
Miglioretti, Mazzini, Oggioni, Testa, & Monaco, 2008). Such an approach may have extended utility, as
virtually all research considers the impact of individual illness perceptions rather than evaluating groups
of inter-related perceptions (i.e. ‘representations’). Hobro et al. (2004) identified two groups, which they
labelled ’adaptors’ and ’non-adaptors’ in a sample of 130 chronic pain patients. Similar groups were also
observed by Miglioretti et al. (2008) in 74 patients with motor neuron disease. Whether distinct patterns
of illness perceptions are present in RA, and whether such patterns relate to clinical and psychological
outcomes has yet to be considered.
8.1.2 The present study
The study presented in this chapter is a longitudinal examination of the role of illness perceptions on
future psychological well-being in RA in a cohort of patients mainly with established disease. It balances
the more statistically involved studies of the ERAS cohort of the previous chapters to provide an insight
into the health psychology of changes in well-being in RA. The ERAS cohort consists of a wealth of
prospectively collected clinical data but a dearth of information concerning psychosocial factors. The
initial aim was to introduce assessments of psychosocial factors (illness perceptions, coping, and social
support) into an existing multi-centre RA inception cohort, the Early RA Network, to which over 1000
patients receiving a recent diagnosis of RA attending 22 centres were recruited between 2004 and 2008.
However, funding issues lead to a dramatic reduction in new cases being recruited to the study and
bureaucratic issues meant that obtaining approvals in a timely fashion were unfeasible. As a result, it
was decided to set up a smaller scale longitudinal study of patients with established disease recruited
from rheumatology clinics at local hospitals in Hertfordshire.
The aim of this study was to assess whether (i) illness perceptions are related to changes in psycho-
logical and physical well-being, including an assessment of positive psychological well-being, and (ii)
whether this effect is mediated by coping strategies. As well as individual perceptions predicting change
in psychological well-being it was hypothesised that distinct patterns of illness perceptions would exist,
relating to the ‘adaptive’ and ‘non-adaptive’ representations of RA.
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8.2 Methods
8.2.1 Participants & procedure
The sample were individuals with a diagnosis of rheumatoid arthritis currently taking at least one disease
modifying anti-rheumatic drug (DMARD) mainly recruited whilst attending outpatient appointments at
rheumatology clinics in six hospitals in Hertfordshire, England.2 Patients were excluded if they were
under 18-years of age or were not responsible for the management of their own medications. Of the 248
eligible patients approached, 189 (76%) agreed to participate and returned completed questionnaires.
To boost numbers of recently diagnosed individuals, postal invitations were sent to 161 patients at-
tending the clinics and receiving a diagnosis of RA in the previous 24-months that had not attended an
appointment within the 3-month recruitment period. Of these 38 (24%) returned completed question-
naires.
Follow-up questionnaires were sent by post after a period of 3-months to patients receiving a diag-
nosis of RA within the past 12-months and to all patients after a period of 6-months. Reminders were
sent to those not returning completed follow-up questionnaires after 4-weeks. Details of the numbers of
participants returning questionnaires are provided in Figure 8.1.
At the 6-month assessment, 171 patients returned completed questionnaires (75.3%), although one
was excluded due to the returned questionnaire not being sufficiently complete. Of those that did not
return the follow-up questionnaire the reason was known for 3 (1 died, 2 moved). Patients who returned
completed questionnaires tended to be younger, in paid employment and had higher levels of positive
outlook at baseline (all p < .05) compared to those that did not.
The study was conducted in collaboration with Miss Lyndsay Hughes, who was investigating the role
of illness perceptions on medication adherence. Approval was granted by the Hertfordshire committee
of the NHS National Research Ethics Service (Reference no: 09/H0311/102).
8.2.2 Measures
8.2.2.1 Illness perceptions
The Revised Illness Perception Questionnaire (IPQ-R; Moss-Morris et al., 2002) tailored to RA was em-
ployed to assess patients’ cognitive representation of their RA. The IPQ-R measures illness perceptions
relating to the symptoms (identity, 14-items), timeline (chronic, 6-items, & cyclical, 4-items), conse-
2Barnet Hospital, Chase Farm Hospital, Hemel Hempstead General Hospital, Lister Hospital (Stevenage), Potters Bar Com-
munity Hospital, St Albans City Hospital.
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Baseline
n = 227
Clinic
Invited n = 241
Returned n = 189
Post
Invited n = 161
Returned n = 38
3-months
(Diagnosis within 12-months)
Sent n = 35
Returned n = 30
6-months
Sent n = 227
Returned n = 170
Figure 8.1: Recruitment flow chart
quences (consequences, 6-items), and controllability (personal, 6-items, & treatment, 5-items) of RA as
well as the extent to which they have a coherent understanding of their condition (coherence, 6-items).
To reduce respondent burden, and in line with similar studies using RA cohorts (e.g. Moss-Morris et al.,
2002), the 18-item causal perceptions scale was not used. Furthermore, the emotional responses to the
illness (6-items) were not included in the analysis due to the overlap with psychological well-being.
In the current sample the internal consistency for the majority of the sub-scales was acceptable
(αIdentity = .83; αTime-line chronic = .85; αTime-line cyclical = .76; αConsequences = .84; αPersonal Control = .81;
αCoherance = .92), although it was low for the treatment control sub-scale (αTreatment Control = .63).3
A confirmatory factor analytic model was used to test the construct validity of the IPQ-R against
the expected structure. Robust weighted least squares estimation was used to account for the binary
“yes”/“no” response format for the identity items and the ordinal response format for all other items.
Model fit was not particularly good (χ2(94)=319.5; RMSEA = .103; CFI = .907; TLI = .927). All items
loaded significantly onto their respective sub-scale. For the treatment control sub-scale the standardised
factor loadings were smaller than for the other sub-scales, as would be expected based on the values of
Chronbach’s α. Inspection of modification indices revealed that the source of misfit was partially due
to two of the treatment control items—’There is very little that can be done to improve my RA’ and ‘The
negative effects of my RA can be prevented (avoided) by my treatment’—also loading onto the coherence
3There has been much recent discussion regarding the limitations of Chronbach’s α as a measure of reliability (e.g. Sijtsma,
2009). Despite these issues it is reported here as an indicator of the likely lower bound of reliability.
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sub-scale. This perhaps indicates a lack of understanding with regard to the disease modifying treat-
ments used in RA. In addition, there was some indication that the identity sub-scale should be split
into symptoms experienced and attributed to RA that were either i) typical of RA (i.e. pain, stiff joints,
swollen joints, tiredness), or ii) not typical of RA (i.e. sore throat, lost appetite, sickness, breathlessness,
stomach cramps). To allow for greater comparability with other studies the standard scoring method
for the identity sub-scale was implemented. Factor scores for the CFA model without any modifications
were estimated for use in the analysis. These were on the z-score metric with a mean of 0 and a standard
deviation of 1.
8.2.2.2 Psychological well-being
The Depression, Anxiety and Positive Outlook Scale (DAPOS; Pincus, C. Williams, Vogel, & Field, 2004)
is designed to measure symptoms pertaining to the named constructs in chronic pain populations. The
DAPOS sub-scales include items that measure the affective component of the constructs and exclude
any items relating to somatic problems. Specifically, Pincus et al., 2004 selected 11 items from the
Beck Depression Inventory (BDI; Beck, Steer, & Brown, 1978) and the Hospital Anxiety and Depression
Scale (HADS; Zigmond & Snaith, 1983) that did not exhibit high correlations with pain and discrim-
inated well across the latent factors identified by an exploratory factor analysis. Each of the items is
scored using a Likert scale response format (ranging from ‘almost never’ to ‘almost all the time’). Three
items—concerning cheerfulness, enjoyment and looking forward to things—form the positive outlook
scale which assesses positive affect. These were originally reverse scored items included in the HADS
depression sub-scale.4
The DAPOS has previously been shown to have good construct validity and test-retest reliability
(Pincus, et al., 2008). In the current sample internal reliability for the three scales was acceptable
(αDepression = .866; αAnxiety = .878; αPositive outlook = .813).
The construct validity of the DAPOS was assessed using confirmatory factor analysis (robust WLS
estimation). The proposed 3-factor model showed levels of fit that were outside acceptable limits
(χ2(9)=178.2; RMSEA = .290; CFI = .907; TLI = .907). The correlation between the anxiety and
depression sub-scales was high at .87, indicating that they likely measure the same latent construct.
The model was therefore respecified with all anxiety and depression items loading onto a single general
distress factor. Fit was more agreeable for this model, although the RMSEA was still outside acceptable
4A recent, paper has indicated better fit to the two-factor model by accounting for the positively worded items using a
methods factor (Schönberger & Ponsford, 2010)
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limits (χ2(14)=68.6; RMSEA = .132; CFI = .970; TLI = .981). In addition, following from the results of
Chapter 5, a bifactor model for the anxiety and depression factor was considered. This model provided
better fit to the data (χ2(14)=39.4; RMSEA = .090; CFI = .986; TLI = .991) but the factor loadings
for the items on the anxiety and depression factors were small and preliminary analysis revealed no
correlation between the anxiety and depression group-factors with demographic or clinical variables.
Resultantly, the factor scores for the 2-factor model were included in the analysis.
8.2.2.3 Coping
The Brief Cope was used to assess coping (Carver, 1997). This 10-item questionnaire assess 5 types
of coping style: active, instrumental, planning, acceptance and denial. The factorial validity of the
instrument was assessed using confirmatory factor analysis with parameter estimated using the robust
WLS approach. The fit of the expected model was good (χ2(13) = 20.8; RMSEA = .052; CFI = .993;
TLI = .993) and modification indices suggested no adjustments to the model were necessary. Hence, the
factor scores for the model as is were used in the analysis.
8.2.2.4 Functional disability
Functional disability was measured using the Health Assessment Questionnaire (HAQ) disability index.
As was previously described, the HAQ assesses rheumatic patients’ functional limitation during the past
week across eight common activities: dressing, arising, eating, walking, hygiene, reach, grip, and com-
mon activities (Kirwan & Reeback, 1986). Scores range between 0 and 3 with higher values indicating
greater disability. Scores are weighted if patients require help or aid to perform a particular activity.
Generally, scores greater than 1 indicate that an individual has moderate disability, and above 2 severe
disability, although specific cut-offs have not been defined.
8.2.2.5 Pain
Health-related quality of life was assessed using the EQ5D (Rabin, Oemar, Oppe, Janssen, & Herdman,
2011). The total score was not used in the analysis since assessments of psychological distress and func-
tional limitation are already covered by the DAPOS and the HAQ. However, the pain question from the
EQ5D was used. This question asks respondents to rate whether today they “have [no–slight–moderate–
severe–extreme] pain or discomfort”. Although scored on an ordinal scale, responses were approximately
normally distributed. Therefore it was treated as a continuous variable in the analysis.
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8.2.2.6 Demographic information
As well as date of birth and sex, participants were also asked to report their highest level of eduction
and their current employment status. For the analysis education was dichotomised to indicate those that
had achieved a University degree.
8.2.2.7 Clinical information
Clinical information, including medication and disease duration, was collected from the patient’s medical
notes. The Disease Activity Score-28 (DAS28; Prevoo et al., 1995) is a combined index that incorporates
assessments of inflammation (either Erythrocyte Sedimentation Rate [ESR] or C-reactive Protein [CRP]),
physician assessments of the tenderness and swelling of 28 joints (in hands, feet and wrist), and self-
reported general disease severity on a 100mm visual analogue scale (VAS).5 DAS28 has been extensively
validated and is used almost universally in clinical trials (Riel & Schumacher, 2001). Scores range
between 0 and around 10. Generally, scores over 5 indicate severe disease and less than 3 low disease
activity.6 In addition, patients were asked to report whether they considered their RA to currently be
‘active’ or ‘in remission’.
8.2.3 Statistical analysis
8.2.3.1 Latent profile analysis
Latent profile analysis (LPA) is one form of a larger class of models commonly referred to as generalized
latent variable models (see Chapter 4 for greater exposition). Similar to cluster analysis, LPA aims to
group individuals with similar patterns into discrete groups (latent classes) represented by a categorical
latent variable. For the analysis, the IPQ-R sub-scales of identity, timeline chronic, timeline cyclical,
consequences, personal control, treatment control, and coherence were included. The estimated factor
scores from the model described above were used in the analysis and can be interpreted as z-score units
allowing easy comparison across variables (i.e. mean of zero and a standard deviation of one).
LPA models with 1 through 5 latent classes were considered. Within class covariances between the
illness perceptions were unconstrained. The best fitting model was identified using standard model
comparison techniques that have been shown to perform well in simulation studies (Nylund et al., 2007;
Tofighi & Enders, 2006): Bayesian Information Criterion (BIC), consistent Akaike Information Crite-
5The original version of the DAS28 used in ERAS is based on a larger number of joints and does not include the VAS.
6A DAS28 score of less than 2.6, opposed to 1.6 for the original DAS, corresponds to the American Rheumatology Association
preliminary criteria for clinical remission (Fransen et al., 2004).
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rion (CAIC) and the Lo-Mendell-Rubin likelihood ratio test (LMR-LRT). Entropy, a summary measure of
classification quality, is also reported.
8.2.3.2 Missing data
As was already indicated the majority of missing data in the analysis was due to non-returned ques-
tionnaires at the 6-month assessment. The vast majority of covariates were complete except for the
two physiological markers of inflammation, ESR and CRP, as well as the composite measures of disease
activity, DAS28. These variables were only available if a blood test was performed at the time of the
visit and the results recorded in the patient’s medical notes. They were missing for ESR in 134 (59%),
CRP in 104 (45%), and DAS28 in 52 (23%) at the baseline assessment. The amount of missing data
for other variables at baseline was negligible, ranging between 0 and 6 (3%) for the other clinical and
demographic variables used in the analysis.
With regard to individual items within the questionnaires assessing illness perceptions, coping and
psychological well-being missing responses were more common. For the DAPOS missing item responses
ranged between 6 (3%) and 12 (6%), for the IPQ-R between 1 (.5%) and 17 (8%), and for the Cope
between 4 (2%) and 7 (3%). Across the majority of participants only a few items was missing for each
scale. For the DAPOS 212 (93%) had either no or one missing response, out of a total of 11-items, and
for the IPQ-R 215 had three or less missing responses out of a total 52-items, and for the Cope 220
(97%) had either one or no missing responses.
Missing responses within scales were imputed using the Stata ice routine which performs multiple
imputation by chained equations (Royston, 2004, 2007; van Buuren et al., 1999). Due to the ordinal
response format of most items, and to avoid out of range predictions, ordinal logistic regression models
were used to impute missing responses for all items. The imputation analysis also included age and
sex. Only one imputed dataset was generated. Since the proportion of missing item responses was low
and the items being combined this is unlikely to result in downwardly biasing the estimated variance
(Allison, 2002).
The largest cause of missing data was the non-return of questionnaires at the 6-month assessment
(57, 25%). Ten multiply imputed data sets were generated using ice. All items used in the regression
analyses were included in the imputation models along with other relevant variables that may have in-
fluenced missingness. This was to ensure that the validity of the missing at random assumption stretched
as widely as possible. For the one individual known to have died missing responses at the 6-month
assessment were not imputed. Hence all longitudinal analyses using multiply imputed data were based
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Table 8.1: Sample demographic and clinical characteristics (N = 227)
N Mean SD Min Max
Age 224 57.7 15.0 19 89
Sex 227
Male 55 24%
Female 172 76%
Education 222
High School 110 50%
College 61 27%
University 32 14%
Postgraduate 19 9%
Working 227
No 131 58%
Yes 96 42%
Disease duration (years) 222 12.6 10.8 0.5 54
Disease status 226
Remission 73 32%
Active 153 68%
Biologic therapy 223
No 146 65%
Yes 77 35%
Disease activity score 175 3.6 1.5 0 8.08
HAQ disability 227 1.1 0.8 0 2.88
Pain 225 2.1 0.6 0 5
on 226 individuals.
Sensitivity analysis was performed comparing the results from the multiply imputed data, and com-
bined using the Stata mim package using Rubin’s rule (Little & Rubin, 1987; Carlin, Galati, & Royston,
2008), with the results of a complete case analysis. The findings from the complete case analysis are
given in Appendix E.
8.3 Results
8.3.1 Sample
Using the data without missing values imputed. The demographic profile of the sample was as expected
for a hospital based study and was comparable to that of the ERAS cohort (Table 8.1). The mean age
at the self-reported time of disease onset for the sample was 45.1 years (SD = 15.5), indicating that the
sample was younger compared to the ERAS cohort. Furthermore, there were slightly more females than
expected (76% vs. 66% for ERAS).
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8.3.2 Cross-sectional associations
Table 8.2 displays the inter-correlations between illness perceptions, coping, demographic, clinical vari-
ables and psychological well-being measured at the baseline assessment.
A high correlation was observed between perceptions of treatment and personal control of the con-
dition (r = .66). Both control perceptions correlated moderately and negatively with consequences and
coherence, indicating that individuals with increased beliefs of the seriousness of their condition and
whom reported worse understanding of the condition also reported having lower beliefs about the con-
trollability of the condition. Identity, which refers to the symptoms experienced, correlated positively
and highly with the perceptions of the consequences of the condition (r = .69) and moderately with per-
ceptions of the cyclicality of the condition (r = .40). Furthermore, perceptions of chronicity correlated
moderately with perceptions of the cyclicality of the condition (r = .43) and consequences (r = .34).
At baseline, distress and positive outlook showed a moderate negative correlation (r = −.47). Nei-
ther correlated particularly highly with HAQ disability (rDistress = .18; rPositive outlook = −.06) or pain
(rDistress = .27; rPositive outlook = −.20). This is somewhat surprising given the strength of the associations
reported for the HADS total scores and HAQ disability and pain in the previous chapter. The correlation
between HAQ disability and pain was moderate (r = .50)
Illness perceptions showed weak to moderate associations with psychological and physical well-
being, with correlations ranging between r = −.37 and .56. The SRM predicts that illness perceptions
should influence coping so stronger associations would be expected. Furthermore, coping showed only
weak cross-sectional associations with psychological distress (r = −.20 to .29) or positive outlook (r =
−.14 to .26). Consequently the rest of this chapter will focus on the direct effect of illness perceptions on
psychological well-being since the magnitude of the associations does not support a mediational process.
Moderate positive associations were observed between perceptions of identity, consequences and co-
herence with psychological distress. A moderate negative association was observed between perceptions
of treatment control with distress, but only a small negative correlation was observed with perceptions
of personal control. Positive outlook exhibited relatively low correlations with the difference illness per-
ceptions that were in the opposite direction to those observed with distress. The highest correlation
was observed for treatment control (r = .27), which suggested a tenuous but plausible link between the
level of positive outlook and perceptions of treatment control. Furthermore, higher levels of HAQ dis-
ability and pain at baseline were associated with higher perceptions of illness identity as well as higher
perceptions of the consequences of the condition.
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8.3.2.1 Discrete patterns of illness perceptions
Since moderate correlations were observed between the illness perceptions, indicating possible overlap-
ping clusters of perception, LPA was implemented to assess whether illness perceptions fell into discrete
patterns. LPA models with 1 through 5 latent classes were considered. Within class covariances between
the illness perceptions were unconstrained.
Unconditional model Table 8.3 shows the model fit statistics for the latent profile models for the 1-
through 5-class solutions. Of the information theoretic statistics both the consistent AIC and the BIC
provided evidence for the 2-class model providing the optimal solution. The AIC continued to reduce
with 6-classes but has been shown previously to over select the number of classes in mixture models
(Nylund et al., 2007; Tofighi & Enders, 2006). Furthermore, it is not consistent with relatively small
sample sizes, particularly when the ratio of the sample size to the number of free parameters is low
(Tofighi & Enders, 2006), and so should not be used to base model selection decisions on in this instance.
As a further test of the appropriate number of classes we can use the LMR likelihood ratio test, which
compares the model with K classes to one with K − 1 classes. For the models with 3 or more classes
the test is non-significant (p > .05) indicating that the extraction of more than 2-classes provides no
significant improvement model fit.
The means and 95% confidence intervals for the 2-class solution are shown in Figures 8.2. The
different patterns for the classes were characterized by differences in perceptions of the chronicity, con-
sequences and coherence of the condition. Specifically, the second class (n = 81, 36%) consisted of
individuals with greater perceptions of chronicity and consequences of RA, and lower perceived under-
standing of their condition. In line with previous research (Hobro et al., 2004; Miglioretti et al., 2008),
this class is henceforth referred to as ‘non-adapters’ and the remaining class ‘adapters’.
Table 8.3: Model fit for unconditional LPA of illness perception (N = 227)
1 2 3 4 5
Params. 29 59 89 119 149
LL -1824.3 -1708.5 -1649.6 -1595.2* -1531.0*
AIC 3706.6 3535.0 3477.3 3428.3 3360.1
CAIC 3834.9 3796.1 3871.0 3955.0 4019.3
BIC 3805.9 3737.1 3782.1 3835.9 3870.4
Entropy . .912 .899 .923 .927
LMR-LRT p-value . 0.0001 0.36 0.2342 0.133
*Best log-likelihood not replicated over 100 optimizations of an initial set of 1000 random sets of starting values
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Figure 8.2: Estimated means and 95% CIs of illness perceptions for the unconditional 2-class
solution
The 3-class model split the largest class from the previous model into two. Although no signifi-
cant difference was observed for the illness perceptions of these two classes, the difference appeared to
be characterised by difference in the perception of the chronicity of the condition since it was for this
perception that magnitude of the difference in means was largest. The other class consisting of individ-
uals with greater perceptions of the chronicity and coherence of their condition remained stable. Thus
2-classes was selected for the remainder of the analysis.
Predictors of discrete patterns of illness perception For the 2-class model, latent class membership
was regressed onto selected covariates using a logistic regression model. The inclusion of covariates
as predictors of class membership did not alter the class profiles. The class means across the illness
perceptions were almost identical and the proportion of the sample in each class were almost identical.
The resultant logistic regression estimates averaged over the 10 multiply imputed datasets are presented
in Table 8.4. The parameter estimates for the complete case analysis (excluding ESR) were similar
although the standard errors were increased (see Appendix E).
The strongest predictor of class membership was disease duration, a one-unit increase in the natural
logarithm of disease duration was associated with a two-fold increase in the odds of belonging to the
‘non-adapters’ class. Being in paid employment was also significantly related to membership of this,
relating to a 2.5 times increase in the odds. Inflammation, as indexed by natural logarithm of ESR, was
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Table 8.4: Logistic regression (odds ratios) for class membership with higher perceptions of conse-
quences, chronicity and lower coherence based on 10 multiply imputed datasets
OR SE z p 95% CI
Age 0.99 0.02 -0.64 0.521 0.96 1.02
Sex 1.15 0.41 0.34 0.731 0.50 2.64
Education 0.62 0.43 -1.12 0.265 0.26 1.46
Working 2.45 0.42 2.11 0.035 1.05 5.73
ln(Diagnosis) 2.12 0.24 3.20 0.001 1.32 3.39
HAQ disability 1.42 0.26 1.93 0.054 0.99 2.02
EQ5D pain 0.85 0.32 -0.53 0.597 0.45 1.59
DAS28 1.17 0.15 1.05 0.296 0.87 1.57
ln(ESR) 0.61 0.21 -2.33 0.020 0.40 0.93
Biologic treatment 1.58 0.53 1.38 0.169 0.82 3.04
Active Disease 1.19 0.42 0.49 0.622 0.60 2.37
Distress 1.03 0.25 0.12 0.901 0.63 1.69
Positive outlook 1.26 0.25 0.95 0.342 0.77 2.07
related to a reduction in the odds of membership of the second class of around 39% per one-unit increase
in the natural logarithm of ESR. Conversely, there was a borderline significant association between HAQ
disabilty and membership of the non-adapter class, relating to a 42% increase in the odds of membership
of this class for each one unit increase in HAQ disability, or to put this on a standard deviation metric,
a 31% increase in the odds of membership of the second class for a one standard deviation (SD = .76)
increase in HAQ disability.
In summary, it would appear that two distinct patterns of illness perceptions characterize this sample
of RA patients. The smallest class, accounting for just over one-third of the sample, reported significantly
higher perceptions of the chronicity of the condition and its perceived impact on their lives, furthermore,
less understanding of the condition was also reported. Individuals with this pattern of illness perceptions
were more likely to have greater experience of the condition, be in paid employment and have lower
markers of inflammation compared to the result of the sample. Although there was some indication of
greater functional disability. The predictive validity of these distinct patterns in relation to changes in
psychological and physical well-being will be examined later in the chapter.
8.3.3 Longitudinal associations
I now move on to the main focus of this chapter the longitudinal association between illness perceptions
and psychological well-being. This section will consider whether illness perceptions account for hetero-
geneity in 6-month change scores. In light of the findings of Chapter 7, the role of illness perceptions
in changes in physical well-being will also be considered. Prior to these detailed analyses I will first
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consider whether changes in psychological well-being were observed during the period of follow-up.
8.3.3.1 Change in psychological well-being
At the sample level, psychological well-being changed little between the baseline and 6-month assess-
ments. The mean change in psychological distress was just .01 (SD = .60), which was not statistically
significantly different from zero (t(165) = 0.18; p = .854). Furthermore, the mean change for positive
outlook was also small, -.07 (SD = .77), and non-significant (t(165) = −1.21; p = .229). Although,
at the sample level, changes were relatively small, the size of the standard deviations for the changes
scores indicates substantial variability in changes across individuals.
It is important to remember here that the scaling of time is somewhat arbitrary since the disease
duration at the baseline assessment was wide. Regressing distress at the baseline assessment on the
natural logarithm of the time since diagnosis indicated a significant reduction in distress levels across
the range of disease duration for the sample. Specifically, distress decreased by -.15 standard deviations
(95% CI:-.26,-.04) for every one-unit increase in the natural logarithm of disease duration. Since this
suggests greater change early in the course of the disease it provides support for the nonlinear pattern
observed in Chapter 6.
Latent curve model To further examine changes early in the course of the disease at the individual
level, a linear latent curve model was fitted to the psychological distress data for the 34 individuals
with a diagnosis within 12-months and who were assessed over three-time points (baseline, and then
3- and 6-months after the baseline assessment). Confirming the above findings, the value of the slope
factor, representing the total expected change over 6-months, for the distress model was small and non-
significant, .02 (95% CI: -0.02, 0.06). This indicates that for this sub-sample there was no change in
symptoms of distress over the period. Furthermore, the standard deviation of the latent slope factor was
non-significantly different from zero indicating no heterogeneity in the slopes (σ = .02; SE = .09). It is
important to remember that power will be low given the small sample size.
Similarly, for positive outlook the slope factor was small and non-significant, .01 (95% CI: -.05, .08),
indicating no change over the period for the early disease sub-sample. Again the variance of the slope
factor was small and non-significant.
These findings are in contrast to analyses reported in the immediately preceding section, and also to
the findings of Chapter 3, both of which suggested that a reduction in distress with substantial variability
in changes should be observed. This latter finding is somewhat more surprising but may be due to the
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small size of the sample used for this analysis. It may also be that since all individuals in the sample
were taking DMARDs at baseline, as opposed to the ERAS study where none had, that the reduction in
distress associated with the initiation of disease modifying therapy had already occurred.
8.3.3.2 Illness perceptions as predictors of future psychological well-being
Despite the indications of the latent curve models, the standard deviation of the 6-month change scores
for distress and positive outlook suggest substantial variability. The ability of illness perceptions to
predict future psychological well-being was examined using a hierarchical linear regression modelling
approach. Four models were estimated for each of the illness perceptions assessed in the study. The first
model, ‘M1’, simply regressed the assessment of psychological well-being—either the distress factor score
or the positive outlook factor score—at 6-months on the illness perception at the baseline assessment.
The second model, ’M2’, adjusted for the baseline status on the measure of psychological well-being.
The third model, ’M3’, additionally adjusted for the demographic variables age, sex, education and work
status. The final model, ’M4’, adjusted for level of disease severity at baseline as indicated by HAQ
disability, the EQ5D pain item, Disease Activity Score, ESR, self-reported disease status, disease duration
and whether biologic treatment was being taken.
Due to the large number of models assessed and the resulting difficulty in presenting the results
in an easily interpretable format the standardised regression coefficients for the illness perceptions are
presented graphically for each of the models. Tables are presented that include all variables entered in
the fourth model, but also including all illness perceptions (rather than considering them separately as in
the figures). All results presented are based on the combined estimates across the 10 multiply imputed
datasets. Estimates from the complete case analysis were similar unless otherwise stated and are given
in Appendix E.
Psychological distress Considering first psychological distress, the unadjusted analyses indicated that
the illness perceptions of identity, consequences, cyclical timeline, treatment control and coherence
assessed at baseline were related to the levels on this construct at the 6-month assessment (Figure
8.3). In addition, perceptions of personal control had a borderline significant relationship (p = .051).
After controlling for the initial level of psychological distress the effect for cyclical timeline, treatment
control and coherence was nullified. This suggests that the observed crude effect was due to residual
confounding as a result of the cross-sectional association with distress. Specifically, individuals with
higher beliefs regarding the cyclicality of RA, lower perceptions of the ability of their treatment to control
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Figure 8.3: Standardised parameter estimates for psychological distress at 6-months regressed on
illness perception with varying levels of adjustment (M1 = unadjusted; M2 = baseline distress; M3
= + demographics; M4 = + disease status)
the condition and less understanding of their condition appear likely to have worse psychological distress
at follow-up simply because they are cross-sectionally related. The direction of causality is not clear, but
it would appear that these factors do not lead to changes in distress over time. Further adjustment for
demographic and clinical characteristics did not effect the parameter estimates, which were all non-
significant and close to zero
The parameters for identity and consequences were reduced but remained significant after control-
ling for baseline distress. Both effect size estimates were of similar magnitude, indicating that a one
standard deviation increase in perceptions of identity and consequences related to, on average, around
a 19% or 14% of a standard deviation increase in distress, respectively. Controlling for demographic
confounders did not further attenuate the associations, both remained statistically significant and even
increased slightly in magnitude. Additionally controlling for disease status also slightly increased the
magnitude of the association for both identity and consequences with the parameter estimates remain-
ing statistically significantly different from zero.
Illness perceptions relating to the perceived chronicity of the condition (timeline chronic) were not
related to future psychological distress in the crude analysis or any of the adjusted models. After adjust-
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Table 8.5: Standardised parameter estimates averaged over 10 multiply imputed datasets for psy-
chological distress at 6-months regressed on a combined model of illness perceptions adjusted for
multiple confounders all assessed at baseline
β t p 95% CI
Identity 0.20 2.08 0.039 0.01 0.40
timeline chronic 0.03 0.33 0.739 -0.13 0.18
timeline cyclical -0.09 -1.34 0.183 -0.23 0.04
Consequences 0.08 0.73 0.466 -0.14 0.30
Personal control -0.10 -1.29 0.200 -0.24 0.05
Treatment control 0.15 1.51 0.133 -0.05 0.34
Illness coherence 0.10 1.32 0.190 -0.05 0.26
Age 0.00 -0.86 0.395 -0.02 0.01
Female sex* 0.02 0.18 0.855 -0.22 0.26
Education* 0.13 1.03 0.308 -0.14 0.40
Working* 0.06 0.51 0.610 -0.19 0.31
ln(Diagnosis) -0.04 -0.77 0.444 -0.15 0.07
HAQ disability -0.02 -0.28 0.783 -0.18 0.14
EQ5D pain 0.13 1.21 0.230 -0.09 0.35
DAS28 -0.07 -1.65 0.106 -0.17 0.02
ln(ESR) 0.02 0.22 0.831 -0.15 0.19
Biologic treatment* -0.04 -0.32 0.750 -0.31 0.23
Active Disease* -0.05 -0.45 0.653 -0.28 0.18
Distress 0.60 8.58 0.000 0.46 0.75
Positive outlook -0.15 -2.19 0.036 -0.29 -0.01
*Unstandardised parameter estimates b reported for dichotomous variables
ment all parameter estimates were non-significant and close to zero.
Entering all of the illness perceptions into a combined model along with all confounding variables
revealed identity to be the only illness perception significantly related to future psychological distress
(Table 8.5). The reduction of the effect for consequences to non-significance is likely because of the
overlap of the construct with the perceptions of identity. That is, individuals attributing greater numbers
of symptoms to their condition also tend to report greater perceptions of the seriousness of the condition.
As was observed in the previous chapter there was a strong autoregressive effect for distress. This
accounted for the majority of the variance explained by the model. Also predictive of future distress was
positive outlook. The effect related to a .15 standard deviation lower residualised change in psycholog-
ical distress at the 6-month follow-up for a one standard deviation higher level of positive outlook at
baseline.
It is worthwhile noting that power to detect a significant effect of any of the illness perceptions or
other predictors would be reduced due to the strong autoregressive effect observed for distress.7
7Post-hoc power calculations indicate that after controlling for baseline distress predictors in the model would have to
account for at least an additional 2% of the variance to acheieve power of 80% (based on n= 170;α= .05).
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Figure 8.4: Standardised parameter estimates for positive outlook at 6-months regressed on illness
perception with varying levels of adjustment (M1 = unadjusted; M2 = baseline positive outlook;
M3 = + demographics; M4 = + disease status)
Further analysis, assessing for possible moderating effects of baseline distress or functional disabil-
ity on the effect of illness perceptions on distress at the 6-month assessment were all non-significant
indicating no moderation.
Positive outlook Turning to positive outlook, standardised parameter estimates for varying levels of
adjustment are displayed in Figure E.2. The unadjusted estimates indicate perceptions of treatment
and personal control, identity, coherence and consequences as significant predictors of future positive
outlook. After controlling for the initial level of positive outlook the size of the association for each was
attenuated, remaining significant only for coherence.
For identity and consequences the further adjustment for demographic and then clinical variables
increased the magnitude of the parameter estimates, although statistical significance was not achieved.
In contrast the estimates for coherence were further attenuated after adjustment for demographic and
clinical characteristics and were non-significant (p = .058) after controlling for both demographic and
clinical variables.
The parameter estimates with regard to chronic and cyclical timeline were small and non-significant
for all levels of adjustment.
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Table 8.6: Standardised parameter estimates averaged over 10 multiply imputed datasets for posi-
tive outlook at 6-months regressed on a combined model of illness perceptions adjusted for multiple
confounder’s all assessed at baseline
β t p 95% CI
Identity 0.03 0.28 0.783 -0.21 0.27
timeline chronic 0.04 0.45 0.651 -0.14 0.23
timeline cyclical 0.12 1.49 0.142 -0.04 0.27
Consequences -0.19 -1.58 0.120 -0.43 0.05
Personal control 0.07 0.94 0.347 -0.08 0.22
Treatment control -0.08 -0.70 0.485 -0.30 0.14
Illness coherence -0.10 -1.21 0.229 -0.26 0.06
Age 0.00 -0.58 0.565 -0.01 0.01
Female sex* 0.28 1.99 0.052 -0.01 0.56
Education* 0.12 0.81 0.423 -0.18 0.41
Working* -0.01 -0.06 0.956 -0.28 0.27
ln(Diagnosis) -0.03 -0.42 0.675 -0.17 0.11
HAQ disability 0.19 1.96 0.054 -0.01 0.39
EQ5D pain -0.14 -1.11 0.269 -0.40 0.12
DAS28 -0.03 -0.56 0.581 -0.14 0.08
ln(ESR) 0.13 1.56 0.130 -0.04 0.29
Biologic treatment* 0.17 1.33 0.188 -0.09 0.44
Active Disease* -0.02 -0.12 0.905 -0.28 0.25
Distress -0.18 -2.32 0.023 -0.33 -0.03
Positive outlook 0.49 7.64 0.000 0.37 0.62
*Unstandardised parameter estimates b reported for dichotomous variables
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Figure 8.5: Marginal effect of coherence on positive outlook at 6-months by baseline positive
outlook
The model including all illness perceptions as predictors of future positive outlook whilst simulta-
neously adjusting for baseline positive outlook and psychological distress, as well as demographic and
clinical variables was estimated (Table 8.6). The majority of the variance explained was accounted for by
baseline positive outlook, for which there was a large autoregressive effect. None of the illness percep-
tions was observed to significantly predict positive outlook assessed 6-months later, although the effect
size observed was similar for consequences compared to consequences model four shown in Figure E.2.
Of the control variables, distress at baseline was also a significant predictor of later positive outlook.
Indicating that, controlling for earlier positive outlook, a one standard deviation higher level of distress
at baseline was associated with a 18% reduction in positive outlook 6-months later. Sex was a borderline
significant predictor, relating to around a 28% of a standard deviation higher residualised change in
positive outlook for females. The estimate of HAQ disability was also borderline significant, worse
disease severity was related to an increase in positive outlook at 6-months. It is likely that this effect
is an artefact due to regression to the mean since those with worse disease at baseline would have had
lower positive outlook at baseline. However, it must be emphasised that the effect was not significant
and this suggestion is therefore rather tenuous.
Possible moderation of the effect of illness perceptions at baseline by positive outlook or functional
disability on positive outlook at the 6-month assessment was considered. The analyses indicated a
significant interaction between positive outlook and coherence. Figure 8.5 plots standardised parameter
estimate β for coherence on 6-month positive outlook across values of positive outlook at baseline.
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This indicates that coherence has a significant negative association with future positive outlook only
for patients with levels of positive outlook below the mean value for the sample. This finding can be
interpreted as individuals with less of an understanding of their condition experience lower positive
outlook at 6-months only when there initial level of positive outlook was low, suggesting a possible
vicious cycle.
At this point a caveat is warranted since the analysis was conducted in a post-hoc manner and the
risk of a false positive finding is high. Nevertheless this suggests an interesting and plausible relationship
that warrants further attention.
8.3.3.3 Illness perceptions as predictors of future physical well-being
Further analysis was undertaken to examine whether illness perceptions were predictive of pain and
functional limitation at the 6-month assessment. A similar procedure was used to the assessment of
illness perceptions as predictors of future psychological well-being. Initially, the level of physical well-
being at 6-months was regressed separately on each of the illness perceptions without adjusting for
potential confounder’s (M1). Then the level of physical well-being was included at the second step
(M2). At the third step demographic variables were adjusted for (M3: age, sex, education and work
status). Finally, estimates were adjusted for clinical confounder’s as well as the baseline levels of psycho-
logical well-being (M4: disease status, Disease Activity Score, ESR, disease duration, biologic treatment,
psychological distress, positive outlook and the alternate measure of physical well-being)
Functional limitation Figure 8.6 shows that without adjusting for baseline functional limitation or
possible confounding variables HAQ disability at 6-months was significantly associated with earlier per-
ceptions of identity, consequences, timeline chronic, and perceptions of both personal and treatment
control. However, adjusting for baseline HAQ disability reduced the effect to non-significance for all
illness perceptions. Parameter estimates were stable and remained non-significant with additional levels
of adjustment.
The correlation between between HAQ disability scores at both assessments was extremely high
(r = .91), indicating that 83% of the variance in HAQ disability at follow-up was explained by the
baseline level. As a result any analyses considering HAQ disability controlling would have low power, so
it is not suprising that no significant effect was observed.
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Figure 8.6: Standardised parameter estimates for HAQ disability at 6-months regressed on illness
perceptions with varying levels of adjustment (M1 = unadjusted; M2 = baseline positive outlook;
M3 = + demographics; M4 = + disease status)
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Figure 8.7: Standardised parameter estimates for EQ5D pain question at 6-months regressed on
illness perceptions with varying levels of adjustment (M1 = unadjusted; M2 = baseline positive
outlook; M3 = + demographics; M4 = + disease status)
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Table 8.7: Membership of the non-adapter class as a predictor of 6-month psychological and phys-
ical well-being (multiply imputed data).
Crude Adjusted
b t p 95% CI b t p 95% CI
Distress 0.05 0.36 0.719 -0.20 0.30 0.00 -0.03 0.975 -0.19 0.18
Positive outlook 0.12 0.89 0.376 -0.15 0.40 0.10 0.85 0.398 -0.14 0.34
HAQ disability 0.25 2.01 0.046 0.00 0.49 0.01 0.21 0.838 -0.09 0.11
EQ5D pain 0.10 1.20 0.232 -0.07 0.27 -0.01 -0.15 0.878 -0.16 0.14
Pain The illness perceptions of identity, consequences, coherence, timeline cyclical and treatment con-
trol were associated with pain at 6-months in the unadjusted models (Figure 8.7). Controlling for pain
at baseline the effects were attenuated but remained significant for all except timeline cyclical. Further
controlling for demographic variables, only coherence was non-significant. However, controlling for clin-
ical characteristics and baseline psychological status the effects of identity, consequences and treatment
control were reduced to non-significance. Further analysis indicated that the reduction in the effect was
mainly accounted for by the inclusion of HAQ disability.
8.3.3.4 Distinct patterns of illness perceptions as predictors of future psychological and physical
well-being
Membership of the non-adapter class derived from the 2-class latent profile analysis was entered into
separate regression models as predictors of future psychological and physical well-being (Table 8.7).
Initially the class indicator variable was entered into a crude model that incorporated no other variables.
The adjusted model included the variables included in model 4 of the above models, including the
baseline status on the outcome variable as well as demographic and clinical variables.
In the crude analysis membership of the class with higher perceptions of consequences, chronicity
and coherence was significantly related only to HAQ disability 6-months later, but not distress, posi-
tive outlook or pain. The effect was relatively small, relating to an increase of .25 HAQ units for this
class. Following adjustment for potential confounding variable none of the associations between class
membership and well-being at 6-months was significant.
No substantive difference was observed in comparison to the complete case analysis (see Appendix
E) other than the crude association between membership of the non-adapter class and higher HAQ
disability being reduced to non-significance as a result of the reduced power (p = .086)
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8.4 Discussion
The aim of this chapter was to examine the role of illness perceptions in the relationship between disease
and psychological well-being in RA. Perceptions concerning the attribution of symptoms to the condition,
their illness identity, and the perceived personal consequences of the condition were related to changes
in psychological distress after controlling for demographic and clinical characteristics. Furthermore,
there was some indication that the reported level of understanding of their condition, coherence, was
related to future positive outlook.
Two distinct patterns of illness perceptions were observed. These appeared to be differentiated by
disease duration and activity. Specifically individuals with longer disease duration and lower physiolog-
ical markers of inflammation tended to have higher perceptions of the chronicity of their condition and
consequences of the condition. These individuals perhaps have more realistic representations, which is
further supported by the concurrent higher reports of the perceived understanding of their condition.
This is the first attempt to identify distinct patterns of illness perceptions in RA. Two studies in other
chronic physical conditions have identified patterns that have been termed ‘adapters’ and ‘non-adapters’
using cluster analytic methods (Hobro et al., 2004; Miglioretti et al., 2008). The same labels were used
for the 2-classes derived in this chapter. Unlike the two previous studies no association was observed
between the clusters and psychological well-being. It is likely that, along with psychological distress,
illness perceptions change rapidly early in the course of the disease and distinct patterns at that stage in
the course of RA may therefore differ from the patterns identified here. Furthermore, clusters identified
at such a time may have better predictive validity. Unfortunately this study has not been able to address
this issue.
The findings of the study regarding illness perceptions corroborate those of previous cross-sectional
studies in RA, supporting the utility of the SRM in rheumatology research. In particular, the illness per-
ceptions of identity, consequences and controllability were found to be related to concurrent levels of
distress and disability (H. Murphy et al., 1999; Carlisle et al., 2005; Groarke et al., 2005; Graves et al.,
2009). However, there were some notable differences regarding coping. This study observed no correla-
tion between coping with illness perceptions or distress although such associations have previously been
reported (Uhlig et al., 2000; Treharne et al., 2007; Evers et al., 1997; G. K. Brown, Nicassio, & Wallston,
1989; Groarke et al., 2005). Moreover, Carlisle et al. (2005) observed a ‘mediational’ role of avoidant
coping on the effects of identity and consequences on both psychological distress and disability. Ignoring
that the study was cross-sectional and a mediational conclusion is somewhat tenuous, the present study
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observed no association between coping with either illness perceptions or distress so evidence for such a
relationship is lacking. Differences in the findings reported in this chapter and those of previous studies
may stem from the tools used to assess coping. The analysis in this chapter used the Brief Cope (Carver,
1997), which was not used by other studies. The Brief Cope does not assess of avoidant coping, which
has been indicated by two of the previous studies as being related to worse psychological well-being
both cross-sectionally and longitudinally (Carlisle et al., 2005; Evers et al., 1997). Furthermore, in line
with the conclusions of a recent systematic review of coping, it may be that flexibility in the selection of
appropriate coping strategies rather the tendency to use particular strategies is important (Vriezekolk et
al., 2011).
Previous studies examining longitudinal effects of illness perceptions on psychological well-being
have been limited by small sample sizes. This is further compounded by the reduced statistical power
resulting from the strong autoregressive effect of well-being at one time point on the next. This study
has used a larger sample size, and has used statistical techniques to avoid the loss of power as a result
of missing data at follow up. This will have helped to maintain statistical power for the analysis and
explains the commensurate but stronger findings observed for this study. In line with the findings of
Scharloo et al. (1999) and Sharpe et al. (2001) perceptions of identity and consequences were related
to a residualised change in distress. However, Schiaffino and Revenson (1995) observed an interaction
between perceptions of consequences and functional limitation. This was not observed in the current
study. However, a moderating effect was observed for illness coherence and positive outlook.
It is of note, that other studies have also failed to find an association between illness perceptions and
changes in disability (Scharloo et al., 1999; Treharne, 2004). As with this study it appears that the lack
of effect likely stems from the stability of disability assessed by the HAQ in individuals with established
disease. As a result, it is not clear whether illness perceptions are really not related to changes in
functional limitation or whether there simply is not enough heterogeneity in change in HAQ scores over
6-months to be able to tell. Other measures, that are more sensitive to change, may allow for a more
reliable analysis.
To date, only the unpublished work of Treharne (2004) has investigated the role of illness perceptions
on positive psychological well-being. This found no association between perceptions of consequences
and residualised change in life satisfaction, however no other illness perceptions were considered. This
study has revealed the individuals level of understanding to be an independent predictor of future posi-
tive outlook.
The study has several limitations. A major limitation was to not assess causal perceptions. The
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literature revealed that causal perceptions may have had a longitudinal impact on well-being (Scharloo
et al., 1999). However, it was decided that in order to reduce respondent burden the already long
illness perceptions questionnaire needed to be shortened, and it was the 18-item cause sub-scale that
was excluded. It is unfortunate but ultimately unavoidable that in trying to balance the detail and
breadth of information collected with the burden on the respondent that some important data may not
be collected. Although there exists a brief eight-item (as opposed to 64-item) version of the illness
perception questionnaire (Broadbent, Petrie, Main, & Weinman, 2006) it is likely to suffer from reduced
reliability as only single items are used to assess each illness perception.
A further limitation of this study in common with the wider research in this area is the measurement
of illness-identity. Illness-identity refers to the label given to the condition and the attribution of specific
somatic symptoms to the condition. This is assessed by a count of the number of symptoms experienced
and the number attributed to the condition. In practice, however, whether these symptoms can real-
istically be attributed to the condition is ignored. In section 8.2.2.1 it was noted that these symptoms
appeared to be multi-dimensional. The comparison of RA to non-RA symptoms as a predictor of psy-
chological and physical well-being could be assessed. Furthermore other measures such as the ratio of
all symptoms experienced to those attributed to their RA could also be used. A detailed examination of
illness identity was beyond the scope of the current chapter but should be the focus of future research.
Some concern must be given to the DAPOS. This is a relatively new measure and more standard
assessments would have provided findings that have greater generalisibility. As has already been stated
the need to limit the burden on respondents sometimes means the brevity of the assessment tool on
balance is more important. The DAPOS as an eleven-item instrument was selected on this basis. Corre-
lations between distress with both pain and functional limitation were lower than expected. It may be
that by by removing items that related to pain as well as distress an important component of distress
has been removed. Furthermore, with regard to the DAPOS positive outlook scale, the extent to which
scores on the scale reflect current levels of positive outlook or dispositional optimism is not clear. The
authors of the scale state that they believe it to measure positive affect (Pincus et al., 2004), suggesting
that they believe the tool to measure a state based component. However, that the label of the sub-scale is
’positive outlook’ surely suggests that there is some overlap with trait optimism. Despite these concerns
the findings of this study emphasise the need for considering positive psychological well-being as well as
psychological distress, that has been promoted elsewhere (Seligman & Csikszentmihalyi, 2000). It seems
that although the two are closely related they function independently and have different determinants
and longitudinal effects.
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A further important point for discussion concerning the DAPOS is the relatively low correlations
observed for psychological distress with pain and functional limitation. The previous chapter highlighted
the strength of these associations. However in the current analyses the association was very small. The
DAPOS was designed to measure, without criterion contamination, depression and anxiety. This was
achieved by excluding any items from the HADS and BDI that were observed to cross-load onto a (forced)
somatic factor. It seems that this approach may have excluded important features of distress. Depression
and anxiety share many symptoms with rheumatoid arthritis and the consideration of whether these
symptoms are attributable to the physical or psychological condition may not be important.
The findings of the current study indicate that interventions to change illness perceptions are unlikely
to have an effect on individuals with established disease. Although illness perceptions were observed to
be related to psychological well-being it would seem that higher perceptions of consequences are likely
to correspond with a more realistic view of RA. There may be some support for educational interventions
to improve understanding of the condition, since this may improve positive well-being. Previous studies
in other conditions have shown interventions targeted at illness perceptions following a myocardial
infarction have resulted in improvements in psychological and physical well-being (Petrie et al., 1996).
For the most likely chance of success it seems appropriate to recommend intervention research be guided
towards study of individuals with recent onset RA.
To summarise, illness perceptions play an important, albeit small, role in the relationship between
disease and psychological well-being over time in patients with established disease. Cross-sectional
associations are stronger suggesting considerable interplay between the constructs over shorter periods
of time. Coping on the other hand was not found to be related to illness perceptions or psychological
well-being.
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General discussion
9.1 Overview of the discussion
This chapter summarizes the findings of the four empirical chapters concerning the measurement of and
changes in psychological distress in the ERAS cohort, and the findings of the longitudinal association
between illness perceptions and coping in a separate cohort. The empirical findings are discussed in
the context of the original aims and objectives described in section 3.5.3. This is followed by a general
discussion of the strengths and limitations of the methods and data used in this dissertation, in relation
to the use of observational data (to draw causal conclusions) and the latent variable approach to longi-
tudinal modelling. Finally the implications of the findings of this dissertation with regard to the clinical
management of individuals with RA and future research concerning RA, and more broadly studies of
well-being in chronic physical illness, are considered.
9.2 Overview of the aims and objectives
The systematic review, Chapter 3, identified a considerable body of literature concerning the study of
longitudinal changes in psychological well-being over the course of the disease in individuals with RA.
Although the body of literature was large, much of the research was based on small to medium sized
samples. Several larger studies were conducted with follow-up over several years (e.g. those within
the EURIDISS consortium) but often did not apply advanced longitudinal data analysis methods that
are currently available. For example, analytical methods sometimes made use of data collected at two
time points where more were available. The main limitation, however, was the lack of large longitudinal
studies following individuals from soon after the onset of the disease, and furthermore, using appropriate
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analytical methods to examine the heterogeneity of changes in psychological well-being at the individual
level.
A theoretical model was presented in Figure 3.3 that drew upon the frameworks concerning the
disablement process in RA (Verbrugge & Jette, 1994; Escalante & del Rincon, 2002), the relationship
between psychological distress and physical illness (Katon, 2003), and the role of psychosocial factors
in the pathway between disease to psychological and physical outcomes (Leventhal et al., 1980, 1984).
This model described the relationship between psychological and physical well-being as a complex dy-
namic system. Cross-sectionally, strong associations were indicated between psychological distress and
somatic symptoms. These were expected to persist longitudinally. The model indicated distress as being
influenced by somatic symptoms, which mediated the impact of the underlying disease activity. It was
expected that distress and somatic symptoms at an earlier time would have direct effects on future psy-
chological well-being, also these longitudinal effects were expected be mediated or moderated by other
factors. For example, it was expected that coping strategies would moderate these effects and illness
cognitions would mediate them.
Based on the systematic review and the theoretical model three objectives were presented: (i) To
describe patterns of change in psychological well-being during the RA disease course; (ii) to quantify the
association between psychological well-being and somatic symptoms; and (iii) to investigate the impact
of illness cognitions and coping on psychological well-being. The remainder of this section describes the
empirical findings of this dissertation and discusses the extent to which each of these objectives has been
met. Prior to addressing each objective the findings of Chapter 5 concerning the the measurement of
psychological distress in ERAS cohort is described.
9.2.1 The measurement of psychological distress in RA
The first empirical chapter, Chapter 5, did not directly address the main aims of the dissertation but
provided a detailed examination of the assessment of psychological distress using the Hospital Anxiety
and Depression Scale (HADS; Zigmond & Snaith, 1983). Evidence for a bifactor structure, consisting of a
general psychological distress factor that explained 69% of the common variance in item responses was
found. This factor structure was replicated in samples of patients with end stage renal disease and cancer.
Furthermore, the factor structure of the HADS in RA was found to be non-invariant over time. Although
only sum-scores of the individual scales were available for most individuals in the ERAS cohort, the
findings of this chapter suggested that the use of the HADS total score as an indicator of general distress
that incorporated some of the components specific to depression (anhedonia) and anxiety (autonomic
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arousal) was appropriate. This supported the earlier findings of studies using IRT methods (e.g. Pallant
& Tennant, 2007) that had recommended the HADS total score as a measure of general psychological
distress, since the general factor saturation of the test was high.
The findings of a bifactor structure is at odds with the conclusions of the most recent review of
the construct validity of the HADS, which described a factor structure consisting of three lower order
factors as providing the most acceptable fit (Martin, 2005). However, to my knowledge, this is the
first study to consider a bifactor structure in relation to the HADS. The bifactor structure provides a
more acceptable empirical explanation of the item covariance structure than previous research and may
be viewed as providing a conceptual interpretation that reconciles the ambiguous findings of previous
studies using different methods. Furthermore, the observation of a bifactor structure is commensurate
with current thinking on the factorial structure of psychological distress and mood disorders in general
(T. A. Brown et al., 1998; Krueger & Finger, 2001; Krueger et al., 2005; Watson, 2005; Mineka et al.,
1998) and findings of psychometric studies of other measures of psychological distress (Simms et al.,
2008; Crawford & Henry, 2003; Steer et al., 1999).
Pincus et al. (1996) raised concerns with the potential biasing influence of somatic symptoms of RA
on HADS items. Although evidence for item bias was observed for item D8 “I feel slowed down” as a
function of disease activity and for item D14 “I can enjoy a good book or radio or TV programme” by
gender the impact of this bias was found to have little effect on the estimated association with clinical
and demographic factors.
Caution must be taken when attempting to separate out the influence of somatic symptoms on the
measurement of psychological distress. The experience of somatic symptoms due to both physical and
psychological influences are perhaps inextricably linked. Attempts to remove the influence of somatic
symptoms from the assessment of psychological distress may result in excluding a central component
of distress—that is to say ‘throwing the baby out with the bathwater’ (C. A. Smith, Wallston, & Dwyer,
1995, p.64). For example, the DAPOS (Pincus et al., 2004) used in Chapter 8 was designed as a measure
of distress that excluded symptoms related to pain. However, this was perhaps done with too much
zeal since the resulting estimates of distress and pain observed in the chapter were lower than expected
leading to concern that an important component of the strong psychosomatic impact of RA was being
missed by the measure.
It is perhaps more appropriate to focus attention on tools that allow for the discrimination of the
different features of psychological distress. For example, in a study of the factor structure of the BDI-
II in patients with renal disease Chilcot et al. (2011, see Appendix A) it was shown that it is possible
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to separate out the cognitive and somatic symptoms of depression from a general distress factor. This
method has the advantage of retaining more information while also allowing for the examination of the
influences of separate features of distress on future disease outcomes, such as mortality (Roest et al.,
2011).
9.2.2 Changes in psychological well-being during the RA disease course
With respect to the first objective. The pooled analysis of changes in distress in early RA samples reported
by published studies suggested a decline in distress early in the course of the disease (see section 3.3).
The findings from Chapter 6 supported these findings. At the group level distress did reduce over the first
few years after disease onset and remained stable thereafter. Specifically, latent curve modelling (LCM)
indicated that levels of distress reduced during the early course of the disease, remaining stable after
around 2-years. Further analysis examining the heterogeneity in changes in distress over time, using a
grwoth mixture modelling approach (GMM), revealed four distinct distress trajectories: resilient, chronic
distress, delayed distress and recovered. Interestingly, changes in distress were related to self-reported
somatic symptoms but not serological markers of disease activity. This was the first study to apply this
technique in an RA cohort, and complimented recent studies in cardiovascular disease and breast cancer
(Helgeson et al., 2004; Lam et al., 2009; K. I. Kaptein et al., 2006). This supports the generalisability of
the results to other rheumatological conditions and to chronic physical illnesses in general (Stanton et
al., 2007).
These findings support the assertion of Bonanno (2005), that greater changes are expected early
on in the disease course. This is commensurate with the view that chronic physical illnesses can be
defined as a stressful life-event that is characterised by recurrent stressful situations associated with the
symptoms of the condition (De Ridder et al., 1998; Moos & Schaeffer, 1984; Zautra, 1996).
It is presumed that the changes in psychological distress observed reflect two processes. Firstly, that
individuals’ psychological adjustment to living with a chronic physical illness and the day to day man-
agement of their symptoms (Stanton et al., 2007); and secondly, the improved control of symptoms as
a direct result of reduced disease activity through the use of disease modifying therapy. No direct causal
inferences can be made with regard to these two processes based on the findings reported in this disser-
tation. However, there was clear evidence that distress was strongly related to the experience of somatic
symptoms, including pain and functional limitation, but not to physiological markers of inflammation
(ESR & CRP) or the physicians count of the number of swollen joints (Section 6.3.4). This suggests that
psychological factors, such as illness perceptions, play an important mediating role. In addition, the
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different patterns of change exhibited by the four groups derived from the GMM analysis were related
to changes in somatic symptoms, which supports the second postulation since disease modifying therapy
was typically initiated between the baseline and 1-year assessments.
The methods used in Chapter 6 assumes that changes in distress follow a smooth trajectory. This
conflicts with the understanding that RA is a condition with a flaring-remitting course. As a result the
residuals from the distress trajectories reflect not only random variation in levels of distress, but also
systematic variation in distress as a result of disease flares. This was supported by the improved fit of
models allowing correlated disturbances across time points. The issues of systematic variation from the
trajectories was addressed more directly in Chapter 7.
9.2.3 Association between psychological distress and somatic symptoms
Chapter 7 extended the findings of the preceding chapter to consider whether changes in distress were
related to changes in physical well-being. Analysis, using autoregressive latent trajectory (ALT) models
to jointly model changes in physical function and pain with changes in psychological distress revealed
strong cross-sectional and longitudinal associations. It would appear that changes in psychological dis-
tress are largely related to the deterioration in function associated with the progressive nature of the
condition. To my knowledge this is the first study to employ this type of strategy to examine the link
between distress and somatic symptoms in any chronic physical illness.
These findings extend those of previous studies using autoregressive models by showing the impor-
tance of considering the underlying trajectories of distress, pain and function that may be related to
disease course. Previous research reported only relatively weak longitudinal relations between distress
and somatic symptoms (G. K. Brown, 1990; Smedstad et al., 1997), despite the expected association
(Escalante & del Rincon, 2002; Katon, 2003; Leventhal et al., 1984). Correlations between changes in
distress with changes in symptoms of pain and functional limitation were high (Section 7.3.3). Thus, it
would appear that a trait rather than state approach that takes account of the underlying progression of
the disease is important.
Expanding on this last point it is important to remember that, as well as accounting for the under-
lying trajectory of disease progression ALT models allow modelling of the causal relations between the
residuals of the latent trajectories (Bollen & Curran, 2004). This enables the model to capture the fluctu-
ations in somatic symptoms and thus distress due to disease flares. Strong cross-sectional links between
the residuals to the trajectory were observed, as would be expected, however cross-lagged causal effects
between distress with pain and function were not. This is perhaps not surprising since observations were
221
Chapter 9. General discussion
at yearly intervals. The application of this method to studies using prospective daily diary methods may
be useful (Strand et al., 2006).
9.2.4 Impact of illness cognitions and coping on psychological well-being
The fourth empirical chapter presented a study of the role of illness related cognitions and coping in
changes in psychological and physical well-being over time. Data were from a smaller sample of 227
individuals with RA attending outpatient clinics at six hospitals in Hertfordshire, and were collected
prospectively over 6-months. Coping was not found to be related to illness perceptions or psychological
or physical well-being. However, analysis revealed two groupings of patients with similar patterns of
illness related cognitions—that is closer to the concept of an “illness representation”—that were labelled
adapters and non-adapters in line with previous research (Hobro et al., 2004). The individual illness
perceptions of identity (the symptoms attributed to the condition) and consequences (the perceived
seriousness of the condition) were related to changes in distress, whereas coherence (the reported level
of understanding of the condition) was related to changes in positive well-being. No moderating factors
were observed.
Theoretically illness perceptions are mediators in the pathway from the stressors that arise due to
the impairments and limitations caused by condition to the psychological well-being. To a certain extent
this was supported by the data although mediation was not explicitly considered in the models.
This third objective was only partially met by the findings of the thesis. This was due to the limita-
tions of the study presented in Chapter 8 and also more widely to the robustness of the theory under-
pinning the impact of illness cognitions and coping on psychological well-being. The dynamic process
whereby psychosocial factors impact on psychological well-being was not adequately captured by the
longitudinal study which only included two time-points and involved patients with wide variation in
disease duration. Although a third time point was collected for those with recent RA onset the numbers
were too few for any sensible analysis. As was previously stated the original aims was to incorporate the
assessments into the data collected by the Early RA Network. Had this been successful the information
gleaned may have been useful in driving forward understanding in this area. Nevertheless the findings of
this thesis have provided some useful information regarding the role of illness perceptions, particularly
their clustering in certain groups. With respect to coping, I will again cite the recent review of coping in
RA Vriezekolk et al. (2011, .6): the “flexible use of a variety of coping strategies across situations that
may be beneficial for adjustment to a chronic disease, perhaps especially in RA with its fluctuating and
often unpredictable disease course”.
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9.3 Strengths and limitations
The extent to which the studies presented in this dissertation meet the overall aims and objectives
has been discussed. It is now important to note some of the main strengths and limitations of these
studies. The main strength of this study is the use of sophisticated analytical framework applied to a
large prospective observational study of individuals with RA recruited at the time of diagnosis (ERAS).
This has enabled research undertaken within these studies to make a major contribution to the large
body of research concerning this topic that should drive forward research in this field. However, despite
the impact of the findings presented in this dissertation on research in this area it is important to note
some of the limitations with regard to observational studies in general, and specifically the ERAS cohort.
Furthermore, limitations of the latent variable modelling approach for the analysis of longitudinal data
are discussed.
9.3.1 Strengths and limitations of observational studies
Causal conclusions may be most strongly drawn from experimental studies (Shadish, Cook, & Campbell,
2002). With observational studies, the likelihood of confounding effects due to unmeasured variables
is high. Nevertheless, the Oxford Centre for Evidence Based Medicine still ranks the evidence from
prospective observational studies higher than those from randomised controlled trials in terms of prog-
nostic models. In the presence of natural experiments within observation studies, sophisticated matching
and instrumentation techniques may be employed to statistically control for the effects of residual con-
founding (Morgan & Winship, 2007). In this study no such statistical matching methods were employed.
As such causal conclusions can only be tentatively extrapolated from the findings reported here. The dan-
ger of drawing causal conclusions from observational studies alone has been highlighted in the research
concerning the the effects of hormone replacement therapy on coronary heart disease risk (Hernán et
al., 2008).
As was highlighted in the discussion of chapter 7, the causal association between psychological and
physical well-being is complex. The relationship is almost certainly bidirectional, with psychological
status as likely to influence somatic symptoms as the reverse (Katon, 2003). In RA we can be fairly
confident that the introduction of disease modifying treatment that reduces somatic symptoms early in
the course of the disease accounts for a large portion of the change early in psychological distress at
that time.1 The use of sophisticated matching techniques to more confidently make causal assertions are
1Findings from experimental studies support this bidirectional association. For example, psychological treatments have
been found to impact on somatic symptoms (Zautra et al., 2007; Dixon et al., 2007) and disease-modifying therapies have
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moot as the results would neither confirm nor falsify the expected bidirectional relationship—since it is
assumed to be bidirectional. They would however indicate whether the strength of the direction was
larger in one way or the other, highlighting where intervention would be mot likely to have an effect on
both.
A further limitation of virtually all observational studies, particularly those with long-follow up is
missing data. Although missing data was common in the ERAS study, particularly for the HADS, the
nature of follow up in ERAS were data was collected as part of annual review which formed part of
the standard treatment meant that loss to follow-up was small. The use of full-information maximum
likelihood and multiple imputation allowed for all available data to be included in the data under the
MAR assumption. NMAR sensitivity analysis in Chapter 6 did not reveal the dropout mechanism to be
non-ignorable providing support for the validity of the results in this dissertation.
9.3.1.1 Strengths and limitations of ERAS
The strength of the ERAS cohort include the large sample size recruited from multiple centres, with long
and frequent follow-up in a naturalistic setting and low levels of dropout means that confidence in the
ERAS data and its external validity is high—at least to other RA patients in the UK. Longitudinal analyses
of this traditional ‘pre-biologic’ cohort provide valuable information on natural disease course, outcomes
and prognostic factors in RA. There are however a number of important limitations of the ERAS cohort
that should be noted.
There is a possibility of bias in this type of hospital-based observational study due to the failure to
include patients who go into remission early and therefore do not attend hospital (i.e. left censoring).
As such the ERAS cohort must be seen as a cohort of individuals with RA that is more established and
severe than individuals with more generalised forms of inflammatory arthritis recruited to primary-care
or community based studies. These studies, most notably the Norfolk Arthritis Register (Symmons et al.,
1994), includes a large number of individuals with a milder undifferentiated condition, many of whom
progress to a diagnosis of RA. However, there a number of logistical limitations of such studies. The
main limitation is the difficulty with which diagnosis of RA can be confirmed in population or primary
care based cohorts.
It is important to remember that the problem of confirming diagnosis is present in ERAS as well,
although to a lesser extent. Nevertheless, all individuals do undoubtedly have some form of inflamma-
tory arthritis and since the focus is on the relationship between psychological and physical well-being
been shown to impact of psychological well-being (NICE, 2009b).
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that relates to the symptoms experienced by all with such conditions, the effect on the overall findings
is likely to be small.
A further limitation of primary care based studies, and a strength of ERAS, is considerable attention
devoted to ensuring the comparability of assessments across centres. Ensuring that assessments are
performed uniformly across centres reduces the impact of centre effects on model estimates. In studies
with larger numbers of centres this becomes more difficult, although to some extent the larger number
of centres offsets the bias that is introduced. In this dissertation little attention was paid to the nested
nature of the data within different centres—both the ERAS data and the cohort in Chapter 8. This is
particularly an issue for the analyses in Chapters 6 and 7 since only participants from three centres were
used and over half attended the Winchester centre. However, the characteristics of patients included in
the analysed sample were on the whole very similar to those in the full ERAS sample.
Despite these limitations, the ERAS cohort along with other early RA cohorts have provided much
useful information with regard to the natural but treated history of the disease (Young et al., 2011;
Young, 2009). Comparisons across cohorts will allow for the validation of findings, but also the assess-
ment of age, period and cohort effects.
9.3.2 Strengths and limitations of the latent variable modeling approach
Chapter 4 provided an overview of the latent variable modelling framework used in this dissertation,
with particular reference to the application of latent variable modelling approaches to the analysis of
longitudinal data. There has been considerable debate concerning the utility of latent variable mod-
elling, for cross-sectional as well as longitudinal data. The main criticism has been the usefulness of the
structural model, the path analytic component of a latent variable model, as a mathematical tool for
drawing causal conclusions from observational data, under certain theoretical assumptions (c.f. Freed-
man, 1987; Pearl, 2009). This is an important issue with latent variable modelling in general, however
the main concern here is not of the causal interpretation of the models but rather the usefulness of the
longitudinal models applied to describe longitudinal processes.
Some specific concerns have been raised regarding the application of latent variable modelling to
describe longitudinal trajectories. Specifically, Mulaik (2009, p.281) states that latent variable models
attempt to model longitudinal data ‘in ways where the mathematics seems to outrun the science of
what is represented by these models. To what extent do these models correspond to reality?’ The
issue is that as increasingly advanced statistical methods are developed, and their application becomes
easier through wider access to software, it becomes increasingly easy to generate models that have little
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theoretical grounding and resultantly provide empirical estimates that are of no real value—sometimes
referred to as the ‘rubbish-in rubbish-out’ principle. Voelkle (2008) provides a cautionary example of
this principle in the context of ALT models. In a simulation study it was shown that misspecification of
the trajectory component of the model resulted in extreme bias to the estimates of the autoregressive
part of the model. To avoid such a problem great care was taken in Chapter 7 to ensure that models
were correctly specified.
Further criticism of the latent variable modelling approach, this time in relation to GMM, has been
provided by Bauer and Curran (2003). They suggest that the presence of non-normal data may result
in the multiple trajectory classes appearing optimal even when only one group exists in the popula-
tion. Bauer (2007) went on to describe several other problems with GMM that result from its apparent
sensitivity to various assumptions that are made. I would agree with the several rejoinders written in
respect to the first paper (Cudeck & Henly, 2003; B. Muthén, 2003; Rindskopf, 2003), which are best
summarised by Cudeck and Henly (2003, p.378): “A realistic perspective is that although a healthy skep-
ticism to complex statistical results is appropriate, there are no true models to discover . . . The purpose
of a mathematical model is to summarize data, to formalize the dynamics of a behavioral process, and to
make predictions. All of this is scientifically valuable and can be accomplished with a carefully developed
model, even though the model is false”.
There is always the concern that the complexity of the statistical techniques applied, and a failure
to understand their assumptions, may result in the development of models with no real scientific value.
The diligent researcher must ensure the validity of their findings not simply by confirming that findings
hold across different situations (e.g. patient groups, research designs etc.) but also that models gener-
ated provide realistic results from which the findings might generalise to the real world. As has been
previously noted, the novel findings presented in this dissertation should be interpreted in a tentative
manner since future research is needed to confirm them.
Also in relation to model complexity, the principle of Occam’s razor lex parsimoniae suggests selecting
the the simplest model when a number of models fit the data equally well (i.e. the one that makes the
least assumptions). Information criterion such as the AIC and BIC penalise for model complexity and so
it is this principle that they embrace—and to some extent so does the RMSEA (Mulaik, 2009). As long
as, theoretically grounded, competing models are compared, with assumptions that are made explicit it
should not be too difficult to examine there predictive ability. Furthermore, simpler models are more
generalisable than more complex ones, and thus more easily falsifiable (Popper, 2002).
In conclusion, the potential risks of misinterpreting the findings of complex latent variable mod-
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elling approaches to longitudinal data are clearly outweighed by the potential benefits of extending the
understanding of the complex processes they seek to describe. As is always the case, it is essential to
ensure that model estimates are reasonable and that sensitivity analysis is performed to ensure models
developed are robust.
9.4 Clinical implications
From the perspective of the rheumatologist, who is usually the health professional with the ultimate
responsibility for the clinical management of an individual with RA, the findings of this dissertation have
some important implications. The strong association between psychological distress and the somatic
symptoms of the condition is congruent with current guideline for treating to a low disease activity
target (Kiely et al., 2009; Smolen et al., 2010). Achieving low disease activity is likely to have an indirect
effect on psychological well-being and more generally quality of life. Furthermore, since psychological
well-being is more likely to be amenable to change early in the course of the disease it is individuals
in this group that should be of most concern to health professionals. Again this is in-line with current
treatment guidelines in RA that emphasise the importance of timely treatment (NICE, 2009b).
Treatment with effective but expensive biologic therapies is reserved for those with established active
disease that have failed to respond adequately to conventional disease modifying drugs (NICE, 2009b).
Treatment decision are largely based on disease activity, as indicated by the DAS or DAS28, and it is
therefore important to understand the relationship between DAS and inflammatory disease activity, as
well as potential effects of confounding factors. DAS is based on a physiological marker of inflammation
(either ESR or CRP); physician assessed tenderness and swelling of joints mainly of the hands, wrists
and feet; and a patient reported global disease activity VAS. It has, however, been noted that the largest
contribution to the overall score is based on the tender joint count a marker of pain (Fransen et al.,
2004). Although joint tenderness and self-reported disease activity increase alongside inflammatory
disease activity, they may also be increased by changes in pain processing such as central sensitisation, or
by comorbidities. Patients without RA who have fibromyalgia or central sensitisation report high disease
activity and joint tenderness, generating high DAS28 scores despite low swollen joint count and acute
phase response, scores that may be comparable to those of people with active RA (Leeb, Andel, Sautner,
Nothnagl, & Rintelen, 2004). Evidence of central sensitisation and joint inflammation may coincide,
thereby confounding interpretation of DAS28 in people with RA (Leffler, Kosek, Lerndal, Nordmark, &
Hansson, 2002). People with concurrent RA and fibromyalgia report increased pain (Dhir, Lawrence,
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Aggarwal, & Misra, 2009) and show higher DAS28 scores (Ranzolin et al., 2009) than those with RA
alone, perhaps indicating that central sensitisation or painful co-morbidity influences the scoring.
Assessment of psychological distress in routinely during annual review would provide greater infor-
mation with regard to the factors modulating pain. For those with persistently high levels of distress
who report high disease activity and joint tenderness, but low swollen joint count and acute phase
response, other measures may be considered prior to, or instead of, disease modifying and biologic ther-
apies. These include psychological interventions as well as pain control and remedial therapies. Such
measures could reduce problems associated with drug safety and DMARD monitoring, and for biolog-
ics, costs. Intervention targeted at psychological well-being may also be effective at improving somatic
symptoms, which are the main concern for the patient (Heiberg & Kvien, 2002; Hewlett et al., 2005).
Psychosocial interventions—including cognitive-behavioural, patient education and self-management—
have a twofold role. Firstly, interventions that improve psychological functioning are likely to indirectly
improve somatic symptoms and physical functioning (Katon, 2003; Leventhal et al., 1992). Secondly,
psychosocial interventions that, for example, improve a patients’ understanding of their condition and
for greater self-management may reduce the need for medication, and if not, is likely to improve ac-
ceptability of and adherence to treatment regimes, thereby indirectly improving disease activity and
thus somatic symptoms (Petrie et al., 1996; DiMatteo et al., 2000). Furthermore, in RA cognitive be-
havioural interventions have been indicated as having physiological effects, reducing levels of cortisol or
IL-6 (Zautra et al., 2008; de Brouwer, 2011), and meta-analyses have shown that combined multimodal
cognitive with exercise therapy may be more effective than either alone (Dixon et al., 2007).
A key finding of Chapter 6 was that the majority of individuals were resilient to the effects of their
RA, experiencing little or no disruption in psychological well-being following disease onset. A smaller
number experienced long-term adjustment problems. It may be possible to select patients in need of
psychosocial interventions in addition to standard disease-modifying treatments. Examples include
those with persistently high levels of distress, especially those where the response following initiation of
disease-modifying therapy is limited. The increased use of psychological measures, such as the HADS,
that are not currently used routinely may help to tailor patient care. Broader measures of health related
quality of life, such as the SF36, may be preferable since they incorporate assessments of psychological
distress, physical function, fatigue and pain—the psychological and physical dimensions most affected
by RA (Hewlett et al., 2005)—and other factors such as illness cognitions and social support. Evers,
Kraaimaat, Riel, and Jong (2002) provide an example of an effective tailored treatment approach. Pa-
tients received cognitive-behavioural therapy focusing on fatigue, negative mood, social relationships, or
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pain and functional disability depending on individual psychosocial risk profiles, based on assessments
of psychological distress, illness cognitions of helplessness and acceptance, passive coping and social
functioning.
Increasing availability of biologic therapies is likely to lead to increasing rates of remission in RA
and thus reducing psychological distress associated with the pain, disability and deformity caused by the
disease. However, improving access to psychological therapies remains a concern to health providers
(National Audit Office, 2009; NICE, 2009a). An evidence-based approach suggests that failing to incor-
porate assessment and assistance with psychological needs of the patient is likely to reduce the effec-
tiveness of medicines that have proved so efficacious in clinical trials.
9.5 Directions for future research
The most salient finding of the dissertation for future research is the importance of using large cohorts
of patients recruited as close to symptom onset as possible to examine how RA progresses with time.
Although several large RA inception cohorts exist few collect even basic information of psychological
well-being (Young, 2009). At the very least assessment of psychological distress, or more broadly health
related quality of life should be undertaken. Although, ideally other psychosocial factors should also be
recorded, including social support and illness perceptions.
The findings of much of the current literature concerning psychosocial factors is limited by the ev-
idence being based on small samples, generally with wide variation in disease duration. Furthermore,
much of the research into psychosocial factor in RA has considered risk factors for poor long-term phys-
ical and psychological well-being. Research into resilience factors, that is factors associated with suc-
cessful adaption, is more limited. The resilience approach focuses on identifying characteristics of the
person that permit successful adaptation. Since such a large proportion of those with RA do not expe-
rience long-term adjustment problems, greater focus on resilience factors is clearly needed. Research in
other areas has found factors such as self-esteem, self-efficacy, social support, extroversion, and a sense
of purpose (Stanton et al., 2007; Evers, Zautra, & K., 2011). Furthermore, it is also important that
risk and resilience factors are considered in combination rather than in isolation, as has previously been
typical, since both have separate but related influences on adaptive capacity (Evers et al., 2011).
As well as clinical cohorts there is an increasing need to consider RA patients in the wider context
of chronic physical illness in general. As larger population studies are initiated and linkage to hospital
records becomes more widely available it becomes more feasible to perform nested case-control studies
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to compare groups of individuals with different conditions. This will allow for the assessment of whether
similar distress trajectories exist in these studies and, furthermore, will allow for the examination of the
influence of earlier psychological well-being on the development and progression of chronic physical
illnesses. Birth cohorts have shown the importance of life-course influences on later health (Barker,
Osmond, Golding, Kuh, & Wadsworth, 1989; Kuh & Ben-Shlomo, 2004). As such studies mature it
becomes possible to examine such effects on specific diseases like RA.
9.6 Final conclusions
RA is a chronic progressive condition associated with an insidious decline in function. The somatic
symptoms of the condition, such as pain and fatigue, are associated with increased levels of psychological
distress. Across the course of the disease psychological well-being is relatively stable for the population.
However, it does appear to be increased early in the course of the disease, prior to the initiation of disease
modifying therapy. Early identification and treatment of RA is imperative not only to slow or even halt
the progression of the disease but also so that the individual may maintain their health related quality
of life. This early treatment is currently focused on pharmaceutical interventions. However, the further
inclusion of a psychosomatic approach based on the biopsychosocial model (Engel, 1980) involving the
skills of a wide range of health professional, such as nurses, physiotherapists, occupational therapists
and psychologists is likely to improve outcomes for the patient.
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